# Public copy: quotes from papers without an open licence are withheld (see notes).
excerpts:
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - pots
  papers: 168
  evidence:
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: The cause of POTS is complex but includes partial autonomic neuropathy, hypovolemia, hyperadrenergic
      states (elevated plasma norepinephrine levels), and impaired venous return [5].
    note: 'Found by winnow, kev and lev in p028, p029, p015. Claude judged: supports.'
  - paper: pmid42060631
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Furthermore, the development of primary idiopathic POTS is thought to be related to multiple mechanisms,
      including viral illness (or any condition that activates the innate immune response); peripheral nerve denervation
      with hypersensitivity; α-receptor hypersensitivity; autoantibodies to acetylcholine and β-receptors; central
      hyperadrenergic state; norepinephrine transporter deficiency; reduced baroreceptor gain; idiopathic hypovolemia
      with changes in aldosterone, renin, neuronal nitric oxide synthase, and angiotensin II activities; autoimmune
      reactions; mast cell activation; and decreased heart size and mass [38–51].
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: 'According to current evidence, POTS is a subtype of a cardiovascular autonomic dysregulation, characterized
      by three distinct mechanisms: hypovolemic, hyperadrenergic and neuropathic subtypes [6]. Proposed mechanisms
      include disorders of autonomic cardiovascular regulation, involving both abnormally increased sympathetic
      activity and peripheral sympathetic denervation leading to central hypovolemia.'
    note: 'Found by winnow, kev and lev in p004, p010, p019. Claude judged: supports.'
  - paper: pmid41538594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introdução
    quote: 'São conhecidos três mecanismos fisiopatológicos que podem resultar em fenótipos distintos de POTS: neuropatia
      autonômica parcial, hipovolemia persistente e estado hiperadrenérgico central e que podem coexistir nos pacientes
      portadores de POTS.'
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In a subset of these patients, the main pathophysiological mechanism has been proposed to be primary
      sympathetic activation (hyperadrenergic POTS) [2, 3].
    note: 'Found by winnow, kev and lev in p001, p004, p006. Claude judged: supports.'
  - paper: pmid41314719
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Emerging evidence suggests that trauma-related dysregulation of the autonomic nervous system may manifest
      as POTS, with hypervigilance and hyperadrenergic states proposed as potential mechanisms.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid41163092
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: A number of mechanisms have been described in patients with POTS, including autonomic dysfunction (AD),
      hypovolemia, hyper-adrenergic stimulation, deconditioning, anxiety and hypervigilance [7, 8].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid41103515
    cited: true
    text: full
    license: by
    verdict: supports
    section: Differential diagnosis of OD with PPPD > Hemodynamic orthostatic dizziness > Postural orthostatic tachycardia
      syndrome
    quote: The pathophysiology of POTS is complex and diverse. Potential causes include a partially denervated circulatory
      system, a hyperadrenergic state, hypovolemia, peripheral blood pooling, or prolonged bed rest (15).
    note: 'Found by winnow, kev and lev in p009, p010. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion
    quote: Hypotheses regarding pathophysiology include abnormally increased sympathetic activity, sympathetic denervation
      leading to hypovolemia and reflex tachycardia, and autoimmunity to G-protein coupled receptors (2, 3, 79,
      81, 82).
    note: 'Found by winnow, kev and lev in p026, p024. Claude judged: supports.'
  - paper: pmid40776616
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: However, POTS is a cardiovascular autonomic disorder that differs from VVS. It is caused by a complex
      interaction of cardiac receptor-activating autoantibodies, hyperadrenergic activation, hypovolemia, and partial
      autonomic neuropathy [8,24-26], with impairment of cerebrovascular autoregulation being an important pathogenic
      mechanism.
    note: 'Found by winnow, kev and lev in p028, p030. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The precise pathophysiology of POTS is not fully understood but several factors may contribute, including
      hyperadrenergic stimulation, hypovolemia, peripheral autonomic neuropathy, and autoimmunity.6
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40626134
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Central hypovolemia, peripheral vascular dysfunction, and a hyperadrenergic state may contribute to the
      pathogenesis of POTS.
    note: 'Found by winnow, kev and lev in p003, p001. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Investigations have demonstrated that patients with POTS commonly present orthostatic tachycardia owing
      to SNS hyperactivation [2–4]. These patients typically show elevated SNS activity and diminished parasympathetic
      activity in the evaluation of autonomic function testing, resulting in a substantial increase in HR [7,13].
    note: 'Found by winnow, kev and lev in p004, p005, p028. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: In this study, patients with POTS after HSCT exhibited a significantly greater increase in NE levels
      upon standing, indicating heightened sympathetic activation. NE changes also correlated with changes in HR,
      supporting a central role for adrenergic signaling in post-HSCT POTS.
    note: 'Found by winnow, kev and lev in p004, p032, p033. Claude judged: supports.'
  - paper: pmid40507411
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: 'The consensus meeting of the NIH identified multiple pathophysiological mechanisms leading to orthostatic
      intolerance and POTS [49]: hypovolemia, deconditioning, inflammatory mediators, excessive sympathetic stimulation,
      auto-antibodies, small-fiber neuropathy, and connective tissue laxity.'
    note: 'Found by winnow, kev and lev in p020, p022. Claude judged: supports.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: POTS etiology is heterogeneous. Multiple mechanisms have been considered responsible for the development
      of POTS - peripheral denervation, hyperadrenergic state, hypovolemia, viral illness, mast cell activation,
      and, recently immune dysregulation [5,6].
    note: 'Found by winnow, kev and lev in p034, p005. Claude judged: supports.'
  - paper: pmid40294227
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40294227. Found by winnow, kev and lev in p003, p011, p001. Claude judged: supports.'
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: The increase of catecholamine is one of the main pathogenesis of POTS (Liao et al., 2013).
    note: 'Found by winnow, kev and lev in p007, p020, p006. Claude judged: supports.'
  - paper: pmid39768649
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: 'In the expert consensus on POTS of the NIH, the authors recognized eight possible mechanisms leading
      to POTS [2]: hypovolemia, deconditioning, inflammation such as from mast cell activation syndrome (MCAS),
      excessive central sympathetic activation, auto-antibodies activating cardiac receptors or inhibiting vascular
      receptors, small fiber neuropathy, and hEDS with connective tissue laxity.'
    note: 'Found by winnow, kev and lev in p004, p022, p030. Claude judged: supports.'
  - paper: pmid39582682
    cited: true
    text: full
    license: by
    verdict: supports
    section: Headache disorders in hEDS and HSD > Orthostatic headaches > Postural tachycardia syndrome
    quote: Other possible causes include a hyperadrenergic state, excessive histamine-induced vasodilation possibly
      in context of comorbid mast cell activation syndrome, as well as use of vasoactive drugs (e.g., tricyclic
      antidepressants and opiates) again due to comorbid conditions in hypermobile patients.
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Despite similar clinical characteristics, POTS is likely a heterogeneous group of disorders. These include
      an autoimmune mechanism associated with antibodies to the postsynaptic acetylcholine receptors of the autonomic
      nerves, high levels of circulating norepinephrine as a result of a genetically determined malfunction of norepinephrine
      reuptake proteins, and importantly, a form of autonomic cardiac neuropathy.
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid39297132
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Many pathophysiological mechanisms have been proposed, including, but not limited to, inadequate volume
      regulation (hypovolemic POTS), peripheral noradrenergic denervation (neuropathic POTS), increased sympathetic
      activity and circulating catecholamines (hyperadrenergic POTS), mast cell activation, and the presence of
      activating autoantibodies.1
    note: 'Found by winnow, kev and lev in p001, p007, p002. Claude judged: supports.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: supports
    section: Overview of POTS > Proposed mechanisms underlying POTS
    quote: Several mechanisms have been proposed as the potential pathophysiology behind POTS and are often labeled
      as the sub-types of neuropathic, hyperadrenergic and hypovolemic POTS (40).
    note: 'Found by winnow, kev and lev in p035, p033. Claude judged: supports.'
  - paper: pmid39165715
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Highlight key points
    quote: Many mechanisms have been defined in POTS etiology, such as autonomic denervation, hypovolemia, hyperadrenergic
      stimulation, low condition, and hypervigilance [4].
    note: 'Found by winnow, kev and lev in p007, p001. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p004, p005, p028. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p002, p024, p001. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome
    quote: POTS is theorized to be the culmination of multiple underlying pathological processes, including peripheral
      neuropathy/denervation, hypovolemia with altered renin–aldosterone levels, and a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p009, p013. Claude judged: supports.'
  - paper: pmid38336892
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Various POTS etiologies have been hypothesized such as abnormal hyperadrenergic activation due to catecholamine
      excess, compensatory tachycardia due to peripheral autonomic neuropathy, and chronic autoinflammatory or autoimmune
      processes5.
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Pathophysiology of POTS
    quote: POTS, a syndrome of heterogeneous aetiologies, is linked to deconditioning from prolonged space flight
      or bed rest, volume dysregulation, mast cell activation disorders, autoimmunity, and hyperadrenergic state.[1–3]
      Irrespective of aetiology, the exaggerated orthostatic HR response in POTS is associated with three distinct
      pathophysiological entities, namely peripheral autonomic dysfunction, absolute hypovolaemia, and central hyperadrenergic
      state (Figure 2).
    note: 'Found by winnow, kev and lev in p005, p009, p010. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: POTS may be classified into phenotypes—neuropathic, hypovolemic, and hyperadrenergic—based on suspected
      pathophysiologic mechanism.
    note: 'Found by winnow, kev and lev in p004, p018. Claude judged: supports.'
  - paper: pmid37999672
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37999672. Found by winnow, kev and lev in p006, p025, p026. Claude judged: supports.'
  - paper: pmid37705599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Other etiologies of POTS include abnormally increased sympathetic activity, excess circulating catecholamines
      (CAs), and absolute hypovolemia due to low blood volume.
    note: 'Found by winnow, kev and lev in p005, p023, p025. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Etiopathogenic basis
    quote: The pathophysiological mechanisms resulting in autonomic dysfunction in POTS may include sympathetically
      mediated vasoconstriction in the lower limbs (neuropathic POTS), excessive cardiac sympathoexcitation response
      (hyperadrenergic POTS) with increased serum norepinephrine, volume dysregulation (hypovolemia), baroreceptor
      dysfunction, peripheral neuropathy, and autoimmunity due to molecular mimicry following infections by pathogens
      such as Epstein–Barr virus, cytomegalovirus, or Borrelia Burgdorferi (1, 15).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS could result from mild autonomic neuropathy, hypovolemia and abnormal renin-aldosterone response,
      and genetic or acquired deficiency of norepinephrine receptors leading to a hyperadrenergic state [15].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid37508741
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: The main mechanism of POTS is autonomic nerve dysfunction due to increased sympathetic excitation resulting
      from elevated plasma NE levels [17].
    note: 'Found by winnow, kev and lev in p002, p019. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: '4. Individualized Pharmacologic Therapies for Pediatric POTS: Predictors of Therapeutic Efficacy >
      4.3. Predictors for Metoprolol Efficacy in Pediatric POTS > 4.3.1. Orthostatic Plasma Norepinephrine Level'
    quote: Increased sympathetic activity is a main mechanism underlying POTS. The elevation of upright plasma norepinephrine
      levels may induce impaired vasoconstriction via the baroreceptor reflex [76].
    note: 'Found by winnow, kev and lev in p011, p032, p005. Claude judged: supports.'
  - paper: pmid37378164
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The two significant hypotheses for the pathophysiology can be divided into neuropathic POTS, a form of
      parasympathetic denervation occurring in the lower extremities, forcing a burst of sympathetic outflow as
      a corrective effort. It can also be divided into hyperadrenergic POTS, an excessive outburst of norepinephrine
      when initiating an erect position.
    note: 'Found by winnow, kev and lev in p003, p006. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Pathophysiology of POTS
    quote: Excessive sympathetic outflow (causing orthostatic hypertension), down-regulated venous receptors (causing
      decreased venous return), decreased plasma aldosterone-to-renin ratio (causing reduced sodium retention and
      plasma volume expansion), and elevated angiotensin II without concomitant hypertension (decreased sensitivity
      to vasoconstrictive effects) are some of the mechanisms that have been identified in the pathophysiology of
      POTS [13]. Other factors that have been identified as precipitating POTS include hypovolemia, deconditioning,
      neuroendocrine dysfunction (central hyperadrenergic state), neuropathy, infection, medications (antihypertensives,
      antipsychotics), surgery, pregnancy, concussion, and autoimmunity [14].
    note: 'Found by winnow, kev and lev in p009, p021. Claude judged: supports.'
  - paper: pmid37209261
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction > Mechanisms of Cardiac Damage
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37209261. Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The exact mechanisms of post-COVID-19 POTS are unclear. Still, different hypotheses have been given,
      including autoantibody production against autonomic nerve fibers, direct toxic effects of SARS-CoV-2, or sympathetic
      nervous system stimulation secondary to infection.
    note: 'Found by winnow, kev and lev in p001, p020. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A hyperadrenergic state associated with elevated levels of norepinephrine may also lead to the syndrome.
    note: 'Found by winnow, kev and lev in p003, p014, p015. Claude judged: supports.'
  - paper: pmid36873318
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Multiple pathophysiologic mechanisms have been proposed to explain POTS, including autonomic neuropathy,
      hypovolemia, impaired vasoconstriction, and hyperadrenergic state.2,3
    note: 'Found by winnow, kev and lev in p007, p021, p024. Claude judged: supports.'
  - paper: pmid36781629
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In addition, the norepinephrine elimination mechanism is impaired among POTS patients with significant
      sympathetic activation [28, 29]. Therefore, attention has been given to the role of hyperadrenaline status
      in developing POTS.
    note: 'Found by winnow, kev and lev in p034, p006, p035. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The pathophysiology of POTS remains unknown, however there is a number of physiological mechanisms that
      have been supposed to be involved. These may include sympathetic dysregulation, hypovolemia, hyperadrenergic
      stimulation, deconditioning12,57, autoantibody mediated response57, and mast cell activation58,59.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid36292504
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: As one of the mechanisms of POTS is excess sympathetic activation (Vernino 2021), we hypothesize that
      also in milder COVID-19 patients, initially a high sympathetic drive is present, which disappears over time
      during recovery of the infection.
    note: 'Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid36187012
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Although the underlying mechanisms for POTS are heterogeneous, excessively increased sympathetic activity
      is one of the most contributing factors to POTS.
    note: 'Found by winnow, kev and lev in p022, p006. Claude judged: supports.'
  - paper: pmid36111700
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: The precise aetiology of POTS remains unknown, although the haemodynamic changes are thought to reflect
      convergence of multiple pathophysiological processes including peripheral autonomic neuropathy, hypovolemia,
      elevated sympathetic tone, deconditioning and auto‐antibodies to cardiovascular receptors [7].
    note: 'Found by winnow, kev and lev in p027, p005, p006. Claude judged: supports.'
  - paper: pmid36000360
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > POTS phenotypes
    quote: Hyperadrenergic POTS is believed to result from increased levels of circulating norepinephrine, while
      patients with neuropathic POTS have partial neuropathy in lower vascular beds.
    note: 'Found by winnow, kev and lev in p065, p079, p049. Claude judged: supports.'
  - paper: pmid35992935
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Other proposed pathophysiological mechanisms include abnormally increased sympathetic activity and circulating
      catecholamine excess (hyperadrenergic type; Schondorf and Low, 1993; Jacob and Biaggioni, 1999), and absolute
      hypovolemia due to low blood volume (Vernino et al., 2021).
    note: 'Found by winnow, kev and lev in p005, p025, p004. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p017, p005, p009. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.4. Physiological Predictors
      for the Efficacy of Metoprolol in Pediatric POTS
    quote: A hyperadrenergic state is one of the important mechanisms leading to POTS. Increases in orthostatic
      plasma norepinephrine, which might be the result of damaged baroreflex-mediated vasoconstriction, represent
      the key hyperadrenergic biochemical change in patients with POTS [83].
    note: 'Found by winnow, kev and lev in p040, p003, p010. Claude judged: supports.'
  - paper: pmid35733987
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The etiology is not fully understood, elevated circulating norepinephrine levels have been reported in
      POTS patients suggesting that increased sympathetic activity may play a role (Goldstein et al., 2002; Lambert
      et al., 2008).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid35351159
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Comorbidities of patients with PF
    quote: Enhanced sympathetic response has been proposed as a mechanism of POTS among patients with PF.
    note: 'Found by winnow, kev and lev in p004, p016. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What is the pathophysiology of POTS?
    quote: Features described in subgroups of patients include increased sympathetic nervous system tone (i.e.,
      hyperadrenergic POTS),17 partial peripheral sympathetic denervation leading to relative central hypovolemia
      (i.e., neuropathic POTS)27 and low blood volume (i.e., absolute hypovolemia),28 which may drive some of the
      other hemodynamic findings.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid35232225
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35232225. Found by winnow, kev and lev in p007, p022, p031. Claude judged: supports.'
  - paper: pmid35127870
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Its main pathogenesis includes high catecholamine levels in blood circulation, overexcitement of sympathetic
      nerve function, vasodilation, or low central blood volume (3–6).
    note: 'Found by winnow, kev and lev in p034, p005, p035. Claude judged: supports.'
  - paper: pmid35118574
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35118574. Found by winnow, kev and lev in p006, p027, p029. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mechanisms
    quote: Hyperadrenergic stimulation in POTS is thought to be genetic. This manifestation affects up to 50% of
      patients with POTS and is considered to involve a centrally driven sympathetic activation characterized by
      supine vasoconstriction and tachycardia.5,8,14,15
    note: 'Found by winnow, kev and lev in p018, p013. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Putative Mechanisms for Symptomatic Tachycardia in Post-COVID-19 Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Definition of postural orthostatic tachycardia syndrome
    quote: The onset of POTS has been attributed to dysautonomia, hypovolemia, deconditioning, a hyperadrenergic
      physiologic state, hypervigilance (unusual focus on bodily sensations), or any combination of these conditions.1
    note: 'Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p014, p023, p024. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: ANS in the CNS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026, p006, p024. Claude judged: supports.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Potential causes of excessive sympathetic activation in POTS include absolute or positional central hypovolemia,5
      intrinsically increased sympathetic CNS outflow as proposed in hyperadrenergic POTS, or increased central
      command in the face of postural muscle atrophy.48
    note: 'Found by winnow, kev and lev in p055, p006, p051. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Hyperadrenergic POTS is due to an excess sympathetic response.
    note: 'Found by winnow, kev and lev in p006, p007, p023. Claude judged: supports.'
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: However, it seems that there are two main types of POTS, the adrenergic and neuropathic type (10). The
      adrenergic type is characterized by high plasma norepinephrine (NE) levels due to NE synaptic spillover, with
      values in the upright position exceeding 3.5 nmol/L.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots
    quote: Current perspectives on the pathogenesis of POTS have been categorized as altered central blood volume,
      abnormal autonomic reflexes and elevated sympathetic tone, damaged skeletal muscle pump activity, local vascular
      tension regulation dysfunction, iron insufficiency, mast cell activation (MCA), and autoimmune dysfunction
      (3, 6, 12).
    note: 'Found by winnow, kev and lev in p007, p011, p012. Claude judged: supports.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The cause of POTS has not yet been established (Benarroch, 2012), though many possible disease mechanisms
      including autonomic denervation (Kimpinski et al., 2012; Haensch et al., 2014), autonomic autoimmunity (Ruzieh
      et al., 2017), hypovolemia (Benarroch, 2012; Kimpinski et al., 2012), hyperadrenergic stimulation (Kimpinski
      et al., 2012), and deconditioning have been proposed (Benarroch, 2012; Fu and Levine, 2015).
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid32823577
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: The pathophysiology of POTS is poorly understood [1,2]. Proposed mechanisms include neuropathic and hyperadrenergic
      dysregulation, volume depletion, physical deconditioning, and autoimmunity [14,15,16,17,18].
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Several potential underlying mechanisms have been suggested for POTS including autonomic denervation,
      hypovolemia, hyperadrenergic stimulation, and autoantibodies against adrenergic receptors.
    note: 'Found by winnow, kev and lev in p017, p031. Claude judged: supports.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The pathophysiology of POTS is not well understood, and is thought to reflect the integration of multiple
      pathophysiological processes, including autoimmune, hyperadrenergic, and hypovolemic mechanisms [3].
    note: 'Found by winnow, kev and lev in p006, p032, p035. Claude judged: supports.'
  - paper: pmid32673517
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: POTS is a heterogeneous condition associated with multiple pathophysiological mechanisms. In some patients,
      the orthostatic tachycardia is thought to be caused by a primary sympathetic activation, whereas in others
      it is thought to be secondary to chronic hypovolemia, partial sympathetic denervation in lower limbs, cardiovascular
      deconditioning, mast cell activation, or autoimmunity.7, 8, 9, 10, 11, 12
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid32612820
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The pathophysiology remains unknown but many theories have been described including hypovolemia, autonomic
      dysfunction, hyperadrenergic state, adrenergic receptor deficiency, mast cell activation, renin-aldosterone
      paradox and physical deconditioning [10]. This may explain why various treatment options have been used for
      the management of POTS, but with suboptimal results.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Mechanisms and symptoms
    quote: As noted by Ziffra et al.,1 although not completely understood, the pathophysiology of postural orthostatic
      tachycardia syndrome (POTS) appears to be multifactorial. Autonomic nervous system dysfunction,2 increased
      sympathetic tone,3 and physical deconditioning4,5 are some of the suggested contributory factors.
    note: 'Found by winnow, kev and lev in p001, p011, p019. Claude judged: supports.'
  - paper: pmid32222376
    cited: true
    text: full
    license: none
    verdict: supports
    section: Etiology and the concepts of primary and secondary POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32222376. Found by winnow, kev and lev in p003, p020, p021. Claude judged: supports.'
  - paper: pmid31888497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Sympathetic denervation in lower extremities, preserved cardiac innervation and increased sympathetic
      activities (hyper-adrenergic state) have been shown to be sole etiologies of POTS [2, 3, 6, 8].
    note: 'Found by winnow, kev and lev in p008, p046. Claude judged: supports.'
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Orthostatic Cardiovascular Responses Are Impaired in Patients With Vasovagal Syncope
      and Postural Orthostatic Tachycardia Syndrome
    quote: 'Postural Orthostatic Tachycardia Syndrome includes at least four subtypes: hyperadrenergic POTS with
      excessive sympathetic discharge; hypovolemic POTS (with compensatory tachycardia); neuropathic POTS with impaired
      vasoconstriction and compensatory tachycardia; and, rarely, noradrenaline transporter deficiency with synaptic
      noradrenaline accumulation (Low et al., 1995, 2009; Raj, 2013).'
    note: 'Found by winnow, kev and lev in p053, p011, p013. Claude judged: supports.'
  - paper: pmid31788462
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The role of hyper-adrenergic state in the development of POTS has gained more and more attention in recent
      years.
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid31547749
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: From a pathological viewpoint, an α1AR‐AAb‐mediated impaired pressor response to α1AR endogenous ligand
      norepinephrine would be expected to compensatorily increase the sympathetic output to normalize vasoconstriction
      and blood pressure. The relatively unprotected cardiac chronotropic β1AR would respond to this increased adrenergic
      activity with an enhanced tachycardia, which would be exaggerated by the β1AR‐AAb, and might explain the clinical
      characteristics of POTS.
    note: 'Found by winnow, kev and lev in p003, p023, p005. Claude judged: supports.'
  - paper: pmid31384930
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Several potential underlying mechanisms have been suggested for POTS including autonomic denervation,
      hypovolaemia, hyperadrenergic stimulation, and autoantibodies against adrenergic receptors.2,3
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid31307619
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31307619. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid31156539
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Cardiovascular autoantibodies with a causative role have been proposed in POTS, but another hypothesis
      is the presence of abnormally increased sympathetic activity alongside findings of peripheral autonomic neuropathy.
    note: 'Found by winnow, kev and lev in p038, p007. Claude judged: supports.'
  - paper: pmid30372565
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30372565. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Clinical approach toward POTS diagnosis > Investigations > Plasma and urine catecholamines
    quote: Hyperadrenergic POTS may relate to an increase in production of norepinephrine37 or defective norepinephrine
      clearance.38–42
    note: 'Found by winnow, kev and lev in p015, p003, p016. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid27660311
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27660311. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: 'Abstract > Conclusions:'
    quote: The pathogenesis of POTS is multifactorial, including hypovolemia, abnormal catecholamine state, and
      vascular dysfunction.
    note: 'Found by winnow, kev and lev in p004, p010, p005. Claude judged: supports.'
  - paper: pmid26610893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: INTRODUCTION
    quote: The pathophysiological mechanisms underlying POTS are also diverse and multifactorial, and include hypovolemia,5
      hyperadrenergic states,6 lower-extremity neuropathies,7 and deconditioning.8
    note: 'Found by winnow, kev and lev in p005, p011. Claude judged: supports.'
  - paper: pmid26241226
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: Other possible causes of POTS are a central hyperadrenergic state, which has a genetic predisposition,
      and indolent mastocytosis.7–14
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p023, p026, p027. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Physiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p011, p014, p025. Claude judged: supports.'
  - paper: pmid25811760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The increased plasma level of catecholamine was suggested to be involved in the pathogenesis of POTS
      [18,19], evidenced by a heart rate increment in such children.
    note: 'Found by winnow, kev and lev in p021, p018, p019. Claude judged: supports.'
  - paper: pmid25792354
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25792354. Found by winnow, kev and lev in p004, p017. Claude judged: supports.'
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p005, p020. Claude judged: supports.'
  - paper: pmid25204388
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is known that hyperadrenergic state has been well recognized one of the important mechanisms for POTS,
      and present study firstly provided the information about the role of plasma norepinephrine as a biomarker
      to predict the effect of treatment of metoprolol on POTS children.
    note: 'Found by winnow, kev and lev in p022, p012. Claude judged: supports.'
  - paper: pmid25180969
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Various hypotheses, such as hypovolemia [37], venous pooling [38], hyperadrenergic states [39]–[41],
      and restricted adrenergic neuropathies [42] have been suggested to be possible mechanisms underlying POTS.
    note: 'Found by winnow, kev and lev in p002, p022. Claude judged: supports.'
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: POTS on the other hand may involve sympathetic denervation in the lower limbs, a hyperadrenergic state
      and/or abnormalities in the NET.
    note: 'Found by winnow, kev and lev in p017, p019, p020. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Some patients with POTS have evidence of elevated sympathoneural tone. This hyperadrenergic state is
      likely a driver of the excessive orthostatic tachycardia.
    note: 'Found by winnow, kev and lev in p001, p004, p020. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p045, p048, p070. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p003, p026. Claude judged: supports.'
  - paper: pmid24002370
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion > Norepinephrine and POTS
    quote: 'Despite the heterogeneous pathophysiology of POTS, increased sympathetic activity seems to be a common
      final pathway, and thus an area of focus in POTS research. There are two possible mechanisms for increased
      synaptic concentrations of norepinephrine: an increase in synaptic norepinephrine release or a decrease in
      synaptic norepinephrine clearance.'
    note: 'Found by winnow, kev and lev in p030, p031, p032. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Pathogenesis of POTS is heterogenous and may include sympathetic hyperactivity with peripheral denervation,
      hypovolemia, and physical deconditioning [3].
    note: 'Found by winnow, kev and lev in p009, p006, p008. Claude judged: supports.'
  - paper: pmid23720636
    cited: true
    text: full
    license: by
    verdict: supports
    section: Cognitive impairment theories > Neurotransmitters in CFS and POTS
    quote: Shannon et al. (2000) found that in the case of one family, the cause of POTS was traced to a point mutation
      in the coding region of the NET gene which produced a dysfunctional transporter protein. This defect was found
      to augment the sympathoneural signal, and also increased the rate of overflow of norepinephrine into plasma.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid23283362
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23283362. Found by winnow, kev and lev in p006, p007. Claude judged: supports.'
  - paper: pmid23244360
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Common variant OI: POTS & postural VVS > Hyperadrenergic POTS'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23244360. Found by winnow, kev and lev in p020, p021, p017. Claude judged: supports.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p007, p016. Claude judged: supports.'
  - paper: pmid21906029
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: The orthostatic tachycardia in POTS is easily explained by this increase in sympathetic activity and
      the corresponding decrease in vagal tone evidenced by the decrease in high frequency power spectra of HR.
    note: 'Found by winnow, kev and lev in p029, p033. Claude judged: supports.'
  - paper: pmid21266211
    cited: true
    text: full
    license: none
    verdict: supports
    section: Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21266211. Found by winnow, kev and lev in p030, p004, p007. Claude judged: supports.'
  - paper: pmid19289653
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19289653. Found by winnow, kev and lev in p002, p039. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p001, p003, p004. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: There are some cases, however, in which the primary underlying problem seems to be excessive sympathetic
      discharge. These patients often have extremely high levels of upright norepinephrine.
    note: 'Found by winnow, kev and lev in p028, p024, p031. Claude judged: supports.'
  - paper: pmid12416949
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 12416949. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid11458707
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Unlabelled
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11458707. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid11201632
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11201632. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid9868411
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 9868411. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction and background
    quote: The research does not support the notion that a single mechanism is responsible for the development of
      cognitive symptoms, since POTS is a diverse syndrome with possible hypovolemic, neuropathic, hyperadrenergic,
      autoimmune, and post-viral subtypes.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid42369281
    cited: true
    text: full
    license: by
    verdict: partial
    section: Toward a trauma-informed conceptual model of POTS
    quote: Via the PAG, trauma may set the central autonomic network into one of its escape modes, such as fight,
      flight or freeze; failure to fully recalibrate the autonomic network back to a healthy operating mode after
      the trauma has passed may contribute to a state of persistent sympathetic activation for predisposed individuals,
      in turn leading to a dysregulated brain–body communication system that leads to manifestations of ANS dysregulation
      that increase the risk of a POTS diagnosis.
    note: 'Found by winnow, kev and lev in p011, p020, p035. Claude judged: partial.'
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: It was noted as a potentially characteristic sign of hyperadrenergic/low-flow subtypes of POTS, which
      is characterized by excessive sympathetic activation, whereas the low-flow subtype involves impaired peripheral
      vasoconstriction and reduced venous return; both mechanisms may predispose to transient cutaneous hyperemia
      during autonomic fluctuations.
    note: 'Found by winnow, kev and lev in p016, p005. Claude judged: partial.'
  - paper: pmid41976810
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: 'Sheldon et al. [6] summarise two possible mechanisms for PoTS: firstly, autonomic denervation leading
      to impaired peripheral venoconstriction, which leads to venous pooling, hypovolaemia, and hyperadrenergic
      stimulation with raised plasma norepinephrine levels, or, secondly, deconditioning, which may be compounded
      by anxiety and hypervigilance secondary to the underlying physiological abnormalities.'
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Cardiovascular determinants
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p009, p032, p039. Claude judged: partial.'
  - paper: pmid40310095
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: In addition, many patients with POTS also have a primary hyperadrenergic state, and the sympathetic tone
      is markedly increased, and even more when standing [40,41], which can cause a marked increase in heart rate
      [42], and as a result, their discomfort is more pronounced when they are upright.
    note: 'Found by winnow, kev and lev in p035, p036. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Migraine Headaches
    quote: Post-ganglionic sympathetic denervation and amplified sympatho– adrenomedullary axis activity are felt
      to be related to the pathophysiology of neurogenic and hyperadrenergic POTS, respectively.
    note: 'Found by winnow, kev and lev in p016, p034, p024. Claude judged: partial.'
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: How to Explain the Pathophysiology to Patients and Families
    quote: Anxiety about these symptoms potentiates the pathophysiology, as additional excessive adrenaline is made
      in response—drying out the patient, increasing fluid requirements, and cycling the pathophysiology.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid39463038
    cited: true
    text: full
    license: by
    verdict: partial
    section: DISCUSSION
    quote: Norcliffe‐Kaufman et al. recently reported that patients with POTS have increased somatic vigilance and
      may experience an anxiety‐related hyperadrenergic state in an upright position [31], which can trigger hyperventilation
      and potentially affect cerebral perfusion. The increased sympathetic activity in POTS may therefore be exacerbated
      by a state of heightened anxiety, which could further increase symptoms.
    note: 'Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid39395208
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: Although the A457P model failed to result in the recovery of mature NET when co‐expressed with DHHC1,
      the hypothesis of disordered NET palmitoylation being involved in the pathogenesis of autonomic disorders
      like POTS remains relevant. Indeed, inhibition of this process strongly decreases surface and total NET protein,
      thus impairing the cellular uptake of NE and potentially generating a hyperadrenergic state that mimics the
      cellular and physiologic POTS phenotype.
    note: 'Found by winnow, kev and lev in p001, p092, p054. Claude judged: partial.'
  - paper: pmid39297140
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: While upright, patients can also experience exaggerated sympathetic nervous system activity, paralleled
      by exaggerated increases in ventilation,5, 6, 7, 8, 9 which decreases carbon dioxide levels in the blood (ie,
      hypocapnia).
    note: 'Found by winnow, kev and lev in p006, p003. Claude judged: partial.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The underlying causes of POTS following COVID-19 remain unknown, with various theories proposed such
      as renin–angiotensin–aldosterone system (RAAS) dysregulation, hyperadrenergic reaction, and direct viral infection.
    note: 'Found by winnow, kev and lev in p001, p007, p008. Claude judged: partial.'
  - paper: pmid39076856
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. Symptoms and Pathologic Findings of Cardiovascular Disease in Post-Acute COVID-19 Syndrome > 5.2
      Pathologic Findings > 5.2.4 Postural Orthostatic Tachycardia Syndrome (POTS)
    quote: "Hypothetically, POTS is caused by autonomic dysfunction in long COVID patients \n[138]. Autonomic dysfunction\
      \ in long COVID is provoked by the hyperadrenergic \nstate and the resetting of baroreceptor control, which\
      \ is stimulated by \nangiotensin II upregulation."
    note: 'Found by winnow, kev and lev in p043. Claude judged: partial.'
  - paper: pmid38962840
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: INTRODUCTION
    quote: The increased baroreceptor activity results in an exaggerated sympathoneural response, resulting in compensatory
      reflex tachycardia [8, 10].
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid38585862
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38585862. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: DISCUSSION
    quote: Malfunction of these nuclei could give rise to sympathetic hyperactivity, producing HR and SBP disturbances
      during postural changes, as could be seen in hyperadrenergic POTS [7].
    note: 'Found by winnow, kev and lev in p006, p018, p020. Claude judged: partial.'
  - paper: pmid37631004
    cited: true
    text: full
    license: by
    verdict: partial
    section: 8. Electroceutical Therapy for Autoimmune Disease > 8.7. Postural Orthostatic Tachycardia Syndrome
      (POTS)
    quote: Consistently, induction of antibodies with similar functional properties in a rabbit experimental model
      could trigger a hyperadrenergic POTS phenotype [94].
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Some patients have shown evidence of increased adrenergic function separate from tachycardia, suggesting
      that POTS represents a hyperadrenergic state. Commonly, patients with POTS have increased catecholamine levels
      than healthy controls [8].
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Additionally, the role of angiotensin-converting enzyme 2 (ACE2) receptor dysfunction has been implicated
      in the etiology of POTS, as COVID-19 attenuates ACE2 receptor activity and consequently upregulates sympathetic
      activation [14].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid36818521
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion > Possible Mechanisms for OI and Role of the Autonomic Nervous System
    quote: Many factors, such as hypovolemia, an excessive orthostatic shift in plasma volume, autonomic dysfunction,
      increased sympathetic tone, physical deconditioning, poor venous return, enhanced blood venous pooling, and
      immunological factors, may contribute to the occurrence of OI with POTS.24
    note: 'Found by winnow, kev and lev in p005, p021. Claude judged: partial.'
  - paper: pmid36414707
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: These findings support the hypothesis that POTS may be an autoimmune, inflammatory and hyperadrenergic
      disorder.
    note: 'Found by winnow, kev and lev in p027, p030, p001. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Management: Pharmacologic Treatment > Postural Orthostatic Tachycardia Syndrome49,50,170'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p035, p158, p166. Claude judged: partial.'
  - paper: pmid35802513
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35802513. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34746821
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction > Carotid body – a unifying hypothesis?
    quote: This predisposes patients to hypoperfusion of tissues cephalad to the heart, causing stagnant hypoxia
      from reduced carotid blood flow – a key step causing SNA activation (Marshall, 1994; Prabhakar et al., 2005)
      in the pathophysiologic cascade in POTS.
    note: 'Found by winnow, kev and lev in p001, p010, p011. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: It is postulated that the cytokine storm from the COVID-19 infection results in sympathetic dysregulation,
      causing the abnormal autonomic response in POTS [6].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid34634682
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction > Postural Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34634682. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid34409582
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34409582. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid34268642
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic Disorders and Headache
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34268642. Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid34055686
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The exaggerated response to adrenergic receptors, the increased catecholamine levels, and the exacerbated
      hypovolemic state in the morning may explain the excessive HR increment after standing observed in the morning
      for POTS children and adolescents.
    note: 'Found by winnow, kev and lev in p025, p027. Claude judged: partial.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Hyperadrenergic states, usually the result of a genetic predisposition, can lead to increased norepinephrine
      (NE) levels which, together with impaired clearance or decreased uptake, can manifest as anxiety, tremulousness,
      and elevated diastolic BP.5
    note: 'Found by winnow, kev and lev in p008, p011. Claude judged: partial.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > Sodium Loading in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p009, p043, p048. Claude judged: partial.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: These antibodies exerted a partial antagonistic effect against the peripheral vasoconstrictive compensation
      of orthostasis, resulting in an overshooting sympathoneural response to maintain vascular tone. Consequently,
      this sympathetic response leads to tachycardia via unopposed β1-adrenergic receptor activation.
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: The multiple factors like moderate autonomic dysfunction, increased sympathetic tone, inadequate venous
      return or excessive blood venous pooling, and severe deconditioning may be responsible for POTS symptoms.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid33486983
    cited: true
    text: full
    license: none
    verdict: partial
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33486983. Found by winnow, kev and lev in p003, p017, p022. Claude judged: partial.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid33114659
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: 'The pathophysiological mechanisms of POTS remain poorly understood and three different phenotypes are
      described: the “hyper-adrenergic” [3], the “neuropathic” [6,7,8] and POTS associated with physical deconditioning
      [4,9,10] or to a prolonged exposure to gravity absence [4,11,12,13].'
    note: 'Found by winnow, kev and lev in p005, p050, p003. Claude judged: partial.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p006, p008. Claude judged: partial.'
  - paper: pmid32284866
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: 'The aetiology of POTS is uncertain, but a number of mechanisms have been proposed.

      Increased sympathetic activity appears to be a common feature.'
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Previous studies suggested that metoprolol could achieve better therapeutic effects in children with
      high catecholamine level, high adrenergic status, and β-receptor hypersensitivity (Thieben et al., 2007).
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p031. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: PATHOPHYSIOLOGY OF POTS
    quote: The excessive sympathetic tone is considered to be of central origin in hyperadrenergic POTS, but smaller
      increases in plasma NE upon standing, which are not uncommon in POTS, may also result as a compensatory response
      to hypovolemia and peripheral autonomic neuropathy. In some patients with POTS, a deficiency in the NE transporter
      protein may also lead to an excessive NE response.43,44
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.2 Hyperadrenergic State
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p017, p018, p022. Claude judged: partial.'
  - paper: pmid27938459
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27938459. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: partial
    section: Neurovisceral phenotypes > Joint hypermobility > Association with psychiatric disorder
    quote: In disorders that typically involve impaired collagen (present in blood vessels) such as joint hypermobility
      and postural tachycardia syndrome it is likely that reduced venous return during standing due to venous pooling
      or denervation causing low plasma volume may be responsible for a an increased sympathetic state–as the body
      attempts to compensate for these abnormalities—resulting in orthostatic intolerance and associated symptoms
      (Bohora, 2010; Benarroch, 2012; Mathias et al., 2012).
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid25653673
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Among other mechanisms are the vagal impairment and hyperadrenergic activity supported by the high levels
      of upright plasma epinephrine (reflecting SNS activation) in this study and marked impairment of cardiac baroreflex
      sensitivity (23-25). Furthermore, compensatory increase in cerebral sympathetic outflow leads to elevated
      norepinephrine levels, which result in an increase in HR and myocardial contractility (19, 26).
    note: 'Found by winnow, kev and lev in p024, p025. Claude judged: partial.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Conclusions
    quote: POTS patients have elevated α1AR autoantibodies exerting a partial peripheral antagonist effect resulting
      in a compensatory sympathoneural activation of α1AR for vasoconstriction and concurrent βAR‐mediated tachycardia.
      Coexisting β1AR and β2AR agonistic autoantibodies facilitate this tachycardia. These findings may explain
      the increased standing plasma norepinephrine and excessive tachycardia observed in many POTS patients.
    note: 'Found by winnow, kev and lev in p003, p006, p026. Claude judged: partial.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Pathophysiology
    quote: Muenter swift et al.[19] showed POTS patients have exaggerated muscle sympathetic nerve activity (MSNA)
      responses to baroreflex challenges compared to healthy control subjects, although resting supine MSNA values
      did not differ between the groups.
    note: 'Found by winnow, kev and lev in p014, p012, p013. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p035, p009. Claude judged: partial.'
  - paper: pmid21751966
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21751966. Found by winnow, kev and lev in p002, p020. Claude judged: partial.'
  - paper: pmid19324216
    cited: true
    text: full
    license: none
    verdict: partial
    section: WHY ARE “POSITIVE” TILT TEST RESULTS SIMILAR (EARLY ON) IN FAINTERS AND POTS?
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19324216. Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid17709712
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 17709712. Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid11206727
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11206727. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid11198483
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11198483. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - proposed_mechanism_of
  - pots
  papers: 136
  evidence:
  - paper: pmid42688561
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion > Pathophysiological Mechanisms of POTSHR
    quote: Several mechanisms have been proposed for POTS in COVID-19 survivors, including autoimmunity, autonomic
      neuropathy, hypovolaemia, deconditioning and persistent inflammation, among which autoimmunity is prominent,
      where autoantibodies form against A/B adrenoceptors and muscarinic acetylcholine receptors.
    note: 'Found by winnow, kev and lev in p034. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Research is underway to establish a link between certain autoantibodies, such as G-protein-coupled adrenergic
      receptors and muscarinic cholinergic receptor antibodies found in elevated levels in POTS, which corresponds
      to the theory that POTS may have an immune-mediated pathogenesis [19].
    note: 'Found by winnow, kev and lev in p084. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Besides small fiber neuropathy, proposed POTS mechanisms include immune-mediated inflammation triggered
      by autoantigens or persistent viral particles [11, 20].
    note: 'Found by winnow, kev and lev in p047. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autoimmunity > Autoimmune markers in POTS and other common autonomic disorders
    quote: The pathophysiology of POTS has been deemed largely heterogeneous and traditionally classified as neuropathic,
      hypovolemic, and hyperadrenergic (Low et al., 2009). In the past decade, however, investigators zeroed in
      on autoimmunity as one of the major mechanisms.
    note: 'Found by winnow, kev and lev in p003, p014, p018. Claude judged: supports.'
  - paper: pmid41069916
    cited: true
    text: full
    license: by
    verdict: supports
    section: Editorial
    quote: Although the pathophysiology of POTS remains complex and not fully understood, several studies suggest
      the possibility of an immunological cause in a significant portion of the cases [1,3,5,6,10], which might
      be triggered by stressors such as viral infections, trauma, pregnancy, or surgery [3]. Immune dysfunction
      caused by the aforementioned factors might lead to the formation of autoantibodies against adrenergic, cholinergic,
      and acetylcholine receptors [5], henceforth paving the way to autoimmunity.
    note: 'Found by winnow, kev and lev in p004, p001, p002. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion
    quote: Hypotheses regarding pathophysiology include abnormally increased sympathetic activity, sympathetic denervation
      leading to hypovolemia and reflex tachycardia, and autoimmunity to G-protein coupled receptors (2, 3, 79,
      81, 82).
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid40776616
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: It is caused by a complex interaction of cardiac receptor-activating autoantibodies, hyperadrenergic
      activation, hypovolemia, and partial autonomic neuropathy [8,24-26], with impairment of cerebrovascular autoregulation
      being an important pathogenic mechanism.
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid40763323
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Increased viral exposure may have triggered autoimmune mechanisms that contribute to the pathogenesis
      of POTS. Autoantibodies targeting adrenergic and muscarinic receptors are known to play a role in POTS, and
      viral infections have been shown to stimulate the production of such autoantibodies.6-9
    note: 'Found by winnow, kev and lev in p024, p006, p028. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The precise pathophysiology of POTS is not fully understood but several factors may contribute, including
      hyperadrenergic stimulation, hypovolemia, peripheral autonomic neuropathy, and autoimmunity.6
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Given the proposed role of modulatory autoantibodies targeting ARs in POTS, we also conducted a post
      hoc analysis to measure AR-modulating autoantibody activity in patients with and without POTS.28,29
    note: 'Found by winnow, kev and lev in p004, p010, p032. Claude judged: supports.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In 2012, Wang et al. were the first to imply autoimmunity as a possible etiology of POTS by detecting
      autoimmune IgG antibodies in patients with POTS [9]. Later, in 2014, Li et al. documented specific antibodies
      against receptors in the autonomic nervous system in POTS patients, specifically autoantibodies against adrenergic
      alpha-1 receptors (ADRA1) and autoantibodies against beta-1 (ADRB1) and beta-2 adrenergic receptors (ADRB2)
      [10].
    note: 'Found by winnow, kev and lev in p001, p007, p008. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Case Presentation
    quote: However, an autoimmune basis of post-COVID POTS was evident given a positive ANA, comorbid SFN, and post-infectious
      onset of symptomatology. It was previously demonstrated pre-COVID-19 pandemic that patients with POTS have
      a higher prevalence of positive ANA and other autoimmune markers than the general population [5].
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Other etiologies of POTS have been implicated more recently, including autoimmunity and possible neuroinflammation
      [10,11].
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Patients with autoimmune-related POTS may also present with autoimmune disorders as comorbidities. The
      onset of POTS in these patients may be related to autoantibodies against ganglionic acetylcholine receptors
      and α1-adrenergic receptors, although no definitive pathways have been identified.[10]
    note: 'Found by winnow, kev and lev in p011, p032, p027. Claude judged: supports.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Despite similar clinical characteristics, POTS is likely a heterogeneous group of disorders. These include
      an autoimmune mechanism associated with antibodies to the postsynaptic acetylcholine receptors of the autonomic
      nerves, high levels of circulating norepinephrine as a result of a genetically determined malfunction of norepinephrine
      reuptake proteins, and importantly, a form of autonomic cardiac neuropathy.
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. COVID-19-Related POTS > 2.2. Presumed Mechanism for COVID-19-Related POTS > 2.2.2. Hyperadrenergic
      Reaction
    quote: Increased AR antibodies due to COVID-19 infection may lead to vasoconstriction and tachycardia, which
      has been proposed as a possible mechanism in POTS [35].
    note: 'Found by winnow, kev and lev in p014, p027, p009. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: 'Autoimmune: Autoimmune responses directed at components of the ANS or other self-antigens may contribute
      to the development and progression of POTS, creating an immunological enigma within the etiological framework
      [40,41].'
    note: 'Found by winnow, kev and lev in p014, p020, p003. Claude judged: supports.'
  - paper: pmid38900132
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38900132. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid38736760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The antibodies that recognize the adrenergic and cholinergic receptors can be considered probably responsible
      for some alterations presented by the patient, namely dysautonomia symptoms and POTS. This hypothesis is supported
      by the fact that most patients with POTS possessed autoantibodies that activated ADRA1, ADRB1, and ADRB2 receptors
      [21].
    note: 'Found by winnow, kev and lev in p001, p019, p020. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.1. Adrenergic
      Receptors
    quote: The autoantibody-mediated vasodilation mechanism of POTS is apparent when an individual stands. The augmented
      sympathetic activity leads to orthostatic tachycardia and palpitations.
    note: 'Found by winnow, kev and lev in p013, p015, p021. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Autoimmunity has been proposed as a possible etiological mechanism in POTS, with high prevalence of diverse
      antibodies in previous reports (Fedorowski, 2019).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Particularly, the production of adrenergic autoantibodies is believed to be an important factor in postinfection
      POTS.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010, p018, p009. Claude judged: supports.'
  - paper: pmid37999672
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37999672. Found by winnow, kev and lev in p025, p005, p006. Claude judged: supports.'
  - paper: pmid37981644
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: We speculate that since acute COVID-19 is known to trigger a profound autoimmune response37,38 and there
      is evidence of autoimmunity being a potential disease mechanism in classical POTS39,40, autoimmune factors
      may be decisive for POTS development in PACS.
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The exact etiology of POTS is still unknown, although in recent years evidence has accumulated that in
      a subset of patients with POTS the pathogenesis of dysautonomia may be immune-mediated.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Etiopathogenic basis
    quote: The pathophysiological mechanisms resulting in autonomic dysfunction in POTS may include sympathetically
      mediated vasoconstriction in the lower limbs (neuropathic POTS), excessive cardiac sympathoexcitation response
      (hyperadrenergic POTS) with increased serum norepinephrine, volume dysregulation (hypovolemia), baroreceptor
      dysfunction, peripheral neuropathy, and autoimmunity due to molecular mimicry following infections by pathogens
      such as Epstein–Barr virus, cytomegalovirus, or Borrelia Burgdorferi (1, 15).
    note: 'Found by winnow, kev and lev in p008, p006, p020. Claude judged: supports.'
  - paper: pmid37631004
    cited: true
    text: full
    license: by
    verdict: supports
    section: 8. Electroceutical Therapy for Autoimmune Disease > 8.7. Postural Orthostatic Tachycardia Syndrome
      (POTS)
    quote: Its origin remains under investigation, and a number of underlying physiopathological mechanisms have
      been proposed, including autoimmune reactions [92]. In support of autoimmune-mediated pathways in POTS is
      the identification in a subgroup of patients expressing serum antiadrenergic autoantibodies capable of exerting
      direct agonist and allosteric effects that alter receptor function [93].
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Some patients with POTS have an increased association with autoimmune disorders, suggesting immune-mediated
      pathophysiology of the autonomic nervous system [16].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid37510775
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Pathophysiological mechanisms underlying this phenomenon are unclear though it is believed that autoimmunity
      may play a crucial role through inappropriate activation of adrenergic and angiotensin receptors [15,16,17,18].
    note: 'Found by winnow, kev and lev in p004, p016. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Main Pathogenesis of POTS
    quote: Based on these findings, autoimmune dysfunction is considered one of the pathogenic mechanisms responsible
      for POTS.
    note: 'Found by winnow, kev and lev in p013, p008. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: An autoimmune basis for a small number of POTS patients has been linked to the observation of orthostatic
      symptoms following a viral illness [11]. Additionally, autoantibodies to the ganglionic nicotinic acetylcholine
      receptor and alpha 1 adrenergic, beta 1 and 2 adrenergic, and angiotensin II type 1 receptors have been detected
      in a few patients.
    note: 'Found by winnow, kev and lev in p005, p006, p001. Claude judged: supports.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > RAAS Abnormalities in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: POTS and COVID-19 > Proposed Mechanisms
    quote: More specific to POTS, adrenergic and muscarinic acetylcholine receptor autoantibodies, dysautonomia,
      small fiber neuropathies, platelet storage pool deficiencies, mast cell dysfunction with dysregulated histamine
      release as well as physical deconditioning have been implicated.31
    note: 'Found by winnow, kev and lev in p015, p018, p010. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response. Few of the patients were detected to have autoantibodies to adrenergic, acetylcholine,
      and angiotensin II receptors [12,15].'
    note: 'Found by winnow, kev and lev in p012, p051, p079. Claude judged: supports.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: supports
    section: Dysautonomia in PASC > What do we know about autonomic dysfunction in PASC?
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Autoimmunity with crossreactivity of antibodies against various viral illnesses towards ganglionic nicotinic
      acetylcholine receptors, alpha-1 and beta-1 and 2 adrenergic receptors, and angiotensin type II receptors
      can lead to POTS [9].
    note: 'Found by winnow, kev and lev in p003, p015. Claude judged: supports.'
  - paper: pmid36873318
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: In recent years, autoimmunity has drawn attention as a potential cause of POTS in some patients.4,5 We
      and others have identified the presence of antiadrenergic autoantibodies in a subgroup of POTS patients.6,
      7, 8
    note: 'Found by winnow, kev and lev in p001, p007, p021. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Although post-COVID-19 autonomic pathophysiology is complex and has not been fully elucidated, autoimmunity
      is thought to be a critical aspect of POTS. Several reports have demonstrated that COVID-19 antibodies cross-react
      with autonomic nervous system components, such as ganglia, nerve fibers, and G-protein-coupled receptors,
      which can trigger dysfunction [3,11].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: The aetiology is uncertain, but the hypothesis that, in some patients at least, POTS may be an autoimmune
      disease (AD) is currently being tested [4].
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid36414707
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Proinflammatory state in POTS
    quote: Growing evidence points toward POTS being an autoimmune disease, oftentimes triggered by a viral or bacterial
      infection28.
    note: 'Found by winnow, kev and lev in p001, p024, p027. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Some cases of neuropathic POTS are thought to arise from immune-mediated neuropathy.
    note: 'Found by winnow, kev and lev in p037, p039. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The pathophysiology of POTS remains unknown, however there is a number of physiological mechanisms that
      have been supposed to be involved. These may include sympathetic dysregulation, hypovolemia, hyperadrenergic
      stimulation, deconditioning12,57, autoantibody mediated response57, and mast cell activation58,59.
    note: 'Found by winnow, kev and lev in p007, p026. Claude judged: supports.'
  - paper: pmid36075372
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction > Other cardiovascular complications associated with COVID-19 vaccines > Arrhythmias
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36075372. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Selected Etiology: Autoimmune > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p066, p067, p062. Claude judged: supports.'
  - paper: pmid36000360
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > POTS phenotypes
    quote: Additionally, autoantibodies against β1, β2, α1, M1, M2 receptors may be responsible for some cases of
      POTS [1,56].
    note: 'Found by winnow, kev and lev in p058, p079. Claude judged: supports.'
  - paper: pmid35992935
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In recent years, an increasing number of studies reported the presence of autoantibodies against G-coupled
      protein receptors in patients with neuropathic POTS, suggesting an immune-mediated pathogenesis in a subset
      of these patients (Li et al., 2014; Fedorowski et al., 2017; Ruzieh et al., 2017; Watari et al., 2018; Gunning,
      et al., 2019).
    note: 'Found by winnow, kev and lev in p005, p025. Claude judged: supports.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p013. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p009, p014. Claude judged: supports.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: supports
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Plausibilität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid35766055
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: 'Abstract > Background:'
    quote: The underlying pathophysiology of POTS is not fully understood, but it has been suggested that autoimmunity
      may play a role.
    note: 'Found by winnow, kev and lev in p001, p032, p005. Claude judged: supports.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005, p006. Claude judged: supports.'
  - paper: pmid35680184
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35680184. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Inflammation and
      Autoimmunity
    quote: In addition, the role for the autoimmune system and inflammation in the aetiology of POTS is supported
      by the increased antibodies and incidence of autoimmune conditions seen in patients with POTS compared to
      controls (46).
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What is the pathophysiology of POTS?
    quote: Postural orthostatic tachycardia syndrome may have an immunological cause. Many patients describe a postviral
      onset,29–32 and 15%–20% of patients with POTS report a history of an autoimmune disorder such as Hashimoto
      thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The etiology of POTS is unknown but a number of laboratories, including ours, have reported elevations
      of G-protein-coupled adrenergic receptor and muscarinic acetylcholine receptor autoantibodies in POTS patients,
      detected by a variety of techniques, suggesting that the disorder is an autoimmune condition.
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid35118574
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35118574. Found by winnow, kev and lev in p001, p004, p005. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS
    quote: Although the exact cause of POTS is unknown at this time, autoimmunity, hypovolemia, genetics, and a
      dysregulation of the autonomic nervous system are all thought to play a role in the syndrome.11
    note: 'Found by winnow, kev and lev in p009, p011. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: There is evidence suggesting a major role for autoimmunity in the pathophysiology of post-viral POTS
      [73]. Patients with POTS have been shown to have a higher prevalence of specific autoantibodies (AAbs), including
      G-Protein coupled receptor (GPCR) antibodies, which could explain an increase in sympathetic tone by activating
      adrenergic receptors and eliciting a negative allosteric effect on muscarinic GPCRs [74,75].
    note: 'Found by winnow, kev and lev in p025, p022. Claude judged: supports.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: 'Most patients with POTS have elevated autoantibodies to at least one of a wide range of receptors associated
      with autonomic function: adrenergic receptors (beta1 and beta2), muscarinic receptors (M2 and M4), acetylcholine
      receptors (N type and P/Q type), opioid-like 1 receptors, and angiotensin II type 1 receptors [8]. These biomarkers
      in patients with POTS reinforce the notion that there is an autoimmune component to its pathophysiology.'
    note: 'Found by winnow, kev and lev in p009, p010. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Besides hypovolemia, anemia, neurodegenerative aspects and connective tissue disorders, autoimmunity
      seems to play an important role in the pathogenesis of PoTS in some patients [[3], [4], [5], [6], [7]].
    note: 'Found by winnow, kev and lev in p006, p009, p023. Claude judged: supports.'
  - paper: pmid34409582
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34409582. Found by winnow, kev and lev in p001, p002, p004. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Putative Mechanisms for Symptomatic Tachycardia in Post-COVID-19 Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid34275953
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34275953. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Immune-mediated mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid34246578
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Pathophysiology of POTS
    quote: These autoantibodies have been proposed to be a unifying mechanistic explanation for the cardiovascular
      changes in POTS, but the role of these antibodies remains unclear.
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Role of immunotherapy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p023, p033. Claude judged: supports.'
  - paper: pmid34127505
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34127505. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid34117922
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: The papers discussed in this month’s journal club build upon previous work exploring autoimmunity as
      a causal factor in a sub-population of patients with POTS disease.
    note: 'Found by winnow, kev and lev in p002, p004, p019. Claude judged: supports.'
  - paper: pmid34055446
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Causes of POTS include abnormal blood pressure regulation, impaired nerve function, and autoimmune conditions.
    note: 'Found by winnow, kev and lev in p011, p002, p010. Claude judged: supports.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Primary partial dysautonomia (or neurogenic) POTS is thought to a pathologic immune-mediated response
      via serum auto-antibodies to α1-adrenergic receptors in vascular smooth muscle, muscarinic M4 receptors, and
      α3-Ach receptors on peripheral ganglia.4
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Some of the common causes of the disorder include the hypothalamus-pituitary-adrenal axis dysfunction,
      mitochondrial and mast cell disorders, cardiac sympathetic dysautonomia, irregular activation of the renin-angiotensin
      system, or a baroreflex dysfunction [3,4]. However, proposed mechanisms suggest an autoimmune basis with autoantibodies
      toward alpha-1 adrenergic receptors, beta-1/beta-2 receptors, M1/M2 muscarinic receptors, and ganglionic N-type
      acetylcholine receptors [3-5].
    note: 'Found by winnow, kev and lev in p001, p008, p003. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Fazit für die Praxis
    quote: COVID-19, das multisystemische Inflammationssyndrom bei Kindern (MIS-C) und das posturale orthostatische
      Tachykardiesyndrom (POTS) nach COVID-19 sind durch Veränderungen der Herzfrequenz und Herzratenvariabilität
      (HRV) gekennzeichnet, die auf eine Beteiligung des autonomen Nervensystems hinweisen.Ursächlich werden eine
      Schädigung des sog. cholinergen antiinflammatorischen Signalweges und die Bildung von Autoantikörpern gegen
      adrenerge- und muskarinerge Rezeptoren diskutiert und in unserem Fall tatsächlich nachgewiesen.
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Fisiopatologia e as apresentações clínicas > Amiloidose
    quote: Estudos demonstraram que a teoria autoimune pode ser o mecanismo fisiopatológico das formas “idiopáticas”
      de algumas síndromes disautonômicas, como a falência autonômica pura (FAP), SPOT ou a síndrome da fadiga crônica.43
    note: 'Found by winnow, kev and lev in p050, p047. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: INTRODUCTION
    quote: The syndrome has been postulated to have post-viral autoimmune activation as a possible etiology (3).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026, p004. Claude judged: supports.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: One of the first reports of elevated autoantibodies in dysautonomia was reported by Vernino and co-workers,
      who proposed that ganglionic acetylcholine receptor (AChR) autoimmunity may cause the condition [12]. A series
      of subsequent publications by this group led them to suggest that a substantial percentage of POTS cases might
      be autoimmune [13,14,15,16].
    note: 'Found by winnow, kev and lev in p002, p003, p005. Claude judged: supports.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: A growing body of evidence has shown that POTS may have an autoimmune basis. Multiple studies have shown
      various autoantibodies in conditions leading to dysautonomia.4,5 Therefore, it was hypothesized that autoantibodies
      against adrenergic and muscarinic receptors may play a prominent role in the pathophysiology of POTS.6
    note: 'Found by winnow, kev and lev in p006, p001, p007. Claude judged: supports.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: There are reports suggesting that POTS may be an autoimmune disorder.13–15 In one study, POTS patients
      had elevated levels of autoantibodies that cross-reacted with beta and muscarinic receptors and resulted in
      tachycardia.15
    note: 'Found by winnow, kev and lev in p010, p011. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Gunning III et al. demonstrated antibodies to alpha-1 adrenergic receptors in 89% and M4 anti-acetylcholine
      receptor antibodies in 53% of a cohort of 55 patients [17]. These studies support an autoimmune basis in a
      substantial number of POTS patients, opening up a window for potential immunotherapy in refractory POTS patients.
    note: 'Found by winnow, kev and lev in p007, p025. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots > Autoimmune Dysfunction
    quote: Autoimmune disturbance has been considered as one of the mechanisms involved in POTS due to frequent
      findings of autoantibodies in patients (11, 86, 87).
    note: 'Found by winnow, kev and lev in p007, p019. Claude judged: supports.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The autoimmune hypothesis of POTS etiology could be a link between immune triggers, such as viral and
      bacterial infections, or vaccinations, as patients often identify a triggering factor with the beginning of
      symptoms. Presence of other autoimmune disorders has been reported in 20% of POTS patients (Blitshteyn, 2015).
    note: 'Found by winnow, kev and lev in p037. Claude judged: supports.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: It has been observed that some patients develop POTS following an infection. This observation has given
      rise to the hypothesis of an autoimmune‐mediated cause of POTS.
    note: 'Found by winnow, kev and lev in p016, p018, p031. Claude judged: supports.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Adrenergic receptor AAb activity in POTS
    quote: This allosteric impact is potentially greater than the direct orthosteric effects, and we believe this
      allosteric modulation is involved in the pathophysiology of POTS [7]. These indirect effects are not measured
      with our standard assay.
    note: 'Found by winnow, kev and lev in p007, p035, p036. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Neuropathic Pots: Midodrine and Pyridostigmine'
    quote: Neuropathic POTS is regarded as a restricted autoimmune autonomic ganglionopathy (AAG), associated with
      auto-antibodies in the ganglionic acetylcholine receptor (30, 31).
    note: 'Found by winnow, kev and lev in p011, p026. Claude judged: supports.'
  - paper: pmid32477718
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A separate study by the Mayo Clinic5 aiming to evaluate the prevalence and pathogenetic mechanisms of
      POTS found that, in a population of 152 patients, at least half of the cases had a neuropathic basis and that
      a substantial percentage of cases could be of autoimmune origin (ie, at least one in seven patients).
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid32321428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Beyond genetic norepinephrine transporter deficiency, several theories have been proposed for the syndrome’s
      etiology, including antiadrenergic autoimmunity [2–4], baroreflex dysfunction [5], deconditioning [6], abnormal
      mast cell activation [1], excessive sympathetic drive and/or sympathetic denervation [7].
    note: 'Found by winnow, kev and lev in p026, p005. Claude judged: supports.'
  - paper: pmid31547756
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: There is an emerging body of evidence that suggests an autoimmune basis for POTS.3 Several studies have
      investigated the presence of autoantibodies in POTS and their effects on cholinergic and adrenergic receptors.3
    note: 'Found by winnow, kev and lev in p003, p004, p005. Claude judged: supports.'
  - paper: pmid31547749
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Background
    quote: Previous studies have demonstrated that functional autoantibodies to adrenergic receptors may be involved
      in the pathogenesis of postural tachycardia syndrome.
    note: 'Found by winnow, kev and lev in p001, p003, p005. Claude judged: supports.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Background
    quote: A growing body of evidence suggests that POTS may be an autoimmune disorder. Antinuclear antibodies and
      elevations of ganglionic, adrenergic, and muscarinic acetylcholine receptor antibodies have all been reported.
    note: 'Found by winnow, kev and lev in p001, p003, p004. Claude judged: supports.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: An autoimmune etiology in POTS is suggested by a number of clinical features (e.g., female predominance,
      preceding viral illness, prior vaccination history, and coexistence of other autoimmune conditions) along
      with autoantibodies.6 Antibody‐mediated autoimmune disorders usually have an HLA class II association.7
    note: 'Found by winnow, kev and lev in p002, p014, p015. Claude judged: supports.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This has led to the hypothesis of an autoimmune-mediated etiology of POTS, and recent case series of
      POTS following immune triggers like infection or vaccination (Blitshteyn, 2015; Brinth et al., 2015; Watari
      et al., 2018) support this hypothesis. It has already been established that activating autoantibodies (AAb)
      to the α1-adrenergic (α1AR), β1/2-adrenergic receptors (β1/2AR), and angiotensin-receptor type 1 can be found
      in serum from POTS patients but not in controls (Fedorowski et al., 2017; Yu et al., 2018).
    note: 'Found by winnow, kev and lev in p003, p005, p027. Claude judged: supports.'
  - paper: pmid30883381
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Comments > Two common causes of hemodynamic orthostatic dizziness/vertigo: OH versus POTS'
    quote: Some patients with POTS have anti-ganglionic (α3) acetylcholine receptor antibody, suggesting a limited
      form of autoimmune autonomic neuropathy [46].
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid30372565
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30372565. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: In some individuals, including those with postconcussive onset of POTS symptoms, POTS may be the consequence
      of an autoimmune mediated autonomic neuropathy, which may require treatment targeted to the autoimmune condition
      in addition to exercise and other standard POTS treatments.
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: An autoimmune basis has been suggested as a causal mechanism of POTS, and several autoreactive IgGs have
      been identified, including ganglionic acetylcholine receptor (gAChR), voltage‐gated potassium channel complex,
      cardiac lipid raft‐associated proteins, α1‐adrenergic receptor, as well as β1‐ and β2‐adrenergic receptors.5,
      6, 7
    note: 'Found by winnow, kev and lev in p003, p001, p015. Claude judged: supports.'
  - paper: pmid29618472
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: Most patients with POTS harbor AT1R antibody activity. This supports the concept that AT1R autoantibodies
      and antiadrenergic autoantibodies, acting separately or together, may exert a significant impact on the cardiovascular
      pathophysiological characteristics in POTS.
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.6 Immune-Mediated
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Autoimmunity and mast cell activation syndromes have been postulated as contributing to the development
      of POTS in some patients, but immunotherapy is rarely indicated and the relevance of autoantibodies and mast
      cells in most patients with POTS remains controversial.3–5
    note: 'Found by winnow, kev and lev in p003, p020. Claude judged: supports.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Aims
    quote: To determine the aetiology of POTS, we examined a possible pathophysiological role for autoantibodies
      against α1-adrenergic (α1AR) and β1/2-adrenergic receptors (β1/2AR).
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Autoimmune/Autoantibodies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p031, p032. Claude judged: supports.'
  - paper: pmid25087056
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25087056. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p068, p044. Claude judged: supports.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Background
    quote: Patients with postural tachycardia syndrome (POTS) have exaggerated orthostatic tachycardia often following
      a viral illness, suggesting autoimmunity may play a pathophysiological role in POTS. We tested the hypothesis
      that they harbor functional autoantibodies to adrenergic receptors (AR).
    note: 'Found by winnow, kev and lev in p001, p003, p006. Claude judged: supports.'
  - paper: pmid24102827
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background And Purpose
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24102827. Found by winnow, kev and lev in p003, p001. Claude judged: supports.'
  - paper: pmid23562385
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23562385. Found by winnow, kev and lev in p001, p014, p016. Claude judged: supports.'
  - paper: pmid23002038
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4 Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23002038. Found by winnow, kev and lev in p004, p005, p019. Claude judged: supports.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction and background
    quote: The research does not support the notion that a single mechanism is responsible for the development of
      cognitive symptoms, since POTS is a diverse syndrome with possible hypovolemic, neuropathic, hyperadrenergic,
      autoimmune, and post-viral subtypes.
    note: 'Found by winnow, kev and lev in p017, p007, p060. Claude judged: partial.'
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: While the pathogenesis of POTS remains incompletely understood, the current literature has documented
      the presence of circulating autoantibodies in affected patients [15,16].
    note: 'Found by winnow, kev and lev in p006, p005. Claude judged: partial.'
  - paper: pmid42037722
    cited: true
    text: full
    license: by
    verdict: partial
    section: Mechanistic phenotypes supporting a compensatory framework > Immune-mediated mechanisms
    quote: 'These findings support immune-mediated perturbations of autonomic signaling in selected patients. Yet
      orthostatic tachycardia can still represent a compensatory final common pathway: immune-mediated vasomotor
      impairment or receptor-level signaling changes reduce effective vascular resistance or venous return, and
      HR rises to preserve perfusion.'
    note: 'Found by winnow, kev and lev in p001, p026. Claude judged: partial.'
  - paper: pmid41103515
    cited: true
    text: full
    license: by
    verdict: partial
    section: Differential diagnosis of OD with PPPD > Hemodynamic orthostatic dizziness > Postural orthostatic tachycardia
      syndrome
    quote: Some patients with POTS possess anti-ganglionic (α3) acetylcholine receptor antibodies, indicating a
      limited form of autoimmune autonomic neuropathy (16).
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Finally, COVID-19 may trigger development of autoantibodies, including antiphospholipid antibodies or
      antibodies against adrenergic and muscarinic receptors, that could then contribute to the cardiovascular manifestations
      of LHC (11, 13).
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid39447442
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39447442. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid38464711
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Another major hypothesis is molecular mimicry and its autoimmune response, specifically G-protein-coupled
      receptors antibodies, which can cause an increased sympathetic tone [5, 20]. The autoimmune mechanism has
      been theorized to be associated with COVID-19-related POTS as well, and the data could also be an explanation
      of the higher prevalence in women due to the pathophysiology behind autoimmune diseases.
    note: 'Found by winnow, kev and lev in p039. Claude judged: partial.'
  - paper: pmid38396973
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Presence of Autoantibodies to gAChR and the Pathomechanism Causing Autonomic Dysfunction
    quote: We mentioned the agonistic mechanism of autoantibodies when we reported on autoimmunity in postural orthostatic
      tachycardia syndrome (POTS) [20]. This discussion was inspired by a report at the time, in the same research
      field, of the presence of autoantibodies that activate receptors in patients with POTS [21,22].
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid37400156
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37400156. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid37388279
    cited: true
    text: full
    license: by
    verdict: partial
    section: 'Long Covid symptoms, effect on organs, and pathological mechanisms > Autonomic system sequelae > Mechanisms
      of autonomic dysfunction > Autoimmune attack:'
    quote: It is speculated that autoimmune mechanisms and autoantibody formation may be involved in the manifestation
      of autonomic symptoms in long Covid (121). It has also been shown that postural tachycardia syndrome and orthostatic
      hypotension are associated with these processes (122).
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37378800
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Watari et al. found that anti-ganglionic nicotinic acetylcholine receptor (gAChR) antibodies occurred
      more frequently in patients with POTS compared to HCs, suggesting that anti-gAChR antibodies may be associated
      with POTS and its underlying autonomic [32].
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: partial
    section: Auto-antibodies in POTS and Long Covid—significance and implications for future study
    quote: Antibodies to the α- and β- adrenoceptors may exert effects in POTS by either impaired vasoconstriction
      (mediated by α-adrenoceptors in the peripheral vasculature) resulting in venous pooling and reduced cardiac
      venous return) or positive chronotropic effects, exacerbating postural heart rate rise [11].
    note: 'Found by winnow, kev and lev in p020, p009, p021. Claude judged: partial.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: COVID-19 vaccination induced autoimmunity
    quote: Autoimmunity may be the key pathogenetic pathway of post-vaccination POTS-like symptoms, particularly
      with adjuvanted mRNA vaccines.
    note: 'Found by winnow, kev and lev in p011, p019, p029. Claude judged: partial.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: Molecular mimicry between microbial agents and the human host hypothetically plays a role in the development
      of autoimmunity. In the three cases of postvaccination POTS, the symptoms and signs were almost identical
      to those of PASC, indicating that COVID-19 vaccines share the same target autoantibody epitope with PASC presenting
      as immune-mediated POTS.
    note: 'Found by winnow, kev and lev in p013, p007. Claude judged: partial.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Autonomic dysfunction in POTS could also be a result of the virus itself or the immune response it stimulates,
      with immune-mediated neurological syndromes having been described.8 In addition, there may also be an association
      with POTS and autoantibodies following COVID-19 illness,9 which suggests an autoimmune component to PASC and
      POTS.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid36509178
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Hospitalization status
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36509178. Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Although the exact mechanism of vaccine-induced POTS is not clear, the autoimmune pathophysiology might
      be a key component [13-15].
    note: 'Found by winnow, kev and lev in p001, p014, p004. Claude judged: partial.'
  - paper: pmid35937046
    cited: true
    text: full
    license: by
    verdict: partial
    section: Postural orthostatic tachycardia syndrome and its possible effect on LQTS
    quote: The underlying mechanism of POTS after COVID-19 vaccines is still unclear. Either autoantibodies against
      α1-adrenergic receptors in the cardiovascular system or diminished response to angiotensin II contributes
      to the impairment of vasoconstriction and induced postural tachycardia.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Discussion
    quote: Furthermore, with cohorts of POTS patients recently being found to have adrenergic or muscarinic autoantibodies
      [36,77,78], and given known MC surface expression of adrenergic and muscarinic receptors which are active
      in the regulation of MC function [36], it even becomes possible, at least in theory, to drive MC activation
      (and thus at least those types of POTS underpinned by MCAS) via such autoantibodies as well.
    note: 'Found by winnow, kev and lev in p020, p021. Claude judged: partial.'
  - paper: pmid34993884
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34993884. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: It can be speculated from previous studies that autonomic nervous dysfunction in patients diagnosed with
      comorbidities of POTS and chronic fatigue syndrome may be related to autoantibodies against G-protein-coupled
      receptors and small fiber neuropathy.41–43 However, at present, the exact role of these antibodies is not
      fully understood.
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid33382525
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Background And Purpose
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33382525. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The Mayo Clinic experience study showed some correlation between autoimmunity and POTS. This study entails
      specific antibodies, such as ganglionic acetylcholine receptor antibody [8] and alpha-1 adrenergic receptor
      antibody that act as partial antagonists and induce reflex compensatory sympathetic activation [9].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid27638661
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: These results could explain the variety of labels that have been used to explain this symptomatology,
      as autoantibodies to these receptors have been previously linked with CRPS, POTS, and CFS [28–31].
    note: 'Found by winnow, kev and lev in p035. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The absence of a distal to proximal gradient in sudomotor deficits, observed by us and by others lends
      additional support to the possibility that an immune-mediated process underlies neuropathic POTS [5,8,37].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p034. Claude judged: partial.'
- edge:
  - hypovolemic_evidence
  - proposed_mechanism_of
  - pots
  papers: 89
  evidence:
  - paper: pmid42342500
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42342500. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Hypovolemia is common in POTS and plays a central role in developing a rapid heart rate, even with normal
      blood pressure.
    note: 'Found by winnow, kev and lev in p030, p031, p029. Claude judged: supports.'
  - paper: pmid42037722
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Despite consistent diagnostic criteria, POTS is mechanistically heterogeneous. Major reviews emphasize
      roles for hypovolemia, venous pooling, deconditioning, peripheral autonomic neuropathy, hyperadrenergic states,
      and immune-mediated mechanisms.
    note: 'Found by winnow, kev and lev in p015, p007, p017. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: These patients have comparatively reduced levels of standing plasma renin activity and aldosterone, which
      can contribute to systemic volume dysregulation [5]. Relative hypovolemia in this case or following either
      poor fluid intake or loss of fluids due to gastrointestinal disorders can lead to the development of secondary
      orthostatic intolerance and eventually POTS [5].
    note: 'Found by winnow, kev and lev in p012, p018. Claude judged: supports.'
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Cardiovascular determinants
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p009, p031. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The precise pathophysiology of POTS is not fully understood but several factors may contribute, including
      hyperadrenergic stimulation, hypovolemia, peripheral autonomic neuropathy, and autoimmunity.6
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40626134
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Central hypovolemia, peripheral vascular dysfunction, and a hyperadrenergic state may contribute to the
      pathogenesis of POTS.
    note: 'Found by winnow, kev and lev in p001, p003, p007. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Our findings demonstrate that an insufficient cerebral blood supply, driven by hypovolemia and impaired
      vascular compliance, combined with autonomic dysregulation, underlies the hallmark tachycardia in Postural
      Orthostatic Tachycardia Syndrome.
    note: 'Found by winnow, kev and lev in p001, p003, p008. Claude judged: supports.'
  - paper: pmid39614968
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: The negative correlation between BV deviation and upright HR indicates that hypovolemia is one of the
      pathophysiological causes of POTS.
    note: 'Found by winnow, kev and lev in p035, p004, p005. Claude judged: supports.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: supports
    section: Overview of POTS > Proposed mechanisms underlying POTS
    quote: Several mechanisms have been proposed as the potential pathophysiology behind POTS and are often labeled
      as the sub-types of neuropathic, hyperadrenergic and hypovolemic POTS (40).
    note: 'Found by winnow, kev and lev in p033, p036. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: 'Thoracic hypovolemia: While dysautonomia is a core feature, a crucial aspect of understanding POTS is
      the concept of thoracic hypovolemia, where a reduction in blood volume within the thoracic cavity leads to
      a diminished venous return [3].'
    note: 'Found by winnow, kev and lev in p011, p020, p013. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome
    quote: POTS is theorized to be the culmination of multiple underlying pathological processes, including peripheral
      neuropathy/denervation, hypovolemia with altered renin–aldosterone levels, and a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p009, p010. Claude judged: supports.'
  - paper: pmid38328599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Hypovolemic postural orthostatic tachycardia syndrome (POTS) is thought to be caused by dysregulated
      circulating blood volume.
    note: 'Found by winnow, kev and lev in p001, p005. Claude judged: supports.'
  - paper: pmid38171114
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: For those with a reduced blood volume as the main mechanism, due to the reduced blood volume, they cannot
      be successfully compensated by increasing the cardiac output during long-term standing, thereby triggering
      reflexive tachycardia and consequently developing POTS.4
    note: 'Found by winnow, kev and lev in p007, p040, p039. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Hypovolemic POTS is due to dysfunction of the renin–angiotensin–aldosterone system resulting in low plasma
      blood volume and may be identified with 24-h urine sodium concentration less than 100 mmol/L1.
    note: 'Found by winnow, kev and lev in p004, p023. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS could result from mild autonomic neuropathy, hypovolemia and abnormal renin-aldosterone response,
      and genetic or acquired deficiency of norepinephrine receptors leading to a hyperadrenergic state [15].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: POTS in children can result from several pathophysiological mechanisms, including peripheral vascular
      dysfunction, hypovolemia, autonomic dysfunction, a hyperadrenergic state, impaired skeletal-muscle pump activity,
      and autoimmune dysfunction [8,9,10].
    note: 'Found by winnow, kev and lev in p010, p003, p005. Claude judged: supports.'
  - paper: pmid37443510
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: POTS is caused by cerebral hypoperfusion in the brain due to a relative lack of blood volume, thus inducing
      orthostatic intolerance symptoms.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In the majority of patients, intravascular volume is reduced, thus leading to decreased venous return
      to the heart and causing reflex tachycardia and orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p005, p001. Claude judged: supports.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p006, p026, p001. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction and background
    quote: The mechanisms proposed to explain POTS include autonomic neuropathy, increased sympathetic tone, a hypovolemic
      state with an altered renin-angiotensin-aldosterone system, and autoimmunity [13-17].
    note: 'Found by winnow, kev and lev in p011, p003, p020. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Various pathophysiologic mechanisms of POTS exist, but some common ones include hypovolemia, autoimmunity,
      and neuropathy. Reduction in intravascular volume can result in decreased venous return to the heart and lead
      to reflex tachycardia.
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The pathophysiology of POTS remains unknown, however there is a number of physiological mechanisms that
      have been supposed to be involved. These may include sympathetic dysregulation, hypovolemia, hyperadrenergic
      stimulation, deconditioning12,57, autoantibody mediated response57, and mast cell activation58,59.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p005, p017. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.2. Physiological Predictors
      for the Oral Rehydration Salts Efficacy in Pediatric POTS
    quote: One of the major underlying causes of POTS is hypovolemia.
    note: 'Found by winnow, kev and lev in p026, p003, p010. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Hypovolaemia
    quote: Firstly, it has been suggested that POTS occurs due to decreased blood volume and deconditioning of the
      heart, which subsequently increases cardiac sympathetic nervous system (SNS) output (24, 32, 33).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: According to the current points of view, relative central hypovolemia, autonomic nervous dysfunction,
      and peripheral vascular dysfunction are speculated to be the mechanisms for POTS,30 which may be enhanced
      by complications with comorbidities.
    note: 'Found by winnow, kev and lev in p023, p031. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Hypovolemia may trigger hyperadrenergic POTS and lead to cerebral hypoperfusion and the impairment of
      central autonomic networks [56].
    note: 'Found by winnow, kev and lev in p022, p023. Claude judged: supports.'
  - paper: pmid34746821
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction > Carotid body – a unifying hypothesis?
    quote: 'Central hypovolemia is a cardinal feature of POTS: evidence supports excessive reduction of central
      blood volume in typical POTS patients when upright and we demonstrated that central blood volume is reduced
      in POTS (Stewart et al., 2018a). This predisposes patients to hypoperfusion of tissues cephalad to the heart,
      causing stagnant hypoxia from reduced carotid blood flow – a key step causing SNA activation (Marshall, 1994;
      Prabhakar et al., 2005) in the pathophysiologic cascade in POTS.'
    note: 'Found by winnow, kev and lev in p006, p001, p010. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Definition of postural orthostatic tachycardia syndrome
    quote: The onset of POTS has been attributed to dysautonomia, hypovolemia, deconditioning, a hyperadrenergic
      physiologic state, hypervigilance (unusual focus on bodily sensations), or any combination of these conditions.1
    note: 'Found by winnow, kev and lev in p004, p015. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p014, p017, p019. Claude judged: supports.'
  - paper: pmid34055686
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Another acknowledged mechanism is central hypovolemia (1, 2).
    note: 'Found by winnow, kev and lev in p026, p027. Claude judged: supports.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Low Blood Volume in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p045, p009, p010. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots > Altered Central Blood Volume
    quote: When hypovolemia exists at rest, the body cannot fully compensate for the decrease in blood volume after
      standing (27), which has to coexist with elevated HR in the upright position (28). Paradoxically, normal plasma
      volumes in patients with POTS have been reported (29, 30), indicating that hypovolemia is not the unique cause
      of POTS.
    note: 'Found by winnow, kev and lev in p008, p009, p010. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pots Subtypes in Children and Adolescents > Hypovolemic POTS
    quote: Central hypovolemia leads to a decrease in venous return, resulting in an increase of heart rate as compensation.
      Low blood volumes have been observed in many children and adolescents with POTS (23, 24).
    note: 'Found by winnow, kev and lev in p010, p011, p018. Claude judged: supports.'
  - paper: pmid32612820
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The pathophysiology remains unknown but many theories have been described including hypovolemia, autonomic
      dysfunction, hyperadrenergic state, adrenergic receptor deficiency, mast cell activation, renin-aldosterone
      paradox and physical deconditioning [10].
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid32112609
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: The main pathogenesis of POTS is hypovolemia, autonomic nervous dysfunction, hyperadrenergic, muscle
      pump dysfunction, and vascular endothelial dysfunction. These mechanisms can appear to co‐exist (Raj, 2013;
      Sheldon et al., 2015; Thanavaro & Thanavaro, 2011).
    note: 'Found by winnow, kev and lev in p018, p006. Claude judged: supports.'
  - paper: pmid31384930
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Several potential underlying mechanisms have been suggested for POTS including autonomic denervation,
      hypovolaemia, hyperadrenergic stimulation, and autoantibodies against adrenergic receptors.2,3
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p002, p001, p014. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: PATHOPHYSIOLOGY OF POTS
    quote: Hypovolemia is often a contributing factor in POTS, as plasma volume, red cell volume, and total blood
      volume are reduced compared with control subjects in studies.28,38 In POTS, the renin-angiotensin-aldosterone
      system responsible for the regulation of plasma volume does not function properly, impairing the typical water
      and sodium retention needed to build plasma volume.39
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.4 Hypovolemia
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid27660311
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27660311. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: 'Abstract > Conclusions:'
    quote: The pathogenesis of POTS is multifactorial, including hypovolemia, abnormal catecholamine state, and
      vascular dysfunction.
    note: 'Found by winnow, kev and lev in p004, p005, p007. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Physiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p011, p013. Claude judged: supports.'
  - paper: pmid25792354
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25792354. Found by winnow, kev and lev in p022, p004. Claude judged: supports.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: supports
    section: Neurovisceral phenotypes > Postural Tachycardia Syndrome > Clinical picture and autonomic dysfunction
    quote: However, hypovolemia, abnormalities of the noradrenaline transporter (Esler et al., 2006; Lambert et
      al., 2008; Bayles et al., 2012), infection (Schondorf and Low, 1993), deconditioning (Parsaik et al., 2012),
      and poor orthostatic cerebral autoregulation (Ocon et al., 2009) are also implicated in Postural Tachycardia
      Syndrome pathophysiology.
    note: 'Found by winnow, kev and lev in p009, p021. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Another common pathophysiological mechanism in POTS is a hypovolemic state. Many POTS patients with a
      hypovolemic state have been found to have a perturbed renin-angiotensin-aldosterone profile.
    note: 'Found by winnow, kev and lev in p009, p001, p004. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p072, p040. Claude judged: supports.'
  - paper: pmid22721633
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22721633. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid22247480
    cited: true
    text: full
    license: none
    verdict: supports
    section: Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22247480. Found by winnow, kev and lev in p030, p006. Claude judged: supports.'
  - paper: pmid21266211
    cited: true
    text: full
    license: none
    verdict: supports
    section: Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21266211. Found by winnow, kev and lev in p029, p001, p007. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Objectives
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p035, p041, p001. Claude judged: supports.'
  - paper: pmid20479333
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20479333. Found by winnow, kev and lev in p002, p013, p015. Claude judged: supports.'
  - paper: pmid11201632
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11201632. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid42591853
    cited: true
    text: full
    license: by
    verdict: partial
    section: ME/CFS as a low output syndrome due to small heart > Orthostatic intolerance (OI) (classical mechanism)
    quote: It has been reported that patients with postural orthostatic tachycardia, which is often observed in
      patients with chronic OI and/or ME, have a smaller heart coupled with reduced blood volume compared with healthy
      controls (53, 54). Using cardiac magnetic resonance imaging, Fu et al. (53) precisely assessed heart size,
      mass, and blood volume in POTS patients and found that all of these parameters were significantly lower compared
      with healthy sedentary controls.
    note: 'Found by winnow, kev and lev in p013, p021. Claude judged: partial.'
  - paper: pmid42114076
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Recent Findings
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42114076. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Hypovolemia, whether central or secondary to nutritional compromise, can drive the symptoms of POTS [6].
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid41976810
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: 'Sheldon et al. [6] summarise two possible mechanisms for PoTS: firstly, autonomic denervation leading
      to impaired peripheral venoconstriction, which leads to venous pooling, hypovolaemia, and hyperadrenergic
      stimulation with raised plasma norepinephrine levels, or, secondly, deconditioning, which may be compounded
      by anxiety and hypervigilance secondary to the underlying physiological abnormalities.'
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid41703216
    cited: true
    text: full
    license: by
    verdict: partial
    section: Body
    quote: Other studies demonstrate small cardiac chamber size and low stroke volume, indicating reduced cardiac
      filling pressures and impaired venous return [3]. These hemodynamic abnormalities likely contribute to orthostatic
      tachycardia.
    note: 'Found by winnow, kev and lev in p002, p001. Claude judged: partial.'
  - paper: pmid40944681
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: The patient's marked tachycardia in both supine and standing postures with associated symptoms of orthostatic
      intolerance observed after starting tirzepatide may be linked to the combination of lower-than-normal plasma
      volume for her size, which could contribute to a small standing stroke volume, and the drug's action as a
      dual GIP and GLP-1 receptor agonist.
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CBF in OI > CBF in POTS
    quote: More than 50% of POTS participants presented with central hypovolemia, resulting primarily from blood
      sequestration within the splanchnic vasculature, leading to reduced upright cerebral blood volume.
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Cardiovascular deconditioning may be implicated in POTS via cardiac atrophy and hypovolemia causing reactive
      tachycardia.[9]
    note: 'Found by winnow, kev and lev in p009, p039. Claude judged: partial.'
  - paper: pmid39297140
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion > Impaired systemic hemodynamic status in POTS
    quote: Moreover, many patients with POTS have low blood volumes,2 which could also contribute to reduced stroke
      volume and, in turn, reduced brain perfusion. Further investigations into the role of peripheral venous hemodynamic
      status and impaired blood volume regulation as a mechanism driving postural ventilation are warranted.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. The Role of Fibrinaloid Microclots in POTS
    quote: Other mechanisms for POTS in long COVID may include:Relative hypovolemia secondary to inadequate peripheral
      vasoconstriction.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid38287400
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The “low-flow” POTS proposed by Stewart [24] is also characterized by a decrease in central blood volume,
      similar to the hemodynamic characteristics of the Su group.
    note: 'Found by winnow, kev and lev in p029, p031. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Pathophysiology of POTS
    quote: A significant number of POTS patients demonstrate a state of chronic intravascular hypovolaemia.[3] Abnormal
      RAAS activity, characterised by inadequate aldosterone secretion by angiotensin II, is the main mechanism
      of hypovolaemia.[13]
    note: 'Found by winnow, kev and lev in p008, p010. Claude judged: partial.'
  - paper: pmid36000360
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > POTS phenotypes
    quote: Several recent studies [1,3,11] speculate that POTS comprise multiple phenotypes including hyperadrenergic,
      neuropathic and hypovolaemic POTS.
    note: 'Found by winnow, kev and lev in p051, p079, p084. Claude judged: partial.'
  - paper: pmid34268642
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic Disorders and Headache
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34268642. Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A subset of patients with POTS has low levels of standing plasma renin activity, aldosterone, and blood
      volume as compared to normovolemic patients [10].
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid32983103
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pediatric VVS and/or POTS Comorbid With Allergic Diseases > Pathogenesis
    quote: At present, it is believed that several mutual mechanisms, including the relative central hypovolemia,
      the dysregulation of peripheral vascular tone, and the imbalance of sympathetic and vagal functions, can all
      reduce the cardiac output when one stands upright and ultimately result in syncope in children with VVS and/or
      POTS (18, 19).
    note: 'Found by winnow, kev and lev in p006, p008. Claude judged: partial.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: partial
    section: Dr. Mehdirad remarks > Mechanisms and symptoms
    quote: Hypovolemia or excessive lower-extremity and splanchnic venous pooling results in inadequate venous return,
      which may possibly explain some of the manifestations of POTS.14
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Orthostatic Cardiovascular Responses Are Impaired in Patients With Vasovagal Syncope
      and Postural Orthostatic Tachycardia Syndrome
    quote: Another contributor to most forms of orthostatic syncope in adults is hypovolemia, which may be associated
      with impaired renal sodium reabsorption in patients with POTS (Raj, 2013).
    note: 'Found by winnow, kev and lev in p015, p012. Claude judged: partial.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The pathogenesis of POTS is still unclear, possibly including autonomic dysfunction (Shannon et al.,
      2000), excessive vasodilation (Liao et al., 2013), and low central blood volume (Zhang et al., 2012).
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid31405524
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31405524. Found by winnow, kev and lev in p008, p028. Claude judged: partial.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Patients with this syndrome have a partial neuropathic state with impaired lower extremity sympathetic
      innervation, abnormal venous pooling, and hypovolemic state with low renin–angiotensin–aldosterone system
      upregulation [24]. A study showed that some patients with POTS had inappropriately normal levels of plasma
      renin activity and paradoxically lower levels of aldosterone despite their hypovolemia when compared to healthy
      subjects [25].
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: Several mechanisms have been proposed for the development of these symptoms including sympathetic denervation
      and central causes such as sympathetic overdrive, hypovolemia, and involvement of the renin-angiotensin-aldosterone
      system.
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid29451148
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: DISCUSSION
    quote: In 1940, MacLean and Allen first reported the presence of hypovolemia in children with POTS, and further
      studies revealed an increased venous capacity in the lower extremities of children with POTS attributable
      to the local anatomy and functional abnormality of the lower limbs.[1617]
    note: 'Found by winnow, kev and lev in p022. Claude judged: partial.'
  - paper: pmid27936059
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Convertino, et al. showed that low blood volume might cause increase in BRS [42]. When POTS patients
      change to upright position from supine position, returned blood volume decreases, and cardiac output decreases;
      at this time, if BRS increases abnormally, it would cause an over excitation caused by sympathetic nervous
      system reflectively when blood pressure of patients decreases slightly, thus to cause an over increase in
      heart rate of children at upright position.
    note: 'Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid26814068
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Objective
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26814068. Found by winnow, kev and lev in p001, p004. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Hemodynamic Physiology of Standing
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p004, p025, p024. Claude judged: partial.'
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid25474569
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Studies indicated that POTS patients, with hypovolemia, had inadequate venous return to the heart in
      an upright position [11]–[13].
    note: 'Found by winnow, kev and lev in p029, p006, p027. Claude judged: partial.'
  - paper: pmid25168872
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Though we did not measure intravascular volume in our patients, one could propose, an alternative, cogent,
      and coherent, interpretation of these observations. Development of the POTS phenotype begins with abnormal
      sympathetic regulation of volume status via renin‐angiotensin system (Garland et al. 2007) leading to volume
      depletion.
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Hypovolemia & Blood Volume Regulation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p023, p015, p020. Claude judged: partial.'
  - paper: pmid16262605
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16262605. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid9244228
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 9244228. Found by winnow, kev and lev in p003. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - proposed_mechanism_of
  - pots
  papers: 83
  evidence:
  - paper: pmid42342500
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42342500. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid42037722
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Despite consistent diagnostic criteria, POTS is mechanistically heterogeneous. Major reviews emphasize
      roles for hypovolemia, venous pooling, deconditioning, peripheral autonomic neuropathy, hyperadrenergic states,
      and immune-mediated mechanisms.
    note: 'Found by winnow, kev and lev in p022, p001, p007. Claude judged: supports.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In neuropathic POTS, peripheral autonomic injury—primarily small‐fiber neuropathy—is a core mechanism.
      This peripheral denervation leads to impaired vasoconstriction in the lower extremities, resulting in excessive
      venous pooling during orthostatic stress, which “passively” triggers compensatory tachycardia.
    note: 'Found by winnow, kev and lev in p023, p025, p004. Claude judged: supports.'
  - paper: pmid41675297
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: This is generally differentiated from neuropathic POTS, which is felt to relate to redistributive central
      hypovolemia in the upright position as opposed to absolute hypovolemia. This is hypothesized to be due to
      small fiber neuropathy leading to decreased adrenergic vasoconstriction in the legs or the splanchnic vasculature,
      causing baroreflex unloading, decreased reflex cardiovagal stimulation, increased reflex sympathetic excitation,
      and reflex tachycardia.46
    note: 'Found by winnow, kev and lev in p048, p059. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This subtype of POTS is presumed to occur due to the impaired sympathetically mediated peripheral vasoconstriction,
      leading to venous pooling in the lower limbs. This sympathetic denervation can cause an impairment of sweating
      in the lower extremities and reduced release of norepinephrine [5].
    note: 'Found by winnow, kev and lev in p016, p093. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Small fiber neuropathy is regarded as one of the potential mechanisms underlying the pathophysiology
      of POTS [20], and in our cohort, QSART abnormalities indicating postganglionic small fiber dysfunction occurred
      with similar frequency in post-COVID and post-vaccination POTS.
    note: 'Found by winnow, kev and lev in p045. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion
    quote: The majority of POTS patients require numerous visits to several physicians of different disciplines
      to be accurately diagnosed due to the multitude of conflicting clinical symptoms (78–80). Hypotheses regarding
      pathophysiology include abnormally increased sympathetic activity, sympathetic denervation leading to hypovolemia
      and reflex tachycardia, and autoimmunity to G-protein coupled receptors (2, 3, 79, 81, 82).
    note: 'Found by winnow, kev and lev in p026, p024. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The precise pathophysiology of POTS is not fully understood but several factors may contribute, including
      hyperadrenergic stimulation, hypovolemia, peripheral autonomic neuropathy, and autoimmunity.6
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40608783
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: It is estimated that approximately 50% of the POTS population have a neuropathic mechanism behind their
      symptoms [2], although no diagnostic criteria for neuropathic POTS exist [9].
    note: 'Found by winnow, kev and lev in p005, p036. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Migraine Headaches
    quote: Post-ganglionic sympathetic denervation and amplified sympatho– adrenomedullary axis activity are felt
      to be related to the pathophysiology of neurogenic and hyperadrenergic POTS, respectively.
    note: 'Found by winnow, kev and lev in p034, p027, p032. Claude judged: supports.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Despite similar clinical characteristics, POTS is likely a heterogeneous group of disorders. These include
      an autoimmune mechanism associated with antibodies to the postsynaptic acetylcholine receptors of the autonomic
      nerves, high levels of circulating norepinephrine as a result of a genetically determined malfunction of norepinephrine
      reuptake proteins, and importantly, a form of autonomic cardiac neuropathy.
    note: 'Found by winnow, kev and lev in p009, p007. Claude judged: supports.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: supports
    section: Overview of POTS > Proposed mechanisms underlying POTS
    quote: Several mechanisms have been proposed as the potential pathophysiology behind POTS and are often labeled
      as the sub-types of neuropathic, hyperadrenergic and hypovolemic POTS (40).
    note: 'Found by winnow, kev and lev in p034, p065, p033. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Sympathetic denervation, characterized by a decrease in sympathetic nerve activity, is another factor
      contributing to autonomic dysfunction in POTS [38]. This denervation disrupts the intricate coordination between
      the nervous and cardiovascular systems, ultimately giving rise to the hallmark symptoms of POTS.
    note: 'Found by winnow, kev and lev in p012, p013. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p005, p029. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p002, p024. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome
    quote: POTS is theorized to be the culmination of multiple underlying pathological processes, including peripheral
      neuropathy/denervation, hypovolemia with altered renin–aldosterone levels, and a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Symptoms and clinicopathologic features of dysautonomia
    quote: Neuropathic POTS is associated with reduced intraepidermal and/or sudomotor (i.e., sweat gland) nerve
      fiber density on skin biopsy indicative of a small-fiber sensory or autonomic neuropathy. It is hypothesized
      that damage to sympathetic vasomotor nerves impairs the compensatory increase in systemic vascular resistance
      during orthostatic stress and/or during exercise, resulting in splanchnic and/or lower limb pooling and reduced
      cerebral blood flow.
    note: 'Found by winnow, kev and lev in p006, p007, p017. Claude judged: supports.'
  - paper: pmid37968647
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Small fiber neuropathy (SFN) has been suggested to be a possible mediator of POTS [16]. SFN can affect
      both autonomic and sensory fibers [17].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Etiopathogenic basis
    quote: The pathophysiological mechanisms resulting in autonomic dysfunction in POTS may include sympathetically
      mediated vasoconstriction in the lower limbs (neuropathic POTS), excessive cardiac sympathoexcitation response
      (hyperadrenergic POTS) with increased serum norepinephrine, volume dysregulation (hypovolemia), baroreceptor
      dysfunction, peripheral neuropathy, and autoimmunity due to molecular mimicry following infections by pathogens
      such as Epstein–Barr virus, cytomegalovirus, or Borrelia Burgdorferi (1, 15).
    note: 'Found by winnow, kev and lev in p006, p008. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS could result from mild autonomic neuropathy, hypovolemia and abnormal renin-aldosterone response,
      and genetic or acquired deficiency of norepinephrine receptors leading to a hyperadrenergic state [15].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. The Development of POTS and Its Associated Manifestations
    quote: Neuropathic POTS is characterized by reduced vessel vasoconstriction in the lower extremities. In neuropathic
      POTS, the dilation of blood vessels causes central blood to be redistributed while standing, leading to compensatory
      tachycardia in response to the orthostatic challenge [19].
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: This case report is about a patient with post-viral neuropathic POTS. Neuropathic POTS is believed to
      be due to the damage of small nerve fibers that regulate the constriction of the blood vessels in the limb
      and abdomen, which leads to interference with vasoconstriction, and therefore causes tachycardia.
    note: 'Found by winnow, kev and lev in p003, p015, p001. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Multiple subtypes of POTS have been proposed, including a neuropathic subtype estimated to be present
      in 50% of POTS patients [3]. In these patients, POTS is hypothesized to be a result of partial sympathetic
      denervation, which leads to inadequate vasoconstriction in the legs upon standing upright, provoking compensatory
      tachycardia [4].
    note: 'Found by winnow, kev and lev in p005, p037, p007. Claude judged: supports.'
  - paper: pmid36111700
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: The precise aetiology of POTS remains unknown, although the haemodynamic changes are thought to reflect
      convergence of multiple pathophysiological processes including peripheral autonomic neuropathy, hypovolemia,
      elevated sympathetic tone, deconditioning and auto‐antibodies to cardiovascular receptors [7].
    note: 'Found by winnow, kev and lev in p006, p027. Claude judged: supports.'
  - paper: pmid36000360
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > POTS phenotypes
    quote: Neuropathic POTS is caused by partial neuropathy of the lower body vasculature, which causes abnormal
      blood pooling in the lower extremities.
    note: 'Found by winnow, kev and lev in p050, p066, p079. Claude judged: supports.'
  - paper: pmid35992935
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Neuropathic POTS is the most common type and is thought to be caused by peripheral sympathetic noradrenergic
      denervation leading to increased venous pooling (Jacob et al., 2000; Peltier et al., 2010).
    note: 'Found by winnow, kev and lev in p005, p024. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mechanisms
    quote: Neuropathic mechanisms may play a pathophysiologic role in approximately one half of patients diagnosed
      with POTS and are thought to be due to partial autonomic denervation and failure of the vasculature of the
      lower extremities to maintain resistance while in an upright position.14,15
    note: 'Found by winnow, kev and lev in p011, p017. Claude judged: supports.'
  - paper: pmid34674068
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Neuropathic POTS is characterized by dysfunction of the peripheral sympathetic nerves predominantly affecting
      the lower limbs. The consequently impaired peripheral vasoconstriction leads to excessive venous blood pooling
      during orthostasis [2, 4].
    note: 'Found by winnow, kev and lev in p021, p004, p005. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p014, p017. Claude judged: supports.'
  - paper: pmid34127505
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34127505. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 15
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p023, p039. Claude judged: supports.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Several lines of evidence support the concept that neuropathic POTS in some individuals is due to a restricted
      peripheral neuropathy; specifically, sympathetic denervation predominantly in the lower hemibody with preservation
      or relative preservation of cardiac sympathetic innervation.
    note: 'Found by winnow, kev and lev in p006, p007, p027. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026, p003. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Neuropathic POTS is usually due to a partial autonomic neuropathy leading to impaired sympathetically-mediated
      vasoconstriction of the lower limbs, leading to venous pooling and impaired venous return.
    note: 'Found by winnow, kev and lev in p007, p022. Claude judged: supports.'
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: The underlying pathophysiological mechanisms leading to POTS are not completely understood. However,
      it seems that there are two main types of POTS, the adrenergic and neuropathic type (10).
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pots Subtypes in Children and Adolescents > Neuropathic POTS
    quote: Partial autonomic neuropathy is the characteristics of this subtype of POTS. The main mechanism of this
      type of POTS is patchy denervation of the sympathetic fibers to the blood vessels in the extremities (28).
    note: 'Found by winnow, kev and lev in p011, p022, p026. Claude judged: supports.'
  - paper: pmid32477718
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A separate study by the Mayo Clinic5 aiming to evaluate the prevalence and pathogenetic mechanisms of
      POTS found that, in a population of 152 patients, at least half of the cases had a neuropathic basis and that
      a substantial percentage of cases could be of autoimmune origin (ie, at least one in seven patients).
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid32284866
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Neuropathic POTS, thought to account for at least half of cases,22 is characterised by distal, predominantly
      lower extremity denervation which may impair vasoconstriction and increase gravitational venous pooling.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid32222376
    cited: true
    text: full
    license: none
    verdict: supports
    section: Etiology and the concepts of primary and secondary POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32222376. Found by winnow, kev and lev in p020, p003, p021. Claude judged: supports.'
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Orthostatic Cardiovascular Responses Are Impaired in Patients With Vasovagal Syncope
      and Postural Orthostatic Tachycardia Syndrome
    quote: Indeed, some forms of POTS reflect selective neuropathy, with sympathetic denervation and impaired vascular
      resistance responses affecting the lower limbs (Raj, 2013).
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: PATHOPHYSIOLOGY OF POTS
    quote: Approximately 50% of people with POTS experience a partial sympathetic denervation of blood vessels in
      the lower extremities, resulting in a reduced vasoconstriction response during upright posture, sometimes
      referred to as neuropathic POTS.30,40 Impaired venous return upon standing causes blood pooling in the lower
      limbs and within the abdominal cavity, which lowers stroke volume and results in compensatory tachycardia
      and reduced exercise capacity.
    note: 'Found by winnow, kev and lev in p015, p031. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p003, p024, p014. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.1 Partial Sympathetic Neuropathy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p016, p015. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid27938459
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27938459. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid27660311
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27660311. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid26610893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: INTRODUCTION
    quote: The pathophysiological mechanisms underlying POTS are also diverse and multifactorial, and include hypovolemia,5
      hyperadrenergic states,6 lower-extremity neuropathies,7 and deconditioning.8
    note: 'Found by winnow, kev and lev in p005, p013. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p023, p019. Claude judged: supports.'
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: POTS on the other hand may involve sympathetic denervation in the lower limbs, a hyperadrenergic state
      and/or abnormalities in the NET.
    note: 'Found by winnow, kev and lev in p016, p020. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS (Table 1)
    quote: POTS is a heterogeneous syndrome with several different pathophysiological mechanisms that can result
      in the typical POTS presentation, and a few more common ones are highlighted in this manuscript (Figure 1)
      (Raj, 2013). Neuropathic POTS is a condition with a partial neuropathy where there is preferential denervation
      of sympathetic nerves in the lower limbs that may account for local/regional blood flow abnormalities including
      venous pooling (Jacob et al., 2000; Stewart et al., 2003).
    note: 'Found by winnow, kev and lev in p004, p005, p008. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p044, p068. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Several lines of evidence point to a restricted peripheral neuropathy, specifically, sympathetic denervation
      predominantly in the lower hemibody, as a cause of POTS in some individuals.
    note: 'Found by winnow, kev and lev in p040, p006, p030. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Pathogenesis of POTS is heterogenous and may include sympathetic hyperactivity with peripheral denervation,
      hypovolemia, and physical deconditioning [3].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid23244360
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Common variant OI: POTS & postural VVS > Postural tachycardia syndrome'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23244360. Found by winnow, kev and lev in p018, p017. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > POTS Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p010, p017. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: 'Three main groups have been identified: neuropathic, hyperadrenergic and POTS related to deconditioning
      [1]. In the neuropathic form, a restricted autonomic neuropathy with partial sympathetic denervation is present
      and predominates in the lower limbs [6], with an inability of the peripheral vasculature to constrict in response
      to orthostatic stress.'
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Pathophysiology
    quote: Many authors speculate on the possible causes for this, including impaired venous innervation and/or
      reduced venous response to sympathetic stimulation.[3] This theory supports a neuropathy that mainly affects
      the lower extremities.
    note: 'Found by winnow, kev and lev in p010, p016. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p034, p009. Claude judged: supports.'
  - paper: pmid20185461
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20185461. Found by winnow, kev and lev in p003, p007. Claude judged: supports.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p003, p018, p031. Claude judged: supports.'
  - paper: pmid17898925
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 17898925. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid17352367
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 17352367. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Considering that POTS patients have high plasma NE levels, it would seem paradoxical that a neuropathy
      is proposed as an underlying process. Yet some of them have a form of dysautonomia, with preferential denervation
      of sympathetic nerves innvervating the lower limbs [22-24].
    note: 'Found by winnow, kev and lev in p024, p027, p042. Claude judged: supports.'
  - paper: pmid12577219
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Method
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 12577219. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid11408377
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11408377. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid11018167
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11018167. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid9868411
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 9868411. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid9848003
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 9848003. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid8423877
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 8423877. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Small fiber neuropathy, characterized by damage to the small nerve fibers that control autonomic functions,
      is often associated with conditions like diabetes and autoimmune diseases, and its emergence in post-COVID-19
      patients suggests a potential neuropathic component to the pathophysiology of Long-COVID POTS.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. The Role of Fibrinaloid Microclots in POTS
    quote: Small fiber neuropathy (SFN) has been well described in long COVID (e.g., [63,65,68,172]) and is a recognized
      cause of dysautonomia in the condition.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A small fiber neuropathy may be present in up to 50% of POTS cases and contributes to dysautonomia as
      seen in our patient.
    note: 'Found by winnow, kev and lev in p003, p004, p006. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Neurotropism
    quote: Thus, it has been proposed that SARS-Cov2 could infect and damage extracardiac postganglionic SNS, leading
      to dysautonomia in a similar way to neuropathic POTS. This disruption could lead to tachycardia due to splanchnic
      venous pooling or reduced mesenteric vasoconstriction during orthostasis (24).
    note: 'Found by winnow, kev and lev in p008, p006. Claude judged: partial.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Moreover, small fiber neuropathy (SFN, neuropathic PoTS) could be detected in around 50 % of patients
      with PoTS [[8], [9], [10]]. Small fiber neuropathy preferentially affects unmyelinated C-fibers, thinly myelinated
      A-δ somatosensory axons and sympathetic and parasympathetic neurons.
    note: 'Found by winnow, kev and lev in p006, p005, p007. Claude judged: partial.'
  - paper: pmid34055418
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The association between POTS and JHS can be explained by predominant peripheral neuropathy in the autonomous
      system and a failure of the peripheral vascular system to maintain resistance in areas exposed to stress due
      to orthostasis, blood stasis in the lower limbs, or pathologies of the central nervous system [11]. The result
      is a functional decrease in blood volume with compensation given by increased heart rate and myocardia contractility.
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patient's with postural tachycardia syndrome have peripheral autonomic dysfunction.
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Much of the evidence in literature indicates that POTS may be a restricted autonomic neuropathy and our
      findings may support this conclusion.
    note: 'Found by winnow, kev and lev in p034. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p004, p031, p033. Claude judged: partial.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Patients with this syndrome have a partial neuropathic state with impaired lower extremity sympathetic
      innervation, abnormal venous pooling, and hypovolemic state with low renin–angiotensin–aldosterone system
      upregulation [24].
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid19687022
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19687022. Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid11198483
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11198483. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - proposed_mechanism_of
  - pots
  papers: 66
  evidence:
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Among proposed etiologies for POTS, Epstein–Barr virus and other pathogens have been identified as potential
      initiating events; frequently, patients report a history of mononucleosis prior to development of debilitating
      symptoms [24].
    note: 'Found by winnow, kev and lev in p006, p036. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Besides small fiber neuropathy, proposed POTS mechanisms include immune-mediated inflammation triggered
      by autoantigens or persistent viral particles [11, 20]. The short latency between infection and symptoms onset
      observed in most cases indicates a direct immune-mediated process, and the stronger immune responsiveness
      of younger individuals may predispose them to POTS development both after COVID-19 infection and vaccination.
    note: 'Found by winnow, kev and lev in p047, p037. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Introduction
    quote: The etiology of POTS has not been entirely defined, but researchers have speculated that an immunological
      stressor such as a viral infection might be an initiating event.
    note: 'Found by winnow, kev and lev in p007, p001, p006. Claude judged: supports.'
  - paper: pmid40977456
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: However, in our discussion, we specifically addressed the potential role of viral infections and autoimmune
      mechanisms in the development of POTS.
    note: 'Found by winnow, kev and lev in p008, p010, p015. Claude judged: supports.'
  - paper: pmid40763323
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Increased viral exposure may have triggered autoimmune mechanisms that contribute to the pathogenesis
      of POTS.
    note: 'Found by winnow, kev and lev in p024, p006. Claude judged: supports.'
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. POTS, Long COVID and the CNS
    quote: Pre-pandemic, POTS was known to occur after a viral or bacterial infection in at least 40% of patients
      and was thought to be of heterogeneous and complex pathophysiology involving central and peripheral autonomic
      nervous system networks, small fiber neuropathy, cerebral hypoperfusion, mast cell hyperactivity and autoimmunity
      [9,10,11].
    note: 'Found by winnow, kev and lev in p005, p008, p011. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > COVID-19 Infection and
      Post-viral Postural Orthostatic Tachycardia Syndrome
    quote: Even though an exact mechanism has not been identified, it is suggested that autoimmune responses to
      viral illness may trigger POTS, with up to 50% of POTS patients reporting a viral illness preceding their
      symptoms.[22]
    note: 'Found by winnow, kev and lev in p011, p032. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The underlying causes of POTS following COVID-19 remain unknown, with various theories proposed such
      as renin–angiotensin–aldosterone system (RAAS) dysregulation, hyperadrenergic reaction, and direct viral infection.
    note: 'Found by winnow, kev and lev in p001, p009, p027. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: The onset of POTS is frequently linked to triggers, such as long COVID-19, the human papillomavirus (HPV)
      vaccine, infections, or trauma, which can subsequently lead to immunological changes.
    note: 'Found by winnow, kev and lev in p014, p020. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: The underlying cause of dysautonomia post-COVID-19 infection is not well understood. However, a viral
      infection by SARS-CoV-2 triggering autoimmune response and direct neurotoxic effects has been suggested as
      an underlying cause for developing post-COVID-19 POTS [57,58].
    note: 'Found by winnow, kev and lev in p027, p006. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dysautonomia and small-fiber neuropathy often occur as a complication of certain infections
    quote: Approximately half of patients with POTS report symptoms of a preceding infection (3). Infectious causes
      of POTS include EBV, herpes viruses, flavivirus, enterovirus 71, retroviruses (HIV), and SARS-CoV-2 (7).
    note: 'Found by winnow, kev and lev in p003, p002, p007. Claude judged: supports.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: "Particularly, the production of adrenergic autoantibodies is believed to be an important factor in postinfection\
      \ POTS.\n30\n Originally, approximately 40% of POTS cases are reported to occur after some infectious diseases."
    note: 'Found by winnow, kev and lev in p026, p009. Claude judged: supports.'
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Up to 50% of patients with POTS describe a viral infection as the trigger of their symptoms.
    note: 'Found by winnow, kev and lev in p005, p024. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Etiopathogenic basis
    quote: The pathophysiological mechanisms resulting in autonomic dysfunction in POTS may include sympathetically
      mediated vasoconstriction in the lower limbs (neuropathic POTS), excessive cardiac sympathoexcitation response
      (hyperadrenergic POTS) with increased serum norepinephrine, volume dysregulation (hypovolemia), baroreceptor
      dysfunction, peripheral neuropathy, and autoimmunity due to molecular mimicry following infections by pathogens
      such as Epstein–Barr virus, cytomegalovirus, or Borrelia Burgdorferi (1, 15).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: It is considered a relatively rare condition that affects approximately 0.2% of the general population,
      and it is estimated that between 500,000 to 1,000,000 individuals in the United States have the condition
      and recently has been linked to post-infectious (viral) etiologies.
    note: 'Found by winnow, kev and lev in p005, p006, p001. Claude judged: supports.'
  - paper: pmid37209261
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction > Mechanisms of Cardiac Damage
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37209261. Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be due to an autoimmune
      response.
    note: 'Found by winnow, kev and lev in p012, p001, p017. Claude judged: supports.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: supports
    section: Dysautonomia in PASC > What do we know about autonomic dysfunction in PASC?
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: More recently, dysautonomia has been observed in patients with coronavirus disease 2019 (COVID-19), and
      POTS has been identified as a possible long-term manifestation of COVID-19. It has also been found that the
      severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) virus binds to the angiotensin-converting enzyme
      2 (ACE2) receptor, possibly causing hyperadrenergic POTS [3].
    note: 'Found by winnow, kev and lev in p001, p003, p015. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Several conditions, including infection, surgery, and pregnancy, can precipitate or even exacerbate POTS.
      The chief etiology is usually post-infection, which has been reported with COVID-19.
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p006, p007. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: It is postulated that the cytokine storm from COVID-19 results in sympathetic dysregulation, causing
      an abnormal autonomic response in POTS.7 The relationship between heart rate variability due to this autonomic
      failure and inflammatory factors from infection has been well studied.7
    note: 'Found by winnow, kev and lev in p023, p002, p011. Claude judged: supports.'
  - paper: pmid36414707
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Proinflammatory state in POTS
    quote: Growing evidence points toward POTS being an autoimmune disease, oftentimes triggered by a viral or bacterial
      infection28.
    note: 'Found by winnow, kev and lev in p024, p002. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p014, p017. Claude judged: supports.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid35680184
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35680184. Found by winnow, kev and lev in p002, p004. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What is the pathophysiology of POTS?
    quote: Postural orthostatic tachycardia syndrome may have an immunological cause. Many patients describe a postviral
      onset,29–32 and 15%–20% of patients with POTS report a history of an autoimmune disorder such as Hashimoto
      thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: With associations of viral infections as a potential etiology of POTS and evidence that many COVID-19
      long haulers are developing POTS, platelets may also play a significant role in the etiology or perpetuation
      of the disorder.
    note: 'Found by winnow, kev and lev in p003, p002, p017. Claude judged: supports.'
  - paper: pmid35181863
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35181863. Found by winnow, kev and lev in p005, p001, p002. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Infections are known triggers of dysautonomia, particularly in POTS.
    note: 'Found by winnow, kev and lev in p008, p017, p022. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Putative Mechanisms for Symptomatic Tachycardia in Post-COVID-19 Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Immune-mediated mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p021, p001. Claude judged: supports.'
  - paper: pmid34127505
    cited: true
    text: full
    license: none
    verdict: supports
    section: Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34127505. Found by winnow, kev and lev in p003, p015, p019. Claude judged: supports.'
  - paper: pmid33983522
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Part II: Resolved Infection > Long COVID'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33983522. Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is postulated that disruption of the body’s autonomic nervous system in POTS has potential triggers
      from viral infections and vaccines.
    note: 'Found by winnow, kev and lev in p008, p010. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Diskussion
    quote: Am Fallbeispiel 2 können wir zeigen, dass Kinder nach SARS-CoV-Infektion eine chronische Regulationsstörung
      des autonomen Nervensystems mit einem POTS entwickeln können, welches in einem einfachen aktiven Stehtest
      mit kontinuierlicher EKG-Registrierung nachweisbar ist.
    note: 'Found by winnow, kev and lev in p001, p007, p010. Claude judged: supports.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: While not definitively established to this point, it has been generally assumed that the development
      of autonomic nervous system impairment in POTS patients is a para- or post-infectious, immune-mediated process.
    note: 'Found by winnow, kev and lev in p013, p006. Claude judged: supports.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p040, p023, p039. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: INTRODUCTION
    quote: The syndrome has been postulated to have post-viral autoimmune activation as a possible etiology (3).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Results > 3.3. Biomarkers of Inflammation
    quote: A significant number of our patients have described Epstein Barr virus infections and gastrointestinal
      pain that could be related to an enteric viral infection preceding the onset of symptoms and ultimately the
      development of POTS.
    note: 'Found by winnow, kev and lev in p032, p001, p003. Claude judged: supports.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p013, p011. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Usually, patients will report the occurrence of a triggering event weeks to months before the onset of
      POTS symptoms.5–7 These triggering events may include a viral illness, trauma, pregnancy, electrical or lighting
      injury, or bariatric surgery.
    note: 'Found by winnow, kev and lev in p011, p010, p013. Claude judged: supports.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The autoimmune hypothesis of POTS etiology could be a link between immune triggers, such as viral and
      bacterial infections, or vaccinations, as patients often identify a triggering factor with the beginning of
      symptoms.
    note: 'Found by winnow, kev and lev in p037, p039. Claude judged: supports.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: One might postulate that a viral infection could stimulate molecular mimicry and that the A1 receptor
      might have stoichiometry similar to an unknown antigenic epitope in infection and/or inflammation. A significant
      number of our patients have described Epstein–Barr virus infections and gastrointestinal pain that could be
      related to an enteric viral infection preceding the onset of symptoms and ultimately the development of POTS
      and its diagnosis.
    note: 'Found by winnow, kev and lev in p025, p002. Claude judged: supports.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: It has been observed that some patients develop POTS after experiencing a febrile illness, presumably
      viral (Grubb, 2008; Li et al., 2014). This has led to the hypothesis of an autoimmune-mediated etiology of
      POTS, and recent case series of POTS following immune triggers like infection or vaccination (Blitshteyn,
      2015; Brinth et al., 2015; Watari et al., 2018) support this hypothesis.
    note: 'Found by winnow, kev and lev in p005, p027. Claude judged: supports.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: The etiology of POTS is unknown although several pathophysiological mechanisms have been proposed.(2006)
      Some subjects report a “viral‐like” illness 2 to 6 months prior to the onset of symptoms, thus supporting
      the hypothesis that an autoimmune‐mediated molecular mimicry might be present.
    note: 'Found by winnow, kev and lev in p001, p004, p025. Claude judged: supports.'
  - paper: pmid23002038
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4 Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23002038. Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p004, p025. Claude judged: supports.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid42524295
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: On the other hand, several viral infections have been associated with brainstem dysfunction and the development
      of POTS-like symptoms (69, 70).
    note: 'Found by winnow, kev and lev in p089, p007. Claude judged: partial.'
  - paper: pmid42245008
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42245008. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: Notably, this is the first report to systematically incorporate HRV and SSR assessments, and explicitly
      identify infection as a precipitating factor.
    note: 'Found by winnow, kev and lev in p006, p027. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: The study will investigate whether other immune mechanisms play a role in contributing to post-COVID-19
      POTS.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Hyperadrenergic states from infection, hypovolemia, and deconditioning are implicated in development
      of orthostatic intolerance post-pandemic. In a retrospective review of 20 patients, 75% had postural tachycardia,
      with residual dysfunction noted 6–8 months post infection [6].
    note: 'Found by winnow, kev and lev in p010, p027, p029. Claude judged: partial.'
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Since the beginning of the pandemic, there have been several published case reports of postural orthostatic
      tachycardia syndrome (POTS) among patients with long-lasting symptoms after complete recovery from COVID-19
      infection [7,8,9,10,11].
    note: 'Found by winnow, kev and lev in p003, p021. Claude judged: partial.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: partial
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Spezifität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p025, p030. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Neurotropism
    quote: Secondly, a suggested and more direct cause of POTS could be related to the spread of COVID-19 to the
      central nervous system (CNS) by neural propagation, causing direct damage on nerves or indirect damage via
      a cytokine storm (28).
    note: 'Found by winnow, kev and lev in p008, p009, p006. Claude judged: partial.'
  - paper: pmid35118574
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35118574. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid34992725
    cited: true
    text: full
    license: by
    verdict: partial
    section: Key Points
    quote: Inappropriate sinus tachycardia and postural orthostatic tachycardia syndrome seem to be common in the
      convalescent period of COVID-19 infection as a result of post-infectious dysautonomia.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The mechanism of post-COVID POTS remains unknown, although inflammatory and autoimmune responses, including
      the generation of autoantibodies, may be at play [6]. It is postulated that the cytokine storm from the COVID-19
      infection results in sympathetic dysregulation, causing the abnormal autonomic response in POTS [6].
    note: 'Found by winnow, kev and lev in p009, p001. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.6 Immune-Mediated
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Its onset may follow an acute infection or vaccination but more commonly appears without antecedent causative
      events.2,6
    note: 'Found by winnow, kev and lev in p028, p004. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Autoimmune/Autoantibodies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p031. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The cholinergic POTS subgroup is therefore consistent with the hypothesis that neuropathic POTS is a
      restricted autonomic neuropathy [6]. Post-ganglionic cholinergic dysautonomia is frequently associated with
      a viral infection and is most likely immune-mediated [6,39-45].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
- edge:
  - deconditioning_evidence
  - proposed_mechanism_of
  - pots
  papers: 40
  evidence:
  - paper: pmid42037722
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Despite consistent diagnostic criteria, POTS is mechanistically heterogeneous. Major reviews emphasize
      roles for hypovolemia, venous pooling, deconditioning, peripheral autonomic neuropathy, hyperadrenergic states,
      and immune-mediated mechanisms.
    note: 'Found by winnow, kev and lev in p001, p017, p007. Claude judged: supports.'
  - paper: pmid41976810
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: 'Sheldon et al. [6] summarise two possible mechanisms for PoTS: firstly, autonomic denervation leading
      to impaired peripheral venoconstriction, which leads to venous pooling, hypovolaemia, and hyperadrenergic
      stimulation with raised plasma norepinephrine levels, or, secondly, deconditioning, which may be compounded
      by anxiety and hypervigilance secondary to the underlying physiological abnormalities.'
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Studies have shown that bed rest or deconditioning can contribute independently to the development of
      POTS, regardless of the underlying mechanism [5]. Longer periods of physical inactivity can lead to cardiac
      muscular atrophy, reduction in stroke volume and overall hypovolemia [14].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid41166031
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: While the first studies of exercise in POTS framed it as countering deconditioning, there has since been
      significant debate as to whether deconditioning is a primary cause of POTS or is more likely to occur secondary
      to the disorder [3].
    note: 'Found by winnow, kev and lev in p005, p006, p028. Claude judged: supports.'
  - paper: pmid40763323
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Postural Orthostatic Tachycardia Syndrome is particularly prevalent during childhood and adolescence,
      and its pathophysiology involves a complex interplay of autonomic dysfunction, immune system factors, and
      physical deconditioning.2
    note: 'Found by winnow, kev and lev in p026, p005. Claude judged: supports.'
  - paper: pmid40538940
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Deconditioning is also considered to be the final pathway in the pathogenesis of PoTS, as well as a factor
      involved in its pathogenesis (12–14, 16–19).
    note: 'Found by winnow, kev and lev in p007, p008, p030. Claude judged: supports.'
  - paper: pmid39678714
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results
    quote: According to the study, it was found that POTS may be a result of deconditioning, and that a carefully
      prescribed exercise training program can be an effective non-drug therapy option for patients with POTS.
    note: 'Found by winnow, kev and lev in p034, p026, p041. Claude judged: supports.'
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Several possible pathophysiologic mechanisms were proposed in the early 1990s when POTS was first described.
      Cardiac deconditioning was among these, when it was observed that patients with POTS were performing at a
      lower level of cardiac performance due to reduced stroke volume and VO2 max than their healthy counterparts
      [4].
    note: 'Found by winnow, kev and lev in p005, p006, p009. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Cardiovascular deconditioning may be implicated in POTS via cardiac atrophy and hypovolemia causing reactive
      tachycardia.[9]
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid36387679
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Introduction
    quote: The multiple factors like moderate autonomic dysfunction, increased sympathetic tone, inadequate venous
      return or excessive blood venous pooling, and severe deconditioning may be responsible for POTS symptoms.[1]
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The pathophysiology of POTS remains unknown, however there is a number of physiological mechanisms that
      have been supposed to be involved. These may include sympathetic dysregulation, hypovolemia, hyperadrenergic
      stimulation, deconditioning12,57, autoantibody mediated response57, and mast cell activation58,59.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid36043022
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: However, recent studies suggest cardiac deconditioning, increased sensitivity to beta-adrenoreceptors,
      and neuropathy in the distal vessels are also responsible for POTS.
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p014, p017, p002. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Hypovolaemia
    quote: Firstly, it has been suggested that POTS occurs due to decreased blood volume and deconditioning of the
      heart, which subsequently increases cardiac sympathetic nervous system (SNS) output (24, 32, 33).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid34987818
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: There are various pathophysiological mechanisms for developing OI in POTS. One mechanism broadly described
      is cardiovascular deconditioning following prolonged bed rest, resulting in cardiac atrophy, and subsequent
      physical deconditioning.
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid34331416
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34331416. Found by winnow, kev and lev in p013, p003. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The cause of POTS has not yet been established (Benarroch, 2012), though many possible disease mechanisms
      including autonomic denervation (Kimpinski et al., 2012; Haensch et al., 2014), autonomic autoimmunity (Ruzieh
      et al., 2017), hypovolemia (Benarroch, 2012; Kimpinski et al., 2012), hyperadrenergic stimulation (Kimpinski
      et al., 2012), and deconditioning have been proposed (Benarroch, 2012; Fu and Levine, 2015).
    note: 'Found by winnow, kev and lev in p035, p008. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Mechanisms and symptoms
    quote: Autonomic nervous system dysfunction,2 increased sympathetic tone,3 and physical deconditioning4,5 are
      some of the suggested contributory factors.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid32321428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Beyond genetic norepinephrine transporter deficiency, several theories have been proposed for the syndrome’s
      etiology, including antiadrenergic autoimmunity [2–4], baroreflex dysfunction [5], deconditioning [6], abnormal
      mast cell activation [1], excessive sympathetic drive and/or sympathetic denervation [7].
    note: 'Found by winnow, kev and lev in p004, p005, p031. Claude judged: supports.'
  - paper: pmid32222376
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32222376. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Orthostatic Cardiovascular Responses Are Impaired in Patients With Vasovagal Syncope
      and Postural Orthostatic Tachycardia Syndrome
    quote: Lastly, physical deconditioning of the heart due to conditions such as viral infections or chronic fatigue
      has also been recognized as a possible mechanism underlying POTS (Fu et al., 2010). There is an association
      between POTS and cardiac deconditioning, and this is thought to be the result of a decreased heart size and
      associated decrease in cardiac output (Fu et al., 2010).
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p002, p003, p001. Claude judged: supports.'
  - paper: pmid25487551
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25487551. Found by winnow, kev and lev in p002, p003, p005. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p059. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: 'The etiology of POTS is probably heterogeneous and the pathophysiology remains unclear. Three main groups
      have been identified: neuropathic, hyperadrenergic and POTS related to deconditioning [1].'
    note: 'Found by winnow, kev and lev in p016, p018. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p007, p009, p035. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p003, p004, p020. Claude judged: supports.'
  - paper: pmid18704621
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 18704621. Found by winnow, kev and lev in p001, p011, p014. Claude judged: supports.'
  - paper: pmid39297132
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: However, the role of venous or splanchnic pooling, alterations of peripheral venous hemodynamics, impaired
      blood volume regulation (relative central hypovolemia), absolute hypovolemia, peripheral small fiber neuropathy,
      and cardiovascular deconditioning as potential mechanisms of reduced stroke volume, brain hypoperfusion, and,
      in turn, postural ventilation have to be explored.1
    note: 'Found by winnow, kev and lev in p004, p005. Claude judged: partial.'
  - paper: pmid35647216
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: 'Physical deconditioning may contribute to post-concussive OT, as it is common after

      concussion and known to contribute to OI.'
    note: 'Found by winnow, kev and lev in p028, p035. Claude judged: partial.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In the case that we presented and in our retrospective cohort, both the symptoms from PANS and POTS often
      lead to inactivity and deconditioning, and this deconditioning may further contribute to POTS.
    note: 'Found by winnow, kev and lev in p034. Claude judged: partial.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p030, p028. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: The multiple factors like moderate autonomic dysfunction, increased sympathetic tone, inadequate venous
      return or excessive blood venous pooling, and severe deconditioning may be responsible for POTS symptoms.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid33316414
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms of post-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33316414. Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: One must also rule out secondary causes of POTS due to circulatory insufficiency as seen with dehydration
      and physical de-conditioning after inanition and prolonged bed rest.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: The pathophysiology underlying POTS remains incompletely understood, is likely to be multifactorial and
      varies in different subgroups of POTS patients. Factors such as moderate autonomic dysfunction, increased
      sympathetic tone, severe deconditioning, inadequate venous return or excessive blood venous pooling may contribute
      to POTS symptoms.2
    note: 'Found by winnow, kev and lev in p003, p010. Claude judged: partial.'
  - paper: pmid25168872
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Observations such as these prompt speculation that POTS is akin to a deconditioned state (Joyner and
      Masuki 2008; Lewis et al. 2013).
    note: 'Found by winnow, kev and lev in p004, p005, p019. Claude judged: partial.'
  - paper: pmid21906029
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: Nonetheless, we cannot rule out that milder forms of cardiovascular deconditioning may contribute to
      the abnormalities observed in POTS [8,35,38].
    note: 'Found by winnow, kev and lev in p032. Claude judged: partial.'
  - paper: pmid21690484
    cited: true
    text: full
    license: none
    verdict: partial
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21690484. Found by winnow, kev and lev in p003, p024, p032. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - pots
  papers: 39
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Newly diagnosed CAD following COVID-19 infection and vaccination
    quote: Following COVID-19 infection, 22 individuals were newly diagnosed with POTS, 12 with VVS, and 1 with
      delayed and 1 with transient OH, whereas in 39 cases presenting with new-onset OI the diagnostic workup excluded
      any CAD (i.e., OIw/oCAD). In most newly diagnosed CAD, the causal association with the passed COVID-19 infection
      was deemed probable (34 out of 36, 94%).
    note: 'Found by winnow, kev and lev in p048, p022, p037. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: A direct link to the development of POTS as a sequela of COVID-19 infection in PASC gives great credence
      to the idea that the etiology of POTS involves an immunologic stressor such as a preceding viral illness.
    note: 'Found by winnow, kev and lev in p007, p001, p006. Claude judged: supports.'
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: An estimated 3 million people in the United States had POTS before the COVID-19 pandemic, but the prevalence
      is now significantly higher and has likely at least doubled, due, in part, to POTS that can follow SARS-CoV-2
      infection as part of Long COVID [1].
    note: 'Found by winnow, kev and lev in p003, p006, p011. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: In recent studies, a considerable number of individuals recovering from COVID-19 have been reported to
      experience POTS within 6 to 8 months post-infection.
    note: 'Found by winnow, kev and lev in p015, p027, p001. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Long COVID-19 triggers an extended inflammatory response, characterized by the continuous production
      of cytokines and other inflammatory mediators [61]. This prolonged state of inflammation can lead to systemic
      effects, including damage to the vascular endothelium [62] and dysregulation of the ANS [63], creating fertile
      ground for the development of conditions such as POTS.
    note: 'Found by winnow, kev and lev in p020, p014. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Not only does contracting SARS-CoV-2 infection confer the possibility of developing long COVID and subsequent
      development of POTS, but recipients of the SARS-CoV-2 vaccine have also been shown to develop POTS at a higher
      rate.
    note: 'Found by winnow, kev and lev in p027, p029. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Recently, several case reports showed an increasing incidence of POTS as a complication of severe acute
      respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients who had chronic signs and symptoms of
      the infection (long COVID (coronavirus disease)).
    note: 'Found by winnow, kev and lev in p005, p001, p002. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports
    quote: The earliest reports of a POTS-like syndrome in the aftermath of COVID-19 infection emerged in March
      2020.37 Since then, there has been growing awareness of a potential link between COVID infections and more
      recently vaccines and POTS.
    note: 'Found by winnow, kev and lev in p005, p015, p021. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Post-COVID Conditions (PCC) encompass a variety of sequelae or health conditions that last four weeks
      or more after a SARS-CoV-2 infection [30]. Although it can affect many different body systems, it can ultimately
      cause autonomic dysfunction, which can lead to postural orthostatic tachycardia syndrome (POTS) [30].
    note: 'Found by winnow, kev and lev in p012, p001, p016. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: More recently, dysautonomia has been observed in patients with coronavirus disease 2019 (COVID-19), and
      POTS has been identified as a possible long-term manifestation of COVID-19. It has also been found that the
      severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) virus binds to the angiotensin-converting enzyme
      2 (ACE2) receptor, possibly causing hyperadrenergic POTS [3].
    note: 'Found by winnow, kev and lev in p001, p003, p015. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Recently, POTS has been identified in ∼20% of cases of PASC, in which symptoms persist >4 weeks after
      the onset of COVID-19 illness.5,6 It is postulated that the cytokine storm from COVID-19 results in sympathetic
      dysregulation, causing an abnormal autonomic response in POTS.7
    note: 'Found by winnow, kev and lev in p023, p002, p011. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Post COVID-19 postural orthostatic tachycardia syndrome
    quote: Viral infection is the most commonly reported and has been shown to trigger POTS in 28–41% of patients19.
      Various infectious pathogens have been suggested to be associated with the onset of POTS, including the Epstein
      Barr virus25–27, upper respiratory infections, gastroenteritis and recently SARS-CoV217,28,29.
    note: 'Found by winnow, kev and lev in p001, p007, p010. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p015, p016. Claude judged: supports.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: supports
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Plausibilität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Inflammation and
      Autoimmunity
    quote: COVID-19 infection can cause a cytokine storm and inflammation that could trigger chronic neuronal dysregulation
      (47). One mechanism could be via the development of autoantibodies which cross-react with autonomic ganglia
      as part of acute and long-term COVID-19 infection, and lead to dysautonomia and POTS.
    note: 'Found by winnow, kev and lev in p008, p009, p006. Claude judged: supports.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: With associations of viral infections as a potential etiology of POTS and evidence that many COVID-19
      long haulers are developing POTS, platelets may also play a significant role in the etiology or perpetuation
      of the disorder.
    note: 'Found by winnow, kev and lev in p003, p002. Claude judged: supports.'
  - paper: pmid34992725
    cited: true
    text: full
    license: by
    verdict: supports
    section: Key Points
    quote: Inappropriate sinus tachycardia and postural orthostatic tachycardia syndrome seem to be common in the
      convalescent period of COVID-19 infection as a result of post-infectious dysautonomia.
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The mechanism of post-COVID POTS remains unknown, although inflammatory and autoimmune responses, including
      the generation of autoantibodies, may be at play [6]. It is postulated that the cytokine storm from the COVID-19
      infection results in sympathetic dysregulation, causing the abnormal autonomic response in POTS [6].
    note: 'Found by winnow, kev and lev in p001, p009. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Diskussion
    quote: Am Fallbeispiel 2 können wir zeigen, dass Kinder nach SARS-CoV-Infektion eine chronische Regulationsstörung
      des autonomen Nervensystems mit einem POTS entwickeln können, welches in einem einfachen aktiven Stehtest
      mit kontinuierlicher EKG-Registrierung nachweisbar ist.
    note: 'Found by winnow, kev and lev in p001, p007, p010. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Autonomic dysfunction presenting as POTS can be a delayed manifestation of COVID-19 infection.
    note: 'Found by winnow, kev and lev in p011, p013. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Researchers speculate that fibrinaloid microclots seen in POTS, particularly long-COVID-associated POTS,
      may lead to microcapillary obstruction and local tissue hypoxia.
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. Conclusions
    quote: This investigation highlights a distinct, shared cytokine profile in POTS and Long COVID-associated POTS,
      consistent with an active innate immune system. These findings suggest an immunological relationship between
      primary viral insult and chronic dysautonomia, suggesting that clinical successes in Long COVID research may
      be applicable to the broader POTS population.
    note: 'Found by winnow, kev and lev in p033, p036. Claude judged: partial.'
  - paper: pmid42245008
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42245008. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Immunologic mechanisms discussed in the literature include persistent immune activation, T-cell/NK cell
      exhaustion, and development of autoantibodies (10–14). The study will investigate whether other immune mechanisms
      play a role in contributing to post-COVID-19 POTS.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The growing number of individuals experiencing OI and POTS after COVID-19 raises important questions
      about the relationship between viral infections, vaccination, and the onset of autonomic dysfunction.
    note: 'Found by winnow, kev and lev in p031, p033. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > COVID-19 Infection and
      Post-viral Postural Orthostatic Tachycardia Syndrome
    quote: Long COVID may be implicated in similar mechanisms related to POTS, including neuropathologies, endothelial
      dysfunction, and blood flow abnormalities.[42]
    note: 'Found by winnow, kev and lev in p032. Claude judged: partial.'
  - paper: pmid39076856
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. Symptoms and Pathologic Findings of Cardiovascular Disease in Post-Acute COVID-19 Syndrome > 5.2
      Pathologic Findings > 5.2.4 Postural Orthostatic Tachycardia Syndrome (POTS)
    quote: "Hypothetically, POTS is caused by autonomic dysfunction in long COVID patients \n[138]. Autonomic dysfunction\
      \ in long COVID is provoked by the hyperadrenergic \nstate and the resetting of baroreceptor control, which\
      \ is stimulated by \nangiotensin II upregulation."
    note: 'Found by winnow, kev and lev in p043. Claude judged: partial.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: Although a causative relationship between PCC, hyperadrenergic POTS, and MCAS remains unrevealed, these
      syndromes can overlap. We want to propose here a correlation produced by a close-loop mechanism with positive
      feedback established after SARS-CoV-2 infection in a previously healthy young patient.
    note: 'Found by winnow, kev and lev in p001, p018. Claude judged: partial.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. The Role of Fibrinaloid Microclots in POTS
    quote: Other mechanisms for POTS in long COVID may include:Relative hypovolemia secondary to inadequate peripheral
      vasoconstriction.
    note: 'Found by winnow, kev and lev in p001, p016, p005. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Recently, there was a surge in the incidence of POTS after the COVID-19 pandemic. Functional antibodies
      against different GPCRs have also been demonstrated in the serum of symptomatic post-COVID-19 patients.[23]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid37670400
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Positional tachycardia and chronic orthostatic intolerance symptoms in PACS mimic Postural Orthostatic
      Tachycardia Syndrome [POTS] [22, 23], a condition that is associated with autonomic nervous system dysfunction
      and that can be triggered after an acute viral illness [24–27].
    note: 'Found by winnow, kev and lev in p004, p007. Claude judged: partial.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: partial
    section: Commonalities with ME/CFS and other post-infection syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: partial.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: •POTS, neurally-mediated syncope from low-volume states maybe observed post-COVID-19.
    note: 'Found by winnow, kev and lev in p027, p009, p029. Claude judged: partial.'
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Since the beginning of the pandemic, there have been several published case reports of postural orthostatic
      tachycardia syndrome (POTS) among patients with long-lasting symptoms after complete recovery from COVID-19
      infection [7,8,9,10,11].
    note: 'Found by winnow, kev and lev in p003, p021. Claude judged: partial.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What is the pathophysiology of POTS?
    quote: Recently, numerous cases of POTS33 and other forms of sinus tachycardia (e.g., inappropriate sinus tachycardia)34
      after a SARS-CoV-2 infection have been reported. Good data on the frequency of POTS among patients with long-term
      complications from COVID-19 (“long COVID syndrome”) are lacking.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. COVID-19 Infection and Dysautonomia
    quote: A growing body of evidence links PASC to CVAD, with a number of reports suggesting the possibility of
      previously infected COVID-19 patients experiencing symptoms suggestive of POTS [10,13,16,43,44,45,46].
    note: 'Found by winnow, kev and lev in p025, p008, p017. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p040. Claude judged: partial.'
  - paper: pmid32970212
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32970212. Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - proposed_mechanism_of
  - pots
  papers: 28
  evidence:
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Cerebral Hypoperfusion
    quote: Cerebral hypoperfusion emerged as one of the major mechanisms of POTS, dysautonomia, myalgic encephalomyelitis/chronic
      fatigue syndrome and probably Long COVID.49,50 Cerebral and brainstem hypoperfusion together with neuroinflammation,
      specifically at the dorsolateral medulla, may be the CNS mechanisms in POTS and Long COVID and need to be
      investigated further.22,51,52
    note: 'Found by winnow, kev and lev in p016, p002, p018. Claude judged: supports.'
  - paper: pmid41103515
    cited: true
    text: full
    license: by
    verdict: supports
    section: Differential diagnosis of OD with PPPD > Hemodynamic orthostatic dizziness > Postural orthostatic tachycardia
      syndrome
    quote: Abnormal cerebral blood flow (CBF) is central to POTS pathophysiology, with findings indicating reduced
      cerebral perfusion, impaired autoregulation, and oscillatory CBF associated with cognitive dysfunction.
    note: 'Found by winnow, kev and lev in p010, p055. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Our findings demonstrate that an insufficient cerebral blood supply, driven by hypovolemia and impaired
      vascular compliance, combined with autonomic dysregulation, underlies the hallmark tachycardia in Postural
      Orthostatic Tachycardia Syndrome.
    note: 'Found by winnow, kev and lev in p001, p047, p050. Claude judged: supports.'
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: CBF in OI > CBF in POTS
    quote: Furthermore, Stewart et al demonstrated that the drop in CBv with head‐up tilt in POTS occurs before
      orthostatic tachycardia and hyperpnea, which suggests that CBv may be driving POTS pathophysiology.
    note: 'Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: supports
    section: '3. Dorsolateral Medulla: Localization for POTS and Long COVID'
    quote: Cerebral hypoperfusion is one of the major mechanisms of POTS, autonomic dysfunction, myalgic encephalomyelitis/chronic
      fatigue syndrome and probably Long COVID [6].
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: '2. POTS and Exercise: What Is Known'
    quote: Although cardiovascular deconditioning has been considered to be the cause or a major mechanism of POTS,
      emerging evidence suggests that this is not the case and that POTS involves various mechanisms, including
      cerebral hypoperfusion and possible neuroinflammation [7,11].
    note: 'Found by winnow, kev and lev in p005, p010. Claude judged: supports.'
  - paper: pmid39544990
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Our findings support the hypothesis that HYCH and POTS represent a spectrum of the same disorder of cerebral
      hypoperfusion. Reduced cerebral blood flow due to venous pooling and related hypocapnia may be a physiological
      substrate.
    note: 'Found by winnow, kev and lev in p050, p036, p037. Claude judged: supports.'
  - paper: pmid39297132
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: In conclusion, the study by Baker et al4 provides valuable insights into the pathophysiology of POTS
      by showing a possible causal relationship between brain hypoperfusion during orthostatic stress and postural
      hyperventilation and sympathetic overactivation in POTS.
    note: 'Found by winnow, kev and lev in p007, p001. Claude judged: supports.'
  - paper: pmid37443510
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: POTS is caused by cerebral hypoperfusion in the brain due to a relative lack of blood volume, thus inducing
      orthostatic intolerance symptoms.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS as a CNS disorder: proposed model'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p017, p026, p027. Claude judged: supports.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Under the hypothesis that POTS is mainly initiated by reduced cerebral blood flow, an earlier study [8]
      also used transcranial doppler ultrasound (TCD) to investigate the oscillatory CBFV in POTS patients with
      the relationship of measured arterial pressure, heart rate, CBFV, and PETCO2 to graded changes in tilt angels.
    note: 'Found by winnow, kev and lev in p001, p008, p003. Claude judged: supports.'
  - paper: pmid29960989
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Hypocapnic hyperventilation is known to produce tachycardia and symptoms often associated with orthostatic
      intolerance; therefore, postural hyperventilation causes a form of postural tachycardia syndrome.
    note: 'Found by winnow, kev and lev in p004, p040. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p005, p026. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: A brain-based model of cerebral hypoperfusion as a mechanism may help explain brain fog in POTS.
    note: 'Found by winnow, kev and lev in p052, p001, p007. Claude judged: partial.'
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Therefore, neurovascular coupling abnormalities should be described as a cerebral-perfusion pathway that
      produces multisystem symptom profiles in POTS.
    note: 'Found by winnow, kev and lev in p035, p033, p034. Claude judged: partial.'
  - paper: pmid42114076
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Recent Findings
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42114076. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid41740821
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41740821. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid41602336
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: While POTS certainly has multifactorial potential causes, in this patient, we propose that it responded
      to addressing impaired venous blood return to the heart, with resulting diminished cerebral blood flow.
    note: 'Found by winnow, kev and lev in p022. Claude judged: partial.'
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Pulmonary determinants
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p033, p030, p039. Claude judged: partial.'
  - paper: pmid39297140
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Stroke volume and cerebrovascular pulsatility as determinants of postural ventilation and
      sympathetic activity in patients with POTS
    quote: Together, these data suggest a role for cerebrovascular pulsatility in the control of ventilation and
      sympathetic activity and strongly implicate reduced brain perfusion41,42 as a key mechanism underlying exaggerated
      postural ventilation in patients with POTS.
    note: 'Found by winnow, kev and lev in p005, p032, p034. Claude judged: partial.'
  - paper: pmid38490814
    cited: true
    text: full
    license: by
    verdict: partial
    section: INTRODUCTION
    quote: During a prolonged cognitive stress test, patients with POTS have a greater reduction in cerebral blood
      velocity that corresponds with a greater symptom score (Wells et al., 2020). Taken together, these data suggest
      that altered cerebrovascular responsiveness may play a role in symptomology in patients with POTS.
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: partial
    section: Symptoms and clinicopathologic features of dysautonomia
    quote: It is hypothesized that damage to sympathetic vasomotor nerves impairs the compensatory increase in systemic
      vascular resistance during orthostatic stress and/or during exercise, resulting in splanchnic and/or lower
      limb pooling and reduced cerebral blood flow. This results in typical POTS symptoms including dizziness, cognitive
      dysfunction (colloquially known as “brain fog”), and fatigue.
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid37227184
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37227184. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35307584
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Mechanisms of symptoms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35307584. Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid34746821
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction > Carotid body – a unifying hypothesis?
    quote: This predisposes patients to hypoperfusion of tissues cephalad to the heart, causing stagnant hypoxia
      from reduced carotid blood flow – a key step causing SNA activation (Marshall, 1994; Prabhakar et al., 2005)
      in the pathophysiologic cascade in POTS.
    note: 'Found by winnow, kev and lev in p010, p002. Claude judged: partial.'
  - paper: pmid25002851
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: In these hyperpneic POTS patients, reduced CBF likely compromised CNS function resulting in increased
      cerebral oxygen demand, neuronal excitability, and continued sympathetic activation (Laffey and Kavanagh,
      2002; Del Pozzi et al., 2014).
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid23390443
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Decreased systolic BP during head-up tilt influences cerebral blood perfusion, which explained symptoms
      of orthostatic intolerance in the symptom-positive group. Ocon et al.20) suggested dynamic cerebral autoregulation
      is less effective in POTS patients based on a perfectly synchronous correlation between mean arterial pressure
      and cerebral blood f low velocity.
    note: 'Found by winnow, kev and lev in p022. Claude judged: partial.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Symptoms
    quote: Patients with POTS experience a variety of symptoms ranging from mild to severe. The most common underlying
      condition is cerebral hypo-perfusion, which might be due to excessive tachycardia, neurological dysfunction
      or other idiopathic causes.[5]
    note: 'Found by winnow, kev and lev in p010, p003. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - proposed_mechanism_of
  - autoimmune_evidence
  papers: 25
  evidence:
  - paper: pmid40977456
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: Nonetheless, in both the introduction and discussion sections, we emphasized that viral infections such
      as SARS-CoV-2 may trigger autoimmune and autonomic dysfunction mechanisms.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Finally, COVID-19 may trigger development of autoantibodies, including antiphospholipid antibodies or
      antibodies against adrenergic and muscarinic receptors, that could then contribute to the cardiovascular manifestations
      of LHC (11, 13).
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: However, a viral infection by SARS-CoV-2 triggering autoimmune response and direct neurotoxic effects
      has been suggested as an underlying cause for developing post-COVID-19 POTS [57,58].
    note: 'Found by winnow, kev and lev in p027, p006. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS and other cardiovascular dysautonomias can develop after a SARS-CoV-2 infection. It is thought that
      these factors might be potent immune triggers that can evoke an autoimmune response in individuals who are
      susceptible.
    note: 'Found by winnow, kev and lev in p005, p004, p006. Claude judged: supports.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: supports
    section: Commonalities with ME/CFS and other post-infection syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Although post-COVID-19 autonomic pathophysiology is complex and has not been fully elucidated, autoimmunity
      is thought to be a critical aspect of POTS. Several reports have demonstrated that COVID-19 antibodies cross-react
      with autonomic nervous system components, such as ganglia, nerve fibers, and G-protein-coupled receptors,
      which can trigger dysfunction [3,11].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p008, p014. Claude judged: supports.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Immune-mediated mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p016, p025. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Diskussion
    quote: In einem aktuellen Review wird eindrucksvoll gezeigt, dass die SARS-CoV-2-Infektion als potenter Trigger
      der Bildung von Autoantikörpern angesehen wird [3].
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: supports.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: One might postulate that a viral infection could stimulate molecular mimicry and that the A1 receptor
      might have stoichiometry similar to an unknown antigenic epitope in infection and/or inflammation.
    note: 'Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: It has been observed that some patients develop POTS after experiencing a febrile illness, presumably
      viral (Grubb, 2008; Li et al., 2014). This has led to the hypothesis of an autoimmune-mediated etiology of
      POTS, and recent case series of POTS following immune triggers like infection or vaccination (Blitshteyn,
      2015; Brinth et al., 2015; Watari et al., 2018) support this hypothesis.
    note: 'Found by winnow, kev and lev in p005, p027. Claude judged: supports.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Some subjects report a “viral‐like” illness 2 to 6 months prior to the onset of symptoms, thus supporting
      the hypothesis that an autoimmune‐mediated molecular mimicry might be present.
    note: 'Found by winnow, kev and lev in p001, p004, p025. Claude judged: supports.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Besides small fiber neuropathy, proposed POTS mechanisms include immune-mediated inflammation triggered
      by autoantigens or persistent viral particles [11, 20]. The short latency between infection and symptoms onset
      observed in most cases indicates a direct immune-mediated process, and the stronger immune responsiveness
      of younger individuals may predispose them to POTS development both after COVID-19 infection and vaccination.
    note: 'Found by winnow, kev and lev in p047. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response.'
    note: 'Found by winnow, kev and lev in p012, p079. Claude judged: partial.'
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: There are a few possibilities that can explain the post-infectious onset of the symptoms. First, a subset
      of PASC can be explained by autoimmune inflammation targeted against the autonomic nervous system.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What is the pathophysiology of POTS?
    quote: Postural orthostatic tachycardia syndrome may have an immunological cause. Many patients describe a postviral
      onset,29–32 and 15%–20% of patients with POTS report a history of an autoimmune disorder such as Hashimoto
      thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The mechanism of post-COVID POTS remains unknown, although inflammatory and autoimmune responses, including
      the generation of autoantibodies, may be at play [6].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The autoimmune hypothesis of POTS etiology could be a link between immune triggers, such as viral and
      bacterial infections, or vaccinations, as patients often identify a triggering factor with the beginning of
      symptoms.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.6 Immune-Mediated
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Post-ganglionic cholinergic dysautonomia is frequently associated with a viral infection and is most
      likely immune-mediated [6,39-45].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - proposed_mechanism_of
  - postinfectious_evidence
  papers: 24
  evidence:
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Particularly, the production of adrenergic autoantibodies is believed to be an important factor in postinfection
      POTS.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: There are a few possibilities that can explain the post-infectious onset of the symptoms. First, a subset
      of PASC can be explained by autoimmune inflammation targeted against the autonomic nervous system.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The exact mechanism of post–COVID-19 POTS is unknown and, at best, speculative at this time. Given the
      lag period of a few weeks between the COVID-19 infection and the onset of POTS symptoms, autoimmunity is a
      likely mechanism.
    note: 'Found by winnow, kev and lev in p011, p010. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The short latency between infection and symptoms onset observed in most cases indicates a direct immune-mediated
      process, and the stronger immune responsiveness of younger individuals may predispose them to POTS development
      both after COVID-19 infection and vaccination.
    note: 'Found by winnow, kev and lev in p047. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Finally, COVID-19 may trigger development of autoantibodies, including antiphospholipid antibodies or
      antibodies against adrenergic and muscarinic receptors, that could then contribute to the cardiovascular manifestations
      of LHC (11, 13).
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: However, a viral infection by SARS-CoV-2 triggering autoimmune response and direct neurotoxic effects
      has been suggested as an underlying cause for developing post-COVID-19 POTS [57,58].
    note: 'Found by winnow, kev and lev in p027, p006. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: An autoimmune basis for a small number of POTS patients has been linked to the observation of orthostatic
      symptoms following a viral illness [11].
    note: 'Found by winnow, kev and lev in p005, p006. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response.'
    note: 'Found by winnow, kev and lev in p012, p001, p079. Claude judged: partial.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: partial
    section: Commonalities with ME/CFS and other post-infection syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: partial.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The chief etiology is usually post-infection, which has been reported with COVID-19. Although post-COVID-19
      autonomic pathophysiology is complex and has not been fully elucidated, autoimmunity is thought to be a critical
      aspect of POTS.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p014, p001, p008. Claude judged: partial.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: partial
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Plausibilität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The mechanism of post-COVID POTS remains unknown, although inflammatory and autoimmune responses, including
      the generation of autoantibodies, may be at play [6].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Furthermore, it is possible that the anti-SARS-CoV2 antibodies might have an autoimmune basis as they
      cross-react with the receptors in the ganglia [16].
    note: 'Found by winnow, kev and lev in p008, p010. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Diskussion
    quote: Ursächlich für derartige – oft postinfektiöse – autonome Veränderungen werden Autoantikörper gegen G‑Protein-gekoppelte
      Rezeptoren angenommen [7], die auch wir bei einigen der von uns untersuchten Kindern mit schweren autonomen
      Regulationsstörungen nachweisen konnten [2].
    note: 'Found by winnow, kev and lev in p011, p012, p001. Claude judged: partial.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: INTRODUCTION
    quote: The syndrome has been postulated to have post-viral autoimmune activation as a possible etiology (3).
    note: 'Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The autoimmune hypothesis of POTS etiology could be a link between immune triggers, such as viral and
      bacterial infections, or vaccinations, as patients often identify a triggering factor with the beginning of
      symptoms.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.6 Immune-Mediated
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Post-ganglionic cholinergic dysautonomia is frequently associated with a viral infection and is most
      likely immune-mediated [6,39-45].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 18
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: We also found that patients with POTS had higher AR autoantibody activity, which may contribute to elevated
      plasma NE levels and excessive tachycardia.
    note: 'Found by winnow, kev and lev in p004, p033, p044. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Pathophysiology of POTS
    quote: The β-adrenergic autoantibodies may also trigger postural overactivation of the sympathetic nervous system.[15]
    note: 'Found by winnow, kev and lev in p009, p010, p018. Claude judged: supports.'
  - paper: pmid37999672
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37999672. Found by winnow, kev and lev in p006, p025, p026. Claude judged: supports.'
  - paper: pmid37631004
    cited: true
    text: full
    license: by
    verdict: supports
    section: 8. Electroceutical Therapy for Autoimmune Disease > 8.7. Postural Orthostatic Tachycardia Syndrome
      (POTS)
    quote: In support of autoimmune-mediated pathways in POTS is the identification in a subgroup of patients expressing
      serum antiadrenergic autoantibodies capable of exerting direct agonist and allosteric effects that alter receptor
      function [93]. Consistently, induction of antibodies with similar functional properties in a rabbit experimental
      model could trigger a hyperadrenergic POTS phenotype [94].
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid36873318
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Induction of these antibodies with similar functional properties produced a hyperadrenergic POTS phenotype
      in a rabbit autoimmune model,9 suggesting that the copresence of the 2 sympathomimetic antibodies is capable
      of causing an excessive increase in adrenergic activity frequently associated with POTS.
    note: 'Found by winnow, kev and lev in p007, p021, p024. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Sequelae of these cross-reacting antibodies possibly include interfering with α1-adrenergic receptors
      leading to a maladaptive vasoconstrictor response and increased sympathetic activation [5].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p009, p011, p030. Claude judged: supports.'
  - paper: pmid35118574
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35118574. Found by winnow, kev and lev in p006, p029. Claude judged: supports.'
  - paper: pmid34409582
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34409582. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: In the serum of some patients with POTS, 1 study showed the presence of α1-adrenergic receptor (α1AR)
      antibodies.7 These antibodies exerted a partial antagonistic effect against the peripheral vasoconstrictive
      compensation of orthostasis, resulting in an overshooting sympathoneural response to maintain vascular tone.
    note: 'Found by winnow, kev and lev in p006, p007. Claude judged: supports.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Adrenergic receptor AAb activity in POTS
    quote: The α1AR-AAb produce partial antagonism to the α1AR natural ligand NE. This inadequate response to upright
      posture would lead to baroreceptor-enhanced sympathetic activity.
    note: 'Found by winnow, kev and lev in p035, p001, p005. Claude judged: supports.'
  - paper: pmid31547749
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: The differential allosteric effect of α1‐adrenergic receptor and β1AR autoantibodies would lead to a
      hyperadrenergic state and overstimulation of cardiac β1AR.
    note: 'Found by winnow, kev and lev in p003, p023, p005. Claude judged: supports.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: This study entails specific antibodies, such as ganglionic acetylcholine receptor antibody [8] and alpha-1
      adrenergic receptor antibody that act as partial antagonists and induce reflex compensatory sympathetic activation
      [9].
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Conclusions
    quote: POTS patients have elevated α1AR autoantibodies exerting a partial peripheral antagonist effect resulting
      in a compensatory sympathoneural activation of α1AR for vasoconstriction and concurrent βAR‐mediated tachycardia.
    note: 'Found by winnow, kev and lev in p003, p006, p026. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Few of the patients were detected to have autoantibodies to adrenergic, acetylcholine, and angiotensin
      II receptors [12,15]. These antibodies cause peripheral vasoconstriction to be less effective and eventually
      cause reflex tachycardia.
    note: 'Found by winnow, kev and lev in p012, p079. Claude judged: partial.'
  - paper: pmid34055446
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: It has been hypothesized that an increase in IL-6 inflammatory markers seen in rheumatologic conditions
      can increase sympathetic drive, thus worsening POTS [4].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'POTS as a CNS disorder: proposed model'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome > Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p026. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - autoimmune_evidence
  papers: 17
  evidence:
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Moreover, the immune response to COVID-19 can lead to autoimmunity, where the body produces antibodies
      that mistakenly target the autonomic nervous system [60].
    note: 'Found by winnow, kev and lev in p020, p014, p019. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS and other cardiovascular dysautonomias can develop after a SARS-CoV-2 infection. It is thought that
      these factors might be potent immune triggers that can evoke an autoimmune response in individuals who are
      susceptible.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: supports
    section: Commonalities with ME/CFS and other post-infection syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Although post-COVID-19 autonomic pathophysiology is complex and has not been fully elucidated, autoimmunity
      is thought to be a critical aspect of POTS. Several reports have demonstrated that COVID-19 antibodies cross-react
      with autonomic nervous system components, such as ganglia, nerve fibers, and G-protein-coupled receptors,
      which can trigger dysfunction [3,11].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Autoimmunity > Autoimmunity in Long COVID
    quote: Autoimmunity has been implicated as one of the major mechanisms of Long COVID, leading to a higher risk,
      overall incidence, and range of autoimmune conditions after SARS-CoV-2 infection (Sharma and Bayry, 2023).
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Finally, COVID-19 may trigger development of autoantibodies, including antiphospholipid antibodies or
      antibodies against adrenergic and muscarinic receptors, that could then contribute to the cardiovascular manifestations
      of LHC (11, 13).
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: The underlying cause of dysautonomia post-COVID-19 infection is not well understood. However, a viral
      infection by SARS-CoV-2 triggering autoimmune response and direct neurotoxic effects has been suggested as
      an underlying cause for developing post-COVID-19 POTS [57,58].
    note: 'Found by winnow, kev and lev in p027, p006. Claude judged: partial.'
  - paper: pmid37388279
    cited: true
    text: full
    license: by
    verdict: partial
    section: 'Long Covid symptoms, effect on organs, and pathological mechanisms > Autonomic system sequelae > Mechanisms
      of autonomic dysfunction > Autoimmune attack:'
    quote: It is speculated that autoimmune mechanisms and autoantibody formation may be involved in the manifestation
      of autonomic symptoms in long Covid (121). It has also been shown that postural tachycardia syndrome and orthostatic
      hypotension are associated with these processes (122).
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: partial
    section: Long Covid—the new pandemic
    quote: Notable autoantibodies include functionally active autoantibodies to the GPCRs (including α1- and β2-adrenoceptors,
      angiotensin receptor, nociception-like opioid receptor and muscarinic M2-receptor) [11]. This is significant
      for the overlap with POTS [12] and autonomic nervous system.
    note: 'Found by winnow, kev and lev in p009, p011. Claude judged: partial.'
  - paper: pmid36509178
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Hospitalization status
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36509178. Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: partial
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Plausibilität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What is the pathophysiology of POTS?
    quote: Postural orthostatic tachycardia syndrome may have an immunological cause. Many patients describe a postviral
      onset,29–32 and 15%–20% of patients with POTS report a history of an autoimmune disorder such as Hashimoto
      thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34992725
    cited: true
    text: full
    license: by
    verdict: partial
    section: Arrhythmia in the COVID-19 Convalescent Period
    quote: Mechanistically, it is unclear why dysautonomia persists into the convalescent period of COVID-19 infection;
      however, similar to other viral syndromes, the cause is theorized to be a post-infectious autoimmune phenomenon.
    note: 'Found by winnow, kev and lev in p027. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Notably, antiphospholipid antibodies were detected in a patient with PASC-related POTS [60] who developed
      clinical signs and symptoms of antiphospholipid syndrome and mast cell activation syndrome following SARS-CoV-2
      infection.
    note: 'Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Diskussion
    quote: Im Zusammenhang mit den erhöhten adrenergen Autoantikörpern in unserem 1. Fallbeispiel erscheint es sinnvoll,
      die Induktion von Autoantikörpern nach SARS-COV-2-Infektion bei Kindern systematisch zu untersuchen. In einem
      aktuellen Review wird eindrucksvoll gezeigt, dass die SARS-CoV-2-Infektion als potenter Trigger der Bildung
      von Autoantikörpern angesehen wird [3].
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: partial.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Given the lag period of a few weeks between the COVID-19 infection and the onset of POTS symptoms, autoimmunity
      is a likely mechanism. However, our patient was not tested for autoantibodies cross-reacting with other receptors
      such as beta or muscarinic receptors.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - proposed_mechanism_of
  - pots
  papers: 15
  evidence:
  - paper: pmid41668453
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Mast cell activation, often manifesting as hives, has been proposed as a contributing mechanism, but
      its prevalence and clinical relevance in POTS and NMH are poorly defined.
    note: 'Found by winnow, kev and lev in p001, p031. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: POTS as an adverse event to HPV vaccine and the connection with EDS could be explained by mast cell activation
      causing POTS and EDS to present in patients post HPV-vaccination.
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Mast Cell Activation
      Syndrome
    quote: Although an exact pathophysiologic mechanism has not been identified, activated mast cells may produce
      circulating vasodilators such as histamine, leading to flushing and orthostatic intolerance as part of a hyperadrenergic
      POTS presentation.[16] Vasodilation results in a compensatory sympathetic response with increased vascular
      resistance and tachycardia, ultimately leading to the release of norepinephrine and neuropeptide Y, which
      are thought to further activate mast cell degranulation and create a positive feedback loop.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid39165715
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > CONCLUSION
    quote: In the literature, MCA was considered to be one of the mechanisms leading to POTS.
    note: 'Found by winnow, kev and lev in p001, p004, p005. Claude judged: supports.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: 'Mast cell implication in hyperadrenergic POTS can be explained predominantly by histamine effects, which
      is a strong vasodilator, as follows: upon vasodilation, blood redistribution to interstitial and third spaces
      occurs, diminishing venous return and cardiac output, which is sensed by high-pressure receptors within the
      arterial wall of the carotid and aorta, causing increased baroreflex activation and enhancing sympathetic
      activity through the blood vessels in order to re-stablish hemodynamic stability [8].'
    note: 'Found by winnow, kev and lev in p006, p020. Claude judged: supports.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: supports
    section: 6. Discussion
    quote: Potential mechanisms underlying a causative MCAS–POTS linkage might involve inappropriate episodic primary
      release (again, either constitutive or reactive in nature) of MCs’ potently vasodilatory mediators, acting
      directly on the endothelium and vascular smooth muscle (e.g., histamine and kinins [68]), or primary MC release
      of other mediators, leading rapidly to vasodilation, e.g., neurostimulatory mediators causing neurally mediated
      vasodilation).
    note: 'Found by winnow, kev and lev in p007, p020, p021. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Finally, the role of excessive mast cell activation in the pathophysiology of POTS has been proposed.
      In mast cell activation disorder, the inappropriate release of histamine and other mast cell mediators in
      response to physical activity or orthostatic stress may lead to orthostatic tachycardia [49].
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid34398691
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: The cause of POTS in individual patients is usually unknown, despite a number of conditions having been
      implicated; these include viral illnesses, trauma, and various inflammatory diseases. Mast cell activation
      (MCA) disorder has also been implicated since chemical mediators released from mast cells may cause symptoms
      suggestive of POTS (eg, postural tachycardia, lightheadedness).
    note: 'Found by winnow, kev and lev in p006, p008, p038. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots > Mast Cell Activation
    quote: In an evaluation of young females with POTS, Shibao et al. (82) found that some of them had flushing
      episodes associated with OI, which suggests that MCA is likely involved in the hyperadrenergic mechanism for
      POTS (82).
    note: 'Found by winnow, kev and lev in p007, p018. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: A patient with severe POTS, MCAS and SIBO responded to a combination of LDN, IVIg and antibiotic therapy.
      We theorise that pre-existing MCAS was the driving force for hyperadrenergic POTS in this patient.
    note: 'Found by winnow, kev and lev in p014, p015. Claude judged: supports.'
  - paper: pmid15710782
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15710782. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1 Introduction
    quote: Mast cell activation disorder has been proposed to be associated with POTS with atypical symptom presentation,
      such as predominant gastrointestinal (GI) symptomatology (Kohno et al., 2021).
    note: 'Found by winnow, kev and lev in p002, p034. Claude judged: partial.'
  - paper: pmid36969375
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Autonomic, allergic, and systemic abnormalities
    quote: Another theory in the literature is the relationship between POTS and mast cell activation disorder (MCAD).
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.5 Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p022. Claude judged: partial.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p070. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - postinfectious_evidence
  papers: 14
  evidence:
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: A direct link to the development of POTS as a sequela of COVID-19 infection in PASC gives great credence
      to the idea that the etiology of POTS involves an immunologic stressor such as a preceding viral illness.
    note: 'Found by winnow, kev and lev in p007, p001, p008. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Recently, POTS has been identified in ∼20% of cases of PASC, in which symptoms persist >4 weeks after
      the onset of COVID-19 illness.5,6 It is postulated that the cytokine storm from COVID-19 results in sympathetic
      dysregulation, causing an abnormal autonomic response in POTS.7
    note: 'Found by winnow, kev and lev in p011, p023. Claude judged: supports.'
  - paper: pmid42245008
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42245008. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Evidence for LHC/POTS and immunologic dysregulation
    quote: Immunologic mechanisms discussed in the literature include persistent immune activation, T-cell/NK cell
      exhaustion, and development of autoantibodies (10–14). The study will investigate whether other immune mechanisms
      play a role in contributing to post-COVID-19 POTS.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: It has been observed that many patients with COVID-19 infection develop POTS as a delayed manifestation
      [9-11,19,22]. Some of these patients have never experienced any symptoms of POTS before.
    note: 'Found by winnow, kev and lev in p012, p017, p018. Claude judged: partial.'
  - paper: pmid36947108
    cited: true
    text: full
    license: none
    verdict: partial
    section: Dysautonomia in PASC > What do we know about autonomic dysfunction in PASC?
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36947108. Found by winnow, kev and lev in p008, p024. Claude judged: partial.'
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: None of the PASC patients had similar symptoms of chronic fatigue, post-exercise malaise, or orthostatic
      intolerance prior to the COVID-19 infection. There are a few possibilities that can explain the post-infectious
      onset of the symptoms.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p010, p012. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Inflammation and
      Autoimmunity
    quote: COVID-19 infection can cause a cytokine storm and inflammation that could trigger chronic neuronal dysregulation
      (47). One mechanism could be via the development of autoantibodies which cross-react with autonomic ganglia
      as part of acute and long-term COVID-19 infection, and lead to dysautonomia and POTS.
    note: 'Found by winnow, kev and lev in p008, p006, p009. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What is the pathophysiology of POTS?
    quote: Many patients describe a postviral onset,29–32 and 15%–20% of patients with POTS report a history of
      an autoimmune disorder such as Hashimoto thyroiditis, rheumatoid arthritis or Sjögren syndrome.4 Recently,
      numerous cases of POTS33 and other forms of sinus tachycardia (e.g., inappropriate sinus tachycardia)34 after
      a SARS-CoV-2 infection have been reported.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34992725
    cited: true
    text: full
    license: by
    verdict: partial
    section: Key Points
    quote: Inappropriate sinus tachycardia and postural orthostatic tachycardia syndrome seem to be common in the
      convalescent period of COVID-19 infection as a result of post-infectious dysautonomia.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: A growing number of patients diagnosed with COVID-19 disease have been reported to have postural orthostatic
      tachycardia syndrome (POTS) after the acute phase.
    note: 'Found by winnow, kev and lev in p001, p009. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Fall 2
    quote: Basierend auf unseren Vorarbeiten über autonome Regulationsstörungen bei Kindern [2] und ersten Fallberichten
      aus der internistischen Kardiologie lag es nahe [6], dass diese postinfektiösen Probleme nach der SARS-CoV-2-Infektion
      Ausdruck eines sog. posturalen orthostatischen Tachykardiesyndroms (POTS) sind.
    note: 'Found by winnow, kev and lev in p011, p007, p010. Claude judged: partial.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusion
    quote: Autonomic dysfunction presenting as POTS can be a delayed manifestation of COVID-19 infection.
    note: 'Found by winnow, kev and lev in p011, p013. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - proposed_mechanism_of
  - pots
  papers: 14
  evidence:
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: There are also many reports that vaccination against the SARS-CoV-2 virus may induce the development
      of POTS (23–25).
    note: 'Found by winnow, kev and lev in p006, p026. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Not only does contracting SARS-CoV-2 infection confer the possibility of developing long COVID and subsequent
      development of POTS, but recipients of the SARS-CoV-2 vaccine have also been shown to develop POTS at a higher
      rate. The proposed explanation is that an immunological response was elicited by the administration of the
      vaccination, resulting in similar symptoms to long COVID.
    note: 'Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: However, POTS can be precipitated by immunologic stressors such as viral infection or vaccination [3].
      Notably, reports of adult cases of new-onset POTS after COVID-19 mRNA vaccination have been emerging [12-15].
    note: 'Found by winnow, kev and lev in p004, p001, p014. Claude judged: supports.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p014. Claude judged: supports.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: supports
    section: 6. Discussion
    quote: Taking all of the above knowledge into consideration, it thus becomes reasonable to hypothesize that
      the emergence of POTS soon after vaccination (whether against HPV or any other infectant) may be due to some
      constituent of the vaccine product (perhaps the immunogen, an adjuvant/excipient, or perhaps different factors
      in different patients) serving to “trigger” a cytokine storm (expressed by a variety of immune cells, including
      MCs, some of which may already be the dysfunctional MCs of MCAS), driving further (subclonal) evolution of
      (likely genomically unstable) MCAS, even in a patient previously not recognized to have MCAS.
    note: 'Found by winnow, kev and lev in p007, p021, p001. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Onset of de novo POTS has been associated with viral infections, trauma, stress, surgery, and vaccinations.
      There have been studies, most notably in Denmark, that found de novo POTS after quadrivalent human papillomavirus
      (HPV) vaccine jabs [6,7].
    note: 'Found by winnow, kev and lev in p001, p008, p003. Claude judged: supports.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This has led to the hypothesis of an autoimmune-mediated etiology of POTS, and recent case series of
      POTS following immune triggers like infection or vaccination (Blitshteyn, 2015; Brinth et al., 2015; Watari
      et al., 2018) support this hypothesis.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: While post-vaccination cardiovascular autonomic dysfunction remains rare [32], small fiber neuropathy
      offers a plausible explanation for POTS cases manifesting after COVID-19 vaccination.
    note: 'Found by winnow, kev and lev in p045. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: However, there have been a few case reports published in peer-reviewed journals that show patients affected
      with POTS after receiving mRNA COVID-19 vaccination. The exact mechanism of action is not known at this time,
      but an autoimmune response to vaccination is one of the possible mechanisms.
    note: 'Found by winnow, kev and lev in p051. Claude judged: partial.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: POTS has been described following both mRNA-based Moderna COVID-19 and Pfizer-BioNTech COVID-19 vaccines
      [5-8]. Interestingly, the cases associated with the latter usually occur one to three weeks post-inoculation,
      a similar time frame to our patient.
    note: 'Found by winnow, kev and lev in p009, p010. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: We also found three case reports of POTS after COVID-19 vaccination. Although causality between POTS
      and vaccines cannot be inferred from these cases, some vaccines are associated with various autoimmune neurological
      diseases such as Guillain-Barre syndrome or multiple sclerosis [37].
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid36075372
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction > Other cardiovascular complications associated with COVID-19 vaccines > Arrhythmias
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36075372. Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: There are also a number of reports of POTS developing subsequent to human papilloma virus immunization
      [22,23,24], implicating a potential role of inflammation and/or molecular mimicking as etiologies for the
      development of POTS.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid24102827
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24102827. Found by winnow, kev and lev in p002, p003, p004. Claude judged: partial.'
- edge:
  - small_fiber_neuropathy_dx
  - proposed_mechanism_of
  - pots
  papers: 10
  evidence:
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Small fibre neuropathy in the lower limbs is the primary reason for decreased release of norepinephrine,
      especially in the lower limbs [13].
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Small fiber neuropathy is regarded as one of the potential mechanisms underlying the pathophysiology
      of POTS [20], and in our cohort, QSART abnormalities indicating postganglionic small fiber dysfunction occurred
      with similar frequency in post-COVID and post-vaccination POTS.
    note: 'Found by winnow, kev and lev in p045, p047. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Due to the nature of POTS being an autonomic imbalance due to a small-fiber neuropathy, the patient was
      offered a traditional osteopathic approach and craniosacral therapy, which is postulated to restore autonomic
      function and balance.
    note: 'Found by winnow, kev and lev in p001, p003, p005. Claude judged: supports.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 15
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Small fiber neuropathy, characterized by damage to the small nerve fibers that control autonomic functions,
      is often associated with conditions like diabetes and autoimmune diseases, and its emergence in post-COVID-19
      patients suggests a potential neuropathic component to the pathophysiology of Long-COVID POTS. Small fiber
      neuropathy may contribute to the impaired regulation of blood pressure and heart rate that is commonly observed
      in these patients [11].
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. The Role of Fibrinaloid Microclots in POTS
    quote: Small fiber neuropathy (SFN) has been well described in long COVID (e.g., [63,65,68,172]) and is a recognized
      cause of dysautonomia in the condition. SFN in long COVID can be driven by autoantibodies (already known to
      be associated with POTS and OH) or, potentially, by ischemia of the small fibres due to microclots.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Besides hypovolemia, anemia, neurodegenerative aspects and connective tissue disorders, autoimmunity
      seems to play an important role in the pathogenesis of PoTS in some patients [[3], [4], [5], [6], [7]]. Moreover,
      small fiber neuropathy (SFN, neuropathic PoTS) could be detected in around 50 % of patients with PoTS [[8],
      [9], [10]].
    note: 'Found by winnow, kev and lev in p006, p007. Claude judged: partial.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: The notion that a neuropathic process may underlie the presentation of some patients with a postural
      tachycardia has prompted clinical investigations and yielded associations with disorders that are recognized
      causes of an autonomic and/or small fiber neuropathy.
    note: 'Found by winnow, kev and lev in p007, p027. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Several lines of evidence point to a restricted peripheral neuropathy, specifically, sympathetic denervation
      predominantly in the lower hemibody, as a cause of POTS in some individuals.
    note: 'Found by winnow, kev and lev in p006, p030. Claude judged: partial.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Considering that POTS patients have high plasma NE levels, it would seem paradoxical that a neuropathy
      is proposed as an underlying process. Yet some of them have a form of dysautonomia, with preferential denervation
      of sympathetic nerves innvervating the lower limbs [22-24].
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - proposed_mechanism_of
  - pots
  papers: 8
  evidence:
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Studies have shown that bed rest or deconditioning can contribute independently to the development of
      POTS, regardless of the underlying mechanism [5]. Longer periods of physical inactivity can lead to cardiac
      muscular atrophy, reduction in stroke volume and overall hypovolemia [14].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The underlying mechanisms remain unknown [18, 19], but viral and/or immune-mediated factors, as well
      as prolonged bed rest and physical deconditioning, may all play a substantial role in the development or exacerbation
      of cardiovascular autonomic disorders (CAD), such as postural orthostatic tachycardia syndrome (POTS), OH,
      and VVS [1, 11, 15, 16].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid34987818
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: There are various pathophysiological mechanisms for developing OI in POTS. One mechanism broadly described
      is cardiovascular deconditioning following prolonged bed rest, resulting in cardiac atrophy, and subsequent
      physical deconditioning.
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p059. Claude judged: supports.'
  - paper: pmid40538940
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Many teenage patients with PoTS experienced deconditioning; however, deconditioning is not the sole cause
      of tachycardia in PoTS (20, 21), and prolonged bed rest can exacerbate orthostatic intolerance, including
      PoTS (22).
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: partial
    section: 1. INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Our patient presented several risk factors for POTS. First, prolonged bed rest following coarctation
      repair may have been an initiating event for his physical deconditioning.
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid18704621
    cited: true
    text: full
    license: none
    verdict: partial
    section: Is the rise in heart rate with POTS really “excessive?”
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 18704621. Found by winnow, kev and lev in p011. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - proposed_mechanism_of
  - autoimmune_evidence
  papers: 7
  evidence:
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p013. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Numerous post-vaccination disorders, such as Guillain-Barre syndrome and transverse myelitis, have been
      reported to exhibit cross-reacting antibodies. These antibodies are proposed to mechanistically react beyond
      target ganglionic acetylcholine receptors, and thus could explain the POTS pathogenesis in the setting of
      post-vaccination [11].
    note: 'Found by winnow, kev and lev in p001, p008, p011. Claude judged: supports.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: In the three cases of postvaccination POTS, the symptoms and signs were almost identical to those of
      PASC, indicating that COVID-19 vaccines share the same target autoantibody epitope with PASC presenting as
      immune-mediated POTS.
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Although the exact mechanism of vaccine-induced POTS is not clear, the autoimmune pathophysiology might
      be a key component [13-15].
    note: 'Found by winnow, kev and lev in p001, p004, p014. Claude judged: partial.'
  - paper: pmid36075372
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction > Other cardiovascular complications associated with COVID-19 vaccines > Arrhythmias
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36075372. Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: There are also a number of reports of POTS developing subsequent to human papilloma virus immunization
      [22,23,24], implicating a potential role of inflammation and/or molecular mimicking as etiologies for the
      development of POTS.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: This has led to the hypothesis of an autoimmune-mediated etiology of POTS, and recent case series of
      POTS following immune triggers like infection or vaccination (Blitshteyn, 2015; Brinth et al., 2015; Watari
      et al., 2018) support this hypothesis.
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
- edge:
  - systemic_autoimmune_disease
  - proposed_mechanism_of
  - pots
  papers: 7
  evidence:
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Primary POTS occur independently, without association with other diseases, while secondary POTS is linked
      to underlying conditions such as diabetes mellitus, amyloidosis, sarcoidosis, autoimmune disorders like lupus
      or Sjogren’s syndrome, chemotherapy, or post-viral illnesses including COVID-19 [10].
    note: 'Found by winnow, kev and lev in p084, p009. Claude judged: supports.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Metabolic, systemic, and autoimmune diseases may also manifest as POTS. Common culprits include diabetes
      mellitus, amyloidosis, heavy metal poisoning, Sjögren’s syndrome, hypermobility syndrome, and paraneoplastic
      syndrome.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: A review of autoimmunity in POTS by Ref. [5] found that “patients with POTS have a higher than expected
      frequency of defined autoimmune disorders such as multiple sclerosis, lupus, Sjögren syndrome or celiac disease”.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What is the pathophysiology of POTS?
    quote: Postural orthostatic tachycardia syndrome may have an immunological cause. Many patients describe a postviral
      onset,29–32 and 15%–20% of patients with POTS report a history of an autoimmune disorder such as Hashimoto
      thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Other diseases that have been associated with POTS that have significant inflammation include sarcoidosis,
      alcoholism, Lupus, Sjogren’s Syndrome, heavy metal intoxication, and following chemotherapy [8,26].
    note: 'Found by winnow, kev and lev in p003, p030, p033. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome has also been reported in association with Sjögren's syndrome
      and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - proposed_mechanism_of
  - deconditioning_evidence
  papers: 6
  evidence:
  - paper: pmid42458878
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: In addition, prolonged bed rest and reduced physical activity related to orthostatic headache may lead
      to cardiovascular deconditioning, which can further aggravate orthostatic intolerance and tachycardic responses
      on standing.
    note: 'Found by winnow, kev and lev in p061. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Hypovolaemia
    quote: COVID-19 can be associated with fever and nocturnal sweating, leading to hypovolaemia, and prolonged
      bed rest, leading to deconditioning and cardiac atrophy.
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid34987818
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: One mechanism broadly described is cardiovascular deconditioning following prolonged bed rest, resulting
      in cardiac atrophy, and subsequent physical deconditioning.
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p059. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: First, prolonged bed rest following coarctation repair may have been an initiating event for his physical
      deconditioning.
    note: 'Found by winnow, kev and lev in p016, p018. Claude judged: supports.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p030. Claude judged: partial.'
- edge:
  - hypovolemic_evidence
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 6
  evidence:
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Hypovolaemia
    quote: Firstly, it has been suggested that POTS occurs due to decreased blood volume and deconditioning of the
      heart, which subsequently increases cardiac sympathetic nervous system (SNS) output (24, 32, 33).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Hypovolemia may trigger hyperadrenergic POTS and lead to cerebral hypoperfusion and the impairment of
      central autonomic networks [56].
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.2 Hyperadrenergic State
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: supports
    section: Neurovisceral phenotypes > Joint hypermobility > Association with psychiatric disorder
    quote: In disorders that typically involve impaired collagen (present in blood vessels) such as joint hypermobility
      and postural tachycardia syndrome it is likely that reduced venous return during standing due to venous pooling
      or denervation causing low plasma volume may be responsible for a an increased sympathetic state–as the body
      attempts to compensate for these abnormalities—resulting in orthostatic intolerance and associated symptoms
      (Bohora, 2010; Benarroch, 2012; Mathias et al., 2012).
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > POTS Pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid40027266
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: The pathophysiology remains elusive; however, central hypovolemia has been identified as the mechanism
      leading to venous pooling, hypovolemia, deconditioning, and hyperadrenergic state.16,17
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 6
  evidence:
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: "Several hypotheses about possible pathomechanisms of POTS or dysautonomia in general after COVID-19\
      \ infection have been proposed: imbalance of the renin-angiotensin-aldosterone system,\n\n26\n\n,\n\n29\n\
      \ brainstem involvement,\n\n43\n\n,\n\n45\n\n,\n\n46\n autoreactivity to antibodies against SARS-CoV-2,\n\n\
      25\n\n,\n\n43\n\n,\n\n47\n dyshomeostasis of immune response\n\n42\n\n,\n\n44\n and denervation of peripheral\
      \ sympathetic nerve fibers."
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: We suspect a neuropathic cause of POTS in our patient that may be secondary to a viral cause, due to
      his history of infection with COVID-19.
    note: 'Found by winnow, kev and lev in p015, p001, p020. Claude judged: supports.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: Sudomotor dysfunction was demonstrated as consistently worsened or new-sequelae to COVID-19 infection.
      COVID-19 may be responsible for triggering new-onset or worsened small-fiber neuropathy in this sample, supporting
      previously reported studies with similar findings.
    note: 'Found by winnow, kev and lev in p008, p027. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Neurotropism
    quote: Thus, it has been proposed that SARS-Cov2 could infect and damage extracardiac postganglionic SNS, leading
      to dysautonomia in a similar way to neuropathic POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The cholinergic POTS subgroup is therefore consistent with the hypothesis that neuropathic POTS is a
      restricted autonomic neuropathy [6]. Post-ganglionic cholinergic dysautonomia is frequently associated with
      a viral infection and is most likely immune-mediated [6,39-45].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - systemic_autoimmune_disease
  - proposed_mechanism_of
  - autoimmune_evidence
  papers: 5
  evidence:
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Primary POTS occur independently, without association with other diseases, while secondary POTS is linked
      to underlying conditions such as diabetes mellitus, amyloidosis, sarcoidosis, autoimmune disorders like lupus
      or Sjogren’s syndrome, chemotherapy, or post-viral illnesses including COVID-19 [10].
    note: 'Found by winnow, kev and lev in p084, p009. Claude judged: partial.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: Patients with one AD are often more prone to others. A review of autoimmunity in POTS by Ref. [5] found
      that “patients with POTS have a higher than expected frequency of defined autoimmune disorders such as multiple
      sclerosis, lupus, Sjögren syndrome or celiac disease”.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Other diseases that have been associated with POTS that have significant inflammation include sarcoidosis,
      alcoholism, Lupus, Sjogren’s Syndrome, heavy metal intoxication, and following chemotherapy [8,26]. In essence,
      if POTS is an autoimmune disorder as defined by the presence of autoantibodies, it could also be considered
      an inflammatory disorder.
    note: 'Found by winnow, kev and lev in p003, p030. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome has also been reported in association with Sjögren's syndrome
      and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 5
  evidence:
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Mast Cell Activation
      Syndrome
    quote: Although an exact pathophysiologic mechanism has not been identified, activated mast cells may produce
      circulating vasodilators such as histamine, leading to flushing and orthostatic intolerance as part of a hyperadrenergic
      POTS presentation.[16] Vasodilation results in a compensatory sympathetic response with increased vascular
      resistance and tachycardia, ultimately leading to the release of norepinephrine and neuropeptide Y, which
      are thought to further activate mast cell degranulation and create a positive feedback loop.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: Hence, mast cell and sympathetic activity could create a closed-loop mechanism with positive feedback,
      as exemplified by the gradually progressing symptoms reported by patients. The more the mast cell is activated,
      the more sympathetic hyperactivity is produced, and vice versa (Fig. 3).
    note: 'Found by winnow, kev and lev in p006, p020, p021. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Associations with mast cell activation disorders
    quote: However, Shibao et al. [95] tested the hypothesis that plasma histamine can cause sympathetic overactivity
      via vasodilatation and compared POTS patients presenting flushing and raised urinary methylhistamine (a mast
      cell mediator metabolite) with patients reporting flushing but with normal urinary metabolites. These MCA/POTS
      patients had predominant flushing breathlessness, headache, lightheadedness, excessive diuresis, diarrhoea,
      nausea and vomiting, and had a marked hyperadrenergic orthostatic response, with higher noradrenaline levels
      and exaggerated blood pressure rise on standing compared with the POTS and control groups [95].
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: We theorise that pre-existing MCAS was the driving force for hyperadrenergic POTS in this patient.
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p070. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 5
  evidence:
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: Although our understanding is not entirely clear, some postulated mechanisms consist of autoantibody
      production against autonomic nerve fibers, direct toxic effects of SARS-COV-2, or sympathetic nervous system
      stimulation secondary to infection.
    note: 'Found by winnow, kev and lev in p012, p079. Claude judged: supports.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Hyperadrenergic states from infection, hypovolemia, and deconditioning are implicated in development
      of orthostatic intolerance post-pandemic.
    note: 'Found by winnow, kev and lev in p010, p029. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p017, p030. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Additionally, the role of angiotensin-converting enzyme 2 (ACE2) receptor dysfunction has been implicated
      in the etiology of POTS, as COVID-19 attenuates ACE2 receptor activity and consequently upregulates sympathetic
      activation [14].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: It is postulated that the cytokine storm from the COVID-19 infection results in sympathetic dysregulation,
      causing the abnormal autonomic response in POTS [6].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 5
  evidence:
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Some cases of neuropathic POTS are thought to arise from immune-mediated neuropathy.
    note: 'Found by winnow, kev and lev in p037, p038, p039. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS as a CNS disorder: proposed model'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome has also been reported in association with Sjögren's syndrome
      and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p034. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Post-ganglionic cholinergic dysautonomia is frequently associated with a viral infection and is most
      likely immune-mediated [6,39-45]. The absence of a distal to proximal gradient in sudomotor deficits, observed
      by us and by others lends additional support to the possibility that an immune-mediated process underlies
      neuropathic POTS [5,8,37].
    note: 'Found by winnow, kev and lev in p040. Claude judged: partial.'
- edge:
  - anxiety_depression
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 4
  evidence:
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: What’s more, researchres confirmed that anxiety and depression could act on hypothalamic-pituitary-adrenocortical
      axis (HPA) and produce hyperactivity of the sympathetic nervous system (Remme, 1998). Studies have shown that
      depression and anxiety could increase sympathetic excitability, upregulated levels of catecholamine in the
      blood, and heart rate (Wang et al., 2018).
    note: 'Found by winnow, kev and lev in p007, p020. Claude judged: supports.'
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: How to Explain the Pathophysiology to Patients and Families
    quote: Anxiety about these symptoms potentiates the pathophysiology, as additional excessive adrenaline is made
      in response—drying out the patient, increasing fluid requirements, and cycling the pathophysiology.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid35802513
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35802513. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Anxiety with its hyperadrenergic response can mimic POTS.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 4
  evidence:
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p017, p030. Claude judged: supports.'
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Neuroinflammation
    quote: Importantly, systemic abnormalities consisting of central hypovolemia, hyperadrenergic response and downstream
      autonomic neuropathy resulting from central autonomic network dysregulation may correlate to the hypovolemic,
      hyperadrenergic and neuropathic POTS phenotypes and may localize to the dorsolateral medulla and hypothalamus
      via nucleus tractus solitarius, dorsal motor nucleus of the vagus and dorsal longitudinal fasciculus traversing
      near the floor of the fourth ventricle.22,52
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: DISCUSSION
    quote: They found gliosis and astrogliosis in a patchy pattern near the nuclei that control sympathetic activity
      in patients deceased by COVID-19 [17]. Malfunction of these nuclei could give rise to sympathetic hyperactivity,
      producing HR and SBP disturbances during postural changes, as could be seen in hyperadrenergic POTS [7].
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p040. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 4
  evidence:
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: We suspect a neuropathic cause of POTS in our patient that may be secondary to a viral cause, due to
      his history of infection with COVID-19.
    note: 'Found by winnow, kev and lev in p015, p001. Claude judged: supports.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: Sudomotor dysfunction was demonstrated as consistently worsened or new-sequelae to COVID-19 infection.
      COVID-19 may be responsible for triggering new-onset or worsened small-fiber neuropathy in this sample, supporting
      previously reported studies with similar findings.
    note: 'Found by winnow, kev and lev in p008, p027. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Neurotropism
    quote: Thus, it has been proposed that SARS-Cov2 could infect and damage extracardiac postganglionic SNS, leading
      to dysautonomia in a similar way to neuropathic POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Small fiber neuropathy, characterized by damage to the small nerve fibers that control autonomic functions,
      is often associated with conditions like diabetes and autoimmune diseases, and its emergence in post-COVID-19
      patients suggests a potential neuropathic component to the pathophysiology of Long-COVID POTS.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - proposed_mechanism_of
  - pots
  papers: 4
  evidence:
  - paper: pmid39582682
    cited: true
    text: full
    license: by
    verdict: supports
    section: Headache disorders in hEDS and HSD > Orthostatic headaches > Postural tachycardia syndrome
    quote: The exact mechanism behind increased prevalence of PoTS in hypermobile patients remains elusive. One
      of the more accepted hypotheses relates to excessive distensibility of the veins, due to the underlying HCTD,
      leading to venous pooling and reduced venous return.
    note: 'Found by winnow, kev and lev in p022, p024. Claude judged: supports.'
  - paper: pmid35620060
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Furthermore, EDS may predispose patients to abnormal venous distention during orthostatic stress, leading
      to the venous pooling found in POTS.
    note: 'Found by winnow, kev and lev in p017, p004, p018. Claude judged: supports.'
  - paper: pmid19946638
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Patients with joint hypermobility syndrome even have more difficulty owing to loss of supporting connective
      tissues in the vessels. Orthostatic intolerance develops in these patients due to the presence of abnormally
      elastic connective tissue in the vasculature.
    note: 'Found by winnow, kev and lev in p006, p007. Claude judged: supports.'
  - paper: pmid34055418
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The association between POTS and JHS can be explained by predominant peripheral neuropathy in the autonomous
      system and a failure of the peripheral vascular system to maintain resistance in areas exposed to stress due
      to orthostasis, blood stasis in the lower limbs, or pathologies of the central nervous system [11].
    note: 'Found by winnow, kev and lev in p005, p012. Claude judged: partial.'
- edge:
  - hypovolemic_evidence
  - proposed_mechanism_of
  - cerebral_hypoperfusion_evidence
  papers: 3
  evidence:
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion > 4.2 Hypovolemia-induced POTS
    quote: In cases of hypovolemia, transitioning from a supine to an upright position leads to insufficient blood
      supply, reducing the blood flow to the brain.
    note: 'Found by winnow, kev and lev in p001, p047, p050. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Hypovolemia may trigger hyperadrenergic POTS and lead to cerebral hypoperfusion and the impairment of
      central autonomic networks [56].
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS as a CNS disorder: proposed model'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026. Claude judged: supports.'
- edge:
  - small_fiber_neuropathy_dx
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 3
  evidence:
  - paper: pmid41675297
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: This is hypothesized to be due to small fiber neuropathy leading to decreased adrenergic vasoconstriction
      in the legs or the splanchnic vasculature, causing baroreflex unloading, decreased reflex cardiovagal stimulation,
      increased reflex sympathetic excitation, and reflex tachycardia.46
    note: 'Found by winnow, kev and lev in p048. Claude judged: supports.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: The notion that a neuropathic process may underlie the presentation of some patients with a postural
      tachycardia has prompted clinical investigations and yielded associations with disorders that are recognized
      causes of an autonomic and/or small fiber neuropathy.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Considering that POTS patients have high plasma NE levels, it would seem paradoxical that a neuropathy
      is proposed as an underlying process. Yet some of them have a form of dysautonomia, with preferential denervation
      of sympathetic nerves innvervating the lower limbs [22-24].
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - anxiety_depression
  - proposed_mechanism_of
  - pots
  papers: 3
  evidence:
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: Anxiety and depression emotion might be involved in the pathogenesis of POTS.
    note: 'Found by winnow, kev and lev in p004, p007, p020. Claude judged: supports.'
  - paper: pmid40763323
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Furthermore, the higher prevalence of palpitations observed during the pandemic may be associated with
      elevated anxiety levels and psychological stress.14-17
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: How to Explain the Pathophysiology to Patients and Families
    quote: Anxiety about these symptoms potentiates the pathophysiology, as additional excessive adrenaline is made
      in response—drying out the patient, increasing fluid requirements, and cycling the pathophysiology. Explaining
      this to patients in this way takes the focus from anxiety as a primary cause, but still informs them that
      it is a contributor to symptoms and must be addressed just like the other parts of treatment.
    note: 'Found by winnow, kev and lev in p009, p019. Claude judged: partial.'
- edge:
  - iron_deficiency
  - proposed_mechanism_of
  - pots
  papers: 3
  evidence:
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots
    quote: Current perspectives on the pathogenesis of POTS have been categorized as altered central blood volume,
      abnormal autonomic reflexes and elevated sympathetic tone, damaged skeletal muscle pump activity, local vascular
      tension regulation dysfunction, iron insufficiency, mast cell activation (MCA), and autoimmune dysfunction
      (3, 6, 12).
    note: 'Found by winnow, kev and lev in p017, p007. Claude judged: supports.'
  - paper: pmid23720007
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Interpretation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23720007. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Additional Associations
      and Postural Orthostatic Tachycardia Syndrome Mimickers > Iron Deficiency and Anemia
    quote: Whether iron deficiency is specifically related to POTS or serves as a mimicker via diminished venous
      return is still under review.[11] Dodson et al. found an association between restless legs syndrome, a condition
      often caused by iron deficiency anemia, and POTS.[52]
    note: 'Found by winnow, kev and lev in p038. Claude judged: partial.'
- edge:
  - sleep_disturbance
  - proposed_mechanism_of
  - pots
  papers: 3
  evidence:
  - paper: pmid25474569
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Irwin et al. found that patients with insomnia had increased nocturnal catecholamine levels as compared
      with controls [34] which might contribute the pathophysiology of POTS.
    note: 'Found by winnow, kev and lev in p028, p006. Claude judged: supports.'
  - paper: pmid42254140
    cited: true
    text: full
    license: by
    verdict: partial
    section: Body
    quote: Dysregulation in any of these inputs can result in fragmented sleep, which can increase sympathetic nervous
      system activity, compounding POTS symptoms like tachycardia, fatigue, and exercise intolerance[4,9].
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid35303039
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In addition, sleeping disorder was common in pediatric postural tachycardia syndrome (POTS) that was
      thought to have similar hemodynamic characteristics to pediatric STS [1, 21]. Sleeping duration of less than
      8 hours was deemed to be a risk factor for pediatric POTS [7].
    note: 'Found by winnow, kev and lev in p006, p024. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - cerebral_hypoperfusion_evidence
  papers: 2
  evidence:
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Pulmonary determinants
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p033, p039. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS (Table 1) > Hyperadrenergic POTS
    quote: Another manifestation of increased SNA during orthostasis in POTS patients includes possibly increasing
      coherence and blunting cerebral autoregulation leading to decreased cerebral blood flow (Ocon et al., 2009).
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
- edge:
  - neuropathic_evidence
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 2
  evidence:
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p004, p031. Claude judged: partial.'
  - paper: pmid12577219
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Method
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 12577219. Found by winnow, kev and lev in p002. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - proposed_mechanism_of
  - hypovolemic_evidence
  papers: 2
  evidence:
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS as a CNS disorder: proposed model'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > RAAS Abnormalities in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p026. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - hypovolemic_evidence
  papers: 2
  evidence:
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Simultaneously, long COVID-19 can cause hypovolemia through various pathways, including decreased intake
      due to illness or direct viral effects on gastrointestinal systems leading to losses through diarrhea [64].
      The resultant decrease in blood volume challenges the body’s ability to maintain adequate blood circulation,
      especially upon standing, which can trigger or exacerbate POTS symptoms.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. The Role of Fibrinaloid Microclots in POTS
    quote: Other mechanisms for POTS in long COVID may include:Relative hypovolemia secondary to inadequate peripheral
      vasoconstriction.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - proposed_mechanism_of
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: "Several hypotheses about possible pathomechanisms of POTS or dysautonomia in general after COVID-19\
      \ infection have been proposed: imbalance of the renin-angiotensin-aldosterone system,\n\n26\n\n,\n\n29\n\
      \ brainstem involvement,\n\n43\n\n,\n\n45\n\n,\n\n46\n autoreactivity to antibodies against SARS-CoV-2,\n\n\
      25\n\n,\n\n43\n\n,\n\n47\n dyshomeostasis of immune response\n\n42\n\n,\n\n44\n and denervation of peripheral\
      \ sympathetic nerve fibers."
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: Mechanisms of Dysautonomia Leading to Postural Orthostatic Tachycardia Syndrome > Neurotropism
    quote: Thus, it has been proposed that SARS-Cov2 could infect and damage extracardiac postganglionic SNS, leading
      to dysautonomia in a similar way to neuropathic POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - proposed_mechanism_of
  - pots
  papers: 2
  evidence:
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Proposed Pathophysiology for Gastrointestinal Symptoms in Postural Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p024, p014. Claude judged: partial.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction > Concurrent clinical syndromes > Irritable bowel syndrome (IBS)
    quote: Although rarely performed, plethysmography may demonstrate splanchnic venous pooling in patients with
      IBS.8 The baroreflex response to reduced venous return (consequent to histamine or localized small molecule
      related vasodilation) can result in POTS.
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - cerebral_hypoperfusion_evidence
  papers: 1
  evidence:
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: partial
    section: '3. Dorsolateral Medulla: Localization for POTS and Long COVID'
    quote: Cerebral hypoperfusion is one of the major mechanisms of POTS, autonomic dysfunction, myalgic encephalomyelitis/chronic
      fatigue syndrome and probably Long COVID [6].
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
- edge:
  - hypovolemic_evidence
  - proposed_mechanism_of
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid25168872
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Volume depletion is a cardinal feature of the deconditioned state (Coyle et al. 1986) and POTS (Benarroch
      2012; Raj 2013) and may account for much of the observed reduction in heart size in patients with CFS (Miwa
      and Fujita 2008; Hurwitz et al. 2010).
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
- edge:
  - long_covid
  - proposed_mechanism_of
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p040. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - proposed_mechanism_of
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Post–COVID-19 POTS > C.2. Possible mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p017. Claude judged: supports.'
- edge:
  - surgery_onset
  - proposed_mechanism_of
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: First, prolonged bed rest following coarctation repair may have been an initiating event for his physical
      deconditioning.
    note: 'Found by winnow, kev and lev in p016, p018. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p026. Claude judged: supports.'
- edge:
  - hypermobility_heds
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: supports
    section: Neurovisceral phenotypes > Joint hypermobility > Association with psychiatric disorder
    quote: In disorders that typically involve impaired collagen (present in blood vessels) such as joint hypermobility
      and postural tachycardia syndrome it is likely that reduced venous return during standing due to venous pooling
      or denervation causing low plasma volume may be responsible for a an increased sympathetic state–as the body
      attempts to compensate for these abnormalities—resulting in orthostatic intolerance and associated symptoms
      (Bohora, 2010; Benarroch, 2012; Mathias et al., 2012).
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
- edge:
  - sleep_disturbance
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid35303039
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Therefore, it can be speculated that the reduced sleeping duration increased sympathetic excitement,
      causing endocrine hormone secretion disorders. In other words, children with insomnia may lead to a maladaptive
      daytime sympathetic excitement, which might be the cause of STS [24].
    note: 'Found by winnow, kev and lev in p006, p024. Claude judged: supports.'
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid34268642
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic Disorders and Headache
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34268642. Found by winnow, kev and lev in p015. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - proposed_mechanism_of
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid37241210
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Association with Postural Tachycardia Syndrome, Reduced Cerebral Blood Flow and Orthostatic Intolerance
    quote: 'Histamine is probably the most important mediator released by overactivated mast cells. Upon a histamine
      discharge, the excess of histamine has the potential to worsen the orthostatic intolerance (OI) via several
      vascular mechanisms: (1) intestinal hyperemia and steal effect when dealing with intestinal releases, (2)
      a systemic vasodilating effect will disturb the highly coordinated orthostatic regulation, not only affecting
      arterial but even stronger venous vessels.'
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - proposed_mechanism_of
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Cardiovascular pathophysiology
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p017. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A recent study found, however, that vaccination against COVID-19 can predispose individuals to develop
      small fiber neuropathy [56]. Small fiber neuropathy is regarded as one of the potential mechanisms underlying
      the pathophysiology of POTS [20], and in our cohort, QSART abnormalities indicating postganglionic small fiber
      dysfunction occurred with similar frequency in post-COVID and post-vaccination POTS.
    note: 'Found by winnow, kev and lev in p045. Claude judged: partial.'
- edge:
  - systemic_autoimmune_disease
  - proposed_mechanism_of
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome has also been reported in association with Sjögren's syndrome
      and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusions
    quote: Although our understanding is not entirely clear, some postulated mechanisms consist of autoantibody
      production against autonomic nerve fibers, direct toxic effects of SARS-COV-2, or sympathetic nervous system
      stimulation secondary to infection.
    note: 'Found by winnow, kev and lev in p001, p012, p079. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - proposed_mechanism_of
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid36981522
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. Discussion
    quote: Afrin and colleagues have hypothesized that pre-existing MCAS might predispose patients to develop long-COVID
      after a SARS-CoV-2 infection by contributing to a hyperinflammatory response [35].
    note: 'Found by winnow, kev and lev in p034. Claude judged: supports.'
- edge:
  - hormonal_transition_onset
  - proposed_mechanism_of
  - pots
  papers: 1
  evidence:
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Given the coincidental timing of female pubertal hormone surges and adolescent onset of VVS and POTS
      in young women, coupled with the known roles of these hormones in modulating cardiovascular homeostasis, it
      is likely that female pubertal hormones play a role in predisposing females to VVS and POTS during puberty.
    note: 'Found by winnow, kev and lev in p005, p054, p001. Claude judged: partial.'
- edge:
  - me_cfs
  - proposed_mechanism_of
  - pots
  papers: 1
  evidence:
  - paper: pmid37241210
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Association with Postural Tachycardia Syndrome, Reduced Cerebral Blood Flow and Orthostatic Intolerance
    quote: The association of MCA with POTS, as an example for orthostatic stress, may be via ME/CFS or separate.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
- edge:
  - surgery_onset
  - proposed_mechanism_of
  - pots
  papers: 1
  evidence:
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Our patient presented several risk factors for POTS. First, prolonged bed rest following coarctation
      repair may have been an initiating event for his physical deconditioning.
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - pots
  papers: 124
  evidence:
  - paper: pmid42458878
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: METHODS > Outcome assessment
    quote: 'Orthostatic hemodynamic abnormality was defined as the presence of any of the following during the HUT
      test: classical orthostatic hypotension (OH), delayed OH, POTS, or syncope, based on the 2018 European Society
      of Cardiology guidelines.'
    note: 'Found by winnow, kev and lev in p041, p059. Claude judged: supports.'
  - paper: pmid42342403
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Eligibility criteria > Screening of participants without a prior diagnosis
    quote: A ΔHR of ≥30 bpm within 10 min of head-up tilt (70°), in the absence of orthostatic hypotension (SBP
      fall ≥20 mm Hg or diastolic BP fall ≥10 mm Hg), fulfils the diagnostic criteria for POTS; in participants
      with a ΔHR of 25–29 bpm, the diagnostic criteria are likewise considered fulfilled if typical orthostatic
      symptoms are present and clinical judgement supports the diagnosis.
    note: 'Found by winnow, kev and lev in p028, p030, p023. Claude judged: supports.'
  - paper: pmid42273028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Participants
    quote: 'We retrospectively identified 382 patients diagnosed with POTS via the head-up tilt table test (HUTT),
      a diagnostic tool with demonstrated higher sensitivity for POTS diagnosis than basic orthostatic vital signs
      at the Cleveland Clinic between 2018 and 2020 (13). A diagnosis of POTS was confirmed by HUTT when the following
      criteria, identified by Stallkamp-Tidd et al. (2), were met:'
    note: 'Found by winnow, kev and lev in p011, p002, p012. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods
    quote: All patients meeting the standardised definition of POTS, whose diagnosis was confirmed with positive
      tilt table testing between August 2023 and August 2024. A tilt table test was considered positive if the heart
      rate increased by >=30 bpm or the heart rate was >= 120 bpm within 10 minutes of standing up from a recumbent
      position, notably in the absence of any orthostatic hypotension (>20 mmHg drop in SBP).
    note: 'Found by winnow, kev and lev in p002, p016, p026. Claude judged: supports.'
  - paper: pmid41420770
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Materials and Methods: > Autonomic testing procedures:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41420770. Found by winnow, kev and lev in p010, p026, p034. Claude judged: supports.'
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods > 2.1. Study Protocol
    quote: After head-up tilt testing (HUTT), 22 patients (7.7% of 287) with post-COVID-19 CFS, 27 patients (5.4%
      of 501) with CFS of insidious onset, and 20 patients (7.5% of 267) with syncope fulfilled diagnostic criteria
      for POTS.
    note: 'Found by winnow, kev and lev in p007, p031, p041. Claude judged: supports.'
  - paper: pmid41156242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Tilt-table testing was abnormal in 82.0% of cases, revealing orthostatic hypotension, reflex syncope,
      or postural tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p014, p019, p001. Claude judged: supports.'
  - paper: pmid40959677
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Background
    quote: The head-up test (HUT) or head-up tilt test (HUTT) is typically required to confirm the diagnosis of
      POTS.
    note: 'Found by winnow, kev and lev in p001, p009, p039. Claude judged: supports.'
  - paper: pmid40761644
    cited: true
    text: full
    license: by
    verdict: supports
    section: Patients and methods > Examination of orthostatic intolerance
    quote: POTS was defined as a sustained increase in heart rate of ≥30 beats per minute, accompanied by characteristic
      orthostatic symptoms in the absence of postural hypotension. This abbreviated procedure is consistent with
      the diagnostic criteria outlined by Freeman et al. (22), and was selected to allow standardized yet clinically
      feasible assessment in a non-cardiology outpatient setting.
    note: 'Found by winnow, kev and lev in p015, p010, p018. Claude judged: supports.'
  - paper: pmid40585261
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Materials and Methods > Autonomic testing procedures:'
    quote: Standard diagnostic criteria were used to identify POTS, orthostatic hypotension, and orthostatic hypertension
      during tilt table testing.
    note: 'Found by winnow, kev and lev in p012, p028. Claude judged: supports.'
  - paper: pmid40533427
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: The confirmed diagnosis was based on international criteria, including a sustained heart rate increase
      of at least 30 beats per minute or at least 40 beats per minute in adolescents (16–19 years of age) during
      a 10‐minute active standing test or head‐up tilt table test, the absence of orthostatic hypotension, and unexplained
      symptoms of orthostatic intolerance lasting at least three months.
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid40437589
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Definition of positive responses to HUTT
    quote: Positive responses to HUTT included vasovagal syncope (VVS), postural orthostatic tachycardia syndrome
      (POTS), and orthostatic hypertension (OHT).
    note: 'Found by winnow, kev and lev in p003, p011, p016. Claude judged: supports.'
  - paper: pmid40433210
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Methods > HUTTs
    quote: A HUTT was considered positive for POTS if a sustained increase in heart rate, of > 30 beats per minute
      within 10 minutes of tilting, was noted in the absence of a drop in blood pressure of > 20/10 mm Hg.
    note: 'Found by winnow, kev and lev in p005, p015, p018. Claude judged: supports.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: Inclusion criteria were symptoms of orthostatic intolerance with a diagnosis of POTS or vasovagal syncope
      confirmed by head-up tilt test.
    note: 'Found by winnow, kev and lev in p012, p016. Claude judged: supports.'
  - paper: pmid40271232
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods
    quote: The tilt table test is the current standard for POTS diagnosis, which involves measuring a patient’s
      heart rate and blood pressure when they are supine compared to when they are tilted upward at a 70° angle
      from the horizontal plane.
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid40003288
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Currently, the only validated tool for diagnosis of POTS in adolescents is the head up tilt table testing
      [13]. During head-up tilt table testing, patients are secured to a table with a footplate in a supine position
      for at least 10 min, and then the table is elevated to approximately 70 degrees (at least 60 degrees) for
      a minimum of 10 additional minutes.
    note: 'Found by winnow, kev and lev in p006, p002. Claude judged: supports.'
  - paper: pmid39552985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The diagnosis of POTS was established only four years later by a tilt table test.
    note: 'Found by winnow, kev and lev in p009, p001, p033. Claude judged: supports.'
  - paper: pmid39308845
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods
    quote: Patients were diagnosed with POTS based on autonomic testing, applying the criteria of a 40 bpm increase
      in heart rate during a head-up tilt table test without concurrent hypotension, as per the published diagnostic
      guidelines for pediatric populations [1].
    note: 'Found by winnow, kev and lev in p005, p017. Claude judged: supports.'
  - paper: pmid39165715
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > METHODS
    quote: Serum tryptase levels were obtained from all patients before the TILT-table test, and serum tryptase
      levels were re-studied after the test was terminated in patients with positive TILT-table tests for POTS.
      Patients diagnosed with POTS were classified as Group 1, and other patients were classified as Group 2.
    note: 'Found by winnow, kev and lev in p002, p019. Claude judged: supports.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case presentation
    quote: The 72-hour Holter did demonstrate persistent sinus tachycardia and head-up tilt-table testing confirmed
      POTS (Table 1, Figure 1, Figure 2). Following a passive head-up tilt-table testing, the patient’s heart rate
      increased by >30 bpm to a maximum of 144 bpm, clinching the diagnostic criteria for POTS.
    note: 'Found by winnow, kev and lev in p006, p012. Claude judged: supports.'
  - paper: pmid38962840
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: METHODS
    quote: The HUT was utilized in this context as a well‐established standardized method to reaffirm the diagnosis
      of POTS on the study day [1, 2].
    note: 'Found by winnow, kev and lev in p013, p014. Claude judged: supports.'
  - paper: pmid38585346
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Reviewed testing
    quote: Tilt table is diagnostic for POTS if within this 10-min time, the patient has a sustained heart rate
      increase of at least 30 beats per minute in the absence of orthostatic hypotension or another condition that
      may explain the sinus tachycardia.
    note: 'Found by winnow, kev and lev in p010, p002. Claude judged: supports.'
  - paper: pmid38486257
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Study participants
    quote: 'All children fulfilled the following diagnostic criteria for VVS or POTS: (1) mainly older children;
      (2) presence of OI symptoms; (3) positive HUTT; and (4) absence of other conditions that might cause similar
      symptoms, such as cerebrovascular disorders and organic heart diseases [2].'
    note: 'Found by winnow, kev and lev in p008, p009. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2 Materials and methods > 2.2 Study population > 2.2.1 The POTS cohort > 2.2.1.2 Cardiovascular autonomic
      testing
    quote: POTS diagnosis was defined as symptoms of orthostatic intolerance lasting for ≥3 months associated with
      a pathological tilt test showing a HR increase >30 bpm from supine position or a HR > 120 bpm in standing,
      with no evidence of orthostatic hypotension (Brignole et al., 2018).
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: Patients underwent a standardized testing protocol to confirm the diagnosis of POTS (head up tilt) and
      specific laboratory testing to establish the POTS phenotype(s) to guide therapy.
    note: 'Found by winnow, kev and lev in p003, p007. Claude judged: supports.'
  - paper: pmid38033543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Standing test and HUTT > HUTT
    quote: Although the standing test is relatively simple and should be prioritized in clinical practice, the HUTT
      can also be used to help diagnose of POTS.
    note: 'Found by winnow, kev and lev in p011, p014. Claude judged: supports.'
  - paper: pmid37508741
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods > 2.3. HUTT
    quote: 'HUTT is divided into two steps: basic head-up tilt test (BHUT) and sublingual nitroglycerin head-up
      tilt test (SNHUT). In this study, only BHUT was used to diagnose POTS.'
    note: 'Found by winnow, kev and lev in p006, p007. Claude judged: supports.'
  - paper: pmid37443510
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: A standing test or head-up tilt test (HUTT) can provide important evidence for the diagnosis of POTS.
    note: 'Found by winnow, kev and lev in p002, p005, p008. Claude judged: supports.'
  - paper: pmid37378800
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Autonomic testing
    quote: Postural orthostatic tachycardia syndrome (POTS) was defined as a persistent increase in heart rate of
      at least 30 beats per minute within 10 min of upright tilt, in the absence of either classical or delayed
      orthostatic hypotension.
    note: 'Found by winnow, kev and lev in p016, p026. Claude judged: supports.'
  - paper: pmid36518687
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Diagnostic procedures > Head-up tilt test
    quote: VVS diagnosis and its hemodynamic subtypes, POTS, OH, and OHT, were identified using HUTT (7).
    note: 'Found by winnow, kev and lev in p010, p013. Claude judged: supports.'
  - paper: pmid36397456
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 3. Results
    quote: 'Based on HUTT results, 70 patients (13.0%) were diagnosed with POTS: 33 adolescents (22.4%), 37 adults
      (13.8%), and no older individuals.'
    note: 'Found by winnow, kev and lev in p005, p014, p016. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: HUT is considered as a golden standard for POTS diagnosis61.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid36111700
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Methods > Investigation protocol
    quote: POTS diagnosis was defined by symptoms of orthostatic intolerance lasting for ≥6 months associated with
      pathological head‐up tilt test or active standing test showing HR increase >30 bpm (HR increase > 40 bpm in
      patients <19 years) or HR exceeding 120 bpm in upright position (prior to nitroglycerine administration),
      within 10 min and in the absence of orthostatic hypotension [3].
    note: 'Found by winnow, kev and lev in p013, p026. Claude judged: supports.'
  - paper: pmid36090156
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Patient 1
    quote: Given the sustained >30 beats/min increase in her heart rate without a significant blood pressure change
      during the tilt table test, she met the criteria for a diagnosis of postural orthostatic tachycardia syndrome
      (POTS).
    note: 'Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid35844239
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Head-Up Tilt Test
    quote: 'A response would be considered positive if the cardiac rate was elevated by ≥40 beats·min−1, or if the
      maximum heart rate reaches the diagnostic criteria (≥130 beats/min for 6- to 12-year-olds, ≥125 beats/min
      for 12- to 18-year-olds); at the same time, blood pressure changes a little (systolic blood pressure drops
      <20 mmHg, diastolic blood pressure decreases <10 mmHg) and any two of the following symptoms present during
      tilting: dizziness/vertigo, thoracic tightness, headache, cardiopalmus, pallor, blurring of vision, weariness,
      or syncope. Any child with a positive response was diagnosed with POTS.'
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.2. Physiological Predictors
      for the Oral Rehydration Salts Efficacy in Pediatric POTS
    quote: Excessive orthostatic tachycardia is the typical hemodynamic standard for both pediatric and adolescent
      POTS sufferers [63]. The HUTT is a widely accepted test to evaluate POTS in children and adolescents [64,65].
    note: 'Found by winnow, kev and lev in p005, p019, p020. Claude judged: supports.'
  - paper: pmid35620060
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patient 2
    quote: 'A tilt table

      test confirmed POTS: 65 BPM supine HR, 104/72 mm Hg supine BP,

      104 BPM standing HR, and 116/84 mm Hg standing BP.'
    note: 'Found by winnow, kev and lev in p011, p015. Claude judged: supports.'
  - paper: pmid35463901
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: It is associated with an increase in heart rate to >30 bpm (>40 bpm in children/adolescents younger than
      19 years) within 10 min of standing (or during a head-up tilt-test to at least 60°) in the absence of orthostatic
      hypotension (6).
    note: 'Found by winnow, kev and lev in p015, p007, p018. Claude judged: supports.'
  - paper: pmid35433537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Materials and Methods
    quote: 53 cases of children aged 5 to 15 years who visited in the Pediatric Syncope Specialist Clinic of The
      Second Xiangya Hospital of Central South University for unexplained syncope or syncope precursor were diagnosed
      with POTS by head-up tilt test (HUTT) as the POTS group.
    note: 'Found by winnow, kev and lev in p002, p010, p012. Claude judged: supports.'
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: supports
    section: Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p014, p004, p008. Claude judged: supports.'
  - paper: pmid35372154
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Clinical Diagnostic Criteria
    quote: 'The diagnostic criteria of pediatric POTS included the following: (1) inducements such as a postural
      change from supine to upright or long-term standing; (2) symptoms of OI elicited by standing upright; (3)
      standing test or HUTT that meets the standards of positive response; and (4) other causes of OI were excluded.
      A positive response for POTS in children during the standing test or HUTT was defined as follows: the heart
      rate is normal at a supine position and increases by ≥ 40 bpm and/or the highest heart rate reaches ≥ 130
      bpm in participants aged 6–12 years; or ≥ 125 bpm in adolescents aged 13–18 years, within the first 10 min
      of the tests.'
    note: 'Found by winnow, kev and lev in p021, p025, p013. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How should patients be evaluated for POTS?
    quote: Although not necessary, a head-up tilt table test (for at least 10 min), ideally with continuous beat-to-beat
      blood pressure monitoring,38 can also be used to diagnose POTS. The tilt table test leads to a slightly greater
      increase in heart rate than the stand test,39 which increases its diagnostic sensitivity.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Case presentation > Cases 1–7
    quote: Postural tachycardia syndrome was diagnosed via tilt table testing, defined as an increased HR of ≥30
      beats per min (b.p.m.) within 10 min of assuming an upright posture and in the absence of orthostatic hypotension
      [blood pressure (BP) fall >20/10 mmHg].8
    note: 'Found by winnow, kev and lev in p006, p009. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Postural Orthostatic Tachycardia Syndrome after COVID-19
    quote: A 36-year-old woman who recovered from symptomatic SARS-CoV-2 infection in self-isolation started experiencing
      fatigue, headache, dizziness, chest pain, and orthostatic palpitations one month after the onset of acute
      infection [44] and was later diagnosed with POTS upon head-up tilt testing.
    note: 'Found by winnow, kev and lev in p021, p037. Claude judged: supports.'
  - paper: pmid34604136
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: 'A hallmark hemodynamic criterion of POTS in children and adolescents is excessive orthostatic tachycardia:
      a heart rate (HR) increment ≥40 bpm or an absolute HR ≥130 bpm for children 12 years and younger or ≥125 bpm
      for adolescents 13–18 years within the first 10 min of the standing test or the head-up tilt test (HUTT) without
      a drop ≥20 mmHg in systolic blood pressure (SBP) or ≥10 mmHg in diastolic blood pressure (DBP) (2). The HUTT
      has been widely accepted for the evaluation of POTS in children and adolescents (3, 4).'
    note: 'Found by winnow, kev and lev in p003, p005, p017. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case description and results
    quote: The tilt table test demonstrated the presence of PoTS with a heart rate increase by 60 bpm up to a total
      of 137 bpm accompanied by symptoms within 10 minutes standing, without orthostatic hypotension.
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid34275953
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34275953. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Autonomic testing in 4 of 6 patients in our series revealed findings potentially compatible with POTS,
      including 2 patients with both hypertension and tachycardia on HUT, consistent with a hyperadrenergic POTS
      subtype. POTS is widely considered to be the most common primary autonomic disorder, and is characterized
      by a heart rate increment that exceeds 30 BPM in adults, or 40 BPM in individuals < 18 years of age, within
      10 min of standing or on TTT (5).
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Observa-se elevação sustentada da frequência cardíaca (FC) ≥ 30 bpm (≥40 bpm se <20 anos) ou FC ≥120
      bpm nos primeiros 10 minutos em posição ortostática ou durante o tilt test, sem hipotensão ortostática clássica
      associada.
    note: 'Found by winnow, kev and lev in p112, p108. Claude judged: supports.'
  - paper: pmid33886001
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33886001. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p025, p022, p027. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: 'Patient #2'
    quote: POTS was confirmed by both active standing test and head-up tilt (symptomatic sinus tachycardia >130
      beats/min).
    note: 'Found by winnow, kev and lev in p012, p005. Claude judged: supports.'
  - paper: pmid33582941
    cited: true
    text: full
    license: none
    verdict: supports
    section: Data and Methods > Head-up tilt test
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33582941. Found by winnow, kev and lev in p009, p013, p014. Claude judged: supports.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Case report
    quote: It was not until March of 2018 and her first consultation with a cardiologist that the patient was diagnosed
      with POTS after a positive head-up tilt table test.
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: There was a highly significant increase in heart rate (p ≤ 0.001) during the first 10 minutes in the
      drug-free passive phase of tilt without substantial change in the systolic and diastolic blood pressure, qualifying
      for POTS and mean the difference in heart rate was ≈34 beats per minute.
    note: 'Found by winnow, kev and lev in p013, p027, p003. Claude judged: supports.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods > 2.1. Subjects
    quote: The POTS was diagnosed if the patient’s heart rate increased by 30 beats per minute (bpm) or measured
      with over 120 bpm within 5–10 min of head-up tilt (HUT). The test was also accompanied with the measurement
      of heart rate and blood pressure to confirm the diagnosis.
    note: 'Found by winnow, kev and lev in p003, p013, p030. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: HUTT may help in difficult clinical scenarios but is mostly used to confirm the clinical diagnosis. A
      protocol used for tilt-table testing includes a 70° baseline upright tilt for a period of 20 minutes to 30
      minutes with continuous heart-rate and blood-pressure monitoring.
    note: 'Found by winnow, kev and lev in p007, p001, p010. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Careful patient history can often lead to the diagnosis of POTS, which can then be confirmed by provocative
      testing such as a head-up tilt table test.
    note: 'Found by winnow, kev and lev in p013, p004, p008. Claude judged: supports.'
  - paper: pmid32222376
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32222376. Found by winnow, kev and lev in p007, p014, p003. Claude judged: supports.'
  - paper: pmid32112609
    cited: true
    text: full
    license: by
    verdict: supports
    section: SUBJECTS AND METHOD > Study subjects
    quote: Totally, 100 cases of children and adolescents (50 males and 50 females, with an average age of 11.0
      ± 2.4 years), with unexplained syncope or presyncope symptoms, diagnosed as POTS by HUTT were enrolled from
      Pediatric Specialist Clinic of the Second Xiangya Hospital of Central South University from August 2013 to
      July 2016.
    note: 'Found by winnow, kev and lev in p020, p005, p007. Claude judged: supports.'
  - paper: pmid31888497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: POTS is the most prevalent form of orthostatic intolerance. It is diagnosed relying on a sustained HR
      increase of greater than 40 beats per minute or an increase to 120 beats per minute or greater within the
      first 10 min of tilt, without arterial hypotension.
    note: 'Found by winnow, kev and lev in p044, p007, p048. Claude judged: supports.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Diagnosis of POTS
    quote: 'The diagnosis of POTS was mainly based on the following (Sheldon et al., 2015; Wang et al., 2018, 2019):
      (1) commonly seen in older children; (2) associated with inducements such as quick position change from supine
      to upright position, or long-term standing before the appearance of OI symptoms; (3) associated with OI symptoms
      such as dizziness, headache, fatigue, blurred vision, chest tightness, palpitations, hand tremors, and even
      syncope; (4) HR increased ≥ 40 bpm or the maximum HR ≥ 130 bpm (in children 6–12 years old) or ≥ 125 bpm (in
      adolescents 13–18 years old) without orthostatic hypotension (BP decrease > 20/10 mmHg) during the first 10
      min of the standing test or BHUTT; and (5) exclusion of other diseases that cause OI symptoms such as cardiovascular
      diseases, metabolic diseases, neurologic diseases, or psychogenic disorders.'
    note: 'Found by winnow, kev and lev in p013, p012. Claude judged: supports.'
  - paper: pmid30560108
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: When a child with clinical symptoms of OI had an HR increase ≥40 beats/min or an HR of ≥130 bpm (children
      aged 6–12 years) or ≥125 bpm (adolescents aged 13–18 years) during the initial 10 min of HUTT or standing-up
      test, without orthostatic hypotension (a BP decrease>20/10 mmHg), the result was defined as a positive response,
      and a diagnosis of POTS was made (20, 23).
    note: 'Found by winnow, kev and lev in p006, p003. Claude judged: supports.'
  - paper: pmid30505831
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Some studies have employed tilt table tests lasting 2–5 min to diagnose one common form of orthostatic
      intolerance, postural tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p007, p014, p001. Claude judged: supports.'
  - paper: pmid30372565
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30372565. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid30305583
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30305583. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29451148
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: METHODS > Technical information
    quote: Head-up tilt test was applied to diagnose POTS. First, children were kept quietly in the supine position
      on the tilt table (HUT-821, Beijing Juchi, China) for 10 min, and their HR, blood pressure, and electrocardiograph
      were recorded by a Dash 2000 Multi-lead Physiological Monitor (General Electric, New York, USA).
    note: 'Found by winnow, kev and lev in p010, p007. Claude judged: supports.'
  - paper: pmid29391028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Case reports
    quote: At age 31, a 70-degree head-up tilt table test showed a 61 bpm increase in HR from 65 bpm supine to a
      peak of 126 bpm at 10 min, with reproduction of her typical orthostatic symptoms, but without orthostatic
      hypotension, thus consistent with POTS.
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Investigations
    quote: The tilt table test demonstrated the presence of hyperadrenergic POTS (increase in heart rate >30 beats/min,
      rise in systolic blood pressure ≥10 mm Hg and serum norepinephrine level ≥600 pg/mL).
    note: 'Found by winnow, kev and lev in p006, p013. Claude judged: supports.'
  - paper: pmid28674628
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: For obvious reasons, patients with POTS demonstrated greatest increase in HR during HUT, outperforming
      that of VVS positive and negative HUT but the difference between patients with VVS and negative HUT was also
      significant. However, although orthostatic increase in HR in POTS is pathognomonic for this syndrome, less
      is known about chronotropic response in patients with VVS compared with normal subjects.
    note: 'Found by winnow, kev and lev in p018, p023. Claude judged: supports.'
  - paper: pmid28554964
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Postural tachycardia syndrome
    quote: Potential POTS patients for the study were selected based on referral to our clinic for chronic orthostatic
      intolerance lasting longer than 6 months; diagnosis was confirmed in our laboratory by means of a screening
      70° upright tilt test (HUT).
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods > 2.3. Cardiovascular Reflex Tests > 2.3.5. HUT
    quote: POTS was defined as a sustained HR rise of at least 30 bpm or a HR of at least 120 bpm in the first 10
      min of tilt, without concomitant OH [23].
    note: 'Found by winnow, kev and lev in p012, p025, p026. Claude judged: supports.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Methods > Diagnostic criteria of postural tachycardia syndrome and classic vasovagal syncope
    quote: The test was diagnostic when patients demonstrated a typical prodrome (such as palpitation, nausea, dizziness,
      lightheadedness, or intense perspiration) reproducing previous events experienced and/or precipitated syncope,
      and the haemodynamic parameters met the diagnostic criteria of POTS or VVS, respectively.4,11,14 Briefly,
      POTS was defined as characteristic symptoms of orthostatic intolerance (lightheadedness, dizziness, and/or
      discomfort) with a maximal and persistent heart rate increase of >30/min (or ≥40/min for those aged ≤19 years)
      or tachycardia of >120/min in standing position, and the absence of orthostatic hypotension, i.e. max systolic/diastolic
      BP drop was <20/10 mmHg on head-up tilt.2,11
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid27631244
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The diagnosis of POTS can be readily made by tilt-table assessment finding a pulse greater than 120 beats/minute
      or an elevation of pulse of 30 BPM in the first 10 minutes of elevation into an upright position, which is
      different than the fall of blood pressure as seen in vasovagal syncope under the same conditions.
    note: 'Found by winnow, kev and lev in p009, p013, p020. Claude judged: supports.'
  - paper: pmid27413567
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: According to the tilt table test the patient was diagnosed with POTS.
    note: 'Found by winnow, kev and lev in p007, p001, p006. Claude judged: supports.'
  - paper: pmid26645307
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this pilot study of adolescents with chronic nausea and POTS confirmed by abnormal HUT test, the use
      of HIRREM was associated with the increase in heart rate variability in the time domain (SDNN) and BRS in
      the frequency domain (HF alpha).
    note: 'Found by winnow, kev and lev in p008, p016. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical Presentation of POTS > Diagnostic Criteria
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid25917768
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25917768. Found by winnow, kev and lev in p008, p003, p004. Claude judged: supports.'
  - paper: pmid25811760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Head-up test and head-up tilt test > Head-up tilt test (HUTT)
    quote: During the test, if an increase in heart rate ≥ 40 beats/min or the maximum heart rate ≥ 120 beats/min
      was accompanied by two of the following symptoms such as dizziness or vertigo, chest tightness, headache,
      palpitations, a change in paleness, blurred vision, fatigue, morning discomfort, or syncope during tilt, the
      diagnosis of POTS was made[20].
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid25510829
    cited: true
    text: full
    license: none
    verdict: supports
    section: Methods > Subjects
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25510829. Found by winnow, kev and lev in p008, p001, p024. Claude judged: supports.'
  - paper: pmid25180969
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Autonomic function tests
    quote: Based on the response pattern to HUT, patients were classified as OH, NCS, or POTS.
    note: 'Found by winnow, kev and lev in p001, p011. Claude judged: supports.'
  - paper: pmid25002851
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Subjects
    quote: POTS was identified during upright tilt table testing to 70° by signs and symptoms of OI and an excessive
      increase in HR within 10 min of head-up tilt (HUT) (Low et al., 1995; Raj, 2006; Medow and Stewart, 2007).
    note: 'Found by winnow, kev and lev in p008, p022, p024. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Diagnostic Evaluation of Possible POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p073, p075, p026. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Methods > Subjects
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p006, p001, p022. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Both active standing tests and HUTT are sensitive for the diagnosis of POTS [3].
    note: 'Found by winnow, kev and lev in p006, p008, p009. Claude judged: supports.'
  - paper: pmid23802020
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'MATERIALS AND METHODOLOGY:'
    quote: Subjects who presented to the Cleveland Clinic from January to December 2007 for evaluation of symptoms
      of orthostatic intolerance and subsequently diagnosed with POTS on head-up Tilt test in the Syncope Clinic
      were included.
    note: 'Found by winnow, kev and lev in p002, p008. Claude judged: supports.'
  - paper: pmid23729158
    cited: true
    text: full
    license: none
    verdict: supports
    section: Schematic design of the study > Definition of different variables
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23729158. Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid23390443
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Methods
    quote: Diagnosis of POTS was based on chronic day-to-day orthostatic intolerance symptoms as well as excessive
      tachycardia during the TTT.
    note: 'Found by winnow, kev and lev in p002, p004, p006. Claude judged: supports.'
  - paper: pmid23270259
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23270259. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case presentation
    quote: A head-up tilt test reproduced the same orthostatic symptoms, with an increased sinus rate and stable
      blood pressure (Table 2). The increase in heart rate without orthostatic hypotension along with the accompanying
      symptoms confirmed the presence of POTS.
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid22689545
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22689545. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p001, p017, p019. Claude judged: supports.'
  - paper: pmid20309394
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Methods
    quote: The diagnosis of POTS was based on clinical history, clinical examination and a positive (POTS pattern)
      head up tilt test (HUTT). The HUTT criterion for diagnosing POTS was an absolute heart rate >120 bpm or an
      increase by > 30bpm within the first ten minutes of an upright tilt.
    note: 'Found by winnow, kev and lev in p008, p002, p014. Claude judged: supports.'
  - paper: pmid20167544
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20167544. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid19264762
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19264762. Found by winnow, kev and lev in p002, p003. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: HUT and Evaluation of Adrenergic Function
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid11227722
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11227722. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid10406593
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 10406593. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid40584422
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Physiological mechanisms of POTS and interpretation
    quote: Schondorf and Low conducted a review of patients aged 20–51 who exhibited POTS during HUTT.
    note: 'Found by winnow, kev and lev in p003, p028. Claude judged: partial.'
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CBF in OI > CBF in POTS
    quote: "Novak et al\n3\n studied diagnostic metrics for assessing multiple forms of OI during head‐up tilt and\
      \ outlined the crucial importance of measuring TCD in conditions with OI. CBv, measured in the middle cerebral\
      \ artery (MCA), served as a more accurate tool in differentiating POTS from other forms of tachycardia."
    note: 'Found by winnow, kev and lev in p029, p036. Claude judged: partial.'
  - paper: pmid39664665
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Case report > Background
    quote: This BP and HR pattern seen during TT was consistent with a diagnosis of orthostatic tachycardia and
      VVS with VASIS type 1 pattern1 (Figure 1A).
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: During her tilt table training, she started having episodes of sinus tachycardia associated with fatigue,
      dizziness, headache, palpitations, and presyncope with no orthostatic hypotension, after achieving 60 degrees
      of head tilt. After ruling out the common causes of tachycardia and syncope, a diagnosis of POTS was established.
    note: 'Found by winnow, kev and lev in p001, p005, p007. Claude judged: partial.'
  - paper: pmid36873318
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: As previously reported, α1AR and β1AR co-immunization produced an enhanced postural HR increase in the
      absence of significant BP change in the rabbit, confirming a POTS-like phenotype of this model.9
    note: 'Found by winnow, kev and lev in p022, p017. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: AST (Figure 2A) and head-up tilt test (Figure 2B) demonstrated an increase in heart rate in excess of
      40 bpm.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: partial
    section: Case report
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid35680184
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35680184. Found by winnow, kev and lev in p001, p003. Claude judged: partial.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case Presentation
    quote: He was subsequently referred to a neuro-autonomic specialist for a formal tilt table test, which revealed
      a heart rate increase of 60 beats/min immediately after tilt, and then remained 45–58 beats above baseline,
      with a maximum heart rate of 136 beats/min, for 8 min of tilt.
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid35097001
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%)
      with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia
      syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH).'
    note: 'Found by winnow, kev and lev in p015, p004, p016. Claude judged: partial.'
  - paper: pmid35056406
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Results > Case Example
    quote: The tilt test provoked her usual orthostatic symptoms, along with POTS, hypocapnia during standing, and
      a severe 40% decline in cerebral blood flow.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Tilt > Centering Point, Response Range
    quote: Gmax and the response range remained unchanged with tilt in control, is reduced in POTS, and further
      reduced in POTS when tilted. Additional key features of POTS include left lateral and downwards shifts of
      centering points and operating points and decreased response range with tilt.
    note: 'Found by winnow, kev and lev in p043, p032, p035. Claude judged: partial.'
  - paper: pmid33114659
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Postural orthostatic tachycardia syndrome (POTS) is an autonomic disorder characterized by a marked increase
      in heart rate (>30 beats per minute) or tachycardia (>120 beats per minute) upon standing or when exposed
      to a passive gravitational stimulus (i.e., head-up tilt) without orthostatic hypotension.
    note: 'Found by winnow, kev and lev in p035, p002, p018. Claude judged: partial.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Materials and Methods
    quote: We analyzed the raw data of the HUT tests individually and made group-level comparisons. The subjects
      included in the POTS group met the current criteria for POTS (Sheldon et al., 2015).
    note: 'Found by winnow, kev and lev in p004, p010, p014. Claude judged: partial.'
  - paper: pmid32669178
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32669178. Found by winnow, kev and lev in p002, p003. Claude judged: partial.'
  - paper: pmid32078525
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32078525. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Results > Hemodynamic, autonomic function tests and catecholamines:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p023, p024, p034. Claude judged: partial.'
  - paper: pmid30755882
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CASE 4
    quote: She had a positive tilt table test with documented hypotension and tachycardia with symptoms. The diagnosis
      of POTS syndrome associated with hypermobility syndrome was considered in this patient.
    note: 'Found by winnow, kev and lev in p003, p020, p023. Claude judged: partial.'
  - paper: pmid30197684
    cited: true
    text: full
    license: by
    verdict: partial
    section: Materials and Methods > Subjects
    quote: The POTS patients showed a rise in heart rate (HR) >40 bpm in first 10 mins of tilt as displayed in Table
      3.
    note: 'Found by winnow, kev and lev in p031, p016. Claude judged: partial.'
  - paper: pmid25748400
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Result
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25748400. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid25071706
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Autonomic testing
    quote: Head-up tilt table testing showed an increase in heart rate of PoTS patients with a median of 38.99 bpm
      (30.00–43.00). This was significantly higher than in controls (p = 0.000), who showed a median in heart rate
      increase by 15.00 bpm (12.00–25.00).
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid24601948
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24601948. Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid22739942
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Material And Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22739942. Found by winnow, kev and lev in p003, p004. Claude judged: partial.'
  - paper: pmid16176538
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16176538. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid8423877
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 8423877. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - active_stand_test
  - evidence_for
  - pots
  papers: 43
  evidence:
  - paper: pmid41713697
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: The highest standing HR was used to calculate ΔHR (difference from supine), and symptoms during the test
      were documented. Patients with ΔHR ≥40 bpm were classified as POTS, while those with ΔHR <40 bpm but experiencing
      orthostatic symptoms were classified as COI.
    note: 'Found by winnow, kev and lev in p014, p002, p019. Claude judged: supports.'
  - paper: pmid41584279
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Inclusion criteria
    quote: Additionally, studies that detailed the use of objective tests, such as the head-up tilt or active standing
      test, for assessment and reported POTS diagnoses confirmed by these tests were also included.
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid40970182
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Procedures > Passive standing test
    quote: Patients were diagnosed with POTS if they exhibited a sustained pulse increase of more than 30 bpm (or
      exceeding 120 bpm) within 10 min of standing, accompanied by clinical signs of orthostatic intolerance persisting
      for at least 3 months, in the absence of orthostatic hypotension (Vernino et al., 2021).
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid40694349
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: While tilt table tests are more sensitive than active standing for detecting POTS,27,28 they may also
      reduce specificity, increasing false positives.
    note: 'Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Methods
    quote: POTS was defined by an increase in HR of more than 30 beats/min within 10 minutes of active standing,
      without a significant drop in systolic BP (<20 mm Hg), and accompanied by symptoms resolving with recumbency—such
      as lightheadedness, fatigue, nausea, palpitations, generalized weakness, blurred vision, exercise intolerance,
      or headache.8,10,13
    note: 'Found by winnow, kev and lev in p013, p032. Claude judged: supports.'
  - paper: pmid40533427
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: The confirmed diagnosis was based on international criteria, including a sustained heart rate increase
      of at least 30 beats per minute or at least 40 beats per minute in adolescents (16–19 years of age) during
      a 10‐minute active standing test or head‐up tilt table test, the absence of orthostatic hypotension, and unexplained
      symptoms of orthostatic intolerance lasting at least three months.
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: The diagnosis of POTS was made in the presence of a sustained increase in heart rate ≥ 30 bpm (at least
      two measurements 1 minute apart) during 10 minutes of standing in the absence of orthostatic hypotension.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid40310134
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods > 2.1. Diagnostic Methods > 2.1.5. Classification of TTT Responses
    quote: POTS was diagnosed based on standardized standing test criteria. The diagnostic threshold included an
      HR increase of at least 40 bpm within 10 min of assuming an upright posture.
    note: 'Found by winnow, kev and lev in p028, p033. Claude judged: supports.'
  - paper: pmid40125494
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: To evaluate for POTS, an active stand test or a formal upright tilt table test may be performed.2
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p001, p025, p003. Claude judged: supports.'
  - paper: pmid38074226
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Case presentation
    quote: The symptoms subsided rapidly within one minute of lying down in a supine position. These findings are
      indicative of POTS.
    note: 'Found by winnow, kev and lev in p010, p015. Claude judged: supports.'
  - paper: pmid38033543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Diagnosis of POTS
    quote: 'The positive criteria for POTS in the associated tests included the following: (1) normal HR when lying
      on the back; (2) within the first 10 min after standing up in standing test or tilted in HUTT an increase
      in HR (≥ 40 bpm) and/or a maximum HR ≥ 130 and ≥ 125 bpm for ages 6–12 and 13–18 years, respectively; (3)
      with out significant orthostatic hypotension (decline of BP < 20/10 mmHg) (Medow et al., 2017; Wang et al.,
      2018).'
    note: 'Found by winnow, kev and lev in p011, p021. Claude judged: supports.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Participants with PASC fulfilling POTS diagnosis
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid37378164
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Furthermore, the following diagnostic criteria used to assist in identifying POTS include a sustained
      heart rate elevation of at least 30 bpm in adults and at least 40 bpm in teens 12-19 years of age from supine
      to standing position during a 10-min stand test or a tilt table test.
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid37255912
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: An Active Stand test was performed on the day of attendance, identifying Postural Orthostatic Tachycardia
      Syndrome (POTS).
    note: 'Found by winnow, kev and lev in p001, p006, p007. Claude judged: supports.'
  - paper: pmid36818521
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Methods > Active 10-min Standing Test
    quote: POTS was diagnosed based on an increase in heart rate of ≥30 beats/min,23 with symptoms of OI. In addition,
      in the present study, an actual heart rate of ≥120 beats/min, indicating accentuated sympathetic activity,
      with symptoms of OI during the test was also considered to occur due to POTS.12
    note: 'Found by winnow, kev and lev in p012, p015, p018. Claude judged: supports.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: We found that according to the results of the active orthostatic test, 37.5% of patients with ME/CFS
      met the diagnostic criteria for POTS.
    note: 'Found by winnow, kev and lev in p015, p046. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How should patients be evaluated for POTS?
    quote: Heart rate and blood pressure must be measured when the patient has been supine for 5–10 minutes to allow
      fluid equilibration, and then after standing for 1 minute, 3 minutes, 5 minutes, 8 minutes and 10 minutes.5
      To diagnose excessive orthostatic tachycardia (required for POTS), patients should have a sustained heart
      rate increase of at least 30 beats/min (for adults) or at least 40 beats/min (for patients aged 12–19 yr)
      on at least 2 of the readings taken when standing.
    note: 'Found by winnow, kev and lev in p026, p027. Claude judged: supports.'
  - paper: pmid35224842
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION > OI across the hypermobility spectrum > Comparison of hemodynamic responses and diagnosis
      of POTS during HUT and active stand
    quote: The active stand test was able to detect POTS at a greater rate than HUT, supporting the fact that active
      stand is a reasonable clinical test to use in this population.
    note: 'Found by winnow, kev and lev in p051, p034. Claude judged: supports.'
  - paper: pmid34987818
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Following the absence of abnormal echocardiogram findings, thyroid dysfunction, vasculitis and rhythm
      disturbances, a possible diagnosis of POTS was established with a positive active stand test and 10-min walk
      test.
    note: 'Found by winnow, kev and lev in p007, p001, p015. Claude judged: supports.'
  - paper: pmid34055686
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Furthermore, the maximum ΔHR (ΔHRmax) and ΔHR at 5 and 10 min in the afternoon and evening standing tests
      yielded moderate predictive values for the POTS diagnosis. The external validation test showed that the afternoon
      ΔHRmax ≥30 bpm to diagnose POTS yielded sensitivity, specificity, and accuracy of 85, 71.4, and 78%, respectively,
      and the evening ΔHRmax ≥25 bpm yielded sensitivity, specificity, and accuracy of 85, 76.2, and 80.5%, respectively.
    note: 'Found by winnow, kev and lev in p003, p016, p017. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Diskussion
    quote: Am Fallbeispiel 2 können wir zeigen, dass Kinder nach SARS-CoV-Infektion eine chronische Regulationsstörung
      des autonomen Nervensystems mit einem POTS entwickeln können, welches in einem einfachen aktiven Stehtest
      mit kontinuierlicher EKG-Registrierung nachweisbar ist.
    note: 'Found by winnow, kev and lev in p007, p010. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: 'Patient #2'
    quote: POTS was confirmed by both active standing test and head-up tilt (symptomatic sinus tachycardia >130
      beats/min).
    note: 'Found by winnow, kev and lev in p010, p012, p015. Claude judged: supports.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Postural tachycardia syndrome (POTS) is defined in adults by orthostatic intolerance symptoms plus an
      excessive increase in heart rate exceeding 30 beats/min within 10 minutes of standing or upright tilt.3 Systolic
      arterial pressure (SAP) is maintained and may increase.4
    note: 'Found by winnow, kev and lev in p005, p043. Claude judged: supports.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and Methods > Diagnosis of POTS
    quote: 'The diagnosis of POTS was mainly based on the following (Sheldon et al., 2015; Wang et al., 2018, 2019):
      (1) commonly seen in older children; (2) associated with inducements such as quick position change from supine
      to upright position, or long-term standing before the appearance of OI symptoms; (3) associated with OI symptoms
      such as dizziness, headache, fatigue, blurred vision, chest tightness, palpitations, hand tremors, and even
      syncope; (4) HR increased ≥ 40 bpm or the maximum HR ≥ 130 bpm (in children 6–12 years old) or ≥ 125 bpm (in
      adolescents 13–18 years old) without orthostatic hypotension (BP decrease > 20/10 mmHg) during the first 10
      min of the standing test or BHUTT; and (5) exclusion of other diseases that cause OI symptoms such as cardiovascular
      diseases, metabolic diseases, neurologic diseases, or psychogenic disorders.'
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Method > Study subjects
    quote: For the diagnosis of POTS, we checked blood pressure and heart rate at supine rest and 0, 1, 3, 5, and
      10 min after standing. Two consecutive tests were conducted, usually in the afternoon and early the next morning,
      to increase the sensitivity.8
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid31118385
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Case Report
    quote: Active standing tests showed a significant heart rate increase (68 bpm during supine position, 109 bpm
      during standing), while her blood pressure was 122/78 mmHg in the spine position and 129/77 mmHg while standing.
      These findings were consistent with POTS (3).
    note: 'Found by winnow, kev and lev in p005, p006. Claude judged: supports.'
  - paper: pmid30560108
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods
    quote: When a child with clinical symptoms of OI had an HR increase ≥40 beats/min or an HR of ≥130 bpm (children
      aged 6–12 years) or ≥125 bpm (adolescents aged 13–18 years) during the initial 10 min of HUTT or standing-up
      test, without orthostatic hypotension (a BP decrease>20/10 mmHg), the result was defined as a positive response,
      and a diagnosis of POTS was made (20, 23).
    note: 'Found by winnow, kev and lev in p006, p003. Claude judged: supports.'
  - paper: pmid30505831
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The various consensus criteria for POTS all require a heart rate (HR) increase of at least 30 beats per
      minute over the course of 10 min upright for adults (or at least 40 bpm for those 12–19 years) compared to
      measurements in the supine position (12–14). These HR changes can be assessed using either passive or active
      standing maneuvers, or head-up tilt testing (15–21).
    note: 'Found by winnow, kev and lev in p006, p017. Claude judged: supports.'
  - paper: pmid26033944
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Comparative studies on the active standing test and HUTT have discovered that both methods have similar
      sensitivity, and that the active standing test has even higher specificity than HUTT (79% vs 23%) when increased
      heart rate is ≥30 bpm, as a POTS diagnostic criterion.
    note: 'Found by winnow, kev and lev in p030, p006, p021. Claude judged: supports.'
  - paper: pmid25474569
    cited: true
    text: full
    license: by
    verdict: supports
    section: Subjects and Methods > Upright Test
    quote: 'The criteria for a positive reaction (POTS) were as follows: the HR increased by over 40 beats/min or
      the maximum HR was over 120 beats/min, and the patients had at least one of the following symptoms during
      the ten minutes standing: dizziness or fainting, chest tightness, headache, palpitations, blurred vision,
      fatigue or syncope for at least 3 months [11], [19]–[22].'
    note: 'Found by winnow, kev and lev in p002, p012, p026. Claude judged: supports.'
  - paper: pmid24227635
    cited: true
    text: full
    license: none
    verdict: supports
    section: Methods > Subjects
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24227635. Found by winnow, kev and lev in p008, p014. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Both active standing tests and HUTT are sensitive for the diagnosis of POTS [3].
    note: 'Found by winnow, kev and lev in p008, p009. Claude judged: supports.'
  - paper: pmid23283362
    cited: true
    text: full
    license: none
    verdict: supports
    section: METHODS > Subjects
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23283362. Found by winnow, kev and lev in p010, p028. Claude judged: supports.'
  - paper: pmid42387884
    cited: true
    text: full
    license: by
    verdict: partial
    section: RESULTS
    quote: Overall, 45/221 (20%) of patients fulfilled the haemo-dynamic algorithm criteria for a positive NLT (at
      least 2 consecutive HR values exceeding the diagnostic threshold of an increase ≥ 30 bpm, no systolic blood
      pressure decrease over 20 mmHg within the first 3 min of standing) and reported orthostatic symptoms during
      the test.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid41163092
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results
    quote: Over 10 min, the HR increased by an average of 10 ± 3 bpm, and systolic BP dropped by 1.3 ± 0 0.4 mmHg.
      A total of 18 patients (8.5%) met the criteria for POTS.
    note: 'Found by winnow, kev and lev in p023, p027, p003. Claude judged: partial.'
  - paper: pmid39592549
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39592549. Found by winnow, kev and lev in p003, p002. Claude judged: partial.'
  - paper: pmid38176772
    cited: true
    text: full
    license: none
    verdict: partial
    section: Methods > Clinical data collection
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38176772. Found by winnow, kev and lev in p015, p010. Claude judged: partial.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Case summary
    quote: Evaluation with a NASA Lean Test revealed marked orthostatic tachycardia, as well as delayed orthostatic
      hypotension. Given her COVID-19 illness 4 months prior, PASC involving autonomic dysfunction was diagnosed.
    note: 'Found by winnow, kev and lev in p002, p020, p021. Claude judged: partial.'
  - paper: pmid35733987
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results
    quote: POTS is associated with a rapid increase in heart rate that occurs within 10 min upon standing. In this
      study, heart rate significantly increased as evidenced by a high delta change between heart rate measurement
      taken in the supine position and after 10 min of standing (Figure 3C).
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid35673757
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35673757. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35035423
    cited: true
    text: full
    license: by
    verdict: partial
    section: 'METHODS > Head up tilt test protocol:'
    quote: In the same setting if the patient’s heart rate increased by 30 beats a minute (bpm) or more (40bpm in
      those aged 12 to 19) usually within 10 minutes of standing. And also if that increase continued for more than
      30 seconds accompanied by other symptoms were suggestive of POTS.
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid24495468
    cited: true
    text: full
    license: none
    verdict: partial
    section: RESULTS > Baseline Characteristics
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24495468. Found by winnow, kev and lev in p011, p018. Claude judged: partial.'
- edge:
  - autonomic_autoantibody_assay
  - evidence_for
  - autoimmune_evidence
  papers: 22
  evidence:
  - paper: pmid38736760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: However, the detection of several types of autoantibodies and the improvement of the clinical picture
      after plasma exchange therapy in this case points to an autoimmune pathogenesis.
    note: 'Found by winnow, kev and lev in p012, p020, p022. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.2. Cholinergic
      Receptors
    quote: Watarai et al. provided further evidence of the autoimmune basis of POTS by examining the presence of
      AAbs in POTS patients and patients with neurally mediated syncope. mAChR AAbs were found in 10 of the POTS
      patients.
    note: 'Found by winnow, kev and lev in p016, p021, p022. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this case the diagnostic work-up of PoTS led to the diagnosis of autoimmune-mediated neuropathic PoTS
      as a crossroad of PoTS, SFN and autoimmunity. The characterisation of autoantibodies against adrenergic and
      muscarinic receptors is nowadays performed in specialized laboratories with the use of life-based bioassays
      on cardiomyocytes confirming the functional role of these autoantibodies [34].
    note: 'Found by winnow, kev and lev in p023, p009, p014. Claude judged: supports.'
  - paper: pmid34409582
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34409582. Found by winnow, kev and lev in p001, p004, p006. Claude judged: supports.'
  - paper: pmid34275953
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34275953. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29618472
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Methods and Results
    quote: Of 17 subjects with POTS, 12 demonstrated significant AT1R antibody activity in immunoglobulin G purified
      from their serum. No significant AT1R antibody activity was found in the subjects with vasovagal syncope or
      healthy subjects.
    note: 'Found by winnow, kev and lev in p016, p023, p002. Claude judged: supports.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: These contractile responses were observed with sera/IgG from each of the POTS patients providing strong
      evidence that this effect was mediated by circulating autoantibodies to their respective target receptors
      and not from stray ligands in the sample (eg, norepinephrine).
    note: 'Found by winnow, kev and lev in p017, p021, p022. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Results
    quote: AR-modulating autoantibody activity was also higher in patients with POTS vs those without and directly
      correlated with heart rate changes.
    note: 'Found by winnow, kev and lev in p004, p025, p014. Claude judged: partial.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Autoantibody concentration against ADRA1, ADRB1, ADRB2, and M4R were not significantly different between
      the groups. Autoimmune mechanisms may lead to abnormal regulation of the renin-angiotensin-aldosterone system
      and may contribute to the pathophysiology of POTS.
    note: 'Found by winnow, kev and lev in p001, p010, p029. Claude judged: partial.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. COVID-19-Related POTS > 2.2. Presumed Mechanism for COVID-19-Related POTS > 2.2.2. Hyperadrenergic
      Reaction
    quote: Autoantibodies to G-protein-coupled receptors were measured in a study of 31 patients with persistent
      long COVID-19 symptoms, and autoantibodies to β2-AR, α1-AR, angiotensin II AT1-receptor, nociceptin-like opioid
      receptor, and muscarinic M2-receptor were identified [33].
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Diagnosis
    quote: Levels of G-AChRs antibody titers >1.0 nmol/L are quite specific for autoimmune autonomic ganglionopathy
      (74).
    note: 'Found by winnow, kev and lev in p020. Claude judged: partial.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The etiology of POTS is unknown but a number of laboratories, including ours, have reported elevations
      of G-protein-coupled adrenergic receptor and muscarinic acetylcholine receptor autoantibodies in POTS patients,
      detected by a variety of techniques, suggesting that the disorder is an autoimmune condition.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34117922
    cited: true
    text: full
    license: by
    verdict: partial
    section: Inflammatory biomarkers in postural orthostatic tachycardia syndrome with elevated g-protein-coupled
      receptor autoantibodies
    quote: All patients in the study (n = 34) had been diagnosed with POTS according to established criteria and
      had known elevations of autoantibodies to alpha-1 adrenergic (100%) and anti-muscarinic cholinergic receptors
      (55.9%). These G-protein-coupled receptors have previously been found to be elevated in POTS patients in a
      number of prior studies investigating the possible autoimmune basis of POTS.
    note: 'Found by winnow, kev and lev in p002, p004, p009. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: A growing body of evidence suggests that postural orthostatic tachycardia syndrome (POTS) may be an autoimmune
      disorder. We have reported in a previous manuscript that 89% of POTS patients (n = 55) had elevations in G-protein-coupled
      adrenergic A1 receptor autoantibodies and 53% had elevations in muscarinic acetylcholine M4 receptor autoantibodies,
      as assessed by ELISA.
    note: 'Found by winnow, kev and lev in p010, p001, p007. Claude judged: partial.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Conclusions
    quote: Serum‐mediated ADRA1A activity is associated with the severity of orthostatic symptoms in patients with
      POTS, independently of the orthostatic hemodynamic response. These findings provide new insights into the
      pathophysiology of POTS and prompt further research on possible autoimmune involvement in patients with POTS.
    note: 'Found by winnow, kev and lev in p016, p018, p039. Claude judged: partial.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: We found that as a group, POTS patients had greater agonist activity at both α1AR and β1AR. These responses
      reinforce previous studies identifying the presence of AAb directed towards cardiovascular G protein-coupled
      receptors (GPCR) in some participants with POTS.
    note: 'Found by winnow, kev and lev in p027, p028, p001. Claude judged: partial.'
  - paper: pmid31547756
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: There is an emerging body of evidence that suggests an autoimmune basis for POTS.3 Several studies have
      investigated the presence of autoantibodies in POTS and their effects on cholinergic and adrenergic receptors.3
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Methods and Results
    quote: We also evaluated serum levels of autoantibodies against 4 subtypes of G‐protein coupled adrenergic receptors
      and 5 subtypes of G‐protein coupled muscarinic acetylcholine receptors by ELISA.
    note: 'Found by winnow, kev and lev in p002, p013, p018. Claude judged: partial.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Several etiologies are suggested in patients with POTS; however, a considerable number of patients with
      POTS seem to have antibodies to one or more of the ARs according to recent studies.2, 3 Among the autoantibodies
      reported in POTS, approximately half of the patients had autoantibodies to β2AR in previous studies.2, 3
    note: 'Found by winnow, kev and lev in p011, p016. Claude judged: partial.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: And, we examined potential immune‐mediation of POTS by evaluating autoantibodies against gAChR, which
      have been implicated in both POTS and POTS‐associated autonomic dysfunction.
    note: 'Found by winnow, kev and lev in p003, p015, p017. Claude judged: partial.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: For the primary objective, we found that antiadrenergic α1AR autoantibody activity was evident in POTS,
      while the VVS subjects were not different from normal subjects.
    note: 'Found by winnow, kev and lev in p018, p021, p025. Claude judged: partial.'
  - paper: pmid23002038
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4 Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23002038. Found by winnow, kev and lev in p019, p021. Claude judged: partial.'
- edge:
  - autonomic_autoantibody_assay
  - evidence_for
  - pots
  papers: 18
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > AR autoantibody activity in patients with POTS
    quote: 'To assess this, we compared AR autoantibody activity in plasma from 8 patients with POTS and 8 without
      at 30 days post-HSCT. Patients with POTS had significantly higher median activity than those without (25.6
      AU [Q1-Q3: 23.8-26.2 AU] vs 22.0 AU [Q1-Q3: 20.5-23.3 AU]; P = 0.006), and this activity significantly correlated
      with the change in HR upon standing (r = 0.653; P = 0.006) (Figure 4, Table 3).'
    note: 'Found by winnow, kev and lev in p004, p025, p014. Claude judged: partial.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Dubey et al reported increased presence of muscarinic receptor type 1 and 2 antibodies in POTS patients
      compared to controls (study enrolled 16 POTS patients and 20 controls) [19].
    note: 'Found by winnow, kev and lev in p001, p029, p037. Claude judged: partial.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. COVID-19-Related POTS > 2.2. Presumed Mechanism for COVID-19-Related POTS > 2.2.2. Hyperadrenergic
      Reaction
    quote: Autoantibodies to G-protein-coupled receptors were measured in a study of 31 patients with persistent
      long COVID-19 symptoms, and autoantibodies to β2-AR, α1-AR, angiotensin II AT1-receptor, nociceptin-like opioid
      receptor, and muscarinic M2-receptor were identified [33]. Increased AR antibodies due to COVID-19 infection
      may lead to vasoconstriction and tachycardia, which has been proposed as a possible mechanism in POTS [35].
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.2. Cholinergic
      Receptors
    quote: Watarai et al. provided further evidence of the autoimmune basis of POTS by examining the presence of
      AAbs in POTS patients and patients with neurally mediated syncope. mAChR AAbs were found in 10 of the POTS
      patients.
    note: 'Found by winnow, kev and lev in p016, p021, p022. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Diagnosis
    quote: The measurement of inflammation or autoimmunity markers is a reasonable option in the context of clinical
      suspicion of POTS associated with SARS-CoV-2 (41, 66).
    note: 'Found by winnow, kev and lev in p020. Claude judged: partial.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Indeed, a variety of antibodies against adrenergic α - and β -, angiotensin II type 1, muscarinic 1–5
      and nociceptin-like receptors have been detected in series of PoTS patients but not in control sera [[22],
      [23], [24]].
    note: 'Found by winnow, kev and lev in p009, p023. Claude judged: partial.'
  - paper: pmid34409582
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34409582. Found by winnow, kev and lev in p001, p004. Claude judged: partial.'
  - paper: pmid34275953
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34275953. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34117922
    cited: true
    text: full
    license: by
    verdict: partial
    section: Inflammatory biomarkers in postural orthostatic tachycardia syndrome with elevated g-protein-coupled
      receptor autoantibodies
    quote: All patients in the study (n = 34) had been diagnosed with POTS according to established criteria and
      had known elevations of autoantibodies to alpha-1 adrenergic (100%) and anti-muscarinic cholinergic receptors
      (55.9%). These G-protein-coupled receptors have previously been found to be elevated in POTS patients in a
      number of prior studies investigating the possible autoimmune basis of POTS.
    note: 'Found by winnow, kev and lev in p002, p004. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Materials and Methods > 2.1. Patients
    quote: In contrast to our previous report that found the most significant elevation of the alpha 1 adrenergic
      receptor (AdrR A1) autoantibody (ab) in 89% (49/55) of POTS patients, all thirty-four patients in this study
      had elevated AdrR A1 Abs (Figure 1).
    note: 'Found by winnow, kev and lev in p010, p031. Claude judged: partial.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Results
    quote: Mean activity values were greater in the POTS vs. Controls for α1AR-AAb (6.2 ​± ​1.2 vs. 5.3 ​± ​1.0;
      P ​< ​0.001) and β1AR-AAb (5.7 ​± ​1.8 vs. 4.1 ​± ​0.9; P ​< ​0.001). Compared to controls, more POTS patients
      were positive for α1AR-AAb activity (22% vs 4%; P ​= ​0.007) and β1AR-AAb activity (52% vs. 2%; P ​< ​0.001).
    note: 'Found by winnow, kev and lev in p027, p028, p003. Claude judged: partial.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: We report that both adrenergic and muscarinic receptor autoantibodies may be detected by ELISA in POTS
      patients. The most prevalent elevation of autoantibody in our investigation was antiadrenergic A1 receptor,
      and detection of other adrenergic and muscarinic receptor autoantibodies were not detected without elevation
      of autoantibodies against the A1 receptor.
    note: 'Found by winnow, kev and lev in p018, p024, p028. Claude judged: partial.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Several etiologies are suggested in patients with POTS; however, a considerable number of patients with
      POTS seem to have antibodies to one or more of the ARs according to recent studies.2, 3 Among the autoantibodies
      reported in POTS, approximately half of the patients had autoantibodies to β2AR in previous studies.2, 3
    note: 'Found by winnow, kev and lev in p011, p016. Claude judged: partial.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: We found that anti‐gAChR antibodies were detected more frequently in patients with POTS compared to NMS
      and controls, suggesting that anti‐gAChR antibodies may be associated with POTS and its underlying autonomic
      dysfunction. POTS and NMS were clearly distinguishable by the prevalence of anti‐gAChR antibodies.
    note: 'Found by winnow, kev and lev in p012, p015, p017. Claude judged: partial.'
  - paper: pmid29618472
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Methods and Results
    quote: Of 17 subjects with POTS, 12 demonstrated significant AT1R antibody activity in immunoglobulin G purified
      from their serum. No significant AT1R antibody activity was found in the subjects with vasovagal syncope or
      healthy subjects.
    note: 'Found by winnow, kev and lev in p023, p002, p003. Claude judged: partial.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Results > Autoantibody activity
    quote: Based on these direct assays, 6 of these 17 POTS patients (35%) harboured both α1AR- and β1AR-AAb (Table
      2). None of these autoantibodies were found in the patients with VVS or healthy controls.
    note: 'Found by winnow, kev and lev in p002, p018, p021. Claude judged: partial.'
  - paper: pmid24572257
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Methods and Results
    quote: The sera of all 14 POTS patients demonstrated significant arteriolar contractile activity (69±3% compared
      to 91±1% of baseline for healthy controls, P<0.001) when coexisting β2AR dilative activity was blocked; and
      this was suppressed by α1AR blockade with prazosin.
    note: 'Found by winnow, kev and lev in p017, p022, p002. Claude judged: partial.'
  - paper: pmid23002038
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4 Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23002038. Found by winnow, kev and lev in p019, p021. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - differential_syncope_oh
  papers: 16
  evidence:
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: After performing tilt table testing on a group of suspected POTS patients in this study, ten were found
      to have orthostatic hypotension and nine had syncope. In patients with orthostatic symptoms, tilt table testing
      is the preferred tool for differentiating between these types of orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid27525257
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: The tilt test was initially introduced to diagnose vasovagal syncope [2]. Since then the diagnostic utility
      of the tilt test has been expanded for diagnosis of orthostatic hypotension, autonomic failure, postural tachycardia
      syndrome, and other forms of orthostatic intolerance [3].
    note: 'Found by winnow, kev and lev in p045, p001, p002. Claude judged: supports.'
  - paper: pmid35372154
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Currently, the differential diagnosis between these two diseases is mainly based on the clinical features
      and haemodynamic responses during the head-up tilt test (HUTT) (2, 7).
    note: 'Found by winnow, kev and lev in p003, p005, p021. Claude judged: partial.'
  - paper: pmid35097001
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Overall, 2,343 (48.1%) showed positive responses as follows: 1,260 (25.9%) with the mixed type, 34 (0.7%)
      with the cardioinhibitory type, 580 (11.9%) with the vasodepressor type, 179 (3.7%) with postural tachycardia
      syndrome (POTS), and 290 (6.0%) with orthostatic hypotension (OH).'
    note: 'Found by winnow, kev and lev in p015, p004, p018. Claude judged: partial.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: partial
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: A avaliação autonômica ampliada, com análise de vários parâmetros hemodinâmicos durante o teste de inclinação,
      é altamente recomendável na investigação e diagnóstico diferencial etiológico da SPOT.
    note: 'Found by winnow, kev and lev in p112. Claude judged: partial.'
  - paper: pmid33582941
    cited: true
    text: full
    license: none
    verdict: partial
    section: Data and Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33582941. Found by winnow, kev and lev in p032, p013. Claude judged: partial.'
  - paper: pmid31250563
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Upright tilt table testing has been used to test for vasovagal syncope (VVS) but can result in “false
      positives” in which tilt‐induced fainting (tilt+) occurs in the absence of real‐world fainting.
    note: 'Found by winnow, kev and lev in p001, p030, p025. Claude judged: partial.'
  - paper: pmid28720881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results
    quote: Forty seven percent of the patients (219/464) showed changes in BP or HR during HUT that fulfilled criteria
      for OH or POTS. Twenty eight percent (132/464) of patients showed OH and 19% (87/464) POTS, and the others
      had normal results on HUT.
    note: 'Found by winnow, kev and lev in p010, p015. Claude judged: partial.'
  - paper: pmid28674628
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Results > Haemodynamic parameters
    quote: In agreement with the predefined diagnostic criteria, the small number of patients with OH showed significantly
      lower SBP and DBP during HUT, whereas those with POTS showed higher HR during HUT (table 2), both at 3 min
      of HUT and at the point of lowest BP.
    note: 'Found by winnow, kev and lev in p018, p002, p003. Claude judged: partial.'
  - paper: pmid28554964
    cited: true
    text: full
    license: by
    verdict: partial
    section: Materials and Methods > Postural tachycardia syndrome
    quote: Excessive tachycardia preceding hypotension and bradycardia is often part of the vasovagal response,
      and can be observed during tilt table testing of patients diagnosed with VVS, who are free of chronic day‐to‐day
      symptoms of OI, but do have postural hypotension and therefore do not have POTS.
    note: 'Found by winnow, kev and lev in p001, p011. Claude judged: partial.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Materials and Methods > 2.3. Cardiovascular Reflex Tests > 2.3.5. HUT
    quote: OH was defined as a sustained diastolic BP drop of at least 10 mmHg or a systolic BP drop of at least
      20 mmHg for normotensive subjects [22]. Vasovagal syncope was defined as a sudden BP and HR decline coupled
      with loss of consciousness.
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Methods > Diagnostic criteria of postural tachycardia syndrome and classic vasovagal syncope
    quote: Vasovagal syncope was defined as a reproduction of syncope during HUT associated with a characteristic
      pattern of pronounced hypotension, bradycardia, or asystole.4
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: CONCLUSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p017, p019. Claude judged: partial.'
  - paper: pmid17205918
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 17205918. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid16627440
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16627440. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid11975909
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11975909. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - plasma_catecholamine_assay
  - evidence_for
  - hyperadrenergic_evidence
  papers: 14
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: In this study, patients with POTS after HSCT exhibited a significantly greater increase in NE levels
      upon standing, indicating heightened sympathetic activation. NE changes also correlated with changes in HR,
      supporting a central role for adrenergic signaling in post-HSCT POTS.
    note: 'Found by winnow, kev and lev in p032, p004, p023. Claude judged: supports.'
  - paper: pmid37261636
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Autonomic examination
    quote: Both the supine [PoTS 309.00 (175.00–405.75) ng/l, HC 173.00 (127.00–283.50) ng/l, p = 0.006] and upright
      [PoTS 648.50 (520.00–1053.00) ng/l, HC 408.00 (287.50–497.50) ng/l, p < 0.001] NE levels were higher in the
      PoTS group, with 53% of patients with PoTS having upright NE plasma levels higher than 600 ng/l, indicating
      a hyperadrenergic state (see Fig. 3B).
    note: 'Found by winnow, kev and lev in p019, p015. Claude judged: supports.'
  - paper: pmid34471549
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Case Presentation
    quote: Furthermore, her supine norepinephrine was 677 pg/mL and her standing norepinephrine level was 855 pg/mL,
      suggestive of hyperadrenergic POTS (Table 1).
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Sodium Loading in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p036, p048. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: A dosagem de epinefrina e norepinefrina plasmática em posição supina e ortostática pode ser útil para
      identificar os casos hiperadrenérgicos, assim como a análise do sódio urinário nas 24 horas e os casos de
      depleção de volume.6
    note: 'Found by winnow, kev and lev in p125. Claude judged: supports.'
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In the current study, NE levels in the supine and tilted position were available for 16 patients, with
      five (31.3%) patients having an upright level of NE above the threshold of 3.5 nmol/L, indicating an increased
      sympathetic drive. Between a third and a half of all patients with POTS belong to the hyperadrenergic type,
      characterized by high standing plasma NE levels, and this study supports these findings (2).
    note: 'Found by winnow, kev and lev in p025, p020. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: THE PATHOGENESIS OF POSTURAL TACHYCARDIA SYNDROME > The high catecholamine status
    quote: Jacob et al.[15] discovered that the plasma norepinephrine and epinephrine levels were significantly
      increased both in supine and in upright positions. Thieben et al.[9] also found a high adrenaline status (standing
      plasma norepinephrine level ≥2600 pg/ml) in POTS patients.
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Investigation of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Diagnosis > Diagnostic criteria for POTS (See also Figure 1)
    quote: Noradrenaline is measured after drawing a blood sample from the patient in both a supine and a standing
      position,[8] with the patient in each position for at least 15 min prior to blood sampling.[8] The increase
      in noradrenaline in the standing position indicates the patient belongs to this sub-group.[8]
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Clinical Presentation of Postural Tachycardia Syndrome (POTS) > Laboratory Abnormalities in POTS
    quote: We often measure plasma norepinephrine levels in both a supine and standing position (at least 15 minutes
      in each position prior to blood sampling). The supine norepinephrine is often high normal in patients with
      POTS, while the upright norepinephrine is usually elevated (>600 pg/ml), a reflection of the exaggerated neural
      sympathetic tone that is present in these patients while upright.
    note: 'Found by winnow, kev and lev in p016, p028. Claude judged: supports.'
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Heretofore, an upright plasma NE ≥ 600 pg/mL has been used as evidence of hyperadrenergic POTS.
    note: 'Found by winnow, kev and lev in p039, p010. Claude judged: partial.'
  - paper: pmid35992935
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In 67% of patients the norepinephrine concentrations during head-up tilt exceeded 3.55 nmol/l (equivalent
      to 600 pg/ml), which is an accepted diagnostic criterion for the presence of hyperadrenergic POTS (Schondorf
      and Low, 1993; Jacob and Biaggioni, 1999; Jacob et al., 2019).
    note: 'Found by winnow, kev and lev in p024, p017. Claude judged: partial.'
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: partial
    section: Sympathetic overactivity may be associated with POTS
    quote: Some investigations (Streeten et al., 1988; Schondorf and Low, 1993; Furlan et al., 1998; Jacob et al.,
      1999), but not all (Jacob et al., 2000; Lambert et al., 2008), have reported that POTS patients have greater
      systemic plasma noradrenaline concentrations at rest or during orthostasis compared with healthy controls,
      suggesting that POTS is associated with a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid21266211
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Stand Test with Supine and Upright Vitals and Catecholamines
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21266211. Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - qsart_sudomotor_testing
  - evidence_for
  - neuropathic_evidence
  papers: 14
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Focus on newly diagnosed POTS following COVID-19 infection and vaccination > Post-COVID POTS
      case vignette
    quote: QSART revealed a diffuse pattern of postganglionic, sympathetic-cholinergic sudomotor dysfunction, and
      the patient was therefore diagnosed with neuropathic POTS [42–44].
    note: 'Found by winnow, kev and lev in p037. Claude judged: supports.'
  - paper: pmid40608783
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: This hypothesis has gained support from different assessment methods, including evidence of reduced IENFD
      on skin biopsies [7–10], findings of decreased norepinephrine spillover in the legs compared to the arms [3],
      supersensitivity of norepinephrine infusion in distal veins resembling the reaction in denervated veins [33],
      and impaired post-ganglionic sudomotor function upon measurement with QSART [9,12–14].
    note: 'Found by winnow, kev and lev in p036, p005. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This denervation will imply a mechanism of small fiber neuropathy (SFN). Evidence for this hypothesis
      includes findings of decreased norepinephrine spillover in the legs compared to the arms [5] and impaired
      sweat production on sudomotor testing [6-8].
    note: 'Found by winnow, kev and lev in p005, p006, p035. Claude judged: supports.'
  - paper: pmid35181863
    cited: true
    text: full
    license: none
    verdict: supports
    section: Case report
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35181863. Found by winnow, kev and lev in p004, p007. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: supports
    section: Sympathetic denervation may be associated with POTS
    quote: Examination of medical records of patients with POTS seen at the Mayo Clinic in Rochester indicated that
      half of the patients had evidence of peripheral sudomotor denervation as estimated by abnormal sudomotor axon
      reflex test and thermoregulatory sweat test (Thieben et al., 2007).
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid25033770
    cited: true
    text: full
    license: none
    verdict: supports
    section: METHODS > Phenotypic classification
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25033770. Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p068, p075. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Consistent with the notion that neuropathic POTS represents a distal autonomic and small fiber neuropathy,
      our diagnostic criteria included distal small fiber pathology, impaired distal sensory function and impaired
      distal sudomotor function. We included impaired sudomotor function in this definition because this is the
      most distal autonomic function measure but excluded measures of heart rate variability because these are more
      proximal measures and seemed likely to be impaired only in more severe cases of POTS.
    note: 'Found by winnow, kev and lev in p016, p030. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: There have been several findings consistent with this hypothesis. The results of sudomotor axon reflex
      testing [22] and galvanic skin stimulation [23] support this as well as skin biopsy results [25].
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Sudomotor testing is also used, as a majority of POTS patients have neuropathic abnormalities. This test
      demonstrates the effectiveness of postganglionic sudomotor nerves.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Clinical evaluation of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p027. Claude judged: partial.'
  - paper: pmid21906029
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: A partial autonomic neuropathy has been proposed as playing a role in the pathophysiology of POTS [18].
      We used QSART to assess the integrity of postganglionic cholinergic sudomotor fibres [15,28].
    note: 'Found by winnow, kev and lev in p031. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - cerebral_hypoperfusion_evidence
  papers: 13
  evidence:
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: CBF in OI > CBF in POTS
    quote: First, they showed that POTS participants had twice the drop in CBv on head‐up tilt compared with controls
      even though BP remained stable.
    note: 'Found by winnow, kev and lev in p029, p032, p036. Claude judged: supports.'
  - paper: pmid37227184
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37227184. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid35056406
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: This study demonstrates that in ME/CFS patients suspected of having PPS, or conversion, CBF measurements
      end-tilt show a large decline compared with a control group of ME/CFS patients. Therefore, hypoperfusion offers
      an explanation of the orthostatic intolerance and syncopal spells in these patients, where it is clear that
      origin might not be behavioral or psychogenic, but have a clear somatic pathophysiologic background.
    note: 'Found by winnow, kev and lev in p015, p001, p013. Claude judged: supports.'
  - paper: pmid32545797
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: The three studies found that the blood flow velocity decrease in patients with a normal HUT but with
      OI symptoms was larger than in healthy volunteers and patients without OI, and similar to the patients with
      POTS or OH. These observations suggest that cerebral hypoperfusion is not only present in POTS and OH patients,
      but also in patients with OI symptoms without POTS and OH.
    note: 'Found by winnow, kev and lev in p018, p001, p020. Claude judged: supports.'
  - paper: pmid32140630
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: The main finding of this study is that extracranial Doppler imaging demonstrates a significant reduction
      in cerebral blood flow during head-up tilt test in ME/CFS patients compared to healthy controls.
    note: 'Found by winnow, kev and lev in p081, p073, p078. Claude judged: supports.'
  - paper: pmid30256820
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: It is concluded that both HYCH and POTS patients have comparable decrease in CBFv which is due to vasoconstrictive
      effect of hypocapnia. Blood flow velocity monitoring can provide an objective biomarker for HYCH in OI patients
      without tachycardia.
    note: 'Found by winnow, kev and lev in p001, p020, p022. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p005, p022. Claude judged: supports.'
  - paper: pmid33947430
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: We recently reported that extracranial Doppler imaging of the internal carotid and vertebral arteries
      can measure the total cerebral blood flow (CBF) during head-up tilt testing (HUT), and thereby provides an
      objective confirmation of OI. In healthy adults, this technique identified a mean 7% reduction in CBF during
      a 30 min HUT.
    note: 'Found by winnow, kev and lev in p008, p030. Claude judged: partial.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: According to a recent hypothesis, upright cognitive impairment in patients with POTS is caused by reduced
      cerebral blood flow velocity (CBFV), and studies have shown that CBFV decreases excessively during 70° tilt
      in a minority of patients with intermittent hyperpnea/hypocapnia [8].
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid33280488
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Methods and Results
    quote: Notably, the reduced CBFv following PCST in the POTS group was similar to that seen during orthostatic
      stress (60.0±14.9 versus 60.4±14.8 cm/s).
    note: 'Found by winnow, kev and lev in p002, p012, p025. Claude judged: partial.'
  - paper: pmid33050553
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The present study examined whether a sitting test, measuring cerebral blood flow by extracranial Doppler,
      would be sufficient to provoke abnormal reductions in cerebral blood flow in severe ME/CFS patients.
    note: 'Found by winnow, kev and lev in p014, p001. Claude judged: partial.'
  - paper: pmid25002851
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Although on average CBF decreased more in POTS than controls (Ocon et al., 2009) more recent studies
      showed that large abnormal decreases in mean CBF occurred during orthostasis in a subset of POTS patients
      in whom a significantly decreased central blood volume during initial orthostasis triggered hyperpnea, hypocapnia,
      and sympathetic activation (Del Pozzi et al., 2014).
    note: 'Found by winnow, kev and lev in p003, p035. Claude judged: partial.'
  - paper: pmid16627440
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16627440. Found by winnow, kev and lev in p002. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - pots
  papers: 12
  evidence:
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: CBF in OI > CBF in POTS
    quote: CBv, measured in the middle cerebral artery (MCA), served as a more accurate tool in differentiating
      POTS from other forms of tachycardia.
    note: 'Found by winnow, kev and lev in p029, p036, p032. Claude judged: supports.'
  - paper: pmid27525257
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion > 4.2. Tachycardia Syndromes (PST, IST, and POTS)
    quote: CBFv is also helpful in classification. CBFv is characteristically reduced in POTS, normal in IST, and
      normal or transiently elevated in PST.
    note: 'Found by winnow, kev and lev in p041, p045, p001. Claude judged: supports.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Previous transcranial Doppler studies have found reduced cerebral blood flow (CBF) in those with POTS
      during orthostatic and cognitive stress11–14. However, the Doppler technique remains confined to research
      settings due to the expertise and time required for measurements and potential inter-operator variability15.
    note: 'Found by winnow, kev and lev in p003, p009. Claude judged: partial.'
  - paper: pmid39297140
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Stroke volume and cerebrovascular pulsatility as determinants of postural ventilation and
      sympathetic activity in patients with POTS
    quote: Indeed, reductions in stroke volume were also predictive of reductions in MCAv pulsatility (Figure 3C),
      and we found that the reduction in MCAv pulsatility during head-up tilt was larger in patients with POTS compared
      with control subjects (Figure 3D, Table 3).
    note: 'Found by winnow, kev and lev in p031, p032. Claude judged: partial.'
  - paper: pmid37227184
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37227184. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35673757
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35673757. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The results of this study contribute toward developing an early accurate diagnosis of impaired CBFV responses
      to CO2 for POTS patients.
    note: 'Found by winnow, kev and lev in p001, p003, p008. Claude judged: partial.'
  - paper: pmid33280488
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion > Clinical Implications
    quote: Whether reduced CBFv is a useful biomarker in the management of POTS remains to be determined.
    note: 'Found by winnow, kev and lev in p002, p025, p033. Claude judged: partial.'
  - paper: pmid30256820
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: During the tilt, CBFv decreased more in HYCH (-22.4±7.7%, p<0.0001) and POTS (-19.0±10.3%, p<0.0001)
      compared to controls (-3.0±5.0%).
    note: 'Found by winnow, kev and lev in p001, p022. Claude judged: partial.'
  - paper: pmid25510829
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Imposition of Graded Orthostatic Challenge > Autospectral Power- Oscillatory Data
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25510829. Found by winnow, kev and lev in p025, p019, p023. Claude judged: partial.'
  - paper: pmid25002851
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Upright > Autospectral power
    quote: Overall CBFv variability was markedly increased in POTS compared to supine or to upright control data
      (P < 0.001). While VLF cerebral blood flow velocity power did not differ for POTS compared to control subjects,
      LF power was significantly larger (P < 0.001) for POTS compared to controls when upright.
    note: 'Found by winnow, kev and lev in p018, p024, p001. Claude judged: partial.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Response to Orthostatic Stress > Neurocardiopulmonary Responses to Tilt
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p005, p023. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - hyperadrenergic_evidence
  papers: 11
  evidence:
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: In the syncope with POTS group, hypertensive responses during HUTT were significantly more prevalent,
      observed in 45% of patients. This combined elevation of heart rate and blood pressure suggests a hyperadrenergic
      mechanism.
    note: 'Found by winnow, kev and lev in p050, p040. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Hyperadrenergic POTS is characterized by high central sympathetic drive, evident by an increase in systolic
      blood pressure (SBP) on HUTT and a standing plasma norepinephrine level of 600 pg/mL or more1,2,9.
    note: 'Found by winnow, kev and lev in p004, p024. Claude judged: supports.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Autonomic testing in 4 of 6 patients in our series revealed findings potentially compatible with POTS,
      including 2 patients with both hypertension and tachycardia on HUT, consistent with a hyperadrenergic POTS
      subtype.
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid33886001
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33886001. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Investigations
    quote: The tilt table test demonstrated the presence of hyperadrenergic POTS (increase in heart rate >30 beats/min,
      rise in systolic blood pressure ≥10 mm Hg and serum norepinephrine level ≥600 pg/mL).
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p014, p019. Claude judged: supports.'
  - paper: pmid36000360
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > POTS phenotypes
    quote: Hyperadrenergic POTS patients have increased levels of plasma norepinephrine during HUT [3].
    note: 'Found by winnow, kev and lev in p015, p065. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid25033770
    cited: true
    text: full
    license: none
    verdict: partial
    section: RESULTS > Autonomic Function Tests, BP monitoring, and Laboratory Data
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25033770. Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: CONCLUSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p001, p019, p007. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - pots
  papers: 10
  evidence:
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Jacob et al. likewise demonstrated lower HF, rMSSD, and pNN50 values in POTS compared with non-POTS patients
      using short-term HRV [37].
    note: 'Found by winnow, kev and lev in p031, p043, p044. Claude judged: partial.'
  - paper: pmid35118574
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35118574. Found by winnow, kev and lev in p027. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Fall 2
    quote: Im Langzeit-EKG zeigten sich keine Herzrhythmusstörung, eine normale mittlere Herzfrequenz mit 80 Schlägen/min,
      aber eine relevante autonome Regulationsstörung mit herabgesetzter globaler HRV (SDNN = 95 ms, Normwert >
      128). Basierend auf unseren Vorarbeiten über autonome Regulationsstörungen bei Kindern [2] und ersten Fallberichten
      aus der internistischen Kardiologie lag es nahe [6], dass diese postinfektiösen Probleme nach der SARS-CoV-2-Infektion
      Ausdruck eines sog. posturalen orthostatischen Tachykardiesyndroms (POTS) sind.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: The slope of ΔRR/ΔSAP is typically reduced in POTS21 compared with controls supine and even more when
      upright.
    note: 'Found by winnow, kev and lev in p008, p048. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: HRV parameters (HF and LF) during HUT test correlated with autonomic dysfunction in POTS and in other
      autonomic neuropathies (Baker et al., 2018b). HRV was lower for POTS patients than for controls in rest and
      during HUT tests (Stewart, 2000; Baker et al., 2018a; Jacob et al., 2019).
    note: 'Found by winnow, kev and lev in p004, p010, p027. Claude judged: partial.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Comparison of Baseline Demographic and HRV Parameters Between POTS and Control Groups
    quote: However, SDNN index, pNN50, TR index, LF, and TP were significantly higher in POTS than control children
      all P < 0.05.
    note: 'Found by winnow, kev and lev in p019, p032. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p001, p029, p033. Claude judged: partial.'
  - paper: pmid22247480
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Baroreflex Function
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22247480. Found by winnow, kev and lev in p025, p033. Claude judged: partial.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p001, p019. Claude judged: partial.'
  - paper: pmid10406593
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 10406593. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - cerebral_hypoperfusion_evidence
  papers: 9
  evidence:
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Pulmonary determinants
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid39544990
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this study, orthostatic lightheadedness/dizziness was accompanied by reduced CBFv in both HYCH and
      POTS during the head-up tilt test. Our previous study (33) showed that changes in CBFv (in addition to end-tidal
      CO2 level that modulates the size of cerebral vessels) indeed correlate with symptoms of cerebral hypoperfusion
      indicating that reduced CBFv leads to cerebral hypoperfusion.
    note: 'Found by winnow, kev and lev in p016, p036. Claude judged: supports.'
  - paper: pmid35056406
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: This study demonstrates that in ME/CFS patients suspected of having PPS, or conversion, CBF measurements
      end-tilt show a large decline compared with a control group of ME/CFS patients. Therefore, hypoperfusion offers
      an explanation of the orthostatic intolerance and syncopal spells in these patients, where it is clear that
      origin might not be behavioral or psychogenic, but have a clear somatic pathophysiologic background.
    note: 'Found by winnow, kev and lev in p013, p015, p001. Claude judged: supports.'
  - paper: pmid32140630
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: First, our study shows that in response to head-up tilt, ME/CFS patients with either delayed orthostatic
      hypotension or POTS develop a cerebral blood flow reduction of 28%, and 29%, respectively, at the end of the
      upright position. This is highly significantly different from the 7% reduction in controls with a normal tilt
      test.
    note: 'Found by winnow, kev and lev in p081, p072, p073. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Response to Orthostatic Stress > Neurocardiopulmonary Responses to Tilt
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p001, p022, p023. Claude judged: supports.'
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CBF in OI > CBF in POTS
    quote: First, they showed that POTS participants had twice the drop in CBv on head‐up tilt compared with controls
      even though BP remained stable.
    note: 'Found by winnow, kev and lev in p029, p036, p032. Claude judged: partial.'
  - paper: pmid33947430
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: We recently reported that extracranial Doppler imaging of the internal carotid and vertebral arteries
      can measure the total cerebral blood flow (CBF) during head-up tilt testing (HUT), and thereby provides an
      objective confirmation of OI. In healthy adults, this technique identified a mean 7% reduction in CBF during
      a 30 min HUT.
    note: 'Found by winnow, kev and lev in p008, p030. Claude judged: partial.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: According to a recent hypothesis, upright cognitive impairment in patients with POTS is caused by reduced
      cerebral blood flow velocity (CBFV), and studies have shown that CBFV decreases excessively during 70° tilt
      in a minority of patients with intermittent hyperpnea/hypocapnia [8].
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid16627440
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16627440. Found by winnow, kev and lev in p002. Claude judged: partial.'
- edge:
  - muscle_sympathetic_nerve_activity
  - evidence_for
  - pots
  papers: 9
  evidence:
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods > Cut point search for DBP rise (DBPVM2l_rise)
    quote: We defined the optimal DBPVM2l_rise cut point as the value where the highest correlations between MSNA
      and DBPVM2l_rise were found in both hyperadrenergic (above the cut point value) and non-hyperadrenergic POTS
      (below the cut point value) using the golden section search method, as detailed in Appendix 1 [20].
    note: 'Found by winnow, kev and lev in p003, p015, p022. Claude judged: partial.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods > Cut point search for DBP rise (DBP)
    quote: Our primary objective was to find the optimal cut point value for DBPVM2l_rise to distinguish hyperadrenergic
      from non-hyperadrenergic POTS. We defined the optimal DBPVM2l_rise cut point as the cut point where the highest
      correlations between MSNA and DBPVM2l_rise were found in both hyperadrenergic (above cut point value) and
      non-hyperadrenergic POTS (below cut point value) using the golden section search method, as detailed in Appendix
      1[24].
    note: 'Found by winnow, kev and lev in p003, p026, p039. Claude judged: partial.'
  - paper: pmid40350041
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40350041. Found by winnow, kev and lev in p008, p011, p015. Claude judged: partial.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p003, p032, p006. Claude judged: partial.'
  - paper: pmid38176772
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Autonomic function
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38176772. Found by winnow, kev and lev in p004, p022. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p001, p026, p033. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid22934032
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pathophysiological conditions > Neural control in the postural orthostatic tachycardia syndrome
    quote: Microneurographic studies have shown that POTS patients have a similar (Bonyhay and Freeman, 2004; Muenter
      Swift et al., 2005; Lambert et al., 2008; Fu et al., 2010) or greater (Furlan et al., 1998) basal MSNA when
      compared to healthy controls. All (Muenter Swift et al., 2005; Lambert et al., 2008; Fu et al., 2010; Baumert
      et al., 2011) except one (Furlan et al., 1998) studies reported enhanced MSNA responses during orthostasis
      in POTS.
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - valsalva_maneuver
  - evidence_for
  - hyperadrenergic_evidence
  papers: 7
  evidence:
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Indirect clinical markers of increased sympathetic activity, such as high systolic blood pressure (SBP)
      overshoot during Valsalva, orthostatic hypertension, high orthostatic plasma catecholamines [4–6], and response
      to sympatholytic drugs have been proposed [3, 7]. Recently, we showed that a subset of patients with POTS
      have increased resting MSNA, indicating greater central sympathetic outflow, and that can be identified by
      an exaggerated diastolic blood pressure (DBP) increase during late phase 2 of the Valsalva maneuver (DBPVM2l_rise).
    note: 'Found by winnow, kev and lev in p003, p006, p001. Claude judged: supports.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Indirect clinical markers of increased sympathetic activity like high systolic blood pressure (SBP) overshoot
      during Valsalva, orthostatic hypertension, high orthostatic plasma catecholamines[2–5], and response to sympatholytic
      drugs have been proposed[6, 7]. Recently, we showed that POTS patients with clinical hyperadrenergic features
      can be identified by an exaggerated diastolic blood pressure (DBP) increase during late phase 2 of the Valsalva
      maneuver (DBPVM2l_rise) and that this biomarker can also identify those who improved POTS symptoms with central
      sympatholytic therapy with guanfacine[8].
    note: 'Found by winnow, kev and lev in p003, p038, p005. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p028, p038, p003. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p027, p001, p029. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: As manobras de Valsalva com medida da PA batimento por batimento podem mostrar uma fase 4 exagerada,
      revelando excessiva atividade simpática.
    note: 'Found by winnow, kev and lev in p125. Claude judged: supports.'
  - paper: pmid33886001
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33886001. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p008. Claude judged: supports.'
- edge:
  - skin_biopsy_ienfd
  - evidence_for
  - neuropathic_evidence
  papers: 7
  evidence:
  - paper: pmid42273028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Participants
    quote: Of the initial pool of 382,256 (67%) underwent additional testing with either intraepidermal nerve fiber
      density skin biopsy (IENFD; through which reduced nerve fiber density evidence via punch biopsy is suggestive
      of small fiber neuropathy) or the quantitative sudomotor axon reflex test (QSART; low scores indicate abnormally
      low sweat response to electric stimulation of the skin and are considered suggestive of small autonomic nerve
      fiber damage) to identify presence or absence of the neuropathic subtype of POTS.
    note: 'Found by winnow, kev and lev in p006, p017. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Symptoms and clinicopathologic features of dysautonomia
    quote: Neuropathic POTS is associated with reduced intraepidermal and/or sudomotor (i.e., sweat gland) nerve
      fiber density on skin biopsy indicative of a small-fiber sensory or autonomic neuropathy.
    note: 'Found by winnow, kev and lev in p006, p014, p032. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this cohort, one of the largest POTS cohorts studied, we identified abnormal testing in 35% of patients
      who underwent at least one skin biopsy and/or QSART. These patients with evidence of autonomic SFN are likely
      to have a neuropathic subtype of POTS, though evidence of one subtype does not rule out the presence of other
      subtypes, given the heterogeneity of the disorder.
    note: 'Found by winnow, kev and lev in p005, p006, p033. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case description and results
    quote: A skin biopsy from the distal lower leg 10mm above the malleolus lateralis confirmed a severe SFN with
      an intraepithelial nerve fiber density (IENFD) of 0,2/mm [28].
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Furthermore, in some patients with neuropathic POTS, intraepidermal nerve fiber density is decreased,
      providing objective support for a small fiber neuropathy in these POTS patients.
    note: 'Found by winnow, kev and lev in p007, p026, p027. Claude judged: supports.'
  - paper: pmid25053240
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical Summary
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25053240. Found by winnow, kev and lev in p014, p016, p017. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Definition of neuropathic POTS
    quote: Neuropathic POTS was defined as a skin biopsy below the 5th percentile, and at least 1 other test (quantitative
      sensory testing or quantitative sudomotor direct and indirect testing) result below the 5th percentile.
    note: 'Found by winnow, kev and lev in p016, p030, p002. Claude judged: supports.'
- edge:
  - muscle_sympathetic_nerve_activity
  - evidence_for
  - hyperadrenergic_evidence
  papers: 6
  evidence:
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In a subset of these patients, the main pathophysiological mechanism has been proposed to be primary
      sympathetic activation (hyperadrenergic POTS) [2, 3]. Sympathetic activation can be measured directly using
      microneurography techniques to obtain muscle sympathetic nerve activity (MSNA).
    note: 'Found by winnow, kev and lev in p003, p006, p038. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p003, p032, p006. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The percentage is interestingly close to our previous study in which hyperadrenergic POTS was defined
      using the 4th quartile of baseline MSNA[8].
    note: 'Found by winnow, kev and lev in p003, p040, p002. Claude judged: partial.'
  - paper: pmid15533861
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15533861. Found by winnow, kev and lev in p002. Claude judged: partial.'
- edge:
  - ambulatory_monitoring
  - evidence_for
  - pots
  papers: 6
  evidence:
  - paper: pmid38176772
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Patient evaluation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38176772. Found by winnow, kev and lev in p023, p015. Claude judged: supports.'
  - paper: pmid35307584
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Study 2
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35307584. Found by winnow, kev and lev in p018, p011, p012. Claude judged: supports.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: The 72-hour Holter did demonstrate persistent sinus tachycardia and head-up tilt-table testing confirmed
      POTS (Table 1, Figure 1, Figure 2).
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid32846397
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32846397. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid32477718
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: 'However, during continuous monitoring via her loop recorder, within seconds of standing, sinus tachycardia
      (rate: 150 bpm) ensued without an appreciable drop in blood pressure (Figure 1).'
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid23270259
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23270259. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - valsalva_maneuver
  - evidence_for
  - pots
  papers: 6
  evidence:
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusion
    quote: We propose a clinical marker from the Valsalva maneuver, namely DBPVM2l_rise, as a surrogate for sympathetic
      function that is applicable for POTS subtyping. The relationship of DBPVM2l_rise to sympathetic function has
      been confirmed by a strong correlation with B2B MSNA spike rateVM2 in healthy subjects.
    note: 'Found by winnow, kev and lev in p043, p003, p006. Claude judged: partial.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusion
    quote: We proposed a clinical marker from Valsalva maneuver, namely DBPVM2l_rise, as a surrogate for sympathetic
      function applicable for POTS subtyping.
    note: 'Found by winnow, kev and lev in p044, p003, p029. Claude judged: partial.'
  - paper: pmid33486983
    cited: true
    text: full
    license: none
    verdict: partial
    section: RESULTS > Autonomic Testing
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33486983. Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p001, p034, p024. Claude judged: partial.'
  - paper: pmid25071706
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Autonomic testing showed a significantly higher Valsalva ratio in PoTS patients as compared to normal
      subjects. This conforms to former studies of Sandroni et al. who found a higher Valsalva ratio in PoTS patients
      and ascribed this to an increased β-adrenergic tone (22).
    note: 'Found by winnow, kev and lev in p014, p021. Claude judged: partial.'
  - paper: pmid23729158
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23729158. Found by winnow, kev and lev in p003, p020. Claude judged: partial.'
- edge:
  - regional_norepinephrine_spillover
  - evidence_for
  - neuropathic_evidence
  papers: 5
  evidence:
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This denervation will imply a mechanism of small fiber neuropathy (SFN). Evidence for this hypothesis
      includes findings of decreased norepinephrine spillover in the legs compared to the arms [5] and impaired
      sweat production on sudomotor testing [6-8].
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid25053240
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical Summary
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25053240. Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Using a segmental norepinephrine spillover approach, Jacob et al. [26] demonstrated that patients with
      POTS had normal sympathetic neuronal norepinephrine release in their arms, but less norepinephrine release
      (and thus less sympathetic activation) in their lower body.
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - plasma_blood_volume_assay
  - evidence_for
  - pots
  papers: 5
  evidence:
  - paper: pmid39614968
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Conclusions
    quote: The CO rebreathing method can detect BV deficit, as well as the RBCV deficit in patients with POTS. The
      negative correlation between BV deviation and upright HR indicates that hypovolemia is one of the pathophysiological
      causes of POTS.
    note: 'Found by winnow, kev and lev in p004, p032, p035. Claude judged: partial.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > Blood Volume Abnormalities and Treatments in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p016, p020, p021. Claude judged: partial.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: partial
    section: RESULTS > Comparison of Low Salt Diet Response between POTS and Healthy Controls > Blood volume (Table
      4; Figure 5)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p044, p038, p042. Claude judged: partial.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: partial
    section: Investigation of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p028, p020. Claude judged: partial.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: partial
    section: RESULTS > Physical characteristics
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p026, p035. Claude judged: partial.'
- edge:
  - plasma_catecholamine_assay
  - evidence_for
  - pots
  papers: 5
  evidence:
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Diagnosis > Diagnostic criteria for POTS (See also Figure 1)
    quote: A high plasma level of noradrenaline level is also considered useful to identify POTS patients, and is
      sometimes referred to as a hyper-adrenergic form of POTS. Noradrenaline is measured after drawing a blood
      sample from the patient in both a supine and a standing position,[8] with the patient in each position for
      at least 15 min prior to blood sampling.[8]
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid37261636
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Autonomic examination
    quote: Both the supine [PoTS 309.00 (175.00–405.75) ng/l, HC 173.00 (127.00–283.50) ng/l, p = 0.006] and upright
      [PoTS 648.50 (520.00–1053.00) ng/l, HC 408.00 (287.50–497.50) ng/l, p < 0.001] NE levels were higher in the
      PoTS group, with 53% of patients with PoTS having upright NE plasma levels higher than 600 ng/l, indicating
      a hyperadrenergic state (see Fig. 3B).
    note: 'Found by winnow, kev and lev in p015, p019. Claude judged: partial.'
  - paper: pmid34471549
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentation
    quote: Furthermore, her supine norepinephrine was 677 pg/mL and her standing norepinephrine level was 855 pg/mL,
      suggestive of hyperadrenergic POTS (Table 1).
    note: 'Found by winnow, kev and lev in p005, p009. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid21266211
    cited: true
    text: full
    license: none
    verdict: partial
    section: Methods > Protocol
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21266211. Found by winnow, kev and lev in p021, p009. Claude judged: partial.'
- edge:
  - skin_biopsy_ienfd
  - evidence_for
  - small_fiber_neuropathy_dx
  papers: 5
  evidence:
  - paper: pmid42273028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Participants
    quote: Of the initial pool of 382,256 (67%) underwent additional testing with either intraepidermal nerve fiber
      density skin biopsy (IENFD; through which reduced nerve fiber density evidence via punch biopsy is suggestive
      of small fiber neuropathy) or the quantitative sudomotor axon reflex test (QSART; low scores indicate abnormally
      low sweat response to electric stimulation of the skin and are considered suggestive of small autonomic nerve
      fiber damage) to identify presence or absence of the neuropathic subtype of POTS.
    note: 'Found by winnow, kev and lev in p006, p017. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In clinical practice, patients with suspected neuropathic POTS may undergo a variety of testing for SFN,
      including skin biopsy and quantitative sudomotor axon reflex testing (QSART). In the previous series, 38-45%
      of patients biopsied had reduced IENFD [8,10], and 33-56% of patients had reduced sweat output [6,8].
    note: 'Found by winnow, kev and lev in p006, p042. Claude judged: supports.'
  - paper: pmid36090156
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Patient 2
    quote: A lower leg punch biopsy showed marked reduction in the innervation of the epidermis by free nerve endings
      consistent with small fiber polyneuropathy.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case description and results
    quote: A skin biopsy from the distal lower leg 10mm above the malleolus lateralis confirmed a severe SFN with
      an intraepithelial nerve fiber density (IENFD) of 0,2/mm [28].
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Furthermore, in some patients with neuropathic POTS, intraepidermal nerve fiber density is decreased,
      providing objective support for a small fiber neuropathy in these POTS patients.
    note: 'Found by winnow, kev and lev in p007, p003. Claude judged: supports.'
- edge:
  - active_stand_test
  - evidence_for
  - hyperadrenergic_evidence
  papers: 4
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: In this study, patients with POTS after HSCT exhibited a significantly greater increase in NE levels
      upon standing, indicating heightened sympathetic activation. NE changes also correlated with changes in HR,
      supporting a central role for adrenergic signaling in post-HSCT POTS.
    note: 'Found by winnow, kev and lev in p004, p025, p032. Claude judged: partial.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p001, p025. Claude judged: partial.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. The Development of POTS and Its Associated Manifestations
    quote: The criterion of hyperadrenergic POTS is defined by an elevation in norepinephrine of greater than 600
      pg/mL upon standing and a systolic blood pressure increase of greater than 10 mmHg following 10 min of standing
      [20].
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid35733987
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results
    quote: Supine norepinephrine (Figure 2A) and epinephrine (Figure 2B) were similar between groups. In the standing
      position, both catecholamines significantly increased in POTS patients compared to the healthy controls (Figures
      2C,D).
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
- edge:
  - plasma_blood_volume_assay
  - evidence_for
  - hypovolemic_evidence
  papers: 4
  evidence:
  - paper: pmid39614968
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: The CO rebreathing method can detect BV deficit, as well as the RBCV deficit in patients with POTS. The
      negative correlation between BV deviation and upright HR indicates that hypovolemia is one of the pathophysiological
      causes of POTS.
    note: 'Found by winnow, kev and lev in p004, p032, p038. Claude judged: supports.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Low Blood Volume in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p044, p009, p038. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Investigation of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p028, p020. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > POTS and “deconditioning”
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p026, p035. Claude judged: partial.'
- edge:
  - active_stand_test
  - evidence_for
  - long_covid
  papers: 4
  evidence:
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Pairwise comparison of the average increase in heart rate relative to basal values between the cohorts
      at each minute of the active standing test showed that in ME/CFS that developed after COVID-19, there is a
      more pronounced increase in heart rate starting from the 6th minute of the test compared to the control group.
      This allowed us to assume that POTS is one of the key characteristics of ME/CFS of post-COVID genesis.
    note: 'Found by winnow, kev and lev in p046. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Here we make the diagnosis of orthostatic intolerance and PASC using the NASA Lean Test for a patient
      who is also pregnant.
    note: 'Found by winnow, kev and lev in p002, p024. Claude judged: supports.'
  - paper: pmid36298551
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: 'In 38 children and young adults, we tested if these health problems were related to dysautonomia in
      an active standing test (Group 1: 19 patients after COVID-19; Group 2: 12 patients with a breakthrough infection
      despite a vaccination; and Group 3: 7 patients after a vaccination without COVID-19).'
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: supports
    section: Diskussion
    quote: Am Fallbeispiel 2 können wir zeigen, dass Kinder nach SARS-CoV-Infektion eine chronische Regulationsstörung
      des autonomen Nervensystems mit einem POTS entwickeln können, welches in einem einfachen aktiven Stehtest
      mit kontinuierlicher EKG-Registrierung nachweisbar ist.
    note: 'Found by winnow, kev and lev in p007, p010. Claude judged: supports.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - long_covid
  papers: 4
  evidence:
  - paper: pmid36614874
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Results > 3.3. Tilt Table Test Response
    quote: 'A total of 7/11 (63.64%) patients with PASC met criteria for POTS: they had more than a 30 bpm increase
      in heart rate that sustained for at least 30% of the entire tilt table duration.'
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p014, p004, p005. Claude judged: supports.'
  - paper: pmid42343084
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: The tilt table test, a diagnostic tool commonly used to evaluate orthostatic intolerance, provides a
      controlled setting to assess autonomic responses during postural changes15. Recent studies have demonstrated
      that long COVID-19 patients exhibit abnormal HR and BP responses during tilt testing, further supporting the
      role of ANS dysfunction in this condition16,17.
    note: 'Found by winnow, kev and lev in p004, p005, p039. Claude judged: partial.'
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CBF in OI > CBF in Long COVID
    quote: "However, unlike the study by Novak et al,\n53\n in which a majority of participants with long COVID\
      \ did not have orthostatic tachycardia, in the study by van Campen et al,\n54\n all participants with long\
      \ COVID experienced orthostatic tachycardia on head‐up tilt."
    note: 'Found by winnow, kev and lev in p036, p035. Claude judged: partial.'
- edge:
  - thermoregulatory_sweat_test
  - evidence_for
  - neuropathic_evidence
  papers: 4
  evidence:
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 15
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p022, p035. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid25033770
    cited: true
    text: full
    license: none
    verdict: supports
    section: METHODS > Phenotypic classification
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25033770. Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome > Diagnostic Considerations
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p028. Claude judged: partial.'
- edge:
  - valsalva_maneuver
  - evidence_for
  - neuropathic_evidence
  papers: 4
  evidence:
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: This finding supports the view of neuropathic POTS as resulting from peripheral sympathetic denervation
      [15]. Given that a blunted phase II response was present in a small minority of patients tested, it is likely
      that this represents a specific but not sensitive marker for neuropathic POTS [6,8].
    note: 'Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p033, p034, p006. Claude judged: supports.'
  - paper: pmid25033770
    cited: true
    text: full
    license: none
    verdict: supports
    section: METHODS > Phenotypic classification
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25033770. Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid8988490
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 8988490. Found by winnow, kev and lev in p001. Claude judged: supports.'
- edge:
  - cardiopulmonary_exercise_test
  - evidence_for
  - pots
  papers: 4
  evidence:
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Heart rate
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p004, p012, p019. Claude judged: partial.'
  - paper: pmid40313612
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusion
    quote: These two exercise parameters—peak oxygen pulse and ETCO2—may serve as objective markers for POTS physiology
      and sympathetic hyperactivity, respectively.
    note: 'Found by winnow, kev and lev in p035, p004. Claude judged: partial.'
  - paper: pmid27884959
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: 'Our results support a phenotypic distinction among adolescents with POTS based on circulation during
      exercise: one that maintains the normal coupling between Q˙ and V˙O2, another in whom Q˙ rises more than expected,
      and now a third in whom Q˙ rises less than expected, with respect to V˙O2. How Q˙ is matched to V˙O2, can
      provide insight into pathophysiology of each variant.'
    note: 'Found by winnow, kev and lev in p009, p010, p005. Claude judged: partial.'
  - paper: pmid25168872
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: We previously showed that adolescents with postural orthostatic tachycardia syndrome (POTS) have excessive
      heart rate (HR) during, and slower HR recovery after, exercise – hallmarks of deconditioning.
    note: 'Found by winnow, kev and lev in p001, p004, p011. Claude judged: partial.'
- edge:
  - urine_sodium_24h
  - evidence_for
  - hypovolemic_evidence
  papers: 3
  evidence:
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. The Development of POTS and Its Associated Manifestations
    quote: Patients with hypovolemic POTS typically exhibit reduced plasma volume, red blood cells (RBC), and urinary
      sodium excretion [22]. A study demonstrated that 28.9% of patients had a sodium excretion rate of less than
      100 mEq/L within 24 h, which is indicative of low blood-volume status.
    note: 'Found by winnow, kev and lev in p005, p016. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Hypovolemic Pots: Salt Supplements, Oral Rehydration and Fludrocortisone'
    quote: A low concentration of urinary sodium is an indirect marker of hypovolemia (23, 27). Our previous work
      showed that, compared with the healthy control group, the concentration of 24-h urinary sodium was significantly
      lower in the POTS patients, and the symptom severity of children with POTS inversely correlated at a significant
      level with their 24-h urinary-sodium concentrations.
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: THE PATHOGENESIS OF POSTURAL TACHYCARDIA SYNDROME > The low blood volume
    quote: Zhang et al.[14] found that low 24-h urinary sodium was related to the severity of the symptoms of POTS
      in children and adolescents. These findings also supported the hypothesis that low volume status might play
      a role in the pathogenesis of POTS.
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
- edge:
  - autonomic_autoantibody_assay
  - evidence_for
  - long_covid
  papers: 3
  evidence:
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. COVID-19-Related POTS > 2.2. Presumed Mechanism for COVID-19-Related POTS > 2.2.2. Hyperadrenergic
      Reaction
    quote: Autoantibodies to G-protein-coupled receptors were measured in a study of 31 patients with persistent
      long COVID-19 symptoms, and autoantibodies to β2-AR, α1-AR, angiotensin II AT1-receptor, nociceptin-like opioid
      receptor, and muscarinic M2-receptor were identified [33].
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Diagnosis
    quote: The measurement of inflammation or autoimmunity markers is a reasonable option in the context of clinical
      suspicion of POTS associated with SARS-CoV-2 (41, 66).
    note: 'Found by winnow, kev and lev in p020. Claude judged: partial.'
  - paper: pmid36832445
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: We performed auto-antibody analysis in a research laboratory [17] and found different patterns of elevated
      auto-antibodies against G-protein-coupled receptors in children with long COVID and also after SARS-CoV-2
      vaccination [18]. However, the auto-antibody concentrations against these receptors were not significantly
      different between the controls and the patients with POTS in a recent analysis [19].
    note: 'Found by winnow, kev and lev in p027. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - long_covid
  papers: 3
  evidence:
  - paper: pmid42343084
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: Their study demonstrated reduced HRV indices and blunted BRS during tilt-table testing, reinforcing the
      role of ANS dysregulation in the clinical presentation of long COVID. These findings underscore the need for
      objective physiological assessment in post-COVID populations and inform the rationale for our present investigation14.
    note: 'Found by winnow, kev and lev in p003, p004, p039. Claude judged: partial.'
  - paper: pmid36298551
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Conclusion: The uniform increase in the heart rates and stress indices, together with low pNN20 values,
      indicated dysautonomia in children with health problems after COVID-19 disease and/or vaccination. A total
      of 8 patients fulfilled the criteria of postural orthostatic tachycardia syndrome and 9 patients of an inappropriate
      sinus tachycardia, who were successfully treated with omega-3 fatty acid supplementation and pharmacotherapy.'
    note: 'Found by winnow, kev and lev in p001, p028, p029. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Fall 2
    quote: Im Langzeit-EKG zeigten sich keine Herzrhythmusstörung, eine normale mittlere Herzfrequenz mit 80 Schlägen/min,
      aber eine relevante autonome Regulationsstörung mit herabgesetzter globaler HRV (SDNN = 95 ms, Normwert >
      128). Basierend auf unseren Vorarbeiten über autonome Regulationsstörungen bei Kindern [2] und ersten Fallberichten
      aus der internistischen Kardiologie lag es nahe [6], dass diese postinfektiösen Probleme nach der SARS-CoV-2-Infektion
      Ausdruck eines sog. posturalen orthostatischen Tachykardiesyndroms (POTS) sind.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - qsart_sudomotor_testing
  - evidence_for
  - pots
  papers: 3
  evidence:
  - paper: pmid35181863
    cited: true
    text: full
    license: none
    verdict: supports
    section: Case report
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35181863. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid25180969
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Our QSART findings showing a relative increase in sweat volume in the lower limb support the concept
      that increased sympathetic activity may be a pathophysiological mechanism of POTS.
    note: 'Found by winnow, kev and lev in p022, p017. Claude judged: partial.'
  - paper: pmid20035362
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20035362. Found by winnow, kev and lev in p001, p004, p019. Claude judged: partial.'
- edge:
  - urine_sodium_24h
  - evidence_for
  - pots
  papers: 3
  evidence:
  - paper: pmid37705599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > VVS combined with POTS group
    quote: Zhang et al. reported that POTS children exhibited lower levels of 24 h U-Na than healthy children and
      the U-Na level was negatively correlated with clinical symptom severity. When 24 h U-Na was at 124 mmol, the
      sensitivity and specificity for identifying POTS children were 76.9% and 93%, respectively (9).
    note: 'Found by winnow, kev and lev in p024, p006, p022. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: partial
    section: 'Treatment of Hypovolemic Pots: Salt Supplements, Oral Rehydration and Fludrocortisone'
    quote: Our previous work showed that, compared with the healthy control group, the concentration of 24-h urinary
      sodium was significantly lower in the POTS patients, and the symptom severity of children with POTS inversely
      correlated at a significant level with their 24-h urinary-sodium concentrations. Twenty-four hours sodium
      concentrations of <124 mmol/24 h indicated the effectiveness of salt supplements for treating POTS patients
      (sensitivity 76.9%; specificity 93%) (27).
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: THE INDIVIDUALIZED TREATMENT OF POSTURAL TACHYCARDIA SYNDROME > The oral rehydration salts
    quote: The result showed that compared with the control group, the basal 24-h urinary sodium level was low in
      POTS group (117.09 ± 58.63 mmol/24 h vs. 193.88 ± 91.12 mmol/24 h, P = 0.004). Besides, the symptom severity
      was negatively correlated with basal 24-h urinary sodium excretion.
    note: 'Found by winnow, kev and lev in p009, p015. Claude judged: partial.'
- edge:
  - cardiopulmonary_exercise_test
  - evidence_for
  - deconditioning_evidence
  papers: 2
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Exercise Physiology, Deconditioning, and POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p061, p075. Claude judged: supports.'
  - paper: pmid23729158
    cited: true
    text: full
    license: none
    verdict: supports
    section: Schematic design of the study > Definition of different variables
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23729158. Found by winnow, kev and lev in p009, p026. Claude judged: supports.'
- edge:
  - qsart_sudomotor_testing
  - evidence_for
  - hyperadrenergic_evidence
  papers: 2
  evidence:
  - paper: pmid25180969
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Our QSART findings showing a relative increase in sweat volume in the lower limb support the concept
      that increased sympathetic activity may be a pathophysiological mechanism of POTS.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - qsart_sudomotor_testing
  - evidence_for
  - long_covid
  papers: 2
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Focus on newly diagnosed POTS following COVID-19 infection and vaccination > Post-COVID POTS
      case vignette
    quote: QSART revealed a diffuse pattern of postganglionic, sympathetic-cholinergic sudomotor dysfunction, and
      the patient was therefore diagnosed with neuropathic POTS [42–44].
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid36718227
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Conclusion
    quote: A consistent abnormality was noted in sudomotor/sympathetic cholinergic function in patients with new-onset
      and worsening dysautonomia post-COVID-19 infection.
    note: 'Found by winnow, kev and lev in p030, p034. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - neuropathic_evidence
  papers: 2
  evidence:
  - paper: pmid34674068
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In patients with neuropathic POTS, a continuous increase in the circumference of the lower leg was measured
      during the HUT position, most likely due to the increased pooling of blood as a consequence of the impaired
      vasoconstriction caused by the peripheral sympathetic dysfunction [2, 4, 31].
    note: 'Found by winnow, kev and lev in p021, p003, p022. Claude judged: partial.'
  - paper: pmid8988490
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 8988490. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - neuropathic_evidence
  papers: 2
  evidence:
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p001, p033, p035. Claude judged: supports.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: 'The pathophysiology in this case supports a hypothesis of neuropathic POTS following HSCI. This is suggested
      by: (1) abnormal SSR and reduced HR variability (SDNN < 70 milliseconds) indicating sympathetic dysregulation
      [14], (2) absence of anemia/hypovolemia, (3) normal supine renin/aldosterone levels.'
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
- edge:
  - active_stand_test
  - evidence_for
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Pairwise comparison of the average increase in heart rate relative to basal values between the cohorts
      at each minute of the active standing test showed that in ME/CFS that developed after COVID-19, there is a
      more pronounced increase in heart rate starting from the 6th minute of the test compared to the control group.
      This allowed us to assume that POTS is one of the key characteristics of ME/CFS of post-COVID genesis.
    note: 'Found by winnow, kev and lev in p046. Claude judged: partial.'
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Diskussion
    quote: Am Fallbeispiel 2 können wir zeigen, dass Kinder nach SARS-CoV-Infektion eine chronische Regulationsstörung
      des autonomen Nervensystems mit einem POTS entwickeln können, welches in einem einfachen aktiven Stehtest
      mit kontinuierlicher EKG-Registrierung nachweisbar ist.
    note: 'Found by winnow, kev and lev in p007, p010. Claude judged: partial.'
- edge:
  - end_tidal_co2
  - evidence_for
  - pots
  papers: 2
  evidence:
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Our patient’s 34% reduction in end tidal CO2 is also consistent with POTS (see Figure 2).
    note: 'Found by winnow, kev and lev in p013, p008. Claude judged: supports.'
  - paper: pmid33352894
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Results
    quote: The POTS also showed a lower PETCO2 (24.67 ± 4.11 mmHg), MSBP, and MABP in comparison to the Healthy-Youth
      group at the tilt up position.
    note: 'Found by winnow, kev and lev in p030, p001, p075. Claude judged: partial.'
- edge:
  - genetic_testing
  - evidence_for
  - pots
  papers: 2
  evidence:
  - paper: pmid39964606
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusions and perspective
    quote: With convincing statistical significance, we have illuminated the role of both common and rare genetic
      variants in POTS development.
    note: 'Found by winnow, kev and lev in p008, p018, p047. Claude judged: partial.'
  - paper: pmid16203873
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16203873. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - qsart_sudomotor_testing
  - evidence_for
  - small_fiber_neuropathy_dx
  papers: 2
  evidence:
  - paper: pmid42273028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Testing necessary to characterize neuropathic POTS commonly includes methods to identify small-fiber
      neuropathy, such as nerve fiber density skin biopsy or quantitative sudomotor axon reflex testing (QSART)
      (7–9).
    note: 'Found by winnow, kev and lev in p006, p017. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Skin biopsy and quantitative sudomotor axon reflex testing (QSORT) are preferred methods of assessment
      for autonomic small fiber neuropathy (SFN).
    note: 'Found by winnow, kev and lev in p006, p001, p033. Claude judged: supports.'
- edge:
  - genetic_testing
  - evidence_for
  - autoimmune_evidence
  papers: 1
  evidence:
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Autoimmune etiology is gaining increasing attention. The HLA association revealed in this study further
      emphasizes autoimmunity in the pathogenesis of POTS.
    note: 'Found by winnow, kev and lev in p001, p011, p018. Claude judged: supports.'
- edge:
  - end_tidal_co2
  - evidence_for
  - cerebral_hypoperfusion_evidence
  papers: 1
  evidence:
  - paper: pmid30256820
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'HYCH was defined by: (1) Symptoms of OI; (2) Orthostatic hypocapnia (low ET-CO2); (3) Abnormal decline
      in orthostatic CBFv due to hypocapnia; 4) Absence of tachycardia, orthostatic hypotension, or other causes
      of low CBFv or hypocapnia.'
    note: 'Found by winnow, kev and lev in p001, p025. Claude judged: partial.'
- edge:
  - cardiac_mri
  - evidence_for
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > POTS and “deconditioning”
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p035, p037. Claude judged: partial.'
- edge:
  - plasma_blood_volume_assay
  - evidence_for
  - deconditioning_evidence
  papers: 1
  evidence:
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > POTS and “deconditioning”
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p035. Claude judged: partial.'
- edge:
  - ambulatory_monitoring
  - evidence_for
  - differential_syncope_oh
  papers: 1
  evidence:
  - paper: pmid35372154
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Objectives
    quote: To explore the role of the Poincaré plot derived from a 24-hour Holter recording in distinguishing vasovagal
      syncope (VVS) from postural tachycardia syndrome (POTS) in pediatric patients.
    note: 'Found by winnow, kev and lev in p001, p007, p027. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - differential_syncope_oh
  papers: 1
  evidence:
  - paper: pmid27525257
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Characteristic pattern associated with a particular orthostatic syndrome can be grouped into abnormalities
      predominantly affecting blood pressure (orthostatic hypotension, orthostatic hypertension syndrome, vasomotor
      oscillations, and neurally mediated syncope—cardioinhibitory, vasodepressor, and mixed), cerebral blood flow
      (orthostatic hypoperfusion syndrome, primary cerebral autoregulatory failure), and heart rate (tachycardia
      syndromes: postural tachycardia syndrome, paroxysmal sinus tachycardia, and inappropriate sinus tachycardia).
      Psychogenic pseudosyncope is associated with stable CBFv.'
    note: 'Found by winnow, kev and lev in p045, p001, p035. Claude judged: partial.'
- edge:
  - ambulatory_monitoring
  - evidence_for
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - autonomic_autoantibody_assay
  - evidence_for
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: We also show that POTS following HSCT is associated with a significantly greater increase in NE levels
      upon standing and higher AR autoantibody activity—both of which correlate with changes in HR—supporting a
      central role for adrenergic signaling in post-HSCT POTS.
    note: 'Found by winnow, kev and lev in p025, p040, p004. Claude judged: partial.'
- edge:
  - cardiopulmonary_exercise_test
  - evidence_for
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid40313612
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Conclusion
    quote: These exercise parameters may serve as markers for POTS physiology and sympathetic hyperactivity, both
      of which could play a role in the pathophysiology of SLS.
    note: 'Found by winnow, kev and lev in p004, p027. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p001, p019. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - hypermobility_heds
  papers: 1
  evidence:
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Spectral analysis showed significant higher baroreflex sensitivity values at rest compared to controls.
      Conclusions. This study confirms the abnormal cardiovascular autonomic profile in adults with JHS/EDS-HT and
      found the higher baroreflex sensitivity as a potential disease marker and clue for future research.
    note: 'Found by winnow, kev and lev in p001, p024, p027. Claude judged: partial.'
- edge:
  - active_stand_test
  - evidence_for
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid23538032
    cited: true
    text: full
    license: none
    verdict: partial
    section: METHODS > Supine and Upright Posture Study
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23538032. Found by winnow, kev and lev in p013. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - long_covid
  papers: 1
  evidence:
  - paper: pmid39895557
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: CBF in OI > CBF in Long COVID
    quote: In all these cases, monitoring CBF was the most sensitive and specific biomarker of disease.
    note: 'Found by winnow, kev and lev in p036, p035. Claude judged: supports.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - mast_cell_activation
  papers: 1
  evidence:
  - paper: pmid39165715
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: In the present study, which did not reach statistical significance, serum tryptase levels (both baseline
      and after 45–60 min of the TILT-table test) were higher in patients presenting with symptoms related to MCA
      compared to others.
    note: 'Found by winnow, kev and lev in p022, p026. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - me_cfs
  papers: 1
  evidence:
  - paper: pmid32140630
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: The main finding of this study is that extracranial Doppler imaging demonstrates a significant reduction
      in cerebral blood flow during head-up tilt test in ME/CFS patients compared to healthy controls.
    note: 'Found by winnow, kev and lev in p073, p078, p084. Claude judged: partial.'
- edge:
  - autonomic_autoantibody_assay
  - evidence_for
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In this case the diagnostic work-up of PoTS led to the diagnosis of autoimmune-mediated neuropathic PoTS
      as a crossroad of PoTS, SFN and autoimmunity. The characterisation of autoantibodies against adrenergic and
      muscarinic receptors is nowadays performed in specialized laboratories with the use of life-based bioassays
      on cardiomyocytes confirming the functional role of these autoantibodies [34].
    note: 'Found by winnow, kev and lev in p014, p023. Claude judged: partial.'
- edge:
  - muscle_sympathetic_nerve_activity
  - evidence_for
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid30879357
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30879357. Found by winnow, kev and lev in p001, p033, p034. Claude judged: partial.'
- edge:
  - plasma_catecholamine_assay
  - evidence_for
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid35992935
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: We therefore conclude that in patients with neuropathic POTS, the excessive increase in plasma norepinephrine
      in the upright position occurs mainly in response to the reduced vasoconstrictor function of the sympathetic
      nervous system.
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - quantitative_sensory_testing
  - evidence_for
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Our definition thus has a structural small fiber criterion (intra-epidermal nerve fiber density), a functional
      small fiber criterion (quantitative sensory testing) and a functional autonomic criterion (quantitative sudomotor
      function testing).
    note: 'Found by winnow, kev and lev in p030, p022. Claude judged: partial.'
- edge:
  - head_up_tilt_test
  - evidence_for
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p014, p008. Claude judged: partial.'
- edge:
  - heart_rate_variability
  - evidence_for
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid33935300
    cited: true
    text: full
    license: by
    verdict: partial
    section: Fall 2
    quote: Im Langzeit-EKG zeigten sich keine Herzrhythmusstörung, eine normale mittlere Herzfrequenz mit 80 Schlägen/min,
      aber eine relevante autonome Regulationsstörung mit herabgesetzter globaler HRV (SDNN = 95 ms, Normwert >
      128). Basierend auf unseren Vorarbeiten über autonome Regulationsstörungen bei Kindern [2] und ersten Fallberichten
      aus der internistischen Kardiologie lag es nahe [6], dass diese postinfektiösen Probleme nach der SARS-CoV-2-Infektion
      Ausdruck eines sog. posturalen orthostatischen Tachykardiesyndroms (POTS) sind.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - cardiac_mri
  - evidence_for
  - pots
  papers: 1
  evidence:
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > “The Grinch syndrome” – a new name for POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p026, p035, p037. Claude judged: supports.'
- edge:
  - regional_norepinephrine_spillover
  - evidence_for
  - pots
  papers: 1
  evidence:
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: partial
    section: Sympathetic overactivity may be associated with POTS
    quote: More robust and precise assessment of sympathetic activity by direct measurements of total body and regional
      noradrenaline spillover have been performed in a few investigations and the results have been variable. Evidence
      of sympathoexitation was confirmed in one study (Jordan et al., 2002), but not in others (Jacob et al., 1999;
      Goldstein et al., 2002a; Lambert et al., 2008).
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
- edge:
  - skin_biopsy_ienfd
  - evidence_for
  - pots
  papers: 1
  evidence:
  - paper: pmid25053240
    cited: true
    text: full
    license: none
    verdict: partial
    section: Clinical Summary
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25053240. Found by winnow, kev and lev in p014, p016. Claude judged: partial.'
- edge:
  - quantitative_sensory_testing
  - evidence_for
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid33299671
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33299671. Found by winnow, kev and lev in p004. Claude judged: supports.'
- edge:
  - thermoregulatory_sweat_test
  - evidence_for
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 15
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p022. Claude judged: supports.'
- edge:
  - beta_blocker_therapy
  - indicates
  - hyperadrenergic_evidence
  papers: 28
  evidence:
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment and Outcomes
    quote: Metoprolol was considered a rational choice as the patient's clinical presentation was dominated by sympathetic
      hyperactivity and marked tachycardia with relatively stable blood pressure.
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid40626134
    cited: true
    text: full
    license: by
    verdict: supports
    section: THE CURRENT STATUS OF INDIVIDUALIZED TREATMENT OF POTS IN CHILDREN > β‐Adrenergic receptor blockers
      in treating children with POTS
    quote: β‐Adrenergic receptor blockers can block the effect of excessively increased catecholamine levels in
      some patients to alleviate symptoms. Biomarkers or indices reflecting hyperadrenergic status could guide the
      therapeutic response to β‐adrenoreceptor blockers, such as metoprolol.
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Given our findings suggesting a central role for adrenergic signaling in the development of POTS post-HSCT,
      treatment with a nonselective β-AR blocker such as propranolol may be appropriate.
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid39768649
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: In case of a hyperadrenergic reaction, beta-blockade or ivabradine may be preferable, whether in combination
      with blood volume increasing interventions or not.
    note: 'Found by winnow, kev and lev in p038, p035. Claude judged: supports.'
  - paper: pmid39706392
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39706392. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.5. Treatments for COVID-19-Related POTS Due to Increased Norepinephrine in the Blood
    quote: β-blockers can inhibit β-ARs that react to norepinephrine or epinephrine secreted from sympathetic nerve
      endings. The β-blockers help reduce tachycardia, decrease excess epinephrine, and alleviate orthostatic intolerance
      [52].
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p003, p029. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: For example, for hyperadrenergic POTS, the sympathetic output is blocked via beta-blockers, or sympathetic
      symptoms such as tachycardia may be combated by pharmacotherapies such ivabradine which inhibits I(f) channels.
    note: 'Found by winnow, kev and lev in p021, p005. Claude judged: supports.'
  - paper: pmid38033543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Metoprolol acts as a blocker by antagonizing adrenergic receptor hyperactivation and has been speculated
      to work mainly in children with a hyperadrenergic state. Therefore, biomarkers are needed to identify children
      with a high adrenergic status in clinical practice to individualize the therapeutic regimen and improve the
      efficacy of pediatric POTS management.
    note: 'Found by winnow, kev and lev in p005, p027, p025. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: '4. Individualized Pharmacologic Therapies for Pediatric POTS: Predictors of Therapeutic Efficacy >
      4.3. Predictors for Metoprolol Efficacy in Pediatric POTS'
    quote: For the POTS patients with an overactivated sympathetic activity as the primary pathophysiologic mechanism,
      metoprolol reduces heart-rate stimulation, counters the effects of elevated catecholamine levels, and alleviates
      symptoms by targeting β-adrenergic receptors.
    note: 'Found by winnow, kev and lev in p031, p032. Claude judged: supports.'
  - paper: pmid36781629
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Since metoprolol blocks β-adrenoceptors within cardiovascular tissues to reduce excessive sympathetic
      nerve activity in POTS, it would be only effective for POTS patients with high plasma catecholamine levels
      and sympathetic activity as the main pathogenesis [6].
    note: 'Found by winnow, kev and lev in p006, p034, p035. Claude judged: supports.'
  - paper: pmid36187012
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Metoprolol, one of the most prescribed β-adrenoceptor blockers, targets the adrenergic receptor to lessen
      the symptoms of pediatric patients with POTS with increased sympathetic activity as the main pathogenic mechanism.
    note: 'Found by winnow, kev and lev in p022, p023, p006. Claude judged: supports.'
  - paper: pmid36158335
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this patient, the effectiveness of metoprolol in resolving her symptoms suggests sympathetic dysregulation
      as an underlying etiology of her symptoms.
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.4. Physiological Predictors
      for the Efficacy of Metoprolol in Pediatric POTS
    quote: Beta-adrenoceptor blockers are often applied in the management of pediatric POTS patients. They inhibit
      sympathetic nervous system activity and reduce stimulation of the heart rate and cardiac baroreceptors, thereby
      blocking the effects of increased blood catecholamine levels.
    note: 'Found by winnow, kev and lev in p010, p038, p040. Claude judged: supports.'
  - paper: pmid35127870
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Metoprolol, as a β-adrenergic receptor blocker, is only effective for POTS children with overexcitement
      of sympathetic nerve function or high catecholamine status by acting on β1 receptor (30). The patients of
      POTS with other mechanisms as mentioned above might be the non-responders to the treatment of metoprolol.
    note: 'Found by winnow, kev and lev in p005, p035, p032. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: If the burst of sympathetic activity is excessive, there will be a hyperadrenergic response with orthostatic
      tachycardia. This is the rationale for the use of low-dose beta-blockers in POTS.
    note: 'Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Management Strategies for Pots in Children and Adolescents > Pharmacological Treatment
    quote: β1-Selective blockers are useful for “hyperadrenergic” subtypes of POTS patients (96).
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Hyperadrenergic Pots: β-Blockers'
    quote: In the treatment of this type of POTS, β-blockers for blocking β-adrenoceptors are preferred, which could
      prevent the effect of having excessive catecholamines in the plasma.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Treatment
    quote: In the less common presentation of POTS with “hyperadrenergic response” in the upright position, improper
      baroreceptor function results in sustained high sympathetic tone that may be due to increased production or
      decreased clearance of norepinephrine. As such, alpha-agonist therapy (eg, midodrine) may be less desirable
      and, instead, nonselective β-blocker (propranolol23) or ivabradine24 (approved by the United States Food and
      Drug Administration for chronic heart failure treatment only) may be helpful.
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid31412221
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31412221. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid25811760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is used to treat POTS by blocking β-adrenoceptor, and as a result, blocking high levels of catecholamines
      in circulation, and lowering the heart rate [3].
    note: 'Found by winnow, kev and lev in p002, p018, p003. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment approaches: Addressing neurohormonal imbalances (Table 1) > Hyperadrenergic state—heart
      rate control'
    quote: Attempts to manage the hyperadrenergic state in these individuals center around HR control. The use of
      beta-blockade to decrease HR has been met with conflicting data.
    note: 'Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Beta-blockers
    quote: Beta blockers have been reported to be a useful treatment for POTS patients with beta-receptor super-sensitivity,
      high noradrenaline levels and/or hyper-adrenergic states.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038, p035. Claude judged: supports.'
  - paper: pmid42132710
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Prior studies and beneficial usage of ivabradine and beta-blockers in POTS
    quote: Beta-blockers, specifically propranolol, have been shown, in low doses, to improve orthostatic tachycardia
      and reduce norepinephrine levels in these patients.6
    note: 'Found by winnow, kev and lev in p052. Claude judged: partial.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Hyperadrenergic forms of POTS may respond to agents such as labetalol and clonidine due to their sympatholytic
      activity.8 Low-dose propranolol has also demonstrated efficacy in reducing tachycardia and achieving symptomatic
      control in POTS.9
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Treatment of POTS (Table 2) > Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p039. Claude judged: partial.'
  - paper: pmid25204388
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: Differences in noradrenergic activity between hyperadrenergic and other types of POTS may explain this
      inconsistency, and previous studies of efficacy of β-blockers in POTS subjects did not stratify participants
      into POTS subtypes according to their underlying causes. Hyperadrenergic subgroup with β-blockers would seem
      reasonable.
    note: 'Found by winnow, kev and lev in p003, p017, p005. Claude judged: partial.'
- edge:
  - volume_expansion_therapy
  - indicates
  - hypovolemic_evidence
  papers: 23
  evidence:
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: When hypovolemia is suspected, fludrocortisone, a synthetic mineralocorticoid, is commonly used to expand
      plasma volume and promote sodium retention, though potential side effects include acne, headache, hypokalemia,
      and fluid retention.
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion > 4.5 Rationality of current treatment approaches
    quote: Clinicians are advised to consider increasing salt intake or using water retention agents as a treatment
      strategy to improve hypovolemia and thereby alleviate POTS symptoms [12].
    note: 'Found by winnow, kev and lev in p060. Claude judged: supports.'
  - paper: pmid38328599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Summary figure
    quote: Patients with hypovolemic POTS may increase circulating blood volume through exercise, hydration, salt
      loading, and compression stockings. These patients are often prescribed fludrocortisone and desmopressin in
      an effort to retain water and salt and to limit potential fluctuations in circulating blood volume.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: For hypovolemic POTS, interventions are aimed at increasing plasma volume, including but not limited
      to high fluid and salt intake, exercise, and fludrocortisone3.
    note: 'Found by winnow, kev and lev in p021, p005. Claude judged: supports.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Blood Volume Abnormalities and Treatments in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Case summary > Management
    quote: Fludrocortisone is recommended for those with hypovolemia to increase sodium retention and expand the
      volume, but this effect might only last a few days.1
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Pharmacologic management > Fludrocortisone and desmopressin
    quote: For hypovolemic POTS, fludrocortisone and desmopressin may help with symptom control. Fludrocortisone
      is a mineralocorticoid with glucocorticoid activity that works by increasing salt and water retention, which
      subsequently increases the intravascular volume, preventing compensatory tachycardia.17
    note: 'Found by winnow, kev and lev in p013, p015. Claude judged: supports.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Sodium Loading in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p046, p001, p010. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Management Strategies for Pots in Children and Adolescents > Pharmacological Treatment
    quote: Pediatric patients with POTS who are strongly suspected of having hypovolemia or inadequate salt intake
      are recommended to use oral rehydration salts (ORSs) for 1–3 months (5, 23, 98, 104) or to accept short-term
      intravenous saline as rescue treatment for patients with clinical decompensation and significant deterioration
      of symptoms (25). Saline supplements can alleviate symptoms in “hypovolemic” patients.
    note: 'Found by winnow, kev and lev in p024, p008, p023. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p022, p023. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Volume Expansion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p015, p019. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Sodium chloride 0.9% (Normal saline)
    quote: This appears to be a good, low-cost treatment option with few side effects for POTS patients who suffer
      hypovolemia caused by sympathetic neuropathy, which leads to venous pooling during upright posture, or other
      idiopathic causes.[28]
    note: 'Found by winnow, kev and lev in p018, p020. Claude judged: supports.'
  - paper: pmid22561596
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22561596. Found by winnow, kev and lev in p001, p007, p029. Claude judged: supports.'
  - paper: pmid20668563
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Tachycardia associated with POTS has been shown to respond acutely to the bolus administration of isotonic
      fluids to correct the underlying hypovolemia.[18]
    note: 'Found by winnow, kev and lev in p013, p009. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: In patients in whom the presence of hypovolemia is either known or strongly suspected, fludrocortisone
      (an aldosterone analogue) is often used. Through enhanced sodium retention, it should expand the plasma volume,
      although there is a paucity of data regarding the exact mechanisms of action.
    note: 'Found by winnow, kev and lev in p039. Claude judged: supports.'
  - paper: pmid9244228
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 9244228. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.2. Physiological Predictors
      for the Oral Rehydration Salts Efficacy in Pediatric POTS
    quote: Hypovolemia is one of the pathogeneses of POTS. Although the underlying pathophysiology of POTS is uncertain
      and much effort has been made to treat cases, increasing the blood volume by elevating salt and fluid consumption
      has been confirmed to benefit children and adolescents with POTS.
    note: 'Found by winnow, kev and lev in p016, p018. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment > Nonpharmacologic interventions
    quote: Patients with hypovolemia should increase their daily fluid and salt intake to increase the fluid volume
      within the intravascular space and assist in preventing dehydration.
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid33689063
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33689063. Found by winnow, kev and lev in p001, p007. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Fluid intake up to 2.5 liters daily, which is equivalent to 10 standard cups a day and a total of 10
      grams of sodium chloride daily, noting that one salt tablet contains one gram of sodium chloride, helps expand
      the plasma volume and improve venous return and the re-loading of the right atrium.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: partial
    section: Ms. Lei, Ms. Sheikh, and Dr. Raj consider
    quote: Lasting improvements in POTS symptoms rely on therapy regimens founded upon lifestyle changes that begin
      with the maintenance of high fluid and dietary salt intake, with the primary goal of augmenting plasma volume.
      A high-sodium diet has been shown to expand both total blood volume and plasma volume, concurrently reducing
      orthostatic tachycardia and upright plasma norepinephrine.10
    note: 'Found by winnow, kev and lev in p035, p010. Claude judged: partial.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: partial
    section: 3. VOLUME EXPANSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p014, p001. Claude judged: partial.'
  - paper: pmid28185102
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28185102. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - indicates
  - autoimmune_evidence
  papers: 13
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The autoimmune etiology and association of these conditions with systemic autoimmune and inflammatory
      disorders, autonomic neuropathy, and post-acute infectious syndromes, including Long COVID, suggest that immunotherapies
      should be considered as a therapeutic option, at least in a subset of patients.
    note: 'Found by winnow, kev and lev in p001, p022, p025. Claude judged: supports.'
  - paper: pmid38311655
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Objective
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38311655. Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case Presentation
    quote: In view of his multiple autoimmune diseases (PANS, thyroiditis, celiac disease) and markers of active
      autoimmunity (lymphopenia, thrombocytopenia, anti-platelet antibodies, anti-histone antibodies, anti-thyroid
      antibodies, and complement consumption/activation), we initiated immunomodulation with rituximab, nine weekly
      intravenous methylprednisolone infusions, methotrexate, and hydroxychloroquine.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: These findings suggest that autoimmune-mediated neuropathic PoTS can be treated sufficiently with IVIg
      whereas SCIg minimizes side-effects.
    note: 'Found by winnow, kev and lev in p010, p004, p005. Claude judged: supports.'
  - paper: pmid34117922
    cited: true
    text: full
    license: by
    verdict: supports
    section: Immunomodulatory treatment in postural tachycardia syndrome
    quote: However, there is increasing interest in the potential for immunotherapy in POTS, as a result of the
      accumulation of evidence for autoimmunity as a causal factor in a subset of patients. The aim of this case-series
      was to evaluate the use of intravenous immunoglobulin therapy (IVIG) in six patients with refractory POTS
      disease with serological evidence for autoimmunity.
    note: 'Found by winnow, kev and lev in p014, p015, p002. Claude judged: supports.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion > Immunomodulatory Treatments in Patients With POTS
    quote: The present results support the hypothesis that POTS is an autoimmune disease, which, in turn, may suggest
      that some patients with POTS could benefit from immunomodulatory therapies.
    note: 'Found by winnow, kev and lev in p037, p036. Claude judged: supports.'
  - paper: pmid29781817
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Study Design
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29781817. Found by winnow, kev and lev in p003, p006. Claude judged: supports.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment
    quote: Finally, immunotherapy is emerging as potentially effective in severe, treatment-refractory patients
      with POTS, post-COVID dysautonomia and other forms of dysautonomia and is considered standard therapy for
      autonomic disorders such as autoimmune autonomic ganglionopathy (AAG) and autoimmune autonomic neuropathies
      (AAN) in general [36–38].
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.6. Treatment
    quote: The question arose whether the available knowledge pertaining to the autoimmunity in orthostatic intolerance
      patients would predict a role for immune modulation therapeutics in patients with refractory orthostatic intolerance
      and evidence of existing AAbs. Several case reports and case series demonstrate that immune modulation agents
      have a possible role in the treatment of orthostatic intolerance in patients who have symptoms refractory
      to the commonly used pharmacological and non-pharmacological treatments.
    note: 'Found by winnow, kev and lev in p033, p038. Claude judged: partial.'
  - paper: pmid36008726
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36008726. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Because the autoimmune nature of POTS is suspected to be related to adrenergic autoantibodies, it is
      possible that upstream inhibition of TNF-alpha alters the levels and activity of these antibodies, attenuating
      the inflammatory response that induces symptoms. Although the exact mechanism behind the treatment’s efficaciousness
      must be further studied, we present one of the first recorded alleviations of POTS using immunomodulatory
      therapy.
    note: 'Found by winnow, kev and lev in p007, p009. Claude judged: partial.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: While lacking in vivo animal model confirmation, the strong association found in the HLA‐DQ locus, along
      with the functionality of the autoantibodies demonstrated experimentally,2, 3 supports the hypothesis that
      autoimmune POTS is antibody‐mediated. Immunotherapeutic agents, including IVIg, may be considered for the
      treatment of prominent POTS in this regard.
    note: 'Found by winnow, kev and lev in p015, p014. Claude judged: partial.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Conclusion
    quote: This concept, if validated, would provide concrete support for novel therapeutic approaches against POTS
      based on immunotherapy. These could currently include suppression of autoantibody production using immunoglobulin
      infusions and in the foreseeable future by development of decoy peptides that are specific for autoantibodies
      that target the identified receptor epitopes.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
- edge:
  - exercise_reconditioning
  - indicates
  - deconditioning_evidence
  papers: 11
  evidence:
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: '2. POTS and Exercise: What Is Known'
    quote: Both programs follow a traditional graded cardiovascular exercise approach with the assumption that cardiovascular
      deconditioning is involved in POTS [21].
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p001, p003, p005. Claude judged: supports.'
  - paper: pmid25487551
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25487551. Found by winnow, kev and lev in p003, p008. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: Recovery > Management of POTS and Associated Conditions > “Get Moving”—Exercise and Activity in the
      Management of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p097. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p033, p041. Claude judged: supports.'
  - paper: pmid39678714
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Results
    quote: According to the study, it was found that POTS may be a result of deconditioning, and that a carefully
      prescribed exercise training program can be an effective non-drug therapy option for patients with POTS.
    note: 'Found by winnow, kev and lev in p034, p041. Claude judged: partial.'
  - paper: pmid37598401
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In line with previous work, the individuals with POTS recruited in this study were primarily deconditioned
      and over half were severely deconditioned. Although symptoms for individuals with POTS are caused by a variety
      of factors, results of this study highlight that an exercise intervention can improve deconditioning with
      an observed increase in peak VO2 of 3.4 mL/min/kg on average, which was almost 12% predicted and meant a shift
      from being severely deconditioned to moderately deconditioned for the ET group.
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Many of our patients with POTS are bed rested and cardiovascular deconditioned. Our findings are, therefore,
      highly consistent with studies53,54 indicating that exercise reconditioning may be the ideal treatment for
      POTS because it increases parasympathetic and decreases sympathetic cardiac activity.
    note: 'Found by winnow, kev and lev in p057. Claude judged: partial.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Accordingly, it seems reasonable that exercise-based rehabilitation may be effective in the medium- and
      long-term treatment of POTS and related conditions with deconditioning [30].
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid21690484
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21690484. Found by winnow, kev and lev in p032, p024. Claude judged: partial.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: partial
    section: Management > Deconditioned POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p030. Claude judged: partial.'
- edge:
  - central_sympatholytic_therapy
  - indicates
  - hyperadrenergic_evidence
  papers: 10
  evidence:
  - paper: pmid42696970
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42696970. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Furthermore, patients identified using the DBPVM2l_rise clinical biomarker reported clinical improvements
      after treatment with the central sympatholytic guanfacine, consistent with the hypothesis that this is a central
      hyperadrenergic POTS phenotype.
    note: 'Found by winnow, kev and lev in p035, p041. Claude judged: supports.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Hyperadrenergic POTS is one of the major subtypes that could benefit from sympatholytics, if correctly
      identified.
    note: 'Found by winnow, kev and lev in p042, p005. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p004, p005, p028. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Pharmacologic Treatment > Postural Orthostatic Tachycardia Syndrome49,50,170'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p166. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p039, p015. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Vanderbilt Approach to
      Pharmacotherapy for POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: Central sympatholytic medications are often useful and well tolerated in patients with the central hyperadrenergic
      form of POTS, but may not be as well tolerated in neuropathic POTS.
    note: 'Found by winnow, kev and lev in p029, p034, p040. Claude judged: supports.'
- edge:
  - lifestyle_modification
  - indicates
  - hypovolemic_evidence
  papers: 6
  evidence:
  - paper: pmid41301791
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Neurologic Evaluation > 4.5. Treatment
    quote: Elevating the head of the bed to 70 degrees may decrease nocturia and help with morning dizziness and
      presyncope by reducing the release of atrial natriuretic peptide, thereby reducing hypovolemia.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid37393658
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > Blood Volume Abnormalities and Treatments in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37393658. Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid33689063
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33689063. Found by winnow, kev and lev in p007, p001. Claude judged: partial.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: partial
    section: Management Strategies for Pots in Children and Adolescents > Non-pharmacological Interventions
    quote: Low-flow POTS patients usually suffer from the combination of hypovolemia and muscle pump dysfunction
      (50), which makes it necessary to drink plenty of water and wear compression garments, which can reduce the
      venous pooling caused by insufficient peripheral venous reflux and increase peripheral blood return to the
      heart (98).
    note: 'Found by winnow, kev and lev in p021, p023. Claude judged: partial.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: partial
    section: Ms. Lei, Ms. Sheikh, and Dr. Raj consider
    quote: Lasting improvements in POTS symptoms rely on therapy regimens founded upon lifestyle changes that begin
      with the maintenance of high fluid and dietary salt intake, with the primary goal of augmenting plasma volume.
    note: 'Found by winnow, kev and lev in p035, p010. Claude judged: partial.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Treatment > Diet
    quote: Increasing electrolyte and water intake was shown to decrease tachycardia in POTS patients with idiopathic
      forms of the disease, as a result of increased blood pressure through increasing blood volume.[24] This is
      also thought to be helpful in POTS patients with pooling blood and/or hypovolemia.[8]
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
- edge:
  - midodrine_therapy
  - indicates
  - neuropathic_evidence
  papers: 6
  evidence:
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Lastly, midodrine, an α1-agonist vasoconstrictor, may be particularly useful in neuropathic POTS, where
      impaired vascular tone leads to excessive venous pooling [7].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In neuropathic POTS, the loss of peripheral vascular resistance due to the sympathetic denervation, especially
      in the lower limbs, can be addressed with the use of vasoconstrictors like midodrine [13,24].
    note: 'Found by winnow, kev and lev in p093, p095. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: '4. Individualized Pharmacologic Therapies for Pediatric POTS: Predictors of Therapeutic Efficacy >
      4.2. Predictors for Midodrine Efficacy in Pediatric POTS > 4.2.6. Subtypes of POTS'
    quote: Midodrine hydrochloride is expected to have a greater effect on improving the hemodynamic abnormalities
      in neuropathic POTS by promoting vasoconstriction, reducing venous capacitance, and thereby decreasing orthostatic
      tachycardia. However, its effects on hemodynamic improvement in hyperadrenergic POTS are limited due to the
      different pathophysiology compared with that of neuropathic POTS.
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Neuropathic Pots: Midodrine and Pyridostigmine'
    quote: In neuropathic POTS, impaired peripheral vasoconstriction caused by adrenergic denervation can lead to
      peripheral venous pooling (64). Midodrine, an alpha1-adrenergic agonist, can effectively constrict peripheral
      vessels, and increase venous return.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid23978222
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Effects of midodrine on postural tachycardia
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23978222. Found by winnow, kev and lev in p001, p024, p028. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Vasoconstrictor Therapy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p017. Claude judged: supports.'
- edge:
  - antihistamine_therapy
  - indicates
  - mast_cell_activation
  papers: 4
  evidence:
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: For example, pacing is recommended care to manage energy levels and avoid PEM in ME/CFS; fluid/electrolytes,
      compression stockings and Mestinon to help manage OI; beta-blockers and ivabradine to aid tachycardia present
      in POTS; IgG for use in immune dysfunction; antihistamines (H1 and/or H2 inhibitors) and other select treatments
      to manage MCAS; low-dose naltrexone to manage pain; and melatonin to mitigate sleep problems.
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: CASE PRESENTATION
    quote: The patient was referred for further evaluation to the Autonomic Nervous System Laboratory at the Instituto
      Nacional de Ciencias Médicas y Nutrición, where MCAS was suspected based on a medical history of rash in accordance
      with orthostatic intolerance symptoms. A trial with a histamine blocker (Loratadine 10 mg/12 h) was initiated,
      achieving remission of symptoms after a few weeks.
    note: 'Found by winnow, kev and lev in p024, p014. Claude judged: supports.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: supports
    section: 7. Mast-Cell-Directed Treatment
    quote: Our case series suggests that when MCAS is suspected and then diagnosed, MC-directed therapy can be effective
      in improving neuropsychiatric manifestations. Treatment with antihistamines, MC-stabilizing agents, and other
      pharmacologic modalities such as LDN, along with non-pharmacologic approaches including avoiding symptomatic
      triggers and adopting low-histamine and gluten/dairy-free diets, can be effective, are inexpensive, and have
      a low side effect profile compared to standard antidepressant and antianxiety therapies.
    note: 'Found by winnow, kev and lev in p012, p007, p025. Claude judged: supports.'
  - paper: pmid34398691
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion > Laboratory Recognition of MCA and Its Limitations
    quote: "Specifically, patients with MCA may benefit from histamine receptor (H1 and H2) blockers used in conjunction\
      \ with mast cell stabilizer agents and possibly vitamin D.\n5\n, \n6\n, \n7\n, \n8\n These agents are not\
      \ usually part of a typical POTS treatment regimen."
    note: 'Found by winnow, kev and lev in p006, p027. Claude judged: supports.'
- edge:
  - exercise_reconditioning
  - indicates
  - long_covid
  papers: 3
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 7. Treatment
    quote: In the case of POTS related to SARS-CoV-2 infection, published cases have supported the recommendation
      of various non-pharmacological interventions, such as increased salt and fluid intake (unless contraindicated),
      waist-high compression garments, and regular and graduate-supervised exercises (84, 85). The utility of an
      exercise program in a recumbent or semi-recumbent position (rowing or cycling) for 8 weeks, followed by a
      subsequent 4-week jogging phase, has been demonstrated (86).
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Management > 4.2. Exercise
    quote: This exercise method may be particularly favorable for patients with COVID-19-related POTS [65]. Exercises
      for COVID-19-related POTS management should include both aerobic and anaerobic movements, such as thigh resistance
      training and muscular strength training [59].
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid39198662
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The main findings of this study were that individually tailored exercise was safe and feasible for patients
      with PCC-POTS.
    note: 'Found by winnow, kev and lev in p026, p001. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - indicates
  - long_covid
  papers: 3
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The autoimmune etiology and association of these conditions with systemic autoimmune and inflammatory
      disorders, autonomic neuropathy, and post-acute infectious syndromes, including Long COVID, suggest that immunotherapies
      should be considered as a therapeutic option, at least in a subset of patients.
    note: 'Found by winnow, kev and lev in p038, p040, p001. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: The most directly relevant evidence to the cognitive dimension of this research question in the source
      set reviewed here is provided by the first published case of plasma exchange producing documented improvement
      in cognitive function in a patient with long-COVID-related POTS and autoimmune neurological dysfunction (Seeley
      MC et al., 2023), establishing proof of concept for the cognitive-immunotherapy link even within the evidentiary
      constraints of a case report.
    note: 'Found by winnow, kev and lev in p057. Claude judged: partial.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Thus, IVIG could show potential as a possible therapeutic strategy for refractory post-viral PTS, particularly
      following COVID-19 infection.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
- edge:
  - prokinetic_therapy
  - indicates
  - gi_dysmotility
  papers: 2
  evidence:
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Abstract
    quote: To our knowledge, no prior case series has described metoclopramide as a targeted prokinetic bridge therapy
      specifically in adolescents with dysautonomia-associated GI dysmotility symptoms.
    note: 'Found by winnow, kev and lev in p003, p007, p011. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: Recovery > Management of POTS and Associated Conditions > Medications for Gastrointestinal Function
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p094, p095. Claude judged: partial.'
- edge:
  - ivabradine_therapy
  - indicates
  - hyperadrenergic_evidence
  papers: 2
  evidence:
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: For example, for hyperadrenergic POTS, the sympathetic output is blocked via beta-blockers, or sympathetic
      symptoms such as tachycardia may be combated by pharmacotherapies such ivabradine which inhibits I(f) channels.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Accordingly, inhibition of the tachycardia response with ivabradine may disrupt this feedback loop and
      blunt symptoms of sympathetic activation. Ivabradine may also reduce NE spillover by lowering sinoatrial node
      pacemaker activity, thereby decreasing sympathetic tone without the negative inotropic effects associated
      with beta blockers.43
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
- edge:
  - exercise_reconditioning
  - indicates
  - hypovolemic_evidence
  papers: 2
  evidence:
  - paper: pmid31412221
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31412221. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p033, p041, p005. Claude judged: supports.'
- edge:
  - ivabradine_therapy
  - indicates
  - long_covid
  papers: 2
  evidence:
  - paper: pmid37469536
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37469536. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Management of post–COVID-19 POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p026. Claude judged: supports.'
- edge:
  - immunomodulatory_therapy
  - indicates
  - mast_cell_activation
  papers: 2
  evidence:
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Mast-Cell-Directed Treatment
    quote: For severe cases of MCAS, immune modulators can be helpful. These medications include hydroxyurea and
      various tyrosine kinase inhibitors (TKI).
    note: 'Found by winnow, kev and lev in p027. Claude judged: partial.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: This is the first case to our knowledge where immunotherapy with IVIg led to significant and sustained
      improvement in MCAS as has been seen in publications of autoimmune neuromuscular diseases and a single case
      of POTS.9 10 Other patients with MCAS have had response in their MC symptoms to IVIg.2
    note: 'Found by winnow, kev and lev in p001, p011, p014. Claude judged: partial.'
- edge:
  - serotonergic_therapy
  - indicates
  - anxiety_depression
  papers: 1
  evidence:
  - paper: pmid40454385
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case presentation > Tertiary hospitalization
    quote: The diagnosis of anxiety disorder was made based on the criteria outlined in the DSM-5, following a comprehensive
      clinical assessment and standardized diagnostic interviews. Based on the established efficacy of paroxetine
      in treating anxiety disorders with autonomic dysfunction, paroxetine hydrochloride tablets (20 mg/day, orally)
      were administered as anxiolytic treatment.
    note: 'Found by winnow, kev and lev in p008, p012, p003. Claude judged: supports.'
- edge:
  - exercise_reconditioning
  - indicates
  - arrhythmia_differential
  papers: 1
  evidence:
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Management: Exercise and Rehabilitation > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p146, p147. Claude judged: partial.'
- edge:
  - pyridostigmine_therapy
  - indicates
  - autoimmune_evidence
  papers: 1
  evidence:
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Neuropathic Pots: Midodrine and Pyridostigmine'
    quote: We propose that if a child with POTS is seropositive for AChR-ab, pyridostigmine should be used appropriately.
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
- edge:
  - exercise_reconditioning
  - indicates
  - cerebral_hypoperfusion_evidence
  papers: 1
  evidence:
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: What to Do in Clinic
    quote: Encouraging exercise makes sense, as through improving fitness and lower extremity muscle tone, the “skeletal
      muscle pump” is improved, which augments venous return to the heart and thus adequate cerebral perfusion.15,28
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
- edge:
  - beta_blocker_therapy
  - indicates
  - chronic_migraine
  papers: 1
  evidence:
  - paper: pmid33174112
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Implications for Diagnosis and Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33174112. Found by winnow, kev and lev in p030. Claude judged: supports.'
- edge:
  - lifestyle_modification
  - indicates
  - gi_dysmotility
  papers: 1
  evidence:
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentations > 2.1. Case 1—13-Year-Old Female with Dysautonomia and Chronic Nausea
    quote: Concurrent interventions included amitriptyline 10 mg nightly (continued from prior), magnesium glycinate
      240 mg daily, Iberogast, ginger capsules 500 mg twice daily, dietary modifications (small frequent low-fat
      meals, improved breakfast intake), hydration and salt expansion, and compression garment use.
    note: 'Found by winnow, kev and lev in p011, p015, p022. Claude judged: partial.'
- edge:
  - compression_therapy
  - indicates
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid38260095
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4 Discussion
    quote: Considering our results of multiple regression analysis, abdominal and lower-extremity compression may
      be a beneficial treatment for individuals with hyperadrenergic POTS. Further studies are needed to examine
      whether abdominal and lower-extremity compression can reduce these individuals’ excessive central sympathetic
      activity and orthostatic tachycardia.
    note: 'Found by winnow, kev and lev in p032. Claude judged: partial.'
- edge:
  - compression_therapy
  - indicates
  - hypermobility_heds
  papers: 1
  evidence:
  - paper: pmid36694653
    cited: true
    text: full
    license: by
    verdict: partial
    section: DISCUSSION
    quote: The use of DEFO garments could be considered as an intervention to allow improved function in people
      with hEDS and PoTs. A garment that encompasses the abdomen and lower body, and exerts a compressive force,
      has previously been shown to reduce heart rate and improve PoTS symptoms in adult patients.
    note: 'Found by winnow, kev and lev in p015, p013. Claude judged: partial.'
- edge:
  - compression_therapy
  - indicates
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid38328599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Summary figure
    quote: Patients with hypovolemic POTS may increase circulating blood volume through exercise, hydration, salt
      loading, and compression stockings.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
- edge:
  - auricular_vagus_nerve_stimulation
  - indicates
  - long_covid
  papers: 1
  evidence:
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > LL‐TS and POTS
    quote: Therefore, that LL‐TS is a noninvasive neuromodulation in autonomic balance for individuals with POTS
      following post‐acute COVID‐19 infection.
    note: 'Found by winnow, kev and lev in p025, p003, p007. Claude judged: supports.'
- edge:
  - compression_therapy
  - indicates
  - long_covid
  papers: 1
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 7. Treatment
    quote: In the case of POTS related to SARS-CoV-2 infection, published cases have supported the recommendation
      of various non-pharmacological interventions, such as increased salt and fluid intake (unless contraindicated),
      waist-high compression garments, and regular and graduate-supervised exercises (84, 85).
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
- edge:
  - lifestyle_modification
  - indicates
  - long_covid
  papers: 1
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Treatment
    quote: It is advisable to avoid situations that can exacerbate symptoms, which has also been shown to be beneficial
      in POTS after SARS-CoV-2 infection (Table 1) (17, 87, 88).
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - compression_therapy
  - indicates
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid31412221
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31412221. Found by winnow, kev and lev in p001. Claude judged: supports.'
- edge:
  - exercise_reconditioning
  - indicates
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid34674068
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: 'These findings taken together support regular exercise as a treatment modality in neuropathic POTS [34]
      and at least partially explain its beneficial effect: Training increases hyperpolarization in the long term
      and reduces muscle membrane depolarization.'
    note: 'Found by winnow, kev and lev in p022. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - indicates
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case description and results
    quote: 18 months after the onset of symptoms, an autoimmune mediated, neuropathic POTS refractory to symptomatic
      treatment was diagnosed. A dose of 2 g/kg body weight IVIg over 5 days was administered 33 months after the
      first manifestation of symptoms.
    note: 'Found by winnow, kev and lev in p005, p010, p017. Claude judged: partial.'
- edge:
  - lifestyle_modification
  - indicates
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Treatment
    quote: It is advisable to avoid situations that can exacerbate symptoms, which has also been shown to be beneficial
      in POTS after SARS-CoV-2 infection (Table 1) (17, 87, 88).
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - exercise_reconditioning
  - indicates
  - secondary_sinus_tachycardia
  papers: 1
  evidence:
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Management: Exercise and Rehabilitation > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p147, p146. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - indicates
  - systemic_autoimmune_disease
  papers: 1
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Immunotherapies > Potential immunologic therapies for POTS, other common autonomic disorders, and Long
      COVID
    quote: These therapies may be used either as a last resort in patients who failed standard non-pharmacologic
      and pharmacologic therapies or as a first-line treatment in patients with POTS and OCADs of suspected autoimmune
      or inflammatory etiologies, or comorbid SFN, UCTD, and other systemic autoimmune disorders.
    note: 'Found by winnow, kev and lev in p029, p038. Claude judged: supports.'
- edge:
  - beta_blocker_therapy
  - treats
  - pots
  papers: 88
  evidence:
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Additional support for autoimmune or inflammatory subgroups of POTS comes from the fact that some patients
      experience persistent cognitive symptoms despite treatment. Common treatment options that may alter heart
      rate or blood pressure without eliminating autoantibodies, lessening brain inflammation, or unblocking small
      vessels include beta-blockers, ivabradine, and midodrine.
    note: 'Found by winnow, kev and lev in p019, p056. Claude judged: supports.'
  - paper: pmid42591853
    cited: true
    text: full
    license: by
    verdict: supports
    section: ME/CFS as a low output syndrome due to small heart > Is POTS a cause of OI?
    quote: Low-dose oral propranolol (20 mg) significantly attenuated tachycardia and improved symptoms in POTS
      (64).
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Beta-blockers may be used to reduce sinus tachycardia and palpitations in POTS. One study observed that
      low-dose oral propranolol attenuated tachycardia in POTS and elicited a better response than high-dose oral
      propranolol, which did not improve or may have worsened symptoms [5].
    note: 'Found by winnow, kev and lev in p091, p100. Claude judged: supports.'
  - paper: pmid42132710
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: Propranolol is a nonselective beta-blocker that has been shown to mitigate tachycardia and symptoms in
      patients with POTS, but may have off-target side effects due to the broad distribution of beta-adrenergic
      receptors throughout the body.6, 7, 8
    note: 'Found by winnow, kev and lev in p005, p007, p052. Claude judged: supports.'
  - paper: pmid41827215
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Beta-blockers (e.g., metoprolol) are commonly used in the treatment of pediatric POTS, as they can reduce
      sympathetic nerve activity and/or lower plasma catecholamine levels [8,9].
    note: 'Found by winnow, kev and lev in p001, p011, p002. Claude judged: supports.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: 'Therapeutic interventions for post‐SCI POTS remain limited in the literature. Based on this case and
      prior reports [5], syncope can be cured by multiple management, including: aggressive infection control, increased
      fluid intake, abdominal binder and compression stocking application during mobilization, slow transfer protocols
      with gradated torso elevation, low‐dose metoprolol (12.5 mg twice daily), and systematic rehabilitation.'
    note: 'Found by winnow, kev and lev in p019, p028, p026. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Beta-adrenergic antagonists like bisoprolol and low-dose propranolol control the tachycardia and often
      provide symptomatic relief in POTS [22].
    note: 'Found by winnow, kev and lev in p092, p095. Claude judged: supports.'
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p009, p032, p039. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Pharmacological interventions > β-Adrenergic blocking agents
    quote: In 49 children, the application of metoprolol (0.5 mg/kg body weight, two times per day) significantly
      attenuated HR increment from the supine to the standing position after 1.5–3 months (p < 0.001) and led to
      an improvement in symptoms [33].
    note: 'Found by winnow, kev and lev in p032, p034, p035. Claude judged: supports.'
  - paper: pmid40681233
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Central sympatholytic agents such as methyldopa or clonidine may also be used, and if these are not tolerated,
      peripheral β-adrenergic therapies are considered.4 Specifically, β-adrenergic blockers are commonly used in
      cardiology clinics to control tachycardia.4
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Treatments Impact Core Disease Symptoms Differently.
    quote: As expected, compression stockings and Mestinon most frequently improved symptoms of POTS (63.7% and
      56.9%, respectively), while beta blockers and ivabradine primarily alleviated POTS symptoms (66.0%).
    note: 'Found by winnow, kev and lev in p018, p033. Claude judged: supports.'
  - paper: pmid40626134
    cited: true
    text: full
    license: by
    verdict: supports
    section: THE CURRENT STATUS OF INDIVIDUALIZED TREATMENT OF POTS IN CHILDREN > β‐Adrenergic receptor blockers
      in treating children with POTS
    quote: Tachycardia associated with the orthostatic position is a clinical feature of POTS. β‐Adrenergic receptor
      blockers can block the effect of excessively increased catecholamine levels in some patients to alleviate
      symptoms.
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion > 4.5 Rationality of current treatment approaches
    quote: 'ANS modulation therapy: Given the role of abnormal ANS function in POTS, medications such as β-blockers
      (e.g., metoprolol) may be considered to control excessive heart rate increases [20,66,67].'
    note: 'Found by winnow, kev and lev in p062. Claude judged: supports.'
  - paper: pmid40520610
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: In 8 of these 39 cases, this included using a beta blocker, which can be effective for both PoTS and
      migraine.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid40437589
    cited: true
    text: full
    license: by
    verdict: supports
    section: Materials and methods > Treatment and follow-up
    quote: In addition, patients with VVS responses took oral rehydration salts (ORS, 250 mL, twice a day), and
      patients with POTS and OHT took metoprolol (0.5-1.0 mg/(kg·d) was administered orally in two divided doses)
      for treatment [12, 13].
    note: 'Found by winnow, kev and lev in p012, p020, p027. Claude judged: supports.'
  - paper: pmid39882369
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: Ivabradine, midodrine, and beta-blockers currently appear to be reasonable front-line choices in pharmacologic
      management of POTS (PASC associated and otherwise).
    note: 'Found by winnow, kev and lev in p004, p016, p023. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Anecdotally, we found that treatment of POTS with therapies targeting sympathetic overactivity, hypovolemia,
      and mast cell hyperactivity has been more efficacious than neuropathic pain medications. These therapies consist
      of beta blockers; increased oral fluids and salt intake; intravenous fluids; and other medications, such as
      pyridostigmine, which enhances parasympathetic transmission; midodrine, which increases vasoconstriction and
      therefore improves venous return and cerebral perfusion; and benzodiazepines, which may reduce IT via GABA-mediated
      actions in the central autonomic networks (Table 1).
    note: 'Found by winnow, kev and lev in p012, p008. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Pharmacologic Therapies > Medications That Target Rapid Heart Rate
    quote: β-blockers are frequently used for tachycardia in POTS patients. These medications reduce cardiac baroreceptor
      activation, lower serum norepinephrine levels, and inhibit sympathetic nerve activity.[66]
    note: 'Found by winnow, kev and lev in p051. Claude judged: supports.'
  - paper: pmid39552985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The patient made a remarkable functional recovery from POTS, as she responded well to pharmacotherapy,
      primarily beta-blockers, along with lifestyle modifications.
    note: 'Found by winnow, kev and lev in p001, p009, p031. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Clinical management
    quote: Eldokla et al. (2022) reported on five patients who developed POTS after mRNA vaccination, managed with
      medications like ivabradine, metoprolol, fludrocortisone, and propranolol [24].
    note: 'Found by winnow, kev and lev in p021, p023, p026. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.5. Treatments for COVID-19-Related POTS Due to Increased Norepinephrine in the Blood
    quote: β-blockers can inhibit β-ARs that react to norepinephrine or epinephrine secreted from sympathetic nerve
      endings. The β-blockers help reduce tachycardia, decrease excess epinephrine, and alleviate orthostatic intolerance
      [52].
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: METHODS > Treatment options
    quote: As a standard treatment for POTS, patients were counseled to consume ≥10 g of salt and 2–3 L of water,
      except for those with hypertension and older people; instructed to wear elastic compression stockings up to
      the thighs; and prescribed bisoprolol, a β1‐selective blocker, once daily.
    note: 'Found by winnow, kev and lev in p015, p019. Claude judged: supports.'
  - paper: pmid38033543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: In the Poincaré plot, a T < 573.9 ms combined with an L/T > 2.9 helps predict good outcomes of using
      metoprolol to treat pediatric POTS.
    note: 'Found by winnow, kev and lev in p004, p012, p024. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The treatment of POTS after COVID-19 infection or vaccination is mainly focused on lifestyle modifications,
      such as increased fluid and salt intake, exercise, and graduated compression stockings. Pharmacotherapy, such
      as beta-blockers, fludrocortisone, midodrine, and ivabradine, may also be used in selected cases.
    note: 'Found by winnow, kev and lev in p001, p025. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Beta-adrenoreceptor antagonists like propranolol, metoprolol, and bisoprolol are the most often utilized
      medications for treating POTS, with an equal efficacy between propranolol and bisoprolol.
    note: 'Found by winnow, kev and lev in p014, p001, p021. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: '4. Individualized Pharmacologic Therapies for Pediatric POTS: Predictors of Therapeutic Efficacy'
    quote: The pharmacological treatment options include oral rehydration salts (ORS), midodrine hydrochloride,
      metoprolol, fludrocortisone and some other specialized therapies, such as droxidopa, desmopressin, erythropoietin
      and intravenous immunoglobulin (IVIG) [30,47,48,49,50].
    note: 'Found by winnow, kev and lev in p031, p014, p035. Claude judged: supports.'
  - paper: pmid37443510
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Metoprolol is effective for pediatric POTS at an initial dose of 0.5 mg/(kg·d) divided into 2 administrations.
      The total dose of the drug should not exceed 2 mg/(kg·d).
    note: 'Found by winnow, kev and lev in p004, p024, p001. Claude judged: supports.'
  - paper: pmid37313107
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction and background
    quote: Pharmacologic therapies have been explored in minimizing symptoms and increasing functional ability in
      POTS patients [2]. Treatment targets have focused on reducing heart rate (beta-blockers), increasing cardiac
      output (increase in salt intake), or increasing blood pressure (midodrine).
    note: 'Found by winnow, kev and lev in p004, p030. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports > Pharmacological Therapies
    quote: Beta blockers such as propranolol are particularly favored in hyperadrenergic forms of POTS. Pre-emptive
      administration prior to exercise has been reported to be effective in improving exercise capacity.63
    note: 'Found by winnow, kev and lev in p035, p022, p030. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Beta-blockers: Both beta-1 selective and nonselective beta-blockers have been used in POTS management.
      Beta-blockers help by reducing tachycardia and the hyperadrenergic state and improving exercise intolerance
      and orthostatic intolerance.'
    note: 'Found by winnow, kev and lev in p062, p063. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: While there is no universal pharmacological guideline for POTS, medications such as fludrocortisone,
      pyridostigmine, midodrine, and beta blockers can help with its management, depending on the cause [2]. Beta
      blockers can blunt elevations in heart rate.
    note: 'Found by winnow, kev and lev in p017, p004. Claude judged: supports.'
  - paper: pmid36781629
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: It had an excellent predictive value of the therapeutic effect of metoprolol on POTS among children and
      adolescents.
    note: 'Found by winnow, kev and lev in p002, p004, p019. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Case summary > Management
    quote: Beta-blockers have been recommended to lower standing heart rate and reduce symptoms of tachycardia and
      palpitations,1 and thus metoprolol was also used in this case.
    note: 'Found by winnow, kev and lev in p018, p017, p020. Claude judged: supports.'
  - paper: pmid36187012
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: The baseline supine BRS level > 8.045 ms/mmHg can predict a good therapeutic response to metoprolol and
      the results would assist in guiding the individualized β-adrenoceptor blocker use in pediatric patients suffering
      from POTS.
    note: 'Found by winnow, kev and lev in p022, p002, p004. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.4. Physiological Predictors
      for the Efficacy of Metoprolol in Pediatric POTS
    quote: Beta-adrenoceptor blockers are often applied in the management of pediatric POTS patients. They inhibit
      sympathetic nervous system activity and reduce stimulation of the heart rate and cardiac baroreceptors, thereby
      blocking the effects of increased blood catecholamine levels.
    note: 'Found by winnow, kev and lev in p038, p040, p042. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How is POTS treated? > Pharmacological treatments
    quote: A 2009 randomized crossover study found that low-dose oral propranolol improved tachycardia and symptoms
      on standing,45 and a small, randomized, double-blind study in 2013 showed improved exercise capacity46 in
      patients with POTS. Propranolol has a short half-life and requires dosing 4 times per day.
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid35176758
    cited: true
    text: full
    license: by
    verdict: supports
    section: Proposed model for investigation and management of cardiovascular sequelae and long COVID
    quote: The management of POTS centres around accurate diagnosis following specialist assessment, correction
      of reversible causes (dehydration, heat), optimization of chronic disease management, and patient education.
      In some patients with ongoing palpitations, beta-blockers can be helpful in treating symptoms.234
    note: 'Found by winnow, kev and lev in p043. Claude judged: supports.'
  - paper: pmid35127870
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Beta-adrenoceptor blocker metoprolol was currently one of the main drugs for the treatment of children
      with POTS.
    note: 'Found by winnow, kev and lev in p002, p003, p005. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment > Pharmacologic interventions
    quote: The CCS position statement on POTS states that the most commonly used medications for the management
      of POTS include propranolol, midodrine, pyridostigmine, fludrocortisone, ivabradine, clonidine, methyldopa,
      and occasional 0.9% sodium chloride I.V. infusions.7 All are off-label for the treatment of POTS in the US.
    note: 'Found by winnow, kev and lev in p034, p035. Claude judged: supports.'
  - paper: pmid34847948
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In POTS, β-adrenergic blockers have been reported to improve symptoms [27, 28].
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Possible Treatment for Post-COVID Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid34387611
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Beta-blockers are important treatment option for POTS in children and adolescents,[7,8] but they only
      improve symptoms in approximately 57.10% to 57.89% of children.[9,10]
    note: 'Found by winnow, kev and lev in p002, p004, p005. Claude judged: supports.'
  - paper: pmid34353826
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34353826. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Pharmacologic management > β-blockers
    quote: In a randomized crossover study of 54 patients with POTS who were trialed with 20 mg of propranolol versus
      placebo, orthostatic heart rates were significantly lower with propranolol use as compared with among those
      on placebo.22 In addition, symptom burden was improved in patients on low-dose propranolol relative to placebo
      therapy.22
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacologic management of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Low-dose propranolol has also demonstrated efficacy in reducing tachycardia and achieving symptomatic
      control in POTS.
    note: 'Found by winnow, kev and lev in p010, p014. Claude judged: supports.'
  - paper: pmid33623665
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Pharmacological therapy is considered on an individual basis, consisting of beta-blockers to blunt orthostatic
      increases in heart rate, alpha-adrenergic agents to increase peripheral vascular resistance, mineralocorticoids
      to increase blood volume and serotonin reuptake inhibitors to improve serotonin regulation [4].
    note: 'Found by winnow, kev and lev in p007, p001, p009. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Management Strategies for Pots in Children and Adolescents > Pharmacological Treatment
    quote: In 2009, a single-center retrospective chart analysis and follow-up conducted by the Mayo Clinic showed
      that adolescents with POTS taking β-blockers were more likely to have an improvement in symptoms than those
      taking midodrine (116), suggesting that β-blockers were effective for young POTS patients. β1-Selective blockers
      are useful for “hyperadrenergic” subtypes of POTS patients (96).
    note: 'Found by winnow, kev and lev in p027, p022. Claude judged: supports.'
  - paper: pmid32673517
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Our results also confirmed the efficacy of low‐dose propranolol in reducing orthostatic tachycardia in
      POTS.
    note: 'Found by winnow, kev and lev in p017, p033, p036. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Hyperadrenergic Pots: β-Blockers'
    quote: Propranolol, a non-selective β-blocker, can pass the blood-brain barrier. Thus, it is considered to work
      better than other β-blockers in the treatment of POTS (71).
    note: 'Found by winnow, kev and lev in p028, p017, p027. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Cannom assesses
    quote: In the uncomplicated POTS patient who is symptomatic due to orthostatic tachycardia, the traditional
      approach has been the use of a β-blocker in association with hydration, salt, and compression stockings.
    note: 'Found by winnow, kev and lev in p011, p048. Claude judged: supports.'
  - paper: pmid32489723
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction and background
    quote: Pharmacological therapies include beta-blockers (first line), alpha-agonists (first or second line),
      mineralocorticoids (second line), selective serotonin reuptake inhibitors (SSRIs), and selective serotonin-norepinephrine
      reuptake inhibitors (SSNRIs), and rarely used drugs include pyridostigmine, desmopressin, and erythropoietin
      [4,11].
    note: 'Found by winnow, kev and lev in p004, p024. Claude judged: supports.'
  - paper: pmid32464225
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Study Design
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32464225. Found by winnow, kev and lev in p003, p001, p002. Claude judged: supports.'
  - paper: pmid32112609
    cited: true
    text: full
    license: by
    verdict: supports
    section: SUBJECTS AND METHOD > Methods > Treatment
    quote: 'Health education was taken in the 100 children and adolescents with POTS, including psychological guidance
      of children and their families, avoidance of syncope inducement, drinking more water, keeping urine clear
      (urination twice in the morning and afternoon), assuring enough sleep time (>8 hr/day), erect training (standing
      against the wall, 2 times/day, 30 min/times), oral rehydration salts Ⅲ (made in Xi ''an Anjian Pharmaceutical
      Co., LTD, approval number: H20090205) 5.125 g/bag (each bag was divided into 250 ml water for oral administration,
      2 bags/day; halve the dose for children under 6 years old) and oral metoprolol (from Astrazeneca Pharmaceutical
      Co., LTD, production batch number: 326201), 0.5 ~ 1.0 mg/kg, oral, 2 times/day.'
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Challenge II: Lack Of Standardized Approaches To Physical Rehabilitation And Psychopharmacology >
      Pharmacological Treatment Approaches'
    quote: Beta-blockers as a class have been shown to improve orthostatic symptoms in some patients with POTS by
      decreasing tachycardia through improved heart rate control. For pediatric patients, propranolol, metoprolol,
      and labetalol have been used.
    note: 'Found by winnow, kev and lev in p005, p018. Claude judged: supports.'
  - paper: pmid31788462
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: 'Conclusion: β-blockers are effective in treating POTS in children and adolescents, alleviating orthostatic
      intolerance, and improving hemodynamic abnormalities.'
    note: 'Found by winnow, kev and lev in p002, p003, p005. Claude judged: supports.'
  - paper: pmid31780890
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: A beta-adrenoceptor blocker (β-blocker) is commonly used for treating POTS in children (Kernan and Tobias,
      2010; Bryarly et al., 2019).
    note: 'Found by winnow, kev and lev in p005, p002, p004. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Approach to therapy for patients with POTS > Prognosis
    quote: A prospective, longitudinal study of 56 patients who were treated at the Mayo clinic with a combination
      of nonpharmacologic interventions and β-blockers (54%), fludrocortisone (24%) or midodrine (17%) found improvement
      in 70% of patients, while 30% became worse after 1 year of treatment.82
    note: 'Found by winnow, kev and lev in p024, p026. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: THE INDIVIDUALIZED TREATMENT OF POSTURAL TACHYCARDIA SYNDROME
    quote: Currently, based on the possible pathogenesis, the first-line treatments for POTS mainly include oral
      rehydration salts (ORS), beta-adrenoreceptor blockers, and alpha-adrenoreceptor agonists.
    note: 'Found by winnow, kev and lev in p013, p004, p018. Claude judged: supports.'
  - paper: pmid26241226
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: Other drugs which can also be therapeutically beneficial in patients with POTS are (1) drugs that increase
      peripheral vascular resistance such as midodrine, a prodrug whose active metabolite is an α-adrenoceptor antagonist,
      and somatostatin analogs; (2) drugs that can modify the central and peripheral activity of the sympathetic
      nervous system such as β-adrenoceptor antagonists (mainly propranolol), serotonin and norepinephrine uptake
      inhibitors, and combined α- and β-adrenoceptor antagonists; and (3) drugs that reduce the sympathetic tone
      such as clonidine.2,3,9
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid26199795
    cited: true
    text: full
    license: none
    verdict: supports
    section: Case Description > Case 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26199795. Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p039. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid25811760
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Metoprolol is one of the main drugs for POTS currently. It is used to treat POTS by blocking β-adrenoceptor,
      and as a result, blocking high levels of catecholamines in circulation, and lowering the heart rate [3].
    note: 'Found by winnow, kev and lev in p001, p002, p018. Claude judged: supports.'
  - paper: pmid25204388
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Raj et al. reported that low-dose oral propranolol significantly attenuated tachycardia and improved
      symptoms in POTS, and higher-dose propranolol did not further improve, and might worsen symptoms [8]. Arnold
      et al. also found recently that propranolol could improve HR control and exercise capacity in POTS when given
      at the low doses of propranolol for treatment [10].
    note: 'Found by winnow, kev and lev in p014, p019, p002. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p037, p042. Claude judged: supports.'
  - paper: pmid23616163
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23616163. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Sympatholysis
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p016, p019. Claude judged: supports.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: supports
    section: CASE REPORT
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p018, p012, p016. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038, p035. Claude judged: supports.'
  - paper: pmid21690484
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21690484. Found by winnow, kev and lev in p001, p002, p023. Claude judged: supports.'
  - paper: pmid21686452
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21686452. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid20860911
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Case History
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20860911. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid20668563
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Additionally, once the primary pathophysiologic defect (vasodilatation and relative hypovolemia) is corrected,
      β-adrenergic antagonists may be used to primarily treat the reflex tachycardia. In our patient, pharmacologic
      therapy include both midodrine to treat the loss of vascular tone and metoprolol to prevent reflex tachycardia.[411]
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid19687359
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19687359. Found by winnow, kev and lev in p002, p003, p022. Claude judged: supports.'
  - paper: pmid11206727
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11206727. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid11201632
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Methods And Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11201632. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid11198485
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11198485. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid10750641
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 10750641. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid10406593
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 10406593. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment
    quote: Pharmacotherapy includes first-line medications such as beta-blockers, which decrease resting and postural
      tachycardia by inhibiting beta-1 adrenergic receptors and reducing sympathetic overactivity; fludrocortisone,
      a mineralocorticoid that augments retention of water and sodium and expands plasma volume; midodrine, which
      is an apha-1 agonist that causes vasoconstriction and increased peripheral resistance, and other commonly
      used medications for the orthostatic intolerance, tachycardia and fatigue, such as pyridostigmine, ivabradine,
      clonidine, guanfacine, modafinil, methylphenidate and others [6, 24, 25].
    note: 'Found by winnow, kev and lev in p009, p021, p001. Claude judged: partial.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Given our findings suggesting a central role for adrenergic signaling in the development of POTS post-HSCT,
      treatment with a nonselective β-AR blocker such as propranolol may be appropriate.
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid38867988
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation > History
    quote: Additionally, mast cell activation syndrome (MCAS) was suspected given relief with cetirizine. In addition
      to supportive measures, diltiazem was transitioned to propranolol (20 mg TID) with improved effect.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid36158335
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: At the two-month follow-up, the patient was prescribed metoprolol 25mg and instructed to titrate up to
      50mg for symptomatic relief of tachycardia, diaphoresis, headaches, and near syncopal events.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: partial.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: 'Patient #3'
    quote: The patient received propranolol 10 mg ×3 times a day and pyridostigmine 10 mg ×3, the latter due to
      severe fatigue and muscle weakness. In addition to typical POTS symptoms he developed nausea, orbital edema,
      and gastrointestinal symptoms (Figure 6).
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: partial
    section: Management > Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid17933281
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 17933281. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - exercise_reconditioning
  - treats
  - pots
  papers: 58
  evidence:
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: One study observed that graded exercise therapy in a semi-recumbent position to avoid upright posture,
      such as recumbent bike, swimming, and rowing, improved symptoms by increasing the aldosterone-to-renin ratio
      and decreasing heart rate [61].
    note: 'Found by winnow, kev and lev in p091, p100. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: Compression garments, physical training and salt supplementation have been shown to have beneficial effects
      on symptom burden and/or hemodynamics in patients with POTS and should be the first therapeutic approach in
      patients with POTS.
    note: 'Found by winnow, kev and lev in p086, p015, p022. Claude judged: supports.'
  - paper: pmid41166031
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Exercise is considered a first-line treatment for POTS and is recommended regardless of presumed etiology.
      While the first studies of exercise in POTS framed it as countering deconditioning, there has since been significant
      debate as to whether deconditioning is a primary cause of POTS or is more likely to occur secondary to the
      disorder [3].
    note: 'Found by winnow, kev and lev in p007, p006, p027. Claude judged: supports.'
  - paper: pmid40944681
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Case Summary
    quote: POTS was exacerbated in a 28-year-old woman with obesity after using tirzepatide for weight reduction.
      Her condition was effectively treated with progressive exercise training and counseling, which reduced supine
      and standing heart rates to normal values, before starting tirzepatide.
    note: 'Found by winnow, kev and lev in p006, p002. Claude judged: supports.'
  - paper: pmid40538940
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Exercise training is already recommended as a treatment for PoTS, especially for its prevention and for
      the improvement of deconditioning (1, 4).
    note: 'Found by winnow, kev and lev in p004, p009, p025. Claude judged: supports.'
  - paper: pmid40365455
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: While medications are often used, structured therapeutic exercise – generally beginning with aerobic
      and strength training using recumbent positioning, gradually building toward longer durations and a more upright
      posture – remains a cornerstone of current consensus-driven POTS management.5,6
    note: 'Found by winnow, kev and lev in p007, p025, p026. Claude judged: supports.'
  - paper: pmid40125494
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Current standard treatments begin with the initiation of non-pharmacologic interventions, such as liberal
      dietary salt and water intake to increase blood volume, limiting caffeine intake, a daily exercise program
      for physical reconditioning, and wearing compression stockings.1,5
    note: 'Found by winnow, kev and lev in p008, p014. Claude judged: supports.'
  - paper: pmid39822199
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: Exercise is a well-documented, nonpharmacologic treatment for individuals with autonomic dysfunction
      and associated orthostatic intolerance, such as postural tachycardia syndrome and related disorders. Exercise
      has been shown to increase blood volume, reverse cardiovascular deconditioning, and improve quality of life.
    note: 'Found by winnow, kev and lev in p001, p017, p004. Claude judged: supports.'
  - paper: pmid39678714
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results
    quote: The increase in HR from supine to 10-minute stand and the quality of life improved significantly after
      the intervention. The study concluded that this exercise program was effective in treating POTS and can be
      applied in community setting with physician supervision.
    note: 'Found by winnow, kev and lev in p030, p031, p034. Claude judged: supports.'
  - paper: pmid39597891
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Exercise is a vital component of health and is commonly utilized as a non-pharmacologic therapy for many
      disorders, including postural orthostatic tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p015, p001, p007. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Non-pharmacologic Therapies
    quote: The Levine Protocol is a 3-month exercise program that has shown efficacy in lowering heart rates and
      improving cardiac output in POTS patients.[61]
    note: 'Found by winnow, kev and lev in p045. Claude judged: supports.'
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: What to Do in Clinic
    quote: At follow-up, 71% of the patients significantly improved to the point that they no longer met the diagnostic
      criteria for POTS. Perhaps even more encouraging is that this improvement remained true 6 to 12 months after
      the exercise intervention, based on clinical follow-up.
    note: 'Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Non-pharmacological treatment
    quote: Physical exercise plays a critical role in the management of POTS, particularly when tailored to the
      patient’s subtype and tolerance levels. Initial exercise regimens should involve low-intensity, recumbent
      activities such as rowing or swimming to minimize excessive upright positioning, progressing gradually over
      a three-month period [41].
    note: 'Found by winnow, kev and lev in p029, p030. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.2. Exercise
    quote: Gradually increasing exercise intensity can also relieve POTS-related symptoms and reduce abnormally
      increased heart rate in the standing position.
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid38958137
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: "However, exercise interventions, such as the Levine protocol\n31\n and other nonspecified exercise activities,\
      \ as well as dietary changes were used most often, still being used at the time of survey completion, and\
      \ perceived by patients to be the most effective. Indeed, exercise has been proven to successfully reduce\
      \ POTS symptoms."
    note: 'Found by winnow, kev and lev in p043, p046. Claude judged: supports.'
  - paper: pmid38953100
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Physical activity in FND and comorbid disorders > Physical activity in postural orthostatic tachycardia
      syndrome
    quote: In POTS, exercise intolerance directly correlates with reduced functionality, with 61 % of patients reporting
      the inability to tolerate more than thirty minutes of exercise [70]. Physical reconditioning with exercise
      training is an important component of treatment.
    note: 'Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid38162438
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Postural orthostatic tachycardia syndrome
    quote: Progressive exercise training to build endurance and increase leg resistance is integral to the treatment
      plan. The exercise program may initially be recumbent such as rowing, cycling, or swimming, progressing to
      upright exercise, and patients should be educated that they may initially feel worse.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid37598401
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Previous research has demonstrated that a 3-month exercise training program can help treat the cardiac
      origins of the condition by increasing blood volume, left ventricular mass, and consequently stroke volume
      to improve aerobic fitness [9]. Most importantly starting and maintaining an active lifestyle can be the key
      to reducing or eliminating symptoms [10].
    note: 'Found by winnow, kev and lev in p006, p028, p030. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Every POTS management plan should include exercise training. The exercise protocol starts with recumbent
      aerobic and resistance training progressing to upright exercises.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Incremental aerobic exercise programs should be implemented for all patients with POTS. Despite the patient’s
      intolerance to upright position exercises, patients have shown progress in a recumbent or semi-recumbent position
      such as recumbent biking, swimming, or machine rowing.
    note: 'Found by winnow, kev and lev in p008, p004. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports > Non-Pharmacological Therapies
    quote: Exercise training has proven quite effective overall in improving physical conditioning, soleal muscle
      pump functioning as well as quality of life.65 Exercise prescriptions have proven effective in COVID-POTS.
    note: 'Found by winnow, kev and lev in p032, p030. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Physical exercise: Studies have demonstrated improvement of POTS symptoms with aerobic exercise programs
      with gradual increments as tolerated [12,63,69,70].'
    note: 'Found by winnow, kev and lev in p057. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > POTS management
    quote: Regular, structured, progressive, and supervised exercises have been described as effective non-pharmacological
      treatments to improve POTS-related symptoms9,21,30,31. However, given the possible activity-induced symptoms,
      exercise should be restricted to no upright exercises such as swimming, rowing machines, and recumbent cycles9,21,24,30,31.
    note: 'Found by winnow, kev and lev in p013, p029. Claude judged: supports.'
  - paper: pmid35697326
    cited: true
    text: full
    license: none
    verdict: supports
    section: Supportive Lifestyle Practices > Physical Activity
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35697326. Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment > Nonpharmacologic interventions
    quote: Short-term exercise of at least 30 minutes every other day for 3 months was found to decrease heart rate
      and increase baroreflex sensitivity in patients with POTS.22 It is important that the patient start a graduated
      exercise plan, beginning with recumbent exercises, and take caution not to overexert.14
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Non-pharmacologic management of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p030, p028. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Num estudo que realizou um registro internacional de SPOT, o condicionamento físico progressivo demonstrou
      expansão volêmica e aumentou a área cardíaca dos pacientes, resultando numa melhora significativa dos sintomas.
      Nesse estudo, 71% dos pacientes que completaram o programa de treinamento ficaram livres do diagnóstico de
      SPOT.
    note: 'Found by winnow, kev and lev in p128, p129, p166. Claude judged: supports.'
  - paper: pmid33482385
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33482385. Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Our findings are, therefore, highly consistent with studies53,54 indicating that exercise reconditioning
      may be the ideal treatment for POTS because it increases parasympathetic and decreases sympathetic cardiac
      activity.
    note: 'Found by winnow, kev and lev in p057. Claude judged: supports.'
  - paper: pmid33083000
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Exercise training is also advocated as an essential component of POTS treatment [1].
    note: 'Found by winnow, kev and lev in p024, p007, p008. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Non-Pharmacological Treatments
    quote: Some investigators have found that a regular, short-term progressive physical-exercise program leads
      to improved symptoms in POTS patients (47). Such a regimen consists of rowing on a machine, swimming, recumbent
      and upright biking, and treadmill walking.
    note: 'Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid32489723
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: The primary aspect of POTS treatment is exercise conditioning and all patients are recommended to start
      a gradual physical exercise regimen [5].
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid32284866
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: 'Progressive exercise training has been demonstrated to lead to improvement or

      resolution of POTS.29 However, pharmacotherapy with medications such as propranolol, midodrine or

      fludrocortisone is often required, especially where symptoms are severe.20'
    note: 'Found by winnow, kev and lev in p010, p017. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Challenge II: Lack Of Standardized Approaches To Physical Rehabilitation And Psychopharmacology >
      Physical Rehabilitation Approaches'
    quote: Exercise and normalization of functional activities are major components in the treatment of POTS, and
      it is recommended that patients utilize a rehabilitation specialist (e.g., physical or occupational therapist)
      for implementation and progression.1
    note: 'Found by winnow, kev and lev in p014, p015, p005. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: 2. EXERCISE TRAINING
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p001, p005, p009. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: MANAGEMENT OF POTS
    quote: Some individuals with POTS respond favorably to progressive exercise training, resulting in gradual increase
      in blood volume, exercise capacity, and stroke volume along with improved left ventricular diastolic function.47–50
      Recommendation for exercise to manage POTS stems from a study that engaged primary care physicians in the
      distribution of a 3-month unsupervised exercise program, referred to as the Levine protocol, for patients
      with POTS.51
    note: 'Found by winnow, kev and lev in p019, p018, p023. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: THE INDIVIDUALIZED TREATMENT OF POSTURAL TACHYCARDIA SYNDROME
    quote: Children with POTS and their parents should be informed of the potential aggravating or precipitating
      factors, such as the sudden head-up postural change, prolonged standing posture, and the high environmental
      temperatures. Besides that, exercise training that could improve the autonomic tone is also recommended.[2021]
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Non-Pharmacological Treatment of POTS > Exercise in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p036, p037. Claude judged: supports.'
  - paper: pmid25487551
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25487551. Found by winnow, kev and lev in p003, p008, p009. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment approaches: Addressing neurohormonal imbalances (Table 1) > Hypovolemia and renin-angiotensin-aldosterone
      paradox—volume loading'
    quote: The 3 month exercise program was able to increase the aldosterone:renin ratios well as the plasma volumes
      and blood volumes in these POTS patients. Other benefits included a reduction in orthostatic tachycardia (P
      < 0.01), and significantly improved quality of life as assessed by the SF-36.
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: Recovery > Management of POTS and Associated Conditions > Non-Pharmacologic Strategies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p050, p062, p084. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Exercise
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Non-Pharmacological Treatment of POTS (Table 4) > Exercise Training
      for POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p014, p012, p019. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Exercise
    quote: In a number of studies, exercise has been reported to be beneficial both in alleviating POTS symptoms,
      as well as playing a role in curing the condition.[21] In one study, POTS patients without blood pressure
      fluctuations,[21] were trained gradually to move from lying to sitting to a standing position during different
      activities, such as swimming, rowing, and cycling.
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid21690484
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21690484. Found by winnow, kev and lev in p001, p002, p024. Claude judged: supports.'
  - paper: pmid20579544
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20579544. Found by winnow, kev and lev in p004, p031, p033. Claude judged: supports.'
  - paper: pmid20309394
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Response to Medical therapy
    quote: The therapeutic management approach for these patients was based on our previous experience with the
      management of patients with POTS. Initial therapy consisted of an increase in salt and fluid intake as well
      as aerobic reconditioning with resistance training to increase lower extremity strength.
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid18704621
    cited: true
    text: full
    license: none
    verdict: supports
    section: Summary and what to do next
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 18704621. Found by winnow, kev and lev in p014, p018, p019. Claude judged: supports.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid38074226
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Discussion
    quote: The management of these patients is usually conservative as per previous literature. A regular, structured
      exercise programme is suggested.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Gradual physical training also improves symptoms [18].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid36090156
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Although PASC and POTS might share common pathophysiological mechanisms and respond favorably to graded
      exercise training, few cases of PASC will likely fulfill a diagnosis of POTS. This initial case series shows
      the overlap between PASC, orthostatic intolerance, and POTS in recreational and competitive athletes, demonstrates
      the utility of performing autonomic function testing and CPET in making the diagnosis, and emphasizes the
      role of graded exercise training to treat this condition.
    note: 'Found by winnow, kev and lev in p010, p011, p014. Claude judged: partial.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods > Management > Reconditioning
    quote: Graded-exercise training may be beneficial for symptom control in POTS.16
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Exercise to strengthen the leg muscles, such as cycling, rowing, and squatting exercises can help.
    note: 'Found by winnow, kev and lev in p014, p016. Claude judged: partial.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: partial
    section: Dr. Feigofsky examines
    quote: Exercise in a recumbent or semirecumbent position for 20 minutes to 30 minutes three times a week has
      been proven to be effective in improving orthostatic tolerance.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Accordingly, it seems reasonable that exercise-based rehabilitation may be effective in the medium- and
      long-term treatment of POTS and related conditions with deconditioning [30].
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: partial
    section: Management > Deconditioned POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p030. Claude judged: partial.'
- edge:
  - ivabradine_therapy
  - treats
  - pots
  papers: 54
  evidence:
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Additional support for autoimmune or inflammatory subgroups of POTS comes from the fact that some patients
      experience persistent cognitive symptoms despite treatment. Common treatment options that may alter heart
      rate or blood pressure without eliminating autoantibodies, lessening brain inflammation, or unblocking small
      vessels include beta-blockers, ivabradine, and midodrine.
    note: 'Found by winnow, kev and lev in p019, p056. Claude judged: supports.'
  - paper: pmid42484150
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectivas Futuras
    quote: Este trabalho de revisão publicado por ABC-2025-0347 reafirma a ivabradina como uma estratégia terapêutica
      viável e segura para POTS, mas reforça também a necessidade de mais estudos na área.
    note: 'Found by winnow, kev and lev in p001, p012, p013. Claude judged: supports.'
  - paper: pmid42273028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: For patients with symptoms uncontrolled by conservative measures such as exercise or compression garments,
      clinicians must select from a wide variety of medications when treating POTS—therapies commonly prescribed
      for the treatment of POTS vary widely in mechanism of action and target of effects. Common pharmacologic mechanisms,
      with examples provided in parentheses, include mineralocorticoid agonists (fludrocortisone), medications to
      decrease heart rate (beta-blockers, ivabradine), vasoconstrictors (midodrine), and prescribed salt intake
      (11).
    note: 'Found by winnow, kev and lev in p003, p008, p024. Claude judged: supports.'
  - paper: pmid42132710
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: These results provide the first direct, randomized comparative evidence that ivabradine and propranolol
      produce overlapping short-term hemodynamic and symptomatic improvements in POTS, with no statistically significant
      differences detected between active treatments.
    note: 'Found by winnow, kev and lev in p005, p051, p054. Claude judged: supports.'
  - paper: pmid41538594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusão
    quote: A ivabradina mostrou-se eficaz e segura na terapêutica dos pacientes portadores de POTS.
    note: 'Found by winnow, kev and lev in p005, p015, p017. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Selective sodium channel blockers (funny current), like Ivabradine, which target the cardinal manifestation
      of tachycardia in POTS, have shown effectiveness in low doses in some trials [23].
    note: 'Found by winnow, kev and lev in p092, p094, p095. Claude judged: supports.'
  - paper: pmid41364925
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41364925. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p009, p032. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: For ivabradine, long-term studies are also needed to further investigate potential effects in POTS. On
      the basis of the current evidence, ivabradine could be considered as a pharmacological approach in POTS if
      non-pharmacological interventions alone are not sufficient.
    note: 'Found by winnow, kev and lev in p046, p074, p029. Claude judged: supports.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods and analysis > Analysis > Sample size justification and statistical analysis
    quote: The effect size (10 bpm reduction in standing heart rate) was observed along with improvement of symptoms
      in a prior randomized, placebo-controlled cross-over study demonstrating effectiveness of ivabradine to treat
      POTS (50).
    note: 'Found by winnow, kev and lev in p018, p041, p002. Claude judged: supports.'
  - paper: pmid40681233
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Discussion
    quote: While previous studies support the efficacy of ivabradine in treating POTS, this case reinforces it as
      a viable treatment option and adds real-world evidence for its inclusion in treatment guidelines.
    note: 'Found by winnow, kev and lev in p003, p005, p017. Claude judged: supports.'
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: For example, pacing is recommended care to manage energy levels and avoid PEM in ME/CFS; fluid/electrolytes,
      compression stockings and Mestinon to help manage OI; beta-blockers and ivabradine to aid tachycardia present
      in POTS; IgG for use in immune dysfunction; antihistamines (H1 and/or H2 inhibitors) and other select treatments
      to manage MCAS; low-dose naltrexone to manage pain; and melatonin to mitigate sleep problems.
    note: 'Found by winnow, kev and lev in p018, p033. Claude judged: supports.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment
    quote: Ivabradine is a selective inhibitor of I funny-channels at the sinoatrial node and may be safe and effective
      in patients with POTS and IST [27, 28].
    note: 'Found by winnow, kev and lev in p025, p021. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Ivabradine, a sinoatrial node inhibitor, may also be a suitable treatment for patients with POTS after
      HSCT. It has also shown efficacy in individuals with idiopathic POTS and has been reported to reduce NE levels.27,40,41
    note: 'Found by winnow, kev and lev in p037. Claude judged: supports.'
  - paper: pmid40294227
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40294227. Found by winnow, kev and lev in p001, p005, p011. Claude judged: supports.'
  - paper: pmid39882369
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: Ivabradine, midodrine, and beta-blockers currently appear to be reasonable front-line choices in pharmacologic
      management of POTS (PASC associated and otherwise).
    note: 'Found by winnow, kev and lev in p004, p016, p023. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Pharmacologic Therapies > Medications That Target Rapid Heart Rate
    quote: Ivabradine, a drug approved by the FDA for symptomatic heart failure with reduced ejection fraction,
      is being increasingly used in POTS patients due to its cardiac selectivity.[68] Ivabradine blocks the funny
      (If) current of the sinoatrial node, thereby lowering heart rate and increasing diastolic time without lowering
      blood pressure.[68]
    note: 'Found by winnow, kev and lev in p052. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Clinical management
    quote: Eldokla et al. (2022) reported on five patients who developed POTS after mRNA vaccination, managed with
      medications like ivabradine, metoprolol, fludrocortisone, and propranolol [24].
    note: 'Found by winnow, kev and lev in p022, p023, p026. Claude judged: supports.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Medication use, unfortunately, is often limited by unacceptable side effects. Ivabradine, an If channel
      blocker, is overall tolerated better.
    note: 'Found by winnow, kev and lev in p015, p001. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.5. Treatments for COVID-19-Related POTS Due to Increased Norepinephrine in the Blood
    quote: Ivabradine is typically injected twice a day at a dose of 2.5 to 20 mg to control the heart rate of POTS
      patients in the recumbent position to obtain a heart rate between 50 and 70 beats per minute. This improves
      the symptoms of upright tachycardia in POTS patients [74].
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The patient’s POTS responded favorably to treatment with low-dose fludrocortisone and ivabradine.
    note: 'Found by winnow, kev and lev in p001, p007, p011. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: For example, for hyperadrenergic POTS, the sympathetic output is blocked via beta-blockers, or sympathetic
      symptoms such as tachycardia may be combated by pharmacotherapies such ivabradine which inhibits I(f) channels.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The treatment of POTS after COVID-19 infection or vaccination is mainly focused on lifestyle modifications,
      such as increased fluid and salt intake, exercise, and graduated compression stockings. Pharmacotherapy, such
      as beta-blockers, fludrocortisone, midodrine, and ivabradine, may also be used in selected cases.
    note: 'Found by winnow, kev and lev in p001, p025. Claude judged: supports.'
  - paper: pmid37313107
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Evidence for the use of ivabradine in POTS is scant. However, it was shown to be useful in lowering heart
      rate and relieving symptoms.
    note: 'Found by winnow, kev and lev in p001, p030. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports > Pharmacological Therapies
    quote: Ivabradine (I-funny current; If blocker) acts selectively on the SA node to lower resting heart rates.
      It has been used off-label in patients with POTS and is reported to improve quality of life and reduce resting
      heart rates.69,70
    note: 'Found by winnow, kev and lev in p035, p022, p030. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: It improves the symptoms of orthostatic tachycardia in POTS patients [78-82].
    note: 'Found by winnow, kev and lev in p064. Claude judged: supports.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: We presented the case of a 15-year-old South Asian male who developed suspected POTS two weeks after
      receiving the Pfizer-BioNTech COVID-19 vaccine booster, which was successfully managed with low-dose fludrocortisone
      and ivabradine.
    note: 'Found by winnow, kev and lev in p004, p011, p013. Claude judged: supports.'
  - paper: pmid36575713
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36575713. Found by winnow, kev and lev in p008, p011, p012. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Pharmacologic Treatment > Postural Orthostatic Tachycardia Syndrome49,50,170'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p165. Claude judged: supports.'
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Case Presentation
    quote: The patient was diagnosed with POTS and started on conservative therapy with increased salt consumption,
      fluid intake, and 20 mmHG compression stockings. Given her persistent tachycardia, she was started on ivabradine
      5 mg BID with significant improvement in her tachycardia.
    note: 'Found by winnow, kev and lev in p009, p014. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Management of post–COVID-19 POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment > Pharmacologic interventions
    quote: The CCS position statement on POTS states that the most commonly used medications for the management
      of POTS include propranolol, midodrine, pyridostigmine, fludrocortisone, ivabradine, clonidine, methyldopa,
      and occasional 0.9% sodium chloride I.V. infusions.7 All are off-label for the treatment of POTS in the US.
    note: 'Found by winnow, kev and lev in p038, p034. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Possible Treatment for Post-COVID Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Pharmacologic management > Ivabradine
    quote: Ivabradine is a selective funny current blocker that does not affect blood pressure.23 Due to the selective
      inhibition of the sinus node, ivabradine has been used in the treatment of POTS.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid34127505
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34127505. Found by winnow, kev and lev in p001, p013, p017. Claude judged: supports.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A promising therapy that has been gaining traction recently is ivabradine, a funny sodium channel blocker
      (iF blocker) that has demonstrated effects including reducing the heart rate and providing symptomatic relief
      from POTS as well as IST without significant concomitant drops in BP.7,14,15
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: 'Patient #1'
    quote: She did not tolerate beta-blockers due to worsened orthostatic intolerance, and ivabradine 7.5 mg twice
      a day was started (Table 2) with substantial improvement, although the patient remains on sick leave.
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid33602468
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33602468. Found by winnow, kev and lev in p004, p005. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Treatment protocols for POTS have been described in detail previously.5–7 Existing protocols include
      increased intake rates of dietary fluids and salt, physical counter-maneuvers, and aerobic/resistance training.
      If these therapies are ineffective, pharmacotherapy options including fludrocortisone, midodrine, pyridostigmine,
      and ivabradine are trialed.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: supports.'
  - paper: pmid32489723
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction and background
    quote: However, there has been evidence of beneficial outcomes with the use of ivabradine in POTS patients,
      as seen in prospective and retrospective studies [12-16].
    note: 'Found by winnow, kev and lev in p004, p022, p024. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Approach to therapy for patients with POTS > Pharmacologic interventions
    quote: Ivabradine is an alternative agent to β2 antagonists that has been shown to be of benefit in recent studies.
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid29330767
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29330767. Found by winnow, kev and lev in p004, p003. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid29027608
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29027608. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid28846151
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28846151. Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid28496661
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28496661. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid27413567
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Case 2
    quote: Then the treatment was changed to ivabradine. The patient did well during follow-up for six months without
      any complaints with ivabradine treatment.
    note: 'Found by winnow, kev and lev in p001, p011, p007. Claude judged: supports.'
  - paper: pmid26241226
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: Ivabradine is an effective drug for slowing the HR of POTS patients at rest and during tilting, without
      producing significant adverse effects.
    note: 'Found by winnow, kev and lev in p004, p020, p028. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid24072450
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Aims
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24072450. Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Ivabradine
    quote: Due to the presence of sinus tachycardia in some POTS patients, usage of a sinus node blocker, in particular,
      Ivabradine, was reported to improve their symptoms.
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid42591853
    cited: true
    text: full
    license: by
    verdict: partial
    section: ME/CFS as a low output syndrome due to small heart > Is POTS a cause of OI?
    quote: In the meantime, Ewan et al. (65) reported that the use of the sinus node blocker ivabradine led to dramatic
      improvements in both subjective and objective symptomatology, accompanied by a reduction in heart rate on
      standing, in a 15-year-old female patient with POTS. The use of this medication appears to improve not only
      tachycardia but also symptomatology, including fatigue, suggesting that tachycardia may not only be unnecessary
      for maintaining cerebral perfusion during standing as a compensatory mechanism but also triggers many symptoms,
      possibly through disturbances in the autonomic nervous system.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pharmacologic management of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p032. Claude judged: partial.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: The first patient's symptoms decreased without any medication. However, in the second patient, different
      drugs were administered, but only ivabradine had beneficial effects on the patient's symptoms [35].
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
- edge:
  - midodrine_therapy
  - treats
  - pots
  papers: 46
  evidence:
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Pharmacologic therapy, when appropriate consist of beta blockers, volume expanders, and midodrine. Ivabradine
      can lower sinus rate without affecting blood pressure.
    note: 'Found by winnow, kev and lev in p091. Claude judged: supports.'
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Lastly, midodrine, an α1-agonist vasoconstrictor, may be particularly useful in neuropathic POTS, where
      impaired vascular tone leads to excessive venous pooling [7].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In neuropathic POTS, the loss of peripheral vascular resistance due to the sympathetic denervation, especially
      in the lower limbs, can be addressed with the use of vasoconstrictors like midodrine [13,24].
    note: 'Found by winnow, kev and lev in p093, p095. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: Pyridostigmine and midodrine might improve hemodynamics in POTS and therefore can be chosen individually
      as an additional therapeutic approach if non-pharmacological options alone or combined with β-adrenergic blocking
      agents or ivabradine are insufficient or not suitable.
    note: 'Found by winnow, kev and lev in p050, p053, p087. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.3. Treatment for COVID-19-Related POTS Due to Hypovolemia
    quote: Midodrine acts as a vasoconstrictor, reducing peripheral blood loading and improving orthostatic hypotension,
      and is especially recommended for the neuropathic subtype of POTS.
    note: 'Found by winnow, kev and lev in p024, p025. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In neuropathic POTS, pharmacotherapy targets vasoconstriction with agents such as pyridostigmine and
      midodrine.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid37706146
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: In addition to standard non-pharmacological management, she had previously completed trials of beta blockers,
      fludrocortisone, and midodrine for POTS therapy before discontinuing due to side effects.
    note: 'Found by winnow, kev and lev in p006, p021, p027. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The treatment of POTS after COVID-19 infection or vaccination is mainly focused on lifestyle modifications,
      such as increased fluid and salt intake, exercise, and graduated compression stockings. Pharmacotherapy, such
      as beta-blockers, fludrocortisone, midodrine, and ivabradine, may also be used in selected cases.
    note: 'Found by winnow, kev and lev in p001, p025. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: '4. Individualized Pharmacologic Therapies for Pediatric POTS: Predictors of Therapeutic Efficacy'
    quote: Pediatric patients with POTS are often treated with non-pharmacological interventions, such as health
      education, exercises to improve autonomic function and sleeping therapy. The pharmacological treatment options
      include oral rehydration salts (ORS), midodrine hydrochloride, metoprolol, fludrocortisone and some other
      specialized therapies, such as droxidopa, desmopressin, erythropoietin and intravenous immunoglobulin (IVIG)
      [30,47,48,49,50].
    note: 'Found by winnow, kev and lev in p030, p014, p020. Claude judged: supports.'
  - paper: pmid37313107
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: This review found that midodrine was the most studied and effective medicine for reducing orthostatic
      symptoms, including dizziness and fainting. Additionally, midodrine helped patients with neuropathic and hyperadrenergic
      POTS by decreasing orthostatic hypotension and increasing cerebral blood flow [15].
    note: 'Found by winnow, kev and lev in p004, p030, p001. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patient management
    quote: For pharmacological therapy, the society recommends midodrine (α-adrenergic agonist) and low-dose propranolol
      (nonselective β-blocker) for symptom relieve.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Single or combination pharmacologic therapies were employed in the reported post COVID-19 cases. These
      include fludrocortisone, midodrine, antihistamines and ivabradine.
    note: 'Found by winnow, kev and lev in p015, p017, p029. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.3. Physiological Predictors
      for the Midodrine Hydrochloride Efficacy among POTS Children
    quote: An alpha-1 adrenoreceptor agonist called midodrine hydrochloride can narrow the vascular lumen through
      peripheral blood pressure elevation and its efficacy in the treatment of POTS has been confirmed [73].
    note: 'Found by winnow, kev and lev in p027, p029, p031. Claude judged: supports.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: Two patients received POTS-specific treatment, including fludrocortisone and midodrine, without immunomodulation.
    note: 'Found by winnow, kev and lev in p021, p029. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How is POTS treated? > Pharmacological treatments
    quote: It may be most beneficial in patients with POTS accompanied by low blood pressure.50 It is prescribed
      at 2.5–10 mg every 4 hours (avoiding a dose near bedtime), but it can also be used as needed for acute symptom
      management.
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid34733680
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Case presentation
    quote: A 12-year-old female with POTS treated with midodrine 10 mg three times daily, presented to the emergency
      department (ED) following a suicide attempt.
    note: 'Found by winnow, kev and lev in p004, p002, p003. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case description and results
    quote: PoTS alleviating medications (clonidine 675 μg/day, β-blockers such as nebivolol 5mg/day or propranolol
      80mg/day or bisoprolol 2,5mg/day, etilefrinhydrochloride 10mg/day, midodrine 7,5mg/day, higher doses not tolerated)
      and further treatment like compression stockings, high salt and liquids diet, adapted PoTS exercise program
      failed to provide sufficient relief.
    note: 'Found by winnow, kev and lev in p015, p017. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Pharmacologic management > Midodrine and pyridostigmine
    quote: Midodrine is an α1-adrenergic receptor agonist that has specifically been shown to improve symptoms in
      dysautonomic POTS.19
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacologic management of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatments
    quote: Our center reported that midodrine hydrochloride is effective in the treatment of children with POTS
      through a small non-blinded randomized controlled study (38).
    note: 'Found by winnow, kev and lev in p017, p022, p024. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Treatment
    quote: Additionally, fludrocortisone19 and midodrine20,21 can be helpful in some cases, while some centers have
      reported good results with octreotide (an octapeptide and somatostatin analog) in patients with postprandial
      tachycardia; however, this medication is expensive and only available in injection form.20,22
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Challenge II: Lack Of Standardized Approaches To Physical Rehabilitation And Psychopharmacology >
      Pharmacological Treatment Approaches'
    quote: Midodrine is an alpha-1 adrenergic agonist that has been shown to be helpful in the treatment of POTS
      and its effects are felt within 30–60 mins and last for 2–4 hrs.14
    note: 'Found by winnow, kev and lev in p005, p018. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Approach to therapy for patients with POTS > Pharmacologic interventions
    quote: Fludrocortisone is a reasonable option for increasing the intravascular volume, while midodrine is useful
      in those with peripheral pooling. Specifically, midodrine was superior to placebo in the subgroup of patients
      with peripheral venous pooling (as indicated by an increase in calf diameter during venous occlusion or tilt),
      whereas in patients without peripheral pooling, the HR change with midodrine was not significantly different
      from placebo.44
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030, p015. Claude judged: supports.'
  - paper: pmid27625098
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: THE INDIVIDUALIZED TREATMENT OF POSTURAL TACHYCARDIA SYNDROME > The alpha-adrenoreceptor agonists
    quote: Midodrine, an α1 adrenoreceptor agonist, can act on the α1 adrenergic receptor, constricting the vessels,
      so as to lessen the symptoms of POTS.
    note: 'Found by winnow, kev and lev in p021, p028. Claude judged: supports.'
  - paper: pmid26610893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: In fact, midodrine, which is commonly used to treat symptoms associated with POTS, acts primarily by
      reducing venous pooling.4
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid26241226
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: Other drugs which can also be therapeutically beneficial in patients with POTS are (1) drugs that increase
      peripheral vascular resistance such as midodrine, a prodrug whose active metabolite is an α-adrenoceptor antagonist,
      and somatostatin analogs; (2) drugs that can modify the central and peripheral activity of the sympathetic
      nervous system such as β-adrenoceptor antagonists (mainly propranolol), serotonin and norepinephrine uptake
      inhibitors, and combined α- and β-adrenoceptor antagonists; and (3) drugs that reduce the sympathetic tone
      such as clonidine.2,3,9
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p041. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 4: Postural Tachycardia Syndrome and Vasovagal Syncope in the Young > Treatment of Children
      with Vasovagal Syncope or POTS'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p022, p063, p078. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment approaches: Addressing neurohormonal imbalances (Table 1) > Partial autonomic neuropathy—alpha-1
      agonists'
    quote: More recently, it was shown that “high-flow” POTS patients were much more responsive to the treatment
      of midodrine than “low-flow” POTS patients (Ross et al., 2014).
    note: 'Found by winnow, kev and lev in p025, p026. Claude judged: supports.'
  - paper: pmid24857518
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Objectives
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24857518. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid24253613
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24253613. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid23978222
    cited: true
    text: full
    license: none
    verdict: supports
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23978222. Found by winnow, kev and lev in p004, p023, p024. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid23244360
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Common variant OI: POTS & postural VVS > Neuropathic POTS'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23244360. Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Vasoconstrictor Therapy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p017, p019. Claude judged: supports.'
  - paper: pmid21301135
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21301135. Found by winnow, kev and lev in p003, p001, p002. Claude judged: supports.'
  - paper: pmid20668563
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Partial dysautonomic POTS is best treated by increasing the peripheral vascular resistance and fluid
      volume.[10] This is often accomplished with fludrocortisones which promotes sodium and fluid retention, and
      midodrine which stimulates α1 -adrenergic receptors resulting in vasoconstriction.
    note: 'Found by winnow, kev and lev in p009, p004. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: Since a failure of vascular resistance may be an integral part of neuropathic POTS, vasoconstrictors
      such as midodrine (an alpha-1 agonist) can be employed [40].
    note: 'Found by winnow, kev and lev in p042. Claude judged: supports.'
  - paper: pmid10750641
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 10750641. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid40626134
    cited: true
    text: full
    license: by
    verdict: partial
    section: THE CURRENT STATUS OF INDIVIDUALIZED TREATMENT OF POTS IN CHILDREN > α‐Adrenergic receptor agonists
      in treating children with POTS
    quote: Hence, patients with POTS exhibit abnormally excessive vasodilatation might benefit from α‐adrenoreceptor
      agonists like midodrine hydrochloride.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: INTRODUCTION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Other medications that have demonstrated success in select cases include fludrocortisone, midodrine,
      methylphenidate, and pyridostigmine for orthostatic syndromes.11–13
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid32295399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case
    quote: Fludrocortisone and midodrine were reinitiated prior to the vascular decompression surgery, and ivabradine
      was initiated 2 months later. Ivabradine was beneficial for the POTS symptoms and later allowed tapering of
      fludrocortisone and midodrine.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038. Claude judged: partial.'
  - paper: pmid20309394
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Response to Medical therapy
    quote: 'Pharmacotherapy was used alone or in combination in the following order: fludrocortisone 0.1mg po bid,
      midodrine 5-10 mg po tid, propanolol10 mg po tid, pyrodostigmine 60 mg po bid, serotonin reuptake inhibitor
      or modafinil 100 mg po qam. Not every patient received every medication.'
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
- edge:
  - volume_expansion_therapy
  - treats
  - pots
  papers: 43
  evidence:
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Pharmacologic therapy, when appropriate consist of beta blockers, volume expanders, and midodrine.
    note: 'Found by winnow, kev and lev in p091, p100. Claude judged: supports.'
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: When hypovolemia is suspected, fludrocortisone, a synthetic mineralocorticoid, is commonly used to expand
      plasma volume and promote sodium retention, though potential side effects include acne, headache, hypokalemia,
      and fluid retention. Desmopressin (DDAVP) may provide short-term symptomatic relief by promoting free water
      retention but carries a risk of hyponatremia.
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion > 4.5 Rationality of current treatment approaches
    quote: Clinicians are advised to consider increasing salt intake or using water retention agents as a treatment
      strategy to improve hypovolemia and thereby alleviate POTS symptoms [12].
    note: 'Found by winnow, kev and lev in p060. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Anecdotally, we found that treatment of POTS with therapies targeting sympathetic overactivity, hypovolemia,
      and mast cell hyperactivity has been more efficacious than neuropathic pain medications. These therapies consist
      of beta blockers; increased oral fluids and salt intake; intravenous fluids; and other medications, such as
      pyridostigmine, which enhances parasympathetic transmission; midodrine, which increases vasoconstriction and
      therefore improves venous return and cerebral perfusion; and benzodiazepines, which may reduce IT via GABA-mediated
      actions in the central autonomic networks (Table 1).
    note: 'Found by winnow, kev and lev in p009, p008, p012. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Pharmacologic Therapies > Medications That Target Hypovolemia
    quote: In addition to salt supplementation, fludrocortisone, a glucocorticoid that acts similarly to aldosterone,
      has shown efficacy in improving POTS symptoms.[65]
    note: 'Found by winnow, kev and lev in p054. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Treatment strategies and outcomes > Pharmacological treatment
    quote: Fludrocortisone, a mineralocorticoid that increases plasma volume, is widely used in patients with hypovolemic
      POTS, yielding a 25–30% improvement in orthostatic tolerance [31].
    note: 'Found by winnow, kev and lev in p028, p026. Claude judged: supports.'
  - paper: pmid38958137
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: The medications that seemed to have the highest reported perceived efficacy by patients in combination
      with significant use included ondansetron (typically used for nausea), fludrocortisone (intravascular volume
      expansion), modafinil (fatigue), citalopram (psychiatric/autonomic modulation), and salt supplements (volume
      expansion).
    note: 'Found by winnow, kev and lev in p030, p042. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The management of POTS relies on symptom management through intravascular volume expansion, physical
      exercise, and lifestyle changes as well as compressive garments. Oral fluid intake should be aimed at 3L daily
      with a daily salt intake of about 8-12 g of sodium chloride to help reduce hypovolemia [16].
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patient management
    quote: Given the multifactorial pathogenesis of POTS itself, several studies have compared and evaluated the
      efficacy of various treatment approaches, including intravascular volume expansion, vasopressor therapy, heart
      rate reduction, and miscellaneous therapies [38].
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports > Pharmacological Therapies
    quote: In addition to the aforementioned oral hydration and salt intake, pharmacological volume expansion with
      fludrocortisone (mineralocorticoid agonist) has been found beneficial in a number of patients.
    note: 'Found by winnow, kev and lev in p030, p031, p036. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Patients are encouraged to increase fluid and salt intake, partake in aerobic exercise, and wear compression
      garments [2]. While there is no universal pharmacological guideline for POTS, medications such as fludrocortisone,
      pyridostigmine, midodrine, and beta blockers can help with its management, depending on the cause [2].
    note: 'Found by winnow, kev and lev in p004, p017. Claude judged: supports.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: The main treatment for post-COVID-19 POTS is volume expansion to increase cardiac preload. Various strategies
      exist to achieve volume expansion in POTS patients.
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid35697326
    cited: true
    text: full
    license: none
    verdict: supports
    section: Nutrition Assessment and Management of Patients with POTS > Fluids and Salt
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35697326. Found by winnow, kev and lev in p009, p010, p011. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How is POTS treated? > Pharmacological treatments
    quote: Drugs that expand blood volume can be useful if nonpharmacologic approaches to blood volume expansion
      are not successful, or if low blood volume is objectively documented by an assessment of blood volume using
      nuclear medicine.51 Fludrocortisone (0.1–0.2 mg daily) is a synthetic version of aldosterone that promotes
      renal sodium absorption and secondary blood volume expansion; hypokalemia is a potential adverse effect.
    note: 'Found by winnow, kev and lev in p031, p038. Claude judged: supports.'
  - paper: pmid33926653
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Abstract > Background:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33926653. Found by winnow, kev and lev in p010, p046, p001. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Available management protocols for POTS (Table 2) aim at increasing intake of fluids (water) and salt,
      physical countermaneuvers, and individually adapted aerobic exercise in recumbent position (1,5,9) to help
      correct the physiological abnormalities. Pharmacotherapy includes volume expanders, vasoconstrictors, and
      HR regulators but patients may remain symptomatic and incapable of work.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Management Strategies for Pots in Children and Adolescents > Pharmacological Treatment
    quote: Pediatric patients with POTS who are strongly suspected of having hypovolemia or inadequate salt intake
      are recommended to use oral rehydration salts (ORSs) for 1–3 months (5, 23, 98, 104) or to accept short-term
      intravenous saline as rescue treatment for patients with clinical decompensation and significant deterioration
      of symptoms (25). Saline supplements can alleviate symptoms in “hypovolemic” patients.
    note: 'Found by winnow, kev and lev in p024, p008, p023. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Hypovolemic Pots: Salt Supplements, Oral Rehydration and Fludrocortisone'
    quote: Hypovolemia can be seen in many POTS patients, and increasing fluids intake is an effective treatment
      of POTS symptoms.
    note: 'Found by winnow, kev and lev in p018, p021. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Treatment
    quote: In the common form of POTS, patients who experience a “normal adrenergic response” in the upright position
      may experience symptom resolution with methods such as increasing intravascular volume with intravascular
      saline (during acute decompensation), taking in liberal amounts of salt and water, wearing “belly button–high”
      compression stockings, and sleeping with the head of their bed elevated (to a 30-degree angle). Additionally,
      fludrocortisone19 and midodrine20,21 can be helpful in some cases, while some centers have reported good results
      with octreotide (an octapeptide and somatostatin analog) in patients with postprandial tachycardia; however,
      this medication is expensive and only available in injection form.20,22
    note: 'Found by winnow, kev and lev in p010, p035, p043. Claude judged: supports.'
  - paper: pmid30076469
    cited: true
    text: full
    license: by
    verdict: supports
    section: Treatment by comorbidity, subgrouping, and genetic profile > Treatment by comorbidity
    quote: Chelimsky reported that management of POTS in adolescents with CVS through fluid and salt supplementation,
      fludrocortisone, and low-dose propranolol reduced the numbers of vomiting episodes [6].
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p015, p001, p003. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p029, p030. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Non-Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p034. Claude judged: supports.'
  - paper: pmid23999934
    cited: true
    text: full
    license: none
    verdict: supports
    section: Conclusions > Potential interventions for brain fog > Non-pharmacologic interventions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23999934. Found by winnow, kev and lev in p014, p021, p023. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Volume Expansion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Sodium chloride 0.9% (Normal saline)
    quote: Sodium chloride 0.9% infusion has been reported very beneficial in decreasing symptoms in POTS patients
      and improving quality of life.[28] The infusion loads the POTS patient with sodium,[28] enhances blood and
      blood cell volume, and results in a slight elevation in blood pressure.
    note: 'Found by winnow, kev and lev in p018, p020, p019. Claude judged: supports.'
  - paper: pmid22561596
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'DISCUSSION > Blood Volume Expansion: DDAVP vs. Fludrocortisone'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22561596. Found by winnow, kev and lev in p029, p008, p023. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Non-Pharmacological Treatment of POTS
    quote: Acute blood volume expansion is effective at controlling the heart rate and acutely improving symptoms.
      Jacob et al. [37] found that 1 liter of physiological saline infused intravenously over 1 hour decreased the
      orthostatic tachycardia from 33±5 bpm before the infusion to 15±3 bpm immediately following the infusion.
    note: 'Found by winnow, kev and lev in p039, p037. Claude judged: supports.'
  - paper: pmid40761644
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: In the study by Ruzieh et al., though, intermittent infusions of saline dramatically reduced symptoms
      and improved quality of life in patients suffering from refractory POTS (21).
    note: 'Found by winnow, kev and lev in p003, p006, p008. Claude judged: partial.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: partial
    section: METHODS > Treatment options
    quote: As a standard treatment for POTS, patients were counseled to consume ≥10 g of salt and 2–3 L of water,
      except for those with hypertension and older people; instructed to wear elastic compression stockings up to
      the thighs; and prescribed bisoprolol, a β1‐selective blocker, once daily.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Management: Lifestyle Changes > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p118. Claude judged: partial.'
  - paper: pmid35870963
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Patient 2
    quote: Treatment of orthostatic intolerance consisted of increased dietary intake of fluids and sodium chloride,
      as well as buffered sodium chloride tablets (2712 mg daily).
    note: 'Found by winnow, kev and lev in p027, p023, p031. Claude judged: partial.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.2. Physiological Predictors
      for the Oral Rehydration Salts Efficacy in Pediatric POTS
    quote: Therefore, in patients with POTS, an intravenous saline or oral rehydration solution (ORS) could prevent
      syncope and improve OI and result in changes in the HR. However, the efficacy of salt replenishment was observed
      only in some POTS patients [61,62]; therefore, a worthwhile research topic would be a method for identifying
      responders to this therapy.
    note: 'Found by winnow, kev and lev in p016, p020. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment > Nonpharmacologic interventions
    quote: Two to three liters of water and 10 to 12 g of sodium daily is recommended by the HRS for patients with
      POTS and can be accomplished through diet or supplemental sodium tablets.5,7,23
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods > Pharmacologic management > Fludrocortisone and desmopressin
    quote: For hypovolemic POTS, fludrocortisone and desmopressin may help with symptom control.
    note: 'Found by winnow, kev and lev in p013, p015. Claude judged: partial.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Existing protocols include increased intake rates of dietary fluids and salt, physical counter-maneuvers,
      and aerobic/resistance training. If these therapies are ineffective, pharmacotherapy options including fludrocortisone,
      midodrine, pyridostigmine, and ivabradine are trialed.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Fluid intake up to 2.5 liters daily, which is equivalent to 10 standard cups a day and a total of 10
      grams of sodium chloride daily, noting that one salt tablet contains one gram of sodium chloride, helps expand
      the plasma volume and improve venous return and the re-loading of the right atrium.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid31405524
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31405524. Found by winnow, kev and lev in p009, p004, p030. Claude judged: partial.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p022, p023. Claude judged: partial.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: partial
    section: 'Treatment approaches: Addressing neurohormonal imbalances (Table 1) > Hypovolemia and renin-angiotensin-aldosterone
      paradox—volume loading'
    quote: The use of volume loading with intravenous saline is effective at acutely relieving the symptoms of POTS.
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: partial
    section: Non-Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p031. Claude judged: partial.'
  - paper: pmid20309394
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Response to Medical therapy
    quote: The therapeutic management approach for these patients was based on our previous experience with the
      management of patients with POTS. Initial therapy consisted of an increase in salt and fluid intake as well
      as aerobic reconditioning with resistance training to increase lower extremity strength.
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
- edge:
  - lifestyle_modification
  - treats
  - pots
  papers: 37
  evidence:
  - paper: pmid35697326
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35697326. Found by winnow, kev and lev in p004, p008, p010. Claude judged: supports.'
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Other environmental triggers, such as extreme heat and dehydration, aggravate symptoms of POTS [5]. Early
      counseling is recommended to avoid such conditions by proactively hydrating and increasing sodium intake.
    note: 'Found by winnow, kev and lev in p053, p091, p100. Claude judged: partial.'
  - paper: pmid41301791
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Neurologic Evaluation > 4.5. Treatment
    quote: Finally, aside from a high-sodium diet, gluten-free low-carb diet may be beneficial in some patients
      with POTS [34].
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid41142154
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Dietary management is another key area, as POTS symptoms often respond to changes in salt intake and
      hydration (4).
    note: 'Found by winnow, kev and lev in p032. Claude judged: partial.'
  - paper: pmid40869705
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Additional recommendations include a high-salt diet (6–10 g/day) and increased fluid intake (2.5–3 L/day);
      using compression garments (covering large venous reservoirs in the lower limbs and the pelvic region); consuming
      small, low-carbohydrate meals; avoiding prolonged bed rest; performing counter-maneuvers to prevent syncope
      (e.g., leg crossing and muscle tensing); avoiding caffeine, alcohol, and excessive heat; and strengthening
      psychological and social support [6].
    note: 'Found by winnow, kev and lev in p002, p023. Claude judged: partial.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment
    quote: Avoiding dehydration, prolonged sitting or standing, and medications that can exacerbate orthostatic
      symptoms is advised.
    note: 'Found by winnow, kev and lev in p009, p020. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Treatments and Therapies > Non-pharmacologic Therapies
    quote: Dietary changes can significantly improve the quality of life of POTS patients.
    note: 'Found by winnow, kev and lev in p047, p045. Claude judged: partial.'
  - paper: pmid39552985
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The patient made a remarkable functional recovery from POTS, as she responded well to pharmacotherapy,
      primarily beta-blockers, along with lifestyle modifications.
    note: 'Found by winnow, kev and lev in p001, p009, p025. Claude judged: partial.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case report
    quote: She was discharged from the hospital with the advice to continue with increased fluid and dietary salt
      intake as well as aerobic exercise as tolerated.
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Management > 4.1. Patient Education
    quote: An important aspect of COVID-19-related POTS management is patient education. Avoiding lying down, overeating,
      and high temperatures and humidity, and obtaining sufficient sleep should be primarily considered.
    note: 'Found by winnow, kev and lev in p022, p024. Claude judged: partial.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patient education is a cornerstone of treatment, empowering individuals to understand and manage their
      symptoms. In addition, POTS patients are encouraged to avoid exacerbating factors such as dehydration and
      extreme heat exposure [21].
    note: 'Found by winnow, kev and lev in p007, p011. Claude judged: partial.'
  - paper: pmid38962840
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: INTRODUCTION
    quote: POTS is mainly treated symptomatically with behavior modification, increased fluid and salt intake, compression
      garments, and off‐label medications.
    note: 'Found by winnow, kev and lev in p010, p004, p011. Claude judged: partial.'
  - paper: pmid38958137
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: RESULTS
    quote: Overall, the various types of interventions for POTS shown to be most helpful included the addition of
      medication(s), increased fluid and salt intake, and increased exercise (Table 7). Nearly 90% of patients continued
      to require increased salt and water intake as well as exercise to manage their POTS symptoms, with a median
      fluid intake of 64 ounces per day (IQR 48–96).
    note: 'Found by winnow, kev and lev in p030, p043, p044. Claude judged: partial.'
  - paper: pmid38074226
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Discussion
    quote: The patient should be advised on standing slowly and carefully from a lying or seated position and avoiding
      exacerbating factors such as alcohol intake, caffeine, prolonged standing and dehydration.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Treatment
    quote: It is advisable to avoid situations that can exacerbate symptoms, which has also been shown to be beneficial
      in POTS after SARS-CoV-2 infection (Table 1) (17, 87, 88).
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patient education is a crucial component of managing POTS cases. For the prevention of severe symptoms,
      the patient should be advised to avoid extremes of temperature, do strenuous exercise in upright posture in
      the initial phases, and be vigilant immediately in the post-prandial period after eating.
    note: 'Found by winnow, kev and lev in p020. Claude judged: partial.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Patient management
    quote: Treatment for these patients is aimed at alleviating symptoms, improving blood volume, and lifestyle
      changes.
    note: 'Found by winnow, kev and lev in p027. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports
    quote: Majority of patients showed quite a marked improvement in symptoms with lifestyle measures, beta blockers,
      fludrocortisone and occasional ivabradine use.
    note: 'Found by winnow, kev and lev in p022, p030. Claude judged: partial.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Behavioral changes to reduce triggers and maintenance of an upright posture to avoid deconditioning are
      recommended [12].
    note: 'Found by winnow, kev and lev in p004, p017. Claude judged: partial.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > POTS management
    quote: Other non-pharmacological interventions include increased fluid and salt intake, physical counter maneuvers
      (muscle contraction, leg crossing)33, compression devices, avoidance of medication worsening POTS, and avoidance
      of POTS symptom exacerbation such as caffeine and alcohol intake and heat exposure21,24,34.
    note: 'Found by winnow, kev and lev in p014, p017, p029. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Management: Lifestyle Changes > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p123, p118, p124. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment > Nonpharmacologic interventions
    quote: It is important that the patient start a graduated exercise plan, beginning with recumbent exercises,
      and take caution not to overexert.14 The patient should avoid activities that may cause overheating.
    note: 'Found by winnow, kev and lev in p029, p030. Claude judged: partial.'
  - paper: pmid34792683
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34792683. Found by winnow, kev and lev in p006, p003. Claude judged: partial.'
  - paper: pmid34786979
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results and discussion > Adapting to cope with PoTS
    quote: Dietary changes such as increasing sodium intake,33 reducing refined carbohydrates and foods high in
      fat and fibre are often recommended in this population who are more likely to struggle with delayed gastric
      emptying.34
    note: 'Found by winnow, kev and lev in p049. Claude judged: partial.'
  - paper: pmid33689063
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33689063. Found by winnow, kev and lev in p004, p001, p007. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The management of our POTS patients included education and reassurance, non-pharmacological measures,
      and drugs, as no single therapy is effective. In our experience, most patients responded to counselling, regarding
      the essentiality of doing recumbent exercises, avoid long-standing and overheating, drink an excess of water,
      excess intake of salt, elevate the head end of the bed, elastic compression and beta-blocker therapy.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Treatment protocols for POTS have been described in detail previously.5–7 Existing protocols include
      increased intake rates of dietary fluids and salt, physical counter-maneuvers, and aerobic/resistance training.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: partial.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: partial
    section: Ms. Lei, Ms. Sheikh, and Dr. Raj consider
    quote: Lasting improvements in POTS symptoms rely on therapy regimens founded upon lifestyle changes that begin
      with the maintenance of high fluid and dietary salt intake, with the primary goal of augmenting plasma volume.
    note: 'Found by winnow, kev and lev in p023, p035, p010. Claude judged: partial.'
  - paper: pmid29628432
    cited: true
    text: full
    license: none
    verdict: partial
    section: 5. Treatment Strategies for Cognitive Dysfunction in POTS > 5.2 Non-Pharmacological interventions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29628432. Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Postural Tachycardia Syndrome, Gastrointestinal Symptoms and Splanchnic Circulation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Approach to therapy for patients with POTS
    quote: The first consideration in managing POTS is patient education concerning pathophysiology and symptoms,
      with numerous simple lifestyle strategies aimed to reduce the burden of POTS-related symptoms.
    note: 'Found by winnow, kev and lev in p022, p021, p023. Claude judged: partial.'
  - paper: pmid28674681
    cited: true
    text: full
    license: by
    verdict: partial
    section: Co-morbid Conditions > Orthostatic Intolerance (OI) > Management/Treatment > Avoid Pooling of Blood
    quote: This involves avoiding prolonged standing or sitting, such as by moving around during longer classroom
      lectures, standing and stretching periodically to break up study sessions, and shopping at off hours. Patients
      should avoid saunas, hot-tubs and sunbathing, and take short, cool baths, and showers.
    note: 'Found by winnow, kev and lev in p170. Claude judged: partial.'
  - paper: pmid23999934
    cited: true
    text: full
    license: none
    verdict: partial
    section: Conclusions > Potential interventions for brain fog > Non-pharmacologic interventions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23999934. Found by winnow, kev and lev in p013, p021. Claude judged: partial.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: partial
    section: Non-Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Treatment > Diet
    quote: Changing diet and eating habits and increasing fluid intake help people with POTS. Eating small meals
      has been said to reduce the severity of postprandial hypotension, because the amount of blood required for
      digestion is reduced.[24]
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p012, p018. Claude judged: partial.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: partial
    section: Non-Pharmacological Treatment of POTS
    quote: It is important to educate the patient about the nature of the disorder. The patient should avoid aggravating
      factors such as dehydration, and extreme heat.
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
- edge:
  - compression_therapy
  - treats
  - pots
  papers: 30
  evidence:
  - paper: pmid42299168
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Based on history and physical examination findings, the patient is diagnosed with POTS. She is recommended
      to increase fluid and salt intake, use compression garments, and start a structured recumbent exercise program.
    note: 'Found by winnow, kev and lev in p091, p100. Claude judged: supports.'
  - paper: pmid41976810
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Conservative treatment includes aiming for 2–3 L of fluids a day and 10–12 g of salt a day, using compression
      garments, and techniques such as squeezing the buttocks and crossing the legs when standing [3,4,5].
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid41898333
    cited: true
    text: full
    license: by
    verdict: supports
    section: 12. Discussion
    quote: The evidence for this mechanism comes from improved orthostatic symptoms in patients with POTS following
      compression garment therapy [29,111], symptomatic improvement following interventions that augment venous
      return [113], and experimental evidence demonstrating increased autonomic signaling with occlusion of veins
      [102,103].
    note: 'Found by winnow, kev and lev in p031, p037. Claude judged: supports.'
  - paper: pmid41483109
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Physiological Efficacy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41483109. Found by winnow, kev and lev in p008, p057. Claude judged: supports.'
  - paper: pmid41338488
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: Compression garments are a frequently prescribed treatment for POTS. Compression garments provide pressure
      to the abdomen and legs, shifting pooled blood back to the heart.
    note: 'Found by winnow, kev and lev in p004, p007, p008. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Non-pharmacological interventions
    quote: In total, seven RCT and 13 non-RCTs assessing non-pharmacological therapeutic options in POTS were analysed.
      Interventions include breathing devices, compression garments, physical exercise, salt supplementation, transdermal
      vagus nerve stimulation (tVNS), increased oral water intake, intravenous saline infusions and gluten-free
      diet.
    note: 'Found by winnow, kev and lev in p015, p017, p018. Claude judged: supports.'
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Treatments Impact Core Disease Symptoms Differently.
    quote: As expected, compression stockings and Mestinon most frequently improved symptoms of POTS (63.7% and
      56.9%, respectively), while beta blockers and ivabradine primarily alleviated POTS symptoms (66.0%).
    note: 'Found by winnow, kev and lev in p018, p033. Claude judged: supports.'
  - paper: pmid40475217
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: Abdominal compression bands may relieve symptoms while standing and improve hemodynamic and autonomic
      nervous functions in children with POTS.
    note: 'Found by winnow, kev and lev in p004, p008, p032. Claude judged: supports.'
  - paper: pmid39685762
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Compression garments are known to reduce symptoms in POTS and nOH [17,18,19,20]. Patients with POTS and
      nOH typically have excessive venous pooling in the legs and abdomen due to inadequate vascular tone [21].
    note: 'Found by winnow, kev and lev in p004, p005, p001. Claude judged: supports.'
  - paper: pmid39614865
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39614865. Found by winnow, kev and lev in p004, p005, p001. Claude judged: supports.'
  - paper: pmid39582711
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Although compression garments are commonly used as a treatment for patients with POTS, little is known
      about the patient experience with these garments.
    note: 'Found by winnow, kev and lev in p006, p015, p052. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Non-pharmacological treatment
    quote: Non-pharmacological interventions are crucial in managing POTS and can significantly improve patient
      outcomes. Key strategies include increased fluid and salt intake, physical counter-maneuvers, exercise training,
      and the use of compression garments [37].
    note: 'Found by winnow, kev and lev in p022, p028, p030. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.4. Treatment for COVID-19-Related POTS Due to Intravenous or Splanchnic Pooling
    quote: For non-pharmacological intervention, compression stockings of 30 to 40 mmHg can be used as well as abdominal
      binders of 10 mmHg in POTS [52]. Abdominal binders are more useful than compression stockings because significant
      amounts of venous blood are shifted from visceral veins via abdominal compression [68,69].
    note: 'Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid38260095
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Abdominal and lower-extremity compression garments have been used as a potential treatment for POTS (Heyer,
      2014; Bryarly et al., 2019; Bourne et al., 2021).
    note: 'Found by winnow, kev and lev in p005, p004, p029. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patient management
    quote: Given the multifactorial pathogenesis of POTS itself, several studies have compared and evaluated the
      efficacy of various treatment approaches, including intravascular volume expansion, vasopressor therapy, heart
      rate reduction, and miscellaneous therapies [38]. Based on current evidence, the Canadian Cardiovascular Society
      recommends non-pharmacological therapy as the first line management approach – withdrawal of exacerbating
      medications, increasing blood volume with dietary interventions, use of compression stockings, adoption of
      head-up tilt sleeping position, and semi-recumbent exercises [39].
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Compressive garments significantly reduce venous pooling and improve POTS symptoms [73].
    note: 'Found by winnow, kev and lev in p059. Claude judged: supports.'
  - paper: pmid36694653
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: "Compression garments have been highlighted as a tool in the management of PoTS,\n23\n, \n24\n therefore\
      \ the compressive effects of DEFOs might help to reduce symptoms."
    note: 'Found by winnow, kev and lev in p005, p015. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Lifestyle Changes > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p119, p128. Claude judged: supports.'
  - paper: pmid34390682
    cited: true
    text: full
    license: none
    verdict: supports
    section: Possible Treatment for Post-COVID Tachycardia Syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34390682. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid33478652
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Objectives
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33478652. Found by winnow, kev and lev in p002, p004, p005. Claude judged: supports.'
  - paper: pmid32673517
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: Thus, compression of venous capacitance beds in the abdomen or lower body with compression garments has
      been widely recommended as a nonpharmacologic approach for the treatment of POTS, alone and in combination
      with drug therapy, to attenuate orthostatic venous pooling,1, 4, 14, 15, 16, 17 particularly in the splanchnic
      capacitance bed where excessive pooling has been reported in some POTS patients.18, 19
    note: 'Found by winnow, kev and lev in p012, p001, p013. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Treatment
    quote: In the common form of POTS, patients who experience a “normal adrenergic response” in the upright position
      may experience symptom resolution with methods such as increasing intravascular volume with intravascular
      saline (during acute decompensation), taking in liberal amounts of salt and water, wearing “belly button–high”
      compression stockings, and sleeping with the head of their bed elevated (to a 30-degree angle).
    note: 'Found by winnow, kev and lev in p010, p048. Claude judged: supports.'
  - paper: pmid31788462
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Based on current understanding of potential etiology, several non-pharmacological treatments have been
      introduced into POTS treatment, such as reducing venous pooling by wearing lower-body compression garments
      or practicing resistance training for the thighs (23).
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. REDUCTION IN VENOUS POOLING
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p019, p020, p001. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Approach to therapy for patients with POTS > Nonpharmacologic interventions
    quote: The use of full-length pressure stockings can be of considerable benefit in reducing POTS symptoms.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Non-Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid24840763
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24840763. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Non-Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p042, p030. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Non-Pharmacological Treatment of POTS
    quote: Elastic support hose can help to minimize the degree of peripheral venous pooling and enhance venous
      return. We recommend 30-40 mmHg of counter-pressure and they should come up to the waist.
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038. Claude judged: partial.'
- edge:
  - pyridostigmine_therapy
  - treats
  - pots
  papers: 27
  evidence:
  - paper: pmid41684377
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Case presentation
    quote: Due to persistent symptoms, pyridostigmine was added at 30 mg BID and titrated to 60 mg TID as a treatment
      of POTS, which resulted in significant symptomatic improvement.
    note: 'Found by winnow, kev and lev in p002, p004, p005. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Evidence is still scarce and no studies on its use in children were found, so further studies on the
      long-term use of pyridostigmine in children and adults are essential to assess its effects on POTS. However,
      pyridostigmine could be considered as a potential treatment option in POTS if non-pharmacological interventions
      and the use of β-adrenergic blocking agents or ivabradine are not sufficient.
    note: 'Found by winnow, kev and lev in p040, p029, p074. Claude judged: supports.'
  - paper: pmid40681233
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Short-term use of desmopressin may be considered for patients who are hypovolemic, whereas pyridostigmine
      has been proven to provide long-term improvement in patients.4
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Anecdotally, we found that treatment of POTS with therapies targeting sympathetic overactivity, hypovolemia,
      and mast cell hyperactivity has been more efficacious than neuropathic pain medications. These therapies consist
      of beta blockers; increased oral fluids and salt intake; intravenous fluids; and other medications, such as
      pyridostigmine, which enhances parasympathetic transmission; midodrine, which increases vasoconstriction and
      therefore improves venous return and cerebral perfusion; and benzodiazepines, which may reduce IT via GABA-mediated
      actions in the central autonomic networks (Table 1).
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.6. Treatment for COVID-19-Related POTS Due to an Autoimmune Mechanism
    quote: Pyridostigmine is typically administered in dosages ranging from 30 to 60 mg, three times daily. The
      drug helps reduce heart rate increase upon standing and alleviates the clinical symptoms of orthostatic intolerance
      in patients with POTS [76].
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid37313107
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Although pyridostigmine was proven to alleviate symptoms, insufficient data supports its usage in children
      and adolescents.
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Review of Clinical Reports > Pharmacological Therapies
    quote: Pyridostigmine (an acetylcholinesterase inhibitor) has been used with some benefit, particularly in patients
      with autoimmune / paraneoplastic POTS.
    note: 'Found by winnow, kev and lev in p035, p030. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Pyridostigmine: It’s a reversible acetylcholinesterase inhibitor usually given in a dose of 30 to 60
      mg three times per day. It improves orthostatic heart rate and clinical symptoms of orthostatic intolerance
      in POTS patients [87].'
    note: 'Found by winnow, kev and lev in p067. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Pharmacologic Treatment > Postural Orthostatic Tachycardia Syndrome49,50,170'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p163. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: How is POTS treated? > Pharmacological treatments
    quote: A 2005 study found that pyridostigmine (30–60 mg, given orally 3 times daily) can acutely decrease upright
      heart rate in patients with POTS;48 it acts either by directly increasing vagal tone or by increasing sympathetic
      vasoconstriction.
    note: 'Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Pharmacologic management > Midodrine and pyridostigmine
    quote: In a small, placebo-controlled crossover study of 17 patients with POTS, the orthostatic heart rate was
      significantly improved at two and four hours after the administration of 30 mg of pyridostigmine relative
      to placebo therapy.20 Study participants reported a significant improvement in symptom burden on pyridostigmine
      after four hours without an observed effect on blood pressure, demonstrating that proper vascular tone in
      these patients plays a significant role in dysautonomic POTS.20
    note: 'Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Medicações como midodrina associadas a baixa dose de betabloqueador não seletivo (propranolol), fludrocortisona
      e piridostigmina são úteis nas formas disautonômicas e hipovolêmicas da SPOT.
    note: 'Found by winnow, kev and lev in p133. Claude judged: supports.'
  - paper: pmid33423527
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Hemodynamics Before and During the Modified Oxford Method > SAP Presodium Nitroprusside
    quote: In contrast, SAP was reduced when supine in POTS unmedicated, increasing with the addition of pyridostigmine
      or digoxin to control levels while remaining supine. With tilt, SAP was reduced in all POTS compared with
      control regardless of treatment.
    note: 'Found by winnow, kev and lev in p028, p044, p031. Claude judged: supports.'
  - paper: pmid33244220
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patients and Methods > Medications Associated with DES
    quote: Furthermore, patients with POTS are commonly prescribed pyridostigmine for autonomic symptom management.
    note: 'Found by winnow, kev and lev in p016, p031. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment of Neuropathic Pots: Midodrine and Pyridostigmine'
    quote: Pyridostigmine, a peripheral acetylcholinesterase inhibitor, could be used to treat patients with POTS.
    note: 'Found by winnow, kev and lev in p026, p017. Claude judged: supports.'
  - paper: pmid31788462
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Currently used drugs for POTS include β-adrenoreceptor blockers, α-adrenoreceptor agonists, pyridostigmine
      and fludrocortisone, each of which has a distinct while overlapping mechanism underlying its observed clinical
      efficacy (3).
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Treatment of POTS (Table 2) > Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p040. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid24982638
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Treatment approaches: Addressing neurohormonal imbalances (Table 1) > Hyperadrenergic state—heart
      rate control'
    quote: Pyridostigmine, an acetylcholinesterase inhibitor, has also been used to manage orthostatic tachycardia
      (Raj, 2013).
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: Recovery > Management of POTS and Associated Conditions > Medications for Blood Flow
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p092. Claude judged: supports.'
  - paper: pmid23244360
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Common variant OI: POTS & postural VVS > Neuropathic POTS'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23244360. Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Increasing Vagal Tone
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid22783324
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Treatment > Pyridostigmine bromide
    quote: Occasionally pyridostigmine bromide is used to treat POTS.[41],[42] Pyridostigmine bromide enhances the
      effect of acetylcholine by inhibiting its breakdown,[43] but some studies suggest that the pathophysiology
      in some POTS atients is related to the production of antibodies that block the acetylcholine receptor.
    note: 'Found by winnow, kev and lev in p025, p026. Claude judged: supports.'
  - paper: pmid21410722
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21410722. Found by winnow, kev and lev in p002, p001, p003. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: By increasing the levels of synaptic acetylcholine at both the autonomic ganglia and the peripheral muscarinic
      parasympathetic receptors, pyridostigmine significantly restrained the heart rate in response to standing
      in our patients with POTS. We prescribe pyridostigmine 30mg to 60 mg PO TID alone or in combination with low
      dose propranolol.
    note: 'Found by winnow, kev and lev in p043. Claude judged: supports.'
  - paper: pmid15911704
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15911704. Found by winnow, kev and lev in p002, p003. Claude judged: supports.'
- edge:
  - central_sympatholytic_therapy
  - treats
  - pots
  papers: 17
  evidence:
  - paper: pmid40681233
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Central sympatholytic agents such as methyldopa or clonidine may also be used, and if these are not tolerated,
      peripheral β-adrenergic therapies are considered.4
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Pharmacologic Therapies > Medications That Target Sympathetic Activity
    quote: Clonidine, an α2-adrenergic receptor agonist, improves POTS symptoms by decreasing sympathetic activity
      and reducing autonomic instability.[9] Methyldopa, a longer acting α2-adrenergic receptor agonist, is reported
      to be better tolerated by POTS patients than clonidine.[74]
    note: 'Found by winnow, kev and lev in p055. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Management > 4.5. Treatments for COVID-19-Related POTS Due to Increased Norepinephrine in the Blood
    quote: Clonidine and methyldopa may be effective for POTS by decreasing central sympathetic signals [75].
    note: 'Found by winnow, kev and lev in p026. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p035, p003, p004. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Pharmacologic Treatment > Postural Orthostatic Tachycardia Syndrome49,50,170'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p166. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Na forma hiperadrenérgica, a clonidina ou alfa-metildopa podem ser eficazes (classe IIb).11
    note: 'Found by winnow, kev and lev in p133, p166. Claude judged: supports.'
  - paper: pmid32805514
    cited: true
    text: full
    license: none
    verdict: supports
    section: ETIOLOGY AND PREDISPOSING CONDITIONS > Neurogenic Orthostatic Hypotension > Exacerbating Medications
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32805514. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Treatment > Pharmacologic treatment'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p039. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Pharmacological Treatment of POTS (Table 6) > Vanderbilt Approach to
      Pharmacotherapy for POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p016, p019. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pharmacological Treatment of POTS
    quote: Central sympatholytic medications are often useful and well tolerated in patients with the central hyperadrenergic
      form of POTS, but may not be as well tolerated in neuropathic POTS.
    note: 'Found by winnow, kev and lev in p040, p029. Claude judged: supports.'
  - paper: pmid42696970
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42696970. Found by winnow, kev and lev in p001, p004, p002. Claude judged: partial.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Central sympatholytic drugs like clonidine and methyldopa have been shown to positively impact the symptoms
      in the hyperadrenergic variant of POTS but remain of limited use in the neuropathic variant [2].
    note: 'Found by winnow, kev and lev in p091. Claude judged: partial.'
  - paper: pmid40951270
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: The central sympatholytic drug, e.g., guanfacine, has been shown to improve symptoms in hyperadrenergic
      POTS[8].
    note: 'Found by winnow, kev and lev in p042. Claude judged: partial.'
  - paper: pmid29102451
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome > Pharmacological Treatment
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29102451. Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038. Claude judged: partial.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: partial
    section: Management > Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p029. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - treats
  - pots
  papers: 17
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Immunotherapies > Immunologic therapies and ongoing clinical trials for POTS and other common autonomic
      disorders > Other traditional immunomodulators
    quote: Although immunomodulating therapies have not been typically included in the standard pharmacologic approaches
      for POTS and OCADs, these treatment options have been gaining utility, especially in the context of comorbid
      UCTD, systemic autoimmune disorders, and Long COVID. These pharmacotherapies include oral, IV, and subcutaneous
      (SQ) corticosteroids, low-dose naltrexone, and immunosuppressants, such as hydroxychloroquine.
    note: 'Found by winnow, kev and lev in p022, p025, p029. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Treatments and Therapies > Pharmacologic Therapies > Medications with Undefined Mechanisms or Subtype-specific
      Targets
    quote: For patients with autoimmune-associated POTS, particularly those diagnosed with SFN, IVIG and plasmapheresis
      have demonstrated improvement in symptoms.[79]
    note: 'Found by winnow, kev and lev in p028, p058. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Treatment strategies and outcomes > Pharmacological treatment
    quote: IVIG has emerged as a potential treatment option in immune-mediated POTS cases, showing a 50% improvement
      in HRV in some patients after six months of therapy [28].
    note: 'Found by winnow, kev and lev in p024, p023, p025. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.6. Treatment
    quote: Kesterson et al. presented a case series of seven patients with POTS treated with subcutaneous immunoglobulin
      or plasmapheresis.
    note: 'Found by winnow, kev and lev in p037, p034, p036. Claude judged: supports.'
  - paper: pmid36008726
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36008726. Found by winnow, kev and lev in p001, p004, p003. Claude judged: supports.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Objectives
    quote: We observed postural orthostatic tachycardia syndrome (POTS) which resolved with immunomodulation in
      a patient with Pediatric acute-onset neuropsychiatric syndrome (PANS).
    note: 'Found by winnow, kev and lev in p001, p021. Claude judged: supports.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusions
    quote: These findings suggest that autoimmune-mediated neuropathic PoTS can be treated sufficiently with IVIg
      whereas SCIg minimizes side-effects.
    note: 'Found by winnow, kev and lev in p005, p017, p004. Claude judged: supports.'
  - paper: pmid34117922
    cited: true
    text: full
    license: by
    verdict: supports
    section: Immunomodulatory treatment in postural tachycardia syndrome > Comment
    quote: This case series describes improvement in subjective and objective measures of orthostatic intolerance
      in six patients with positive autoantibodies treated with six cycles of IVIG. The open label nature of the
      case series creates ample opportunity for reporting bias but is a promising result for the use of IVIG in
      patients with refractory POTS with suspected autoimmunity.
    note: 'Found by winnow, kev and lev in p016, p017, p014. Claude judged: supports.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: supports
    section: CNS-targeted therapy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid33382525
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background And Purpose
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33382525. Found by winnow, kev and lev in p004, p001, p002. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract
    quote: IVIg is emerging as a promising therapy for POTS.
    note: 'Found by winnow, kev and lev in p001, p011, p014. Claude judged: supports.'
  - paper: pmid41403551
    cited: true
    text: full
    license: by-nc-sa
    verdict: partial
    section: Case Report
    quote: Self-measurements of blood pressure before, during, and after the three IVIG cycles showed an overall
      reduction in the difference between systolic blood pressure values and heart rate in the supine position compared
      to the upright position [Figure 1]. The tilt table tests before and after the IVIGs also showed a significant
      reduction in the difference in blood pressure between the supine and upright positions [Table 2].
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment
    quote: Finally, immunotherapy is emerging as potentially effective in severe, treatment-refractory patients
      with POTS, post-COVID dysautonomia and other forms of dysautonomia and is considered standard therapy for
      autonomic disorders such as autoimmune autonomic ganglionopathy (AAG) and autoimmune autonomic neuropathies
      (AAN) in general [36–38].
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: While IVIG is still under investigation, two of three patients in this case series noted relative improvement
      in symptoms shortly after its administration. Importantly, all three patients tolerated the IVIG treatment
      without complication.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid33505857
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Although the exact mechanism behind the treatment’s efficaciousness must be further studied, we present
      one of the first recorded alleviations of POTS using immunomodulatory therapy.
    note: 'Found by winnow, kev and lev in p007, p009. Claude judged: partial.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion > Immunomodulatory Treatments in Patients With POTS
    quote: Taken together, these above reports on efficacy of immunomodulatory therapy in select patients with POTS
      lack both systematic assessment of serum positivity for autoantibodies against GPCRs as entrance criterion
      and randomization of patients to a placebo‐controlled arm.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid31547756
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: The use of immunotherapy in POTS is currently controversial, although case reports and case series have
      shown that immune therapy improves POTS symptoms in patients with comorbid autoimmune diseases and refractory
      disease.3, 15, 16
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - physical_countermaneuvers
  - treats
  - pots
  papers: 12
  evidence:
  - paper: pmid41976810
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Conservative treatment includes aiming for 2–3 L of fluids a day and 10–12 g of salt a day, using compression
      garments, and techniques such as squeezing the buttocks and crossing the legs when standing [3,4,5].
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Non-pharmacological treatment
    quote: Exercise and physical counter-maneuvers, such as muscle contraction and leg crossing, are essential for
      promoting venous return and maintaining hemodynamic stability. The incorporation of these non-pharmacological
      strategies into daily routines has been associated with a 40% reduction in HRV and a significant decrease
      in orthostatic symptoms, making them a cornerstone of POTS management [42].
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Management: Lifestyle Changes > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p123. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.1. Physiological Indicators
      Predicting the Efficacy of Non-Pharmacotherapy Treatment in Children with POTS
    quote: These treatments include physical movement, exercise designed to enhance physical fitness, and sleep–wake
      loop rectification. Physical motion, such as stamping, leg crossing, and slow standing with a bowed head,
      help prevent the flow of blood into the lower body parts and sustain cerebral circulation during an upright
      posture [51,52].
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The common protocols for the management of POTS symptoms include exercises in the recumbent position,
      such as physical counterpressure techniques, to help stabilize blood pressure and heart rate.
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid33723532
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Available management protocols for POTS (Table 2) aim at increasing intake of fluids (water) and salt,
      physical countermaneuvers, and individually adapted aerobic exercise in recumbent position (1,5,9) to help
      correct the physiological abnormalities.
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The treatment of POTS requires a two-pronged approach. Conservative measures, including physical counter-maneuvres,
      immediately during a POTS attack is useful to abort episodes.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: supports
    section: 5. PHYSICAL COUNTERMEASURES
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p001, p021, p022. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Approach to therapy for patients with POTS > Nonpharmacologic interventions
    quote: Nonpharmacologic strategies include avoidance of exposures that may contribute to overheating, improving
      venous return by activation of calf muscles and tonic muscle contraction when lightheaded.
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid26199795
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Therapy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26199795. Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Management
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p029, p026. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Treatments and Therapies > Non-pharmacologic Therapies
    quote: Physical maneuvers such as leg crossing, muscle pumping, and squatting may improve acute symptom onset.[60]
    note: 'Found by winnow, kev and lev in p045. Claude judged: partial.'
- edge:
  - serotonergic_therapy
  - treats
  - pots
  papers: 8
  evidence:
  - paper: pmid24227635
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24227635. Found by winnow, kev and lev in p007, p030, p001. Claude judged: supports.'
  - paper: pmid20309394
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Response to Medical therapy
    quote: 'Pharmacotherapy was used alone or in combination in the following order: fludrocortisone 0.1mg po bid,
      midodrine 5-10 mg po tid, propanolol10 mg po tid, pyrodostigmine 60 mg po bid, serotonin reuptake inhibitor
      or modafinil 100 mg po qam.'
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid40454385
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: According to the patient’s condition, treatment with paroxetine hydrochloride was initiated, resulting
      in a significant improvement in POTS symptoms and a rapid cessation of progressive syncope episodes.
    note: 'Found by winnow, kev and lev in p008, p012, p003. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Treatments and Therapies > Pharmacologic Therapies > Medications with Undefined Mechanisms or Subtype-specific
      Targets
    quote: Selective serotonin reuptake inhibitors (SSRIs) have demonstrated symptomatic improvement in POTS patients.[75]
      These medications increase monoamine neurotransmitter availability in the synaptic cleft to increase neurotransmission.[75]
    note: 'Found by winnow, kev and lev in p056. Claude judged: partial.'
  - paper: pmid35870963
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: For example, both orthostatic intolerance and co-morbid anxiety/depression would be expected to respond
      to serotonin reuptake inhibitors.
    note: 'Found by winnow, kev and lev in p018, p031, p041. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment > Pharmacologic interventions
    quote: A review of studies and literature has suggested that the most effective and useful medications in the
      treatment of POTS may be certain beta-blockers, selective serotonin reuptake inhibitors (SSRIs), and fludrocortisone.2
    note: 'Found by winnow, kev and lev in p036, p034. Claude judged: partial.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: Recovery > Management of POTS and Associated Conditions > Medications for Blood Flow
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p090. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p038. Claude judged: partial.'
- edge:
  - auricular_vagus_nerve_stimulation
  - treats
  - pots
  papers: 6
  evidence:
  - paper: pmid42342403
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Background and rationale
    quote: Notably, a recent double-blind, sham-controlled trial study20 revealed that daily AVNT for 2 months notably
      enhances postural tachycardia and autonomic symptoms, indicating improved autonomic control and vascular function
      without affecting BP. AVNT has also been associated with improved autonomic regulation and reduced inflammatory
      markers, highlighting its therapeutic potential in POTS.
    note: 'Found by winnow, kev and lev in p008, p133, p002. Claude judged: supports.'
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > LL‐TS and POTS
    quote: Therefore, that LL‐TS is a noninvasive neuromodulation in autonomic balance for individuals with POTS
      following post‐acute COVID‐19 infection.
    note: 'Found by winnow, kev and lev in p025, p003, p007. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Transcutaneous Vagus Nerve Stimulation in POTS > tVNS and POTS: Clinical Evidence'
    quote: In another open-label clinical trial, 4 hours of tVNS daily at the cymba conchae region for 14 days was
      associated with a significant reduction in orthostatic intolerance and gastrointestinal symptoms in POTS patients.[45]
      A tendency of reduced HR following standing posture was also noted in the tVNS group.
    note: 'Found by winnow, kev and lev in p020, p004, p015. Claude judged: supports.'
  - paper: pmid37999672
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37999672. Found by winnow, kev and lev in p023, p003, p004. Claude judged: supports.'
  - paper: pmid37705568
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Auricular vagus nerve stimulation has also been reported to be useful for POTS [47].
    note: 'Found by winnow, kev and lev in p051. Claude judged: supports.'
  - paper: pmid37631004
    cited: true
    text: full
    license: by
    verdict: partial
    section: 8. Electroceutical Therapy for Autoimmune Disease > 8.7. Postural Orthostatic Tachycardia Syndrome
      (POTS)
    quote: The observation that LLTS ameliorated autoantibody-induced autonomic dysfunction and inflammation suggests
      that noninvasive stimulation could offer a novel, effective, safe neuromodulatory therapeutic strategy for
      patients with POTS, particularly those suffering from the hyperadrenergic subtype.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
- edge:
  - offending_medication_withdrawal
  - treats
  - pots
  papers: 6
  evidence:
  - paper: pmid42037960
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Pharmacologic intervention in POTS patients usually begins with discontinuation of medications that may
      exacerbate tachycardia or hypovolemia, such as vasodilators, diuretics, and serotonin-norepinephrine reuptake
      inhibitors (SNRIs).
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The first step in pharmacological treatment is to discontinue medications that might contribute to tachycardia
      [22].
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Patient management
    quote: Based on current evidence, the Canadian Cardiovascular Society recommends non-pharmacological therapy
      as the first line management approach – withdrawal of exacerbating medications, increasing blood volume with
      dietary interventions, use of compression stockings, adoption of head-up tilt sleeping position, and semi-recumbent
      exercises [39].
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid34327047
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Management > Nonpharmacologic management
    quote: Nonpharmacologic management options are first-line therapies.1,11 This includes cessation of medications
      that may worsen POTS, such as norepinephrine reuptake inhibitors.1
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid26241226
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: Management of POTS is multifaceted and includes discontinuation of any medications that could contribute
      to orthostatic intolerance, such as α-adrenoceptor antagonists, diuretics, cGMP-specific phosphodiesterase
      type 5 inhibitors (sildenafil), and organic nitrates and nitrites, along with identifying those conditions
      that may cause secondary POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid23217691
    cited: true
    text: full
    license: none
    verdict: supports
    section: POSTURAL TACHYCARDIA SYNDROME > Non-Pharmacological Treatment of POTS (Table 4)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23217691. Found by winnow, kev and lev in p012. Claude judged: supports.'
- edge:
  - antihistamine_therapy
  - treats
  - mast_cell_activation
  papers: 3
  evidence:
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: For example, pacing is recommended care to manage energy levels and avoid PEM in ME/CFS; fluid/electrolytes,
      compression stockings and Mestinon to help manage OI; beta-blockers and ivabradine to aid tachycardia present
      in POTS; IgG for use in immune dysfunction; antihistamines (H1 and/or H2 inhibitors) and other select treatments
      to manage MCAS; low-dose naltrexone to manage pain; and melatonin to mitigate sleep problems.
    note: 'Found by winnow, kev and lev in p033, p014. Claude judged: supports.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Materials and Methods
    quote: Medical therapy starts with a combination of non-sedating histamine receptor 1 and histamine receptor
      2 blockers twice daily [9]. If the response is inadequate or the patients have significant symptoms, they
      receive additional over-the-counter MC stabilizing agents such as vitamins C and D and quercetin, a flavonoid.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: supports.'
  - paper: pmid38867988
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation > History
    quote: Additionally, mast cell activation syndrome (MCAS) was suspected given relief with cetirizine.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
- edge:
  - prokinetic_therapy
  - treats
  - gi_dysmotility
  papers: 2
  evidence:
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: This case series describes three adolescent females with specialist-confirmed dysautonomia and refractory
      GI dysmotility who were treated with a standardized short-course, low-dose metoclopramide bridge protocol
      as part of a multidisciplinary management approach. To our knowledge, this is the first published report specifically
      describing metoclopramide as a targeted prokinetic bridge strategy in a pediatric dysautonomia population.
    note: 'Found by winnow, kev and lev in p003, p022, p025. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: Recovery > Management of POTS and Associated Conditions > Medications for Gastrointestinal Function
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p094, p095. Claude judged: partial.'
- edge:
  - exercise_reconditioning
  - treats
  - long_covid
  papers: 2
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 7. Treatment
    quote: In the case of POTS related to SARS-CoV-2 infection, published cases have supported the recommendation
      of various non-pharmacological interventions, such as increased salt and fluid intake (unless contraindicated),
      waist-high compression garments, and regular and graduate-supervised exercises (84, 85). The utility of an
      exercise program in a recumbent or semi-recumbent position (rowing or cycling) for 8 weeks, followed by a
      subsequent 4-week jogging phase, has been demonstrated (86).
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
  - paper: pmid39198662
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Evidence for different treatments of POTS and PCC is limited, and this study aimed to evaluate the feasibility
      of individually tailored physical exercise.
    note: 'Found by winnow, kev and lev in p001, p026. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - treats
  - mast_cell_activation
  papers: 2
  evidence:
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: This is the first case to our knowledge where immunotherapy with IVIg led to significant and sustained
      improvement in MCAS as has been seen in publications of autoimmune neuromuscular diseases and a single case
      of POTS.9 10 Other patients with MCAS have had response in their MC symptoms to IVIg.2
    note: 'Found by winnow, kev and lev in p011, p001, p014. Claude judged: supports.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Mast-Cell-Directed Treatment
    quote: In a case report, a MCAS patient with severe MCAS and postural orthostatic tachycardia syndrome experienced
      significant improvement with regard to depression, anxiety, and dysautonomia symptoms using intravenous immunoglobulin,
      LDN, and antibiotic treatment for small intestinal bacterial overgrowth [21].
    note: 'Found by winnow, kev and lev in p027. Claude judged: partial.'
- edge:
  - serotonergic_therapy
  - treats
  - anxiety_depression
  papers: 1
  evidence:
  - paper: pmid40454385
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Research showed that paroxetine has unique pharmacological and clinical properties compared with other
      selective serotonin reuptake inhibitors (SSRIs). It effectively alleviates symptoms of anxiety disorders,
      such as social anxiety disorder, with efficacy comparable to other SSRIs.
    note: 'Found by winnow, kev and lev in p008, p012, p003. Claude judged: supports.'
- edge:
  - auricular_vagus_nerve_stimulation
  - treats
  - long_covid
  papers: 1
  evidence:
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Objectives
    quote: We conducted controlled, prospective, and randomized clinical trials to explore the potential therapeutic
      benefits of low‐level tragus stimulation (LL‐TS) in patients with POTS following COVID‐19 infection.
    note: 'Found by winnow, kev and lev in p025, p002, p003. Claude judged: supports.'
- edge:
  - immunomodulatory_therapy
  - treats
  - long_covid
  papers: 1
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Combining the limited data outlined in this review, the current and future clinical trials, and our clinical
      experience, we conclude that immunologic therapies present an important and, potentially, very effective therapeutic
      option for patients with POTS, OCADs, and Long COVID. To this end, we believe that patients with severe POTS,
      OCADs, and Long COVID should have access to a variety of therapeutic options involving immunomodulation, including
      a 3–6-month trial of IVIG, SCIG, or plasmapheresis—therapies that are already available to patients with demyelinating
      neuropathies, autonomic neuropathy, autoimmune autonomic ganglionopathy, and other neurologic and autoimmune
      disorders.
    note: 'Found by winnow, kev and lev in p040, p029, p035. Claude judged: supports.'
- edge:
  - ivabradine_therapy
  - treats
  - long_covid
  papers: 1
  evidence:
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: Management of post–COVID-19 POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p026. Claude judged: supports.'
- edge:
  - lifestyle_modification
  - treats
  - long_covid
  papers: 1
  evidence:
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Treatment
    quote: It is advisable to avoid situations that can exacerbate symptoms, which has also been shown to be beneficial
      in POTS after SARS-CoV-2 infection (Table 1) (17, 87, 88).
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - droxidopa_therapy
  - treats
  - pots
  papers: 1
  evidence:
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Clinical management
    quote: Propranolol and droxidopa were eventually added, resulting in symptom reduction and improved orthostatic
      tolerance [18].
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - phenobarbital_therapy
  - treats
  - pots
  papers: 1
  evidence:
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: partial
    section: Management > Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p029. Claude judged: partial.'
- edge:
  - immunomodulatory_therapy
  - treats
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid41403551
    cited: true
    text: full
    license: by-nc-sa
    verdict: supports
    section: Abstract
    quote: This case demonstrates that symptoms and signs of SFN as a manifestation of PACVS may benefit from the
      administration of IVIGs even years after onset.
    note: 'Found by winnow, kev and lev in p001, p006, p004. Claude judged: supports.'
- edge:
  - immunomodulatory_therapy
  - treats
  - systemic_autoimmune_disease
  papers: 1
  evidence:
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Immunotherapies > Immunologic therapies and ongoing clinical trials for POTS and other common autonomic
      disorders > Other traditional immunomodulators
    quote: They have been reported for treatment of autonomic dysfunction either as monotherapy or in combination
      with other immunotherapies in patients with neurologic Sjögren’s syndrome and autonomic neuropathy associated
      with neurosarcoidosis (Flanagan et al., 2014; Goodman, 2014; Pang et al., 2017; Oishi et al., 2021; Kataria
      et al., 2023).
    note: 'Found by winnow, kev and lev in p029. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - pots
  papers: 92
  evidence:
  - paper: pmid42691689
    cited: true
    text: full
    license: none
    verdict: supports
    section: Autonomic system degenerations, generalized dysautonomia, and disorders of autonomic dysregulation
      > Postural orthostatic tachycardia syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42691689. Found by winnow, kev and lev in p044. Claude judged: supports.'
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion > 3.1. Dysautonomia and the Rationale for Prokinetic Bridge Therapy
    quote: 'Patient 3 illustrates a further layer of this pathophysiology: the overlap between POTS, hypermobile
      Ehlers–Danlos syndrome (hEDS), and disorders of gut–brain interaction.'
    note: 'Found by winnow, kev and lev in p027, p036. Claude judged: supports.'
  - paper: pmid42037722
    cited: true
    text: full
    license: by
    verdict: supports
    section: Mechanistic phenotypes supporting a compensatory framework > Venous pooling and connective tissue laxity
    quote: Cross-sectional data show that a substantial minority of POTS patients meet clinical criteria for hypermobile
      Ehlers-Danlos syndrome (hEDS) and many more exhibit generalized joint hypermobility. This overlap is clinically
      relevant because it increases the prior probability of pooling-dominant physiology and supports early use
      of lower-body and abdominal compression, counter-maneuvers, and volume expansion (7).
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Patients with POTS often have a higher prevalence of various comorbidities, including chronic fatigue
      syndrome, syncope, migraines, fibromyalgia, joint hypermobility, Ehlers‐Danlos Syndrome, hypervigilance, anxiety,
      concussions, and autoimmune disorders [3].
    note: 'Found by winnow, kev and lev in p007, p029, p003. Claude judged: supports.'
  - paper: pmid41924132
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: POTS (a form of dysautonomia) has been described in >50% of patients with EDS/HSD.6
    note: 'Found by winnow, kev and lev in p008, p009, p028. Claude judged: supports.'
  - paper: pmid41898333
    cited: true
    text: full
    license: by
    verdict: supports
    section: 11. Vascular Compression Syndromes and HSD
    quote: Additionally, a study evaluating the incidence of vTOS in patients with POTS identified that 70% patients
      also had EDS [129].
    note: 'Found by winnow, kev and lev in p033, p001, p013. Claude judged: supports.'
  - paper: pmid41858767
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: Patients with postural orthostatic tachycardia syndrome (POTS) often suffer from gastrointestinal symptoms
      and concomitant hypermobility spectrum disorders, such as hypermobile Ehlers-Danlos syndrome (hEDS).
    note: 'Found by winnow, kev and lev in p001, p007, p003. Claude judged: supports.'
  - paper: pmid41801611
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Up 80% of patients with hEDS present with syndromes of OI, such as orthostatic hypotension (OH) or POTS
      [17–19].
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS is well known to be associated with several conditions, such as chronic fatigue syndrome and joint
      hypermobility, specifically Ehlers-Danlos syndrome type III, which have been linked to extra-articular manifestations
      such as dysautonomia and POTS [15].
    note: 'Found by winnow, kev and lev in p003, p080, p086. Claude judged: supports.'
  - paper: pmid41301791
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Neurologic Evaluation > 4.2. Examination
    quote: Assessment for joint hypermobility with the Beighton scale is recommended because hypermobility spectrum
      disorders and hypermobile Ehlers–Danlos syndrome (EDS) are highly prevalent in patients with presyncope, vasovagal
      syncope and POTS [25].
    note: 'Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Comorbid conditions commonly observed in hEDS, including MCAS, POTS, and ME/CFS, were significantly more
      prevalent in patients with hEDS with Long COVID than in those without.
    note: 'Found by winnow, kev and lev in p002, p009, p045. Claude judged: supports.'
  - paper: pmid41156242
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Other studies have noted an association between POTS and JH, and it has been estimated that over half
      with POTS have generalised joint laxity, although our experience would suggest that this is an underestimate
      [24].
    note: 'Found by winnow, kev and lev in p004, p016, p020. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4 Discussion
    quote: Finally, we did not assess cohorts for hypermobility spectrum disorders or hypermobile Ehlers–Danlos
      syndromes that are known to be associated with abnormal bleeding. As these conditions are common comorbidities
      in POTS, the δ-SPD we report in POTS patients, in contrast to our control cohorts, might be related to these
      connective tissue disorders rather than POTS.
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Additionally, a strong association between POTS and Ehlers–Danlos Syndrome Type III (EDS) exists. Eighty
      (80) percent of patients with EDS have POTS.
    note: 'Found by winnow, kev and lev in p015, p017, p001. Claude judged: supports.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: supports
    section: Clinical features and evaluation of dysautonomia
    quote: Assessment for joint hypermobility with the Beighton scale is warranted in patients with dysautonomia
      to identify hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (EDS), which are
      highly prevalent in patients with POTS, post-COVID dysautonomia and other forms of dysautonomia [22].
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid40546538
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Approximately 20%-30% of the POTS population also meets the diagnostic criteria for EDS [16].
    note: 'Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid40530951
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Context
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40530951. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid40520610
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Approximately 59% of our PoTS cohort have a diagnosis of hypermobility, similar to the combined finding
      of 55% described by Miller et al. in the first cross-sectional prospective study evaluating the prevalence
      of hypermobile EDS and general joint hypermobility in PoTS (23). To the best of our knowledge, despite being
      well documented as an association, it is not known why PoTS and EDS/hypermobility syndrome overlap, nor why
      there is an association with migraine.
    note: 'Found by winnow, kev and lev in p031, p006. Claude judged: supports.'
  - paper: pmid40387691
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40387691. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid40352770
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: The close association of syndromes of orthostatic intolerance with and without postural orthostatic tachycardia
      syndrome (POTS) with Joint Hypermobility Disorders (JHD) including Hypermobility Spectrum Disorder (HSD) and
      hypermobile Ehlers Danlos Syndrome (hEDS) and with Mast Cell Activation Syndrome (MCAS) is now firmly established.
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is noteworthy that hEDS exhibits a high concurrence with POTS with up to 30% of patients meeting diagnostic
      criteria for both conditions and the reduced venous return due to vascular laxity and blood pooling may be
      responsible for reduced CBF in this population29.
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid39850941
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: "Our sample also displayed high rates of comorbid conditions, including POTS (32.2%) and mast cell activation\
      \ disorder (16.9%), consistent with existing literature suggesting potential associations among POTS, hEDS,\
      \ and mast cell activation disorder.\n13\n One study of 91 patients with POTS found that 31% met clinical\
      \ criteria for hEDS."
    note: 'Found by winnow, kev and lev in p024, p003. Claude judged: supports.'
  - paper: pmid39582682
    cited: true
    text: full
    license: by
    verdict: supports
    section: Headache disorders in hEDS and HSD > Orthostatic headaches > Postural tachycardia syndrome
    quote: The exact mechanism behind increased prevalence of PoTS in hypermobile patients remains elusive. One
      of the more accepted hypotheses relates to excessive distensibility of the veins, due to the underlying HCTD,
      leading to venous pooling and reduced venous return.
    note: 'Found by winnow, kev and lev in p021, p024, p013. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Hypermobile Ehlers–Danlos
      Syndrome and Hypermobility Spectrum Disorder
    quote: Autonomic dysfunction/POTS is also often a component of hEDS and HSD, with symptoms, such as hypotension,
      orthostasis, dizziness, palpitations, exercise intolerance, and memory/concentration problems.[18]
    note: 'Found by winnow, kev and lev in p018, p023, p024. Claude judged: supports.'
  - paper: pmid39301475
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Joint hypermobility has been detected in up to 57% of patients with POTS, 49% of patients with ME/CFS,
      30% of patients with LC, and 27% of patients with fibromyalgia, compared to 10–20% in the general population
      (5, 9–12).
    note: 'Found by winnow, kev and lev in p001, p003, p007. Claude judged: supports.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: There has been an increasingly reported association between Ehlers-Danlos syndrome (EDS), postural orthostatic
      tachycardia syndrome (POTS) and gastrointestinal disorders.
    note: 'Found by winnow, kev and lev in p042, p071, p001. Claude judged: supports.'
  - paper: pmid38958137
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: DISCUSSION
    quote: The findings of migraine, Ehlers–Danlos syndrome, irritable bowel syndrome, and mast cell activation
      syndrome seen comorbidly in this cohort have been previously associated with POTS.
    note: 'Found by winnow, kev and lev in p040. Claude judged: supports.'
  - paper: pmid38912309
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion and conclusion
    quote: '‘Reported comorbidities in children with POTS mainly include allergic disorders, migraine, psychological
      disorders, hyperventilation syndrome, chronic fatigue syndrome, hypermobile Ehlers-Danlos syndrome and hypermobility
      spectrum disorder (hEDS/HSD), gastrointestinal dysfunction, and fibromyalgia’ (Wang et al., 2021: 8946). Current
      understandings of comorbidities of PoTS tend to vary with some links seeming likely but not well understood.'
    note: 'Found by winnow, kev and lev in p043, p003, p018. Claude judged: supports.'
  - paper: pmid38673548
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion > 4.3. Sexual Dysfunction and Neurologic Disorders
    quote: Given a high prevalence of comorbidity between POTS and EDS, there may also be increased rates of these
      gynecologic complications in POTS patients.
    note: 'Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid38545281
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: JH+ were significantly more likely to self-report EDS (29% vs. 3%, p < 0.001) and POTS (33% vs. 20%,
      p ≤ 0.001).
    note: 'Found by winnow, kev and lev in p027, p004, p023. Claude judged: supports.'
  - paper: pmid38469013
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Therapies vary widely for POTS, and successful treatment may be viewed as an art focused on symptom improvement
      and treatment of comorbid or underlying conditions rather than a standardized algorithm [11]. Associations
      with multiple disorders have been identified, such as EDS described above and more recently COVID, and may
      provide insight into previously unrecognized etiologies, novel pathophysiology, and optimal management of
      patient symptoms [10-13].
    note: 'Found by winnow, kev and lev in p009, p008. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Hypermobile spectrum disorders (HSD) including hypermobile Ehlers-Danlos syndrome (hEDS) are also more
      common in POTS (Miller et al., 2020; Tai et al., 2020).
    note: 'Found by winnow, kev and lev in p002, p021, p037. Claude judged: supports.'
  - paper: pmid38275067
    cited: true
    text: full
    license: by
    verdict: supports
    section: STUDIES ON POTS AND HEDS
    quote: There is a strong correlation between POTS and hEDS, and it has been suggested that if an individual
      meets the criterion for POTS, they should also be screened for hEDS [58, 63].
    note: 'Found by winnow, kev and lev in p009, p010, p002. Claude judged: supports.'
  - paper: pmid38162438
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Postural orthostatic tachycardia syndrome
    quote: Over half of patients with POTS were found to experience orthostatic headache (24), and POTS is common
      amongst patients on the hypermobility spectrum (25).
    note: 'Found by winnow, kev and lev in p002, p014. Claude judged: supports.'
  - paper: pmid37234076
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Female reproductive health in illnesses comorbid or associated with Long COVID: A brief overview of
      myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),
      Ehlers-Danlos syndrome (EDS), and endometriosis > Ehlers-Danlos syndrome (EDS), connective tissue disorders
      (CTDs), and reproductive health'
    quote: CTDs, including EDS and its largest subtype hypermobile EDS (hEDS) (56), are relatively common in patients
      with ME/CFS and POTS (57, 58).
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid36908200
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Discussion: > Interpretation: > Comorbid EDS:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36908200. Found by winnow, kev and lev in p040, p042, p011. Claude judged: supports.'
  - paper: pmid36694653
    cited: true
    text: full
    license: by
    verdict: supports
    section: INTRODUCTION
    quote: Additional consideration must also be given to the comorbidities that exist alongside the main condition
      due to its multisystemic nature. These include Postural Tachycardia Syndrome (PoTS),
    note: 'Found by winnow, kev and lev in p002, p005, p012. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders
    quote: The most common type is hEDS, but hypermobility spectrum disorders (HSD) that encompass patients who
      do not qualify for a diagnosis of hEDS are also common among patients with POTS.36,37 The prevalence of hEDS/HSD
      in POTS is high, with reports of 31% of POTS patients meeting the criteria for hEDS and a further 24% for
      non-hEDS generalized joint hypermobility.36,37
    note: 'Found by winnow, kev and lev in p021, p017, p024. Claude judged: supports.'
  - paper: pmid36437696
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background And Purpose
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36437696. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid36000435
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: POTS has been associated with conditions causing peripheral autonomic denervation and connective tissue
      disorders (Joint hypermobility syndrome, Ehlers‐Danlos syndrome), chronic fatigue syndrome, autoimmune disorders,
      and deconditioning.
    note: 'Found by winnow, kev and lev in p010, p029. Claude judged: supports.'
  - paper: pmid35620060
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Postural orthostatic tachycardia syndrome is found in 15–41% of patients with EDS.3
    note: 'Found by winnow, kev and lev in p005, p008, p016. Claude judged: supports.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: This study describes a higher prevalence of POTS in patients with PANS than in the general pediatric
      population and an association of POTS with comorbidities such as joint hypermobility, anxiety, chronic fatigue,
      and family history of cardiovascular issues.
    note: 'Found by winnow, kev and lev in p039, p003, p026. Claude judged: supports.'
  - paper: pmid35525992
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Hypermobility spectrum disorders (HSD) are a common comorbidity [5].
    note: 'Found by winnow, kev and lev in p008, p016. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What other conditions commonly occur in patients with POTS?
    quote: Common comorbid conditions seen with POTS4,21 include hypermobile Ehlers–Danlos syndrome, mast cell activation
      syndrome,22 migraine and ME/CFS (Table 1).18
    note: 'Found by winnow, kev and lev in p018, p006, p017. Claude judged: supports.'
  - paper: pmid35224842
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: INTRODUCTION
    quote: The prevalence of POTS was found to be greater in the EDS‐HT (41%) than control (11%) group; the prevalence
      of OH was lower (~26%) but not significantly different between groups.
    note: 'Found by winnow, kev and lev in p004, p043, p001. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: The co-existence of POTS and hEDS/HSD in adults was reported.44 The findings revealed that 22.7% of pediatric
      POTS had EDS and 39.0% had hypermobility spectrum disorder (HSD).45
    note: 'Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid34765384
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Further, EDS III is uniquely associated with postural orthostatic tachycardia syndrome (POTS) [4].
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid34510391
    cited: true
    text: full
    license: none
    verdict: supports
    section: Overlap of Dysautonomia and Hypermobility Syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34510391. Found by winnow, kev and lev in p009, p010. Claude judged: supports.'
  - paper: pmid34246578
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Pathophysiology of POTS
    quote: The associations of POTS with migraine headache, the hypermobile form of Ehlers-Danlos syndrome (hEDS)
      (De Wandele et al., 2014) and the hypermobility spectrum disorder, allergic disorders like mast cell activation
      syndrome (MCAS) (Shibao et al., 2005), and autoimmune disorders have been clearly described.
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical associations & co-morbidities
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid34055418
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: The association between POTS and JHS can be explained by predominant peripheral neuropathy in the autonomous
      system and a failure of the peripheral vascular system to maintain resistance in areas exposed to stress due
      to orthostasis, blood stasis in the lower limbs, or pathologies of the central nervous system [11].
    note: 'Found by winnow, kev and lev in p005, p012, p002. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Na síndrome de Ehlers-Danlos, uma doença do tecido conjuntivo com hiperelasticidade da pele e hipermotilidade
      articular, 70% dos indivíduos apresentam SPOT e 18% dos pacientes com SPOT apresentam critérios diagnósticos
      para síndrome de Ehlers-Danlos, considerado um mecanismo subjacente para a síndrome.80
    note: 'Found by winnow, kev and lev in p123. Claude judged: supports.'
  - paper: pmid33388686
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33388686. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid33244220
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: EDS has been associated with POTS, and prior studies on EDS have documented ocular manifestations of
      the disease, including dry eye syndrome.20
    note: 'Found by winnow, kev and lev in p025, p033, p037. Claude judged: supports.'
  - paper: pmid32803794
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32803794. Found by winnow, kev and lev in p003, p004, p001. Claude judged: supports.'
  - paper: pmid31954224
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31954224. Found by winnow, kev and lev in p015, p016, p001. Claude judged: supports.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Connective tissue disorders, especially Ehler Danlos syndrome hypermobility type, have a high concurrence
      rate with POTS as found by Cohen and Markham [20].
    note: 'Found by winnow, kev and lev in p011, p012. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: One-third of people with POTS have comorbid Ehlers-Danlos syndrome, a heterogeneous group of inherited
      connective tissues disorders associated with joint laxity, joint subluxations and dislocations, and arthralgia.66,67
      The diagnosis of hypermobile Ehlers-Danlos syndrome, the most common form of Ehlers-Danlos syndrome seen in
      POTS, remains clinical as there is no genetic marker yet identified.68–70
    note: 'Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Postural Tachycardia Syndrome, Gastrointestinal Symptoms, and related co-morbidities GI symptoms
      in Postural Tachycardia Syndrome and Ehlers-Danlos
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p016, p001, p015. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 3. Diagnosis > 3.2 Clinical Features
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p008, p006. Claude judged: supports.'
  - paper: pmid29519641
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29519641. Found by winnow, kev and lev in p004, p001, p003. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction > Concurrent clinical syndromes > Hypermobility syndrome
    quote: Concurrent hypermobility, often referred to as Ehlers Danlos Syndrome, is overrepresented in patients
      with POTS.13 The Beighton score is a standard tool used to document the presence of hypermobility.14
    note: 'Found by winnow, kev and lev in p007, p002. Claude judged: supports.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: In particular, different authors described orthostatic intolerance (OI) and postural orthostatic tachycardia
      symptoms (POTS) in JHS/EDS-HT [10–13].
    note: 'Found by winnow, kev and lev in p002, p024, p025. Claude judged: supports.'
  - paper: pmid27660311
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27660311. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Disorders Overlapping with POTS > Ehlers-Danlos Syndrome (EDS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p017, p018, p019. Claude judged: supports.'
  - paper: pmid25852449
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Participants
    quote: Among the 11 PoTS patients, five had Ehlers-Danlos Syndrome—hypermobility type/joint hypermobility syndrome
      (EDS-HT/JHS) (Kanjwal et al., 2010; Mathias et al., 2012), which is frequently observed in PoTS patients.
    note: 'Found by winnow, kev and lev in p008, p025, p006. Claude judged: supports.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: supports
    section: Neurovisceral phenotypes > Joint hypermobility > Evidence of autonomic dysfunction in Joint Hypermobility
    quote: Orthostatic hypotension, postural tachycardia syndrome, and uncategorized orthostatic intolerance were
      found in over three-quarters of hypermobile patients compared to one tenth of controls.
    note: 'Found by winnow, kev and lev in p001, p009, p011. Claude judged: supports.'
  - paper: pmid25156902
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25156902. Found by winnow, kev and lev in p002, p001. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Typical Presentations of POTS > Physical Features
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Secondary forms of POTS occur in association with other disorders, most commonly diabetes mellitus. Other
      conditions include amyloidosis, sarcoidosis, alcoholism, systemic lupus erythematosus, Sjögren’s syndrome,
      heavy-metal intoxication, joint hypermobility syndrome, pure autonomic failure, multiple-system atrophy and
      paraneoplastic syndrome [7].
    note: 'Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid22143364
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22143364. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid42804409
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42804409. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid39308845
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Many patients with POTS may present with comorbid conditions, including but not limited to Ehlers-Danlos
      syndrome (EDS), mast cell activation, and autoimmune conditions [3].
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid38985772
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Overarching themes > Slowly moving forward and finding positive gains
    quote: You know, it felt like it was the last piece of the jigsaw, especially having hypermobile EDS. You know,
      I understand it kind of goes together.
    note: 'Found by winnow, kev and lev in p044. Claude judged: partial.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: The degree of morbidity is related to the quantity of the affected mast cells (MCs), the number of mutations
      within the mast cell (MC) lineage, the specific organ involvement, the presence of comorbid postural orthostatic
      tachycardia syndrome (POTS) and hypermobile Ehlers-Danlos syndrome (hEDS), and the impact of triggers [10,11,12,13].
    note: 'Found by winnow, kev and lev in p001, p005, p028. Claude judged: partial.'
  - paper: pmid35673757
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35673757. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: We lacked specific clinical histories for samples including Beighton scores used to assess hyperflexibility;
      some of the POTS patient group may have had hypermobility spectrum disorders (HSD) or hypermobile Ehlers–Danlos
      syndrome (h-EDS), which can be associated with easy bruising.
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid34766441
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34766441. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid33677650
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS and mechanical compression of brainstem
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33677650. Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Platelet δ-SPD is also common in Ehlers Danlos syndrome, a comorbidity we have identified in more than
      a third of our POTS patients.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid32489735
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'In univariable analysis, patients with postural orthostatic tachycardia syndrome (POTS) [odds ratio
      (OR): 8.88, 95% CI: 3.69-24.9, p<0.0001], fibromyalgia (OR: 4.43, 95% CI: 2.04-10.1, p=0.0002), history of
      irritable bowel syndrome (OR: 5.01, 95% CI: 2.31-11.2, p<0.0001), and gastroesophageal reflux disease (OR:
      3.33, 95% CI: 1.55-7.44, p=0.002) were more likely to be diagnosed with GI dysmotility.'
    note: 'Found by winnow, kev and lev in p006, p008, p044. Claude judged: partial.'
  - paper: pmid32295399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: 'The patient had no known triggering

      factors but suffered from both EDS and POTS, possibly predisposing for NDPH.'
    note: 'Found by winnow, kev and lev in p006, p015. Claude judged: partial.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: 'Challenge I: Complexities And Misunderstandings'
    quote: 'Garland and colleagues (2015) wrote a well-organized review of POTS and its “overlapping pathophysiological
      mechanisms”: chronic fatigue syndrome, Ehler-Danlos Syndrome and other hypermobile joint syndromes, vasovagal
      syncope, panic attacks, pain, exercise, caffeine, sympathomimetic medications, anticholinergic medications,
      anemia, dehydration, and sinus tachycardia.32'
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid30755882
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: CASE 4
    quote: The diagnosis of POTS syndrome associated with hypermobility syndrome was considered in this patient.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid30001836
    cited: true
    text: full
    license: none
    verdict: partial
    section: 2. EXERCISE TRAINING > 2.1 Endurance training
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30001836. Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid29891041
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29891041. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid28986003
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28986003. Found by winnow, kev and lev in p002, p003, p004. Claude judged: partial.'
  - paper: pmid28924124
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Case Report
    quote: An additional assessment of joint hyperextensibility according to the Beighton hypermobility scale was
      positive with a score of 5/9 (Table 1). Moreover, an orthostatic tolerance test showed apparent postural tachycardia
      (Fig. 2).
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid24934205
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Our finding of high levels of comorbidity, particularly CFS and EDS, is important as it might point towards
      an underlying overlapping mechanism.23–25
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
  - paper: pmid22739942
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22739942. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid20376184
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Conclusions
    quote: Patients with POTS and JHS appear to become symptomatic at an earlier age compared to POTS patients without
      JHS.
    note: 'Found by winnow, kev and lev in p004, p014, p001. Claude judged: partial.'
  - paper: pmid19946638
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: In patients with POTS, the main mechanism is the consistent failure of the peripheral vascular system
      to increase resistance during upright posture. Patients with joint hypermobility syndrome even have more difficulty
      owing to loss of supporting connective tissues in the vessels.
    note: 'Found by winnow, kev and lev in p006, p007. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - pots
  papers: 83
  evidence:
  - paper: pmid42564177
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Although the SSRI/SNRI group demonstrated a lower overall incidence of any of the 23 long COVID symptoms/conditions
      (10.13% versus 18.14%), symptom/condition-specific analyses revealed higher risks for certain neurological
      and autonomic symptoms/conditions, such as POTS and cognitive dysfunction, and lower risks for fever, chills
      and hair loss.
    note: 'Found by winnow, kev and lev in p016, p001, p030. Claude judged: supports.'
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Clinical studies indicate an estimated 66–79% of patients with Long COVID exhibit symptoms of dysautonomia,
      with a substantial proportion meeting the diagnostic criteria of postural orthostatic tachycardia syndrome
      (POTS) [11,12,13].
    note: 'Found by winnow, kev and lev in p004, p027, p001. Claude judged: supports.'
  - paper: pmid42279051
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: A SARS-CoV-2 infection can result in long-term cardiovascular dysautonomia (CVD) characterized by abnormal
      autonomic reflexes upon standing, with a subset meeting diagnostic criteria for Postural Tachycardia Syndrome
      (PoTS) [1].
    note: 'Found by winnow, kev and lev in p002, p001, p004. Claude judged: supports.'
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: POTS, one of the most common autonomic disorders, is a frequent sequela of SARS-CoV-2 as part of Long
      COVID and is a common comorbidity of ME/CFS.8,9
    note: 'Found by winnow, kev and lev in p007, p005, p012. Claude judged: supports.'
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) is a form of dysautonomia characterized by excessive
      tachycardia during orthostatic stress. It is frequently observed in patients with syncope, Chronic Fatigue
      Syndrome (CFS), and post-COVID-19 syndrome (PCS), yet the underlying mechanisms may differ across these conditions.
    note: 'Found by winnow, kev and lev in p004, p001, p007. Claude judged: supports.'
  - paper: pmid41146789
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: In addition to the aforementioned symptoms in the course of LC, in some cases, POTS may also occur.
    note: 'Found by winnow, kev and lev in p018, p001, p002. Claude judged: supports.'
  - paper: pmid41111962
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Both PoTS and OH have been noted in literature to be associated with long COVID (LC); a condition characterized
      by persistent symptoms, lasting greater than 12 weeks, experienced after recovering from an acute COVID-19
      infection (8, 9).
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction > Long COVID
    quote: Consequently, many patients with Long COVID have POTS or OCADs (Blitshteyn and Whitelaw, 2021; Davenport
      et al., 2024), with nearly 70% of patients having a high autonomic symptom burden (Larsen et al., 2022).
    note: 'Found by winnow, kev and lev in p013, p001, p019. Claude judged: supports.'
  - paper: pmid41050528
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Long COVID and one of its principal manifestations, postural orthostatic tachycardia syndrome (POTS),
      have become significant health challenges in the post-COVID-19 pandemic era.
    note: 'Found by winnow, kev and lev in p002, p001, p004. Claude judged: supports.'
  - paper: pmid41038948
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3. It is estimated that up to 70% of patients with PASC have POTS,
      with clinicians worldwide seeing an increasing number of POTS patients4.
    note: 'Found by winnow, kev and lev in p003, p013, p037. Claude judged: supports.'
  - paper: pmid41025260
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41025260. Found by winnow, kev and lev in p001, p003, p004. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: This has led to POTS being a recognized complication of PASC. Clinicians with interests in dysautonomia
      have reported that up to 80% of PASC patients meet POTS diagnostic criteria (19–21).
    note: 'Found by winnow, kev and lev in p004, p006, p032. Claude judged: supports.'
  - paper: pmid40883051
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Background
    quote: Postural orthostatic tachycardia syndrome (POTS) has emerged as a significant cardiovascular phenotype
      among individuals experiencing postacute COVID-19 syndrome, commonly referred to as long COVID.
    note: 'Found by winnow, kev and lev in p001, p003, p006. Claude judged: supports.'
  - paper: pmid40864005
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40864005. Found by winnow, kev and lev in p001, p002, p006. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Cardiovascular autonomic dysfunction is a major complication in a large proportion of patients with long
      coronavirus disease (LC). As one of the most typical phenotypes of cardiovascular autonomic dysfunction, postural
      orthostatic tachycardia syndrome (POTS) is commonly observed as a sequelae of coronavirus disease infection.
    note: 'Found by winnow, kev and lev in p007, p001, p006. Claude judged: supports.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Amidst this quandary, POTS has emerged as the most common form of autonomic dysfunction associated with
      LHC, with as many as 2.5% of those with LHC affected (58).
    note: 'Found by winnow, kev and lev in p005, p044, p001. Claude judged: supports.'
  - paper: pmid40660536
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Abstract > Rationale:'
    quote: Postural orthostatic tachycardia syndrome (POTS) is a type of autonomic dysfunction that can occur following
      coronavirus disease (COVID-19) infection, particularly in adolescents.
    note: 'Found by winnow, kev and lev in p003, p015, p001. Claude judged: supports.'
  - paper: pmid40492086
    cited: true
    text: full
    license: by-nd
    verdict: supports
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3. It is estimated that up to 70% of patients with PASC have POTS,
      with clinicians worldwide seeing an increasing number of POTS patients 4.
    note: 'Found by winnow, kev and lev in p002, p009, p030. Claude judged: supports.'
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Postural orthostatic tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance
      and is frequently observed in post‐COVID conditions.
    note: 'Found by winnow, kev and lev in p001, p006, p023. Claude judged: supports.'
  - paper: pmid39919323
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39919323. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid39884840
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Background
    quote: The prevalence is thought to have increased since as autonomic dysfunction, including POTS, is one of
      the most reported post-acute sequelae of COVID-19, affecting up to half of those with long COVID (Larsen et
      al., 2022; Mallick et al., 2023).
    note: 'Found by winnow, kev and lev in p003, p027. Claude judged: supports.'
  - paper: pmid39882369
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: One of the most common syndromes of PASC bears striking resemblance to POTS, and in some evaluations
      of PASC patients up to 79% were noted to meet diagnostic criteria for POTS (12). The overlap in these conditions
      has drawn significant interest, with questions of whether POTS developing as a syndrome of PASC should be
      managed similarly to non-PASC associated POTS or not (13, 14).
    note: 'Found by winnow, kev and lev in p001, p007, p016. Claude judged: supports.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Temporal association with viral infection is frequently reported and more recently POTS has been identified
      as the dominant phenotype in post-acute sequelae of COVID-19 (PASC)6,7.
    note: 'Found by winnow, kev and lev in p011, p002. Claude judged: supports.'
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. POTS, Long COVID and the CNS
    quote: In the National Academies of Science definition of Long COVID, autonomic dysfunction, including POTS—one
      of the most common autonomic disorders—is listed as a major feature of Long COVID [3].
    note: 'Found by winnow, kev and lev in p001, p006, p008. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Importantly, it was demonstrated in one study that, compared to people with Long COVID who did not experience
      IT, people with Long COVID and IT had higher rates of new-onset mast cell disorders (11% vs. 2.6%); neurologic
      conditions, including small fiber neuropathy (SFN) (22% vs. 8.3%); postural orthostatic tachycardia syndrome
      (POTS) (33% vs. 11%); and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) (21% vs. 11%) [1].
    note: 'Found by winnow, kev and lev in p005, p001, p002. Claude judged: supports.'
  - paper: pmid39838139
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Hence POTS, a syndrome most commonly triggered by viral infections, also associated with cognitive difficulties
      and highly prevalent among patients with LC, becomes a suitable option to achieve this objective.
    note: 'Found by winnow, kev and lev in p005, p044. Claude judged: supports.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: SARS-CoV-2 infection (COVID-19) and the COVID-19 vaccine have been linked to the development of persistent
      symptoms, including orthostatic intolerance (OI) and postural orthostatic tachycardia syndrome (POTS), in
      both children and adults.
    note: 'Found by winnow, kev and lev in p031, p002, p008. Claude judged: supports.'
  - paper: pmid39554298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: INTRODUCTION
    quote: Several complications that exist in the background of long COVID have been reported. Seeley et al. showed
      that 79% of patients with long COVID meet the diagnostic criteria of postural orthostatic tachycardia syndrome
      (POTS).
    note: 'Found by winnow, kev and lev in p007, p019, p020. Claude judged: supports.'
  - paper: pmid39523946
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: 'Abstract > BACKGROUND:'
    quote: Postural orthostatic tachycardia syndrome (POTS) is a frequently diagnosed cardiovascular disorder after
      COVID-19 infection.
    note: 'Found by winnow, kev and lev in p003, p001, p002. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Among the multitude of symptoms associated with long-term COVID-19, POTS has emerged as a significant
      clinical issue, marking a notable increase in prevalence and recognition in the context of the pandemic [58].
      The mechanisms behind this association are not fully elucidated but may involve inflammation, microthrombi,
      and autoimmunity [59,60].
    note: 'Found by winnow, kev and lev in p014, p019, p020. Claude judged: supports.'
  - paper: pmid39198662
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) occurs in approximately 30% of people with highly symptomatic
      post-COVID-19 condition (PCC).
    note: 'Found by winnow, kev and lev in p001, p004, p026. Claude judged: supports.'
  - paper: pmid39076856
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: "Long COVID or post-acute Coronavirus disease 2019 (COVID-19), a malady defined \nby the persistence\
      \ of COVID-19 symptoms for weeks or even months, is expected to \naffect the lives of millions of individuals\
      \ worldwide significantly. \nCardiopulmonary symptoms such as chest discomfort, shortness of breath, fatigue,\
      \ \nand autonomic manifestations such as postural orthostatic tachycardia syndrome, \nand arrhythmias are\
      \ prevalent and widely recognized."
    note: 'Found by winnow, kev and lev in p043, p001, p042. Claude judged: supports.'
  - paper: pmid38585346
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: A subset of these long-hauler patients experienced symptoms of autonomic dysfunction and tested positive
      for postural orthostatic tachycardia syndrome (POTS) via autonomic testing.
    note: 'Found by winnow, kev and lev in p007, p001, p002. Claude judged: supports.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) is a common accompaniment of a variety of chronic, inflammatory
      diseases, including long COVID, as are small, insoluble, ‘fibrinaloid’ microclots.
    note: 'Found by winnow, kev and lev in p004, p006, p001. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Over half of patients with POTS report a preceding infection (3). COVID-19 is increasingly recognized
      as a cause of POTS (4, 5), as well as other infections including Epstein Barr Virus (EBV) (6, 7).
    note: 'Found by winnow, kev and lev in p003, p034. Claude judged: supports.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Coronavirus disease 2019 (COVID‐19) sequelae, also known as long COVID, can present with various symptoms.
      Among these symptoms, autonomic dysregulation, particularly postural orthostatic tachycardia syndrome (POTS),
      should be evaluated.
    note: 'Found by winnow, kev and lev in p001, p003, p009. Claude judged: supports.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: The syndrome is regarded to be the most prevalent cardiovascular dysautonomia and a primary phenotype/subsyndrome
      in the post-acute COVID-19 syndrome that can develop after SARS-CoV-2 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: supports.'
  - paper: pmid37981644
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Post-acute COVID-19 (PACS) are associated with cardiovascular dysfunction, especially postural orthostatic
      tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p002, p001, p003. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The review highlights the importance of recognizing and managing POTS after COVID-19 infection and vaccination,
      and the approach to autonomic disorders should be known by all specialists in different medical areas.
    note: 'Found by winnow, kev and lev in p001, p015, p003. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Recently, several case reports showed an increasing incidence of POTS as a complication of severe acute
      respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients who had chronic signs and symptoms of
      the infection (long COVID (coronavirus disease)).
    note: 'Found by winnow, kev and lev in p001, p002, p009. Claude judged: supports.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p023, p001, p004. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Long Covid—the new pandemic
    quote: An emerging but incompletely understood phenomenon increasingly seen in Long Covid and syncope clinics
      is cardiovascular autonomic dysfunction including postural orthostatic tachycardia syndrome (POTS) and orthostatic
      hypotension. Study of this apparent association with Long Covid may reveal underlying mechanisms and offer
      insight into non-Covid autonomic disorders with comprehension of autonomic nervous and neuroimmune system
      interaction.
    note: 'Found by winnow, kev and lev in p008, p009, p026. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) has emerged as an important component of the Long-COVID
      umbrella, estimated to affect between 2 and 14% of survivors.
    note: 'Found by winnow, kev and lev in p021, p001, p004. Claude judged: supports.'
  - paper: pmid37030518
    cited: true
    text: full
    license: none
    verdict: supports
    section: Recommended Treatments for Long-term Cardiovascular Symptoms of COVID-19
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37030518. Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: POTS (Postural Orthostatic Tachycardia Syndrome) is a multisystem disorder characterized by the abnormal
      autonomic response to an upright posture, causing orthostatic intolerance and excessive tachycardia without
      hypotension. Recent reports suggest that a significant percentage of COVID-19 survivors develop POTS within
      6 to 8 months of infection.
    note: 'Found by winnow, kev and lev in p003, p012, p001. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The number of people afflicted with this dysautonomia has increased dramatically in recent years due
      to the long-term effects of coronavirus disease (COVID-19); however, it is largely underdiagnosed. This case
      report is about a patient with post-viral neuropathic POTS.
    note: 'Found by winnow, kev and lev in p005, p001, p015. Claude judged: supports.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: supports
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p004, p024, p025. Claude judged: supports.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: However, even more interesting is the extremely high prevalence of POTS among patients with the post-COVID
      syndrome (6/8 (75.0%) versus 1/9 (11.1%) in the control group, p = 0.02).
    note: 'Found by winnow, kev and lev in p035, p046, p054. Claude judged: supports.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Postural orthostatic tachycardia syndrome has recently been identified in ∼20% of patients with post-acute
      sequelae of COVID-19 (PASC).
    note: 'Found by winnow, kev and lev in p001, p002, p005. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: These persistent symptoms have been termed post-acute COVID-19 syndrome or long-COVID6. Among these symptoms,
      several are associated with neurological disorders, notably postural orthostatic tachycardia syndrome (POTS)6.
    note: 'Found by winnow, kev and lev in p003, p030, p001. Claude judged: supports.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Selected Etiology: Post-COVID-19 > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p107, p111. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p003, p010. Claude judged: supports.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p012, p001, p011. Claude judged: supports.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Although it is unknown how many more patients are seeking care as a result of COVID-19 than they were
      before the pandemic, American Autonomic Society statement reports suggest a sharp rise in instances, the majority
      of which are linked to long-COVID-19 [10]. These data suggest that POTS may be significantly related to COVID-19.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p001, p004, p006. Claude judged: supports.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: supports
    section: “Post-COVID-19 Tachycardia Syndrome”
    quote: From a cardiovascular point of view, recent papers have highlighted an association between orthostatic
      intolerance (OI), including orthostatic hypotension (OH) and postural orthostatic tachycardia syndrome (POTS),
      with long COVID (17–19).
    note: 'Found by winnow, kev and lev in p004, p001, p002. Claude judged: supports.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: With associations of viral infections as a potential etiology of POTS and evidence that many COVID-19
      long haulers are developing POTS, platelets may also play a significant role in the etiology or perpetuation
      of the disorder.
    note: 'Found by winnow, kev and lev in p003, p002. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Background
    quote: Postural tachycardia syndrome (PTS) is a novel identified sequela of COVID-19 infection. This observational
      study describes clinical presentation, testing, and treatment response in seven patients diagnosed with PTS
      following COVID-19 infection.
    note: 'Found by winnow, kev and lev in p012, p001, p002. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Postural Orthostatic Tachycardia Syndrome after COVID-19
    quote: In March 2021, the American Autonomic Society (AAS) issued a statement concerning the clinical overlap
      of PASC with POTS [4]. The AAS stated that most PASC symptoms can be suggestive of POTS when the patient also
      suffers from excessive orthostatic tachycardia, and that further, in-depth studies are needed to elucidate
      the duration of post-COVID CVAD, its underlying pathophysiology, and optimum treatment.
    note: 'Found by winnow, kev and lev in p008, p018, p028. Claude judged: supports.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: A growing number of patients diagnosed with COVID-19 disease have been reported to have postural orthostatic
      tachycardia syndrome (POTS) after the acute phase.
    note: 'Found by winnow, kev and lev in p002, p001, p003. Claude judged: supports.'
  - paper: pmid34607799
    cited: true
    text: full
    license: by
    verdict: supports
    section: RESULTS > Final list of recommendations > Recommendations relating to diagnosis of underlying disorder
      (Box 3)
    quote: Autonomic dysfunction, especially manifesting as PoTS, occurs commonly post COVID-19.12
    note: 'Found by winnow, kev and lev in p034, p028. Claude judged: supports.'
  - paper: pmid34192289
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: While autopsy studies have shown that the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
      rarely causes direct myocardial injury, several syndromes such as myocarditis, pericarditis, and Postural
      Orthostatic Tachycardia Syndrome have been implicated in PACS.
    note: 'Found by winnow, kev and lev in p023, p001, p021. Claude judged: supports.'
  - paper: pmid34151246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome and COVID-19
    quote: This condition, called ”long COVID-19.” or ”post-acute sequelae of SARS-CoV-2 infection” is associated
      with multiple cardiopulmonary and neurologic symptoms, including severe chronic fatigue, palpitations, chest
      pain, breathlessness, and dysautonomia, features characteristic of postural tachycardia syndrome (POTS).184,
      185, 186 POTS impacts heart rate, blood pressure, and cardiac function and can be caused by many factors,
      including viral infections.187 Although it remains unclear whether SARS-CoV-2 triggers POTS, emerging evidence
      indicates a close association between COVID-19 and POTS-like symptoms.
    note: 'Found by winnow, kev and lev in p052, p001. Claude judged: supports.'
  - paper: pmid33983522
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Part II: Resolved Infection > Long COVID'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33983522. Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid33869099
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Learning Points
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33869099. Found by winnow, kev and lev in p001, p002. Claude judged: supports.'
  - paper: pmid33740207
    cited: true
    text: full
    license: none
    verdict: supports
    section: Long-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33740207. Found by winnow, kev and lev in p004, p001, p002. Claude judged: supports.'
  - paper: pmid42788130
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Case Presentation
    quote: Subsequent worsening of long COVID-19 symptoms alongside systemic dysautonomia emerged, including postural
      orthostatic tachycardia syndrome, orthostatic hypotension, and mast cell activation syndrome.
    note: 'Found by winnow, kev and lev in p002, p011, p015. Claude judged: partial.'
  - paper: pmid41713697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Recent adult literature on long-COVID describes a POTS-like autonomic syndrome marked by COI, tachycardia,
      fatigue, pain, and cognitive symptoms, with some patients demonstrating delayed worsening months after the
      acute infection.
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid39043760
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: In this regard, Tsuchida and colleagues9 reported that treatment with a small dose of a beta-blocker
      was effective for ST-positive long COVID patients with POTS, suggesting that the manifestation of OI symptoms
      of POTS could be, at least in part, originated from the increase of HR in long COVID patients.
    note: 'Found by winnow, kev and lev in p004, p019, p022. Claude judged: partial.'
  - paper: pmid38900132
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38900132. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Not only does contracting SARS-CoV-2 infection confer the possibility of developing long COVID and subsequent
      development of POTS, but recipients of the SARS-CoV-2 vaccine have also been shown to develop POTS at a higher
      rate.
    note: 'Found by winnow, kev and lev in p006, p027, p029. Claude judged: partial.'
  - paper: pmid38469013
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Associations with multiple disorders have been identified, such as EDS described above and more recently
      COVID, and may provide insight into previously unrecognized etiologies, novel pathophysiology, and optimal
      management of patient symptoms [10-13].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: All five patients who suffered a COVID-19 infection subsequently reported a pronounced and persistent
      exacerbation of POTS symptoms.
    note: 'Found by winnow, kev and lev in p019, p023, p003. Claude judged: partial.'
  - paper: pmid36981522
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: He was found to have profound postural tachycardia syndrome, several ranges of motion restrictions, and
      mast cell activation syndrome.
    note: 'Found by winnow, kev and lev in p001, p023, p035. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract
    quote: Among patients with PASC, postural orthostatic tachycardic syndrome (POTS) has been increasingly recognized.
    note: 'Found by winnow, kev and lev in p001, p004, p002. Claude judged: partial.'
  - paper: pmid36090156
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Although PASC and POTS might share common pathophysiological mechanisms and respond favorably to graded
      exercise training, few cases of PASC will likely fulfill a diagnosis of POTS. This initial case series shows
      the overlap between PASC, orthostatic intolerance, and POTS in recreational and competitive athletes, demonstrates
      the utility of performing autonomic function testing and CPET in making the diagnosis, and emphasizes the
      role of graded exercise training to treat this condition.
    note: 'Found by winnow, kev and lev in p014, p009. Claude judged: partial.'
  - paper: pmid35679657
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35679657. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35241011
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: CFS/ME has been associated with several viruses, including the 2003 severe acute respiratory syndrome
      coronavirus (SARS-CoV; 6), and has been recently garnering media attention as a post-acute consequence of
      SARS-CoV-2 infection. Below, we describe a dramatic case of POTS in a COVID-19 patient.
    note: 'Found by winnow, kev and lev in p005, p002, p004. Claude judged: partial.'
  - paper: pmid34541421
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Cardiovascular Complications
    quote: The combination of several commonly reported PASC symptoms (eg, dyspnea, palpitations, chest discomfort)
      in conjunction with orthostatic tachycardia may be a manifestation of postural tachycardia syndrome (POTS)
      (44). Several case studies have linked new diagnoses of POTS with prior COVID-19 infection (45, 46, 47), and
      additional surveillance will be necessary to characterize the frequency and persistence of these symptoms.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Conclusions: We present clinical features and results of autonomic testing in 6 patients with a history
      COVID-19 infection. While all patients reported typical features of orthostatic intolerance, fatigue, and
      activity intolerance, the results of autonomic testing were heterogenous, with orthostatic hypotension in
      1 patient, excessive postural tachycardia typical of postural tachycardia syndrome in 4 patients, and postural
      hypertension in 3 patients.'
    note: 'Found by winnow, kev and lev in p003, p004, p006. Claude judged: partial.'
  - paper: pmid33786700
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33786700. Found by winnow, kev and lev in p020, p001, p004. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - associated_with
  - pots
  papers: 74
  evidence:
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Among proposed etiologies for POTS, Epstein–Barr virus and other pathogens have been identified as potential
      initiating events; frequently, patients report a history of mononucleosis prior to development of debilitating
      symptoms [24].
    note: 'Found by winnow, kev and lev in p004, p001, p006. Claude judged: supports.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: This has led to POTS being a recognized complication of PASC. Clinicians with interests in dysautonomia
      have reported that up to 80% of PASC patients meet POTS diagnostic criteria (19–21).
    note: 'Found by winnow, kev and lev in p006, p025, p001. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: As one of the most typical phenotypes of cardiovascular autonomic dysfunction, postural orthostatic tachycardia
      syndrome (POTS) is commonly observed as a sequelae of coronavirus disease infection.
    note: 'Found by winnow, kev and lev in p007, p001, p010. Claude judged: supports.'
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. POTS, Long COVID and the CNS
    quote: Pre-pandemic, POTS was known to occur after a viral or bacterial infection in at least 40% of patients
      and was thought to be of heterogeneous and complex pathophysiology involving central and peripheral autonomic
      nervous system networks, small fiber neuropathy, cerebral hypoperfusion, mast cell hyperactivity and autoimmunity
      [9,10,11].
    note: 'Found by winnow, kev and lev in p006, p001, p005. Claude judged: supports.'
  - paper: pmid39838139
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Hence POTS, a syndrome most commonly triggered by viral infections, also associated with cognitive difficulties
      and highly prevalent among patients with LC, becomes a suitable option to achieve this objective.
    note: 'Found by winnow, kev and lev in p005, p044. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > COVID-19 Infection and
      Post-viral Postural Orthostatic Tachycardia Syndrome
    quote: Even though an exact mechanism has not been identified, it is suggested that autoimmune responses to
      viral illness may trigger POTS, with up to 50% of POTS patients reporting a viral illness preceding their
      symptoms.[22]
    note: 'Found by winnow, kev and lev in p011, p031, p032. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction > 1.1. Definition and Clinical Features of POTS
    quote: Prior to diagnosis of POTS, patients often report illnesses involving viral infections in the upper respiratory
      or gastrointestinal systems. Identified viruses and bacteria associated with POTS include influenza, Epstein–Barr
      virus, and Borrelia burgdorferi [15].
    note: 'Found by winnow, kev and lev in p009, p001, p011. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: The onset of POTS is frequently linked to triggers, such as long COVID-19, the human papillomavirus (HPV)
      vaccine, infections, or trauma, which can subsequently lead to immunological changes.
    note: 'Found by winnow, kev and lev in p014, p019. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Over half of patients with POTS report a preceding infection (3). COVID-19 is increasingly recognized
      as a cause of POTS (4, 5), as well as other infections including Epstein Barr Virus (EBV) (6, 7).
    note: 'Found by winnow, kev and lev in p003, p013, p002. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: It is considered a relatively rare condition that affects approximately 0.2% of the general population,
      and it is estimated that between 500,000 to 1,000,000 individuals in the United States have the condition
      and recently has been linked to post-infectious (viral) etiologies.
    note: 'Found by winnow, kev and lev in p001, p002, p009. Claude judged: supports.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p006, p015, p023. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction > Clinical Features
    quote: Antecedent illness with viral infections of the upper respiratory and gastrointestinal tracts have been
      reported prior to onset of POTS.2,14,15 Offending organisms identified include Epstein-Barr virus, Influenza
      and Borrelia burgdorferi.16
    note: 'Found by winnow, kev and lev in p010, p021, p013. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response.'
    note: 'Found by winnow, kev and lev in p003, p012, p001. Claude judged: supports.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Interestingly, POTS itself often develops following infectious diseases and, at least in some cases,
      may be associated with the production of autoantibodies against adrenergic and cholinergic receptors [35].
    note: 'Found by winnow, kev and lev in p046, p035. Claude judged: supports.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: POTS has largely been involved in post-viral symptomatology15–18, with 28–41% of POTS cases reported
      to be associated with viral infections19,20, suggesting post viral autoimmune activation is a possible pathophysiological
      mechanism16.
    note: 'Found by winnow, kev and lev in p001, p003, p007. Claude judged: supports.'
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p001, p014, p016. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Postural Orthostatic Tachycardia Syndrome after COVID-19
    quote: POTS is misdiagnosed in up to 75% of patients and viral infection is recognized as a trigger in up to
      41% of cases [63].
    note: 'Found by winnow, kev and lev in p008, p016, p017. Claude judged: supports.'
  - paper: pmid34192289
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Cardiovascular manifestations of PACS > Postural Orthostatic Tachycardia Syndrome
    quote: POTS has previously been implicated in persistent post-viral symptomatology, with over 40% of POTS cases
      thought to be associated with viral infection, possibly triggered by induced autoimmunity or molecular mimicry.
    note: 'Found by winnow, kev and lev in p023, p001, p020. Claude judged: supports.'
  - paper: pmid33983522
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Part II: Resolved Infection > Long COVID'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33983522. Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is notable that 40–50% of POTS patients report an antecedent history of infection prior to symptom
      onset (13, 14). Various types of infections have been reported in association with the development of POTS,
      including Mycoplasma pneumonia (15), Epstein Barr virus (16, 17), Trypanosoma cruzii (18), and Borrelia burgdorferi
      (19, 20).
    note: 'Found by winnow, kev and lev in p006, p013. Claude judged: supports.'
  - paper: pmid33740207
    cited: true
    text: full
    license: none
    verdict: supports
    section: Research opportunities to understand Long-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33740207. Found by winnow, kev and lev in p004, p007. Claude judged: supports.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A higher proportion of POTS patients reported symptoms of antecedent infections in our group of adolescents
      (60%) than previously described for adults (35%) (Kimpinski et al., 2012).
    note: 'Found by winnow, kev and lev in p039, p025, p037. Claude judged: supports.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: Antecedent infections were frequently reported in patients in POTS patients.
    note: 'Found by winnow, kev and lev in p001, p013. Claude judged: supports.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: supports
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021, p022, p035. Claude judged: supports.'
  - paper: pmid42746015
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: PoTS is often triggered by viral infections, shows a female predominance (3), and can be associated with
      myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS, ICD-10-GM G93.3, ICD-10-CM G93.32, ICD-11 8E49)
      (1).
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid42279051
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: A SARS-CoV-2 infection can result in long-term cardiovascular dysautonomia (CVD) characterized by abnormal
      autonomic reflexes upon standing, with a subset meeting diagnostic criteria for Postural Tachycardia Syndrome
      (PoTS) [1].
    note: 'Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: POTS, one of the most common autonomic disorders, is a frequent sequela of SARS-CoV-2 as part of Long
      COVID and is a common comorbidity of ME/CFS.8,9
    note: 'Found by winnow, kev and lev in p005, p007. Claude judged: partial.'
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: A central feature common to both PCS and CFS is orthostatic intolerance, frequently attributable to POTS.
      Reported prevalence of POTS in CFS ranges from 5.7% to 70%, largely depending on diagnostic criteria and study
      populations, while prevalence in PCS has been reported between 2% and 14% [7,8,9].
    note: 'Found by winnow, kev and lev in p004, p007. Claude judged: partial.'
  - paper: pmid41146789
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: The mechanism of POTS is not fully explained. Presently, it is considered that the etiology of POTS can
      be related to viral infections or other conditions, which involve an excessive activation of the immune system,
      α-receptor hyperactivity, and the presence of autoantibodies against receptor molecules on human cells [24-26].
    note: 'Found by winnow, kev and lev in p018, p002, p011. Claude judged: partial.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Long COVID
    quote: Consequently, many patients with Long COVID have POTS or OCADs (Blitshteyn and Whitelaw, 2021; Davenport
      et al., 2024), with nearly 70% of patients having a high autonomic symptom burden (Larsen et al., 2022).
    note: 'Found by winnow, kev and lev in p004, p013, p019. Claude judged: partial.'
  - paper: pmid41050528
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation
    quote: After a new COVID-19 infection in February 2021, he developed typical long COVID symptoms of dysautonomia,
      post-exertional malaise (PEM), and symptoms compatible with POTS.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid41038948
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3. It is estimated that up to 70% of patients with PASC have POTS,
      with clinicians worldwide seeing an increasing number of POTS patients4.
    note: 'Found by winnow, kev and lev in p003, p013. Claude judged: partial.'
  - paper: pmid40883051
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Background
    quote: Postural orthostatic tachycardia syndrome (POTS) has emerged as a significant cardiovascular phenotype
      among individuals experiencing postacute COVID-19 syndrome, commonly referred to as long COVID.
    note: 'Found by winnow, kev and lev in p006, p001, p031. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Background
    quote: Prior to COVID-19, POTS was a relatively rare phenomenon, affecting otherwise healthy individuals following
      viral illness or trauma.
    note: 'Found by winnow, kev and lev in p005, p006, p009. Claude judged: partial.'
  - paper: pmid40660536
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: It frequently manifests during adolescence and can be triggered by immune stressors, such as viral infections,
      including COVID-19.[3,5,6]
    note: 'Found by winnow, kev and lev in p003, p015, p001. Claude judged: partial.'
  - paper: pmid40492086
    cited: true
    text: full
    license: by-nd
    verdict: partial
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Background
    quote: Postural orthostatic tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance
      and is frequently observed in post‐COVID conditions.
    note: 'Found by winnow, kev and lev in p001, p005, p009. Claude judged: partial.'
  - paper: pmid39882369
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: One of the most common syndromes of PASC bears striking resemblance to POTS, and in some evaluations
      of PASC patients up to 79% were noted to meet diagnostic criteria for POTS (12).
    note: 'Found by winnow, kev and lev in p001, p007. Claude judged: partial.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentation
    quote: However, an autoimmune basis of post-COVID POTS was evident given a positive ANA, comorbid SFN, and post-infectious
      onset of symptomatology.
    note: 'Found by winnow, kev and lev in p005, p007. Claude judged: partial.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: partial.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: SARS-CoV-2 infection (COVID-19) and the COVID-19 vaccine have been linked to the development of persistent
      symptoms, including orthostatic intolerance (OI) and postural orthostatic tachycardia syndrome (POTS), in
      both children and adults.
    note: 'Found by winnow, kev and lev in p031, p002, p008. Claude judged: partial.'
  - paper: pmid39554298
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION > Fatigue
    quote: POTS has been reported to occur after viral infections, and cases of POTS following COVID‐19 have also
      been reported.
    note: 'Found by winnow, kev and lev in p020, p019. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Case reports have described a new onset of autonomic dysfunction symptoms with features of POTS/inappropriate
      sinus tachycardia in the post-acute phase of COVID-19 infection [55,56]. The underlying cause of dysautonomia
      post-COVID-19 infection is not well understood.
    note: 'Found by winnow, kev and lev in p006, p027, p034. Claude judged: partial.'
  - paper: pmid38585346
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Autonomic dysfunction is a common consequence suffered by COVID long-haulers, manifesting in symptoms
      including headache, fatigue, orthostatic intolerance, tachycardia/palpitations, temperature intolerance, and
      more, reflecting the growing incidence of POTS pathophysiology in these patients (7).
    note: 'Found by winnow, kev and lev in p007, p002, p008. Claude judged: partial.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: partial
    section: INTRODUCTION
    quote: Factors contributing to the development of POTS after COVID‐19 infection are hypovolemia, neurotropism,
      inflammation, and autoimmunity.
    note: 'Found by winnow, kev and lev in p003, p009, p011. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: The syndrome is regarded to be the most prevalent cardiovascular dysautonomia and a primary phenotype/subsyndrome
      in the post-acute COVID-19 syndrome that can develop after SARS-CoV-2 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37981644
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Post-acute COVID-19 (PACS) are associated with cardiovascular dysfunction, especially postural orthostatic
      tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p002, p001, p003. Claude judged: partial.'
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Patients with POTS often experience an exacerbation of their symptoms associated with (viral) infections
      and often fear the same symptom aggravation after vaccination.
    note: 'Found by winnow, kev and lev in p023, p001, p003. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Epidemiology
    quote: In a recent systematic review of cardiovascular autonomic dysfunction and COVID-19, POTS was the most
      frequent diagnosis in individuals with post–COVID-19 orthostatic complaints (37).
    note: 'Found by winnow, kev and lev in p001, p004, p014. Claude judged: partial.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The number of people afflicted with this dysautonomia has increased dramatically in recent years due
      to the long-term effects of coronavirus disease (COVID-19); however, it is largely underdiagnosed. This case
      report is about a patient with post-viral neuropathic POTS.
    note: 'Found by winnow, kev and lev in p005, p001, p020. Claude judged: partial.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p001, p003, p004. Claude judged: partial.'
  - paper: pmid36729924
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36729924. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract
    quote: Among patients with PASC, postural orthostatic tachycardic syndrome (POTS) has been increasingly recognized.
    note: 'Found by winnow, kev and lev in p004, p001, p006. Claude judged: partial.'
  - paper: pmid36703776
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: Here, we present a case report of severe dysautonomia following a COVID‐19 infection in a patient with
      pre‐existing poorly controlled type‐1 diabetes. This patient exhibited symptoms consistent with both postural
      orthostatic tachycardia syndrome (POTS), as well as orthostatic hypotension.
    note: 'Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
  - paper: pmid36518330
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Postural orthostatic tachycardia syndrome has recently been identified in ∼20% of patients with post-acute
      sequelae of COVID-19 (PASC).
    note: 'Found by winnow, kev and lev in p001, p002, p005. Claude judged: partial.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p010, p011. Claude judged: partial.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: partial
    section: Myalgien und POTS als Folge von Long-COVID? Versuch einer objektiven Bewertung > Spezifität.
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p012, p025, p030. Claude judged: partial.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: A range of diseases, including viral or bacterial infections, can cause POTS. Because an increasing number
      of patients who recovered from COVID-19 are now reporting POTS-like symptoms including brain fog, tachycardia
      and severe chronic fatigue, some experts believe coronavirus may be a trigger for POTS.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: “Post-COVID-19 Tachycardia Syndrome”
    quote: From a cardiovascular point of view, recent papers have highlighted an association between orthostatic
      intolerance (OI), including orthostatic hypotension (OH) and postural orthostatic tachycardia syndrome (POTS),
      with long COVID (17–19).
    note: 'Found by winnow, kev and lev in p004, p008. Claude judged: partial.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: With associations of viral infections as a potential etiology of POTS and evidence that many COVID-19
      long haulers are developing POTS, platelets may also play a significant role in the etiology or perpetuation
      of the disorder.
    note: 'Found by winnow, kev and lev in p003, p002. Claude judged: partial.'
  - paper: pmid35241011
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: When dysautonomia manifests in the form of postural orthostatic tachycardia syndrome (POTS), patients
      report dizziness, lightheadedness, fatigue and tachycardia when standing from a sitting or lying position.
      Dysautonomia has been associated with several non-infectious conditions, from diabetes mellitus to Parkinson’s
      disease, as well as with viral infections, including, among others, HIV, hepatitis C, mumps, and Epstein-Barr
      virus [1].
    note: 'Found by winnow, kev and lev in p005, p002, p004. Claude judged: partial.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Discussion
    quote: This novel case series describes the development of PTS in the context of COVID-19 infection.
    note: 'Found by winnow, kev and lev in p012, p002, p003. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: A growing number of patients diagnosed with COVID-19 disease have been reported to have postural orthostatic
      tachycardia syndrome (POTS) after the acute phase.
    note: 'Found by winnow, kev and lev in p002, p001, p003. Claude judged: partial.'
  - paper: pmid34541421
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Cardiovascular Complications
    quote: Several case studies have linked new diagnoses of POTS with prior COVID-19 infection (45, 46, 47), and
      additional surveillance will be necessary to characterize the frequency and persistence of these symptoms.
      Whether and how COVID-19 infection directly causes POTS is still unknown.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid34151246
    cited: true
    text: full
    license: by
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome and COVID-19
    quote: POTS impacts heart rate, blood pressure, and cardiac function and can be caused by many factors, including
      viral infections.187 Although it remains unclear whether SARS-CoV-2 triggers POTS, emerging evidence indicates
      a close association between COVID-19 and POTS-like symptoms.
    note: 'Found by winnow, kev and lev in p052. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Epidemiology & natural history
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p001, p008. Claude judged: partial.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: A significant number of our patients have described Epstein–Barr virus infections and gastrointestinal
      pain that could be related to an enteric viral infection preceding the onset of symptoms and ultimately the
      development of POTS and its diagnosis.
    note: 'Found by winnow, kev and lev in p002, p025. Claude judged: partial.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > The Role of Immune System in POTS
    quote: Its onset is occasionally preceded by or associated with a viral-like illness or post vaccination which
      leads to the suspicion that autoimmunity may have an important role in these patients (Li et al., 2014; Brinth
      et al., 2015).
    note: 'Found by winnow, kev and lev in p027, p005. Claude judged: partial.'
  - paper: pmid28738696
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28738696. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid28674681
    cited: true
    text: full
    license: by
    verdict: partial
    section: Etiology and Pathophysiology > Pathophysiological Basis for Symptoms > Circulatory Abnormalities
    quote: More work is needed to define the causes of NMH and POTS. Both can follow infectious illnesses, and themselves
      can be secondary to autoimmune phenomena.
    note: 'Found by winnow, kev and lev in p035. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Autoimmune/Autoantibodies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p031. Claude judged: partial.'
  - paper: pmid25087056
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25087056. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid24830783
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24830783. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - postinfectious_evidence
  papers: 63
  evidence:
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: POTS, one of the most common autonomic disorders, is a frequent sequela of SARS-CoV-2 as part of Long
      COVID and is a common comorbidity of ME/CFS.8,9
    note: 'Found by winnow, kev and lev in p005, p007. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: It is considered a relatively rare condition that affects approximately 0.2% of the general population,
      and it is estimated that between 500,000 to 1,000,000 individuals in the United States have the condition
      and recently has been linked to post-infectious (viral) etiologies. We present a case of a 53-year-old woman
      who was diagnosed with POTS following extensive autoimmune workup, who was also status post-severe acute respiratory
      syndrome coronavirus 2 (SARS-CoV-2) infection.
    note: 'Found by winnow, kev and lev in p001, p002, p004. Claude judged: supports.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p006, p007, p015. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autonomic dysfunction in acute and Long Covid > Long Covid autonomic dysfunction
    quote: There have been many reports of clinical cases and series describing POTS, inappropriate sinus tachycardia
      and orthostatic hypotension (all impairments of the cardiovascular autonomic nervous system) following Covid
      infection [33–42].
    note: 'Found by winnow, kev and lev in p008, p013. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction and background
    quote: With the reporting of an increasing number of cases, POTS is gaining recognition in patients with COVID-19
      in the post-infectious stage [8].
    note: 'Found by winnow, kev and lev in p012, p001, p003. Claude judged: supports.'
  - paper: pmid35381331
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35381331. Found by winnow, kev and lev in p001, p014, p016. Claude judged: supports.'
  - paper: pmid35241011
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: The emergence of dysautonomia as a consequence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2;
      or COVID-19) is becoming more prevalent. We have seen evidence in several post-COVID patients and in the literature
      of varying degrees of autonomic dysfunction.
    note: 'Found by winnow, kev and lev in p005, p001, p002. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Background
    quote: Postural tachycardia syndrome (PTS) is a novel identified sequela of COVID-19 infection. This observational
      study describes clinical presentation, testing, and treatment response in seven patients diagnosed with PTS
      following COVID-19 infection.
    note: 'Found by winnow, kev and lev in p012, p001, p002. Claude judged: supports.'
  - paper: pmid34607799
    cited: true
    text: full
    license: by
    verdict: supports
    section: RESULTS > Final list of recommendations > Recommendations relating to diagnosis of underlying disorder
      (Box 3)
    quote: Autonomic dysfunction, especially manifesting as PoTS, occurs commonly post COVID-19.12
    note: 'Found by winnow, kev and lev in p028, p034. Claude judged: supports.'
  - paper: pmid33927679
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: That dysautonomia should occur in conjunction with or following COVID-19 should be expected, given a
      reported prevalence of dysautonomia in 50% of severe acute respiratory syndrome (SARS) patients studied in
      the 2002 SARS epidemic (4), and that the most prevalent, primary autonomic disorder, postural tachycardia
      syndrome (POTS), is commonly associated with antecedent or concomitant infection.
    note: 'Found by winnow, kev and lev in p003, p006. Claude judged: supports.'
  - paper: pmid33786700
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33786700. Found by winnow, kev and lev in p020, p004, p006. Claude judged: supports.'
  - paper: pmid42512077
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Materials and Methods > 2.2. Patients
    quote: Patients in Group 2 were diagnosed prior to the pandemic and patients in Group 4 required symptom onset
      following a documented positive SARS-CoV-2 screening test.
    note: 'Found by winnow, kev and lev in p004, p001, p009. Claude judged: partial.'
  - paper: pmid42279051
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: A SARS-CoV-2 infection can result in long-term cardiovascular dysautonomia (CVD) characterized by abnormal
      autonomic reflexes upon standing, with a subset meeting diagnostic criteria for Postural Tachycardia Syndrome
      (PoTS) [1]. CVD develops during or following an acute COVID-19 infection, persisting beyond three months to
      years after exclusion of alternative diagnoses [2].
    note: 'Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid41713697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Recent adult literature on long-COVID describes a POTS-like autonomic syndrome marked by COI, tachycardia,
      fatigue, pain, and cognitive symptoms, with some patients demonstrating delayed worsening months after the
      acute infection. Although these data are largely derived from adult cohorts, we are increasingly seeing similar
      postinfectious autonomic symptom patterns in pediatric patients.
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A similar trajectory was observed for patients with POTS, suggesting that post-viral autonomic dysfunction
      may also act as a diagnostic trigger for hEDS.
    note: 'Found by winnow, kev and lev in p011, p046, p001. Claude judged: partial.'
  - paper: pmid41146789
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: The mechanism of POTS is not fully explained. Presently, it is considered that the etiology of POTS can
      be related to viral infections or other conditions, which involve an excessive activation of the immune system,
      α-receptor hyperactivity, and the presence of autoantibodies against receptor molecules on human cells [24-26].
    note: 'Found by winnow, kev and lev in p018, p002, p011. Claude judged: partial.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The autoimmune etiology and association of these conditions with systemic autoimmune and inflammatory
      disorders, autonomic neuropathy, and post-acute infectious syndromes, including Long COVID, suggest that immunotherapies
      should be considered as a therapeutic option, at least in a subset of patients.
    note: 'Found by winnow, kev and lev in p001, p013, p019. Claude judged: partial.'
  - paper: pmid41050528
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation
    quote: After a new COVID-19 infection in February 2021, he developed typical long COVID symptoms of dysautonomia,
      post-exertional malaise (PEM), and symptoms compatible with POTS.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid41038948
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3. It is estimated that up to 70% of patients with PASC have POTS,
      with clinicians worldwide seeing an increasing number of POTS patients4.
    note: 'Found by winnow, kev and lev in p003, p013. Claude judged: partial.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Introduction
    quote: As many as 80% of coronavirus disease 2019 (COVID-19) long-hauler patients meet the diagnostic criteria
      for POTS, highlighting awareness of this debilitating multisystem disorder. The etiology of POTS has not been
      entirely defined, but researchers have speculated that an immunological stressor such as a viral infection
      might be an initiating event.
    note: 'Found by winnow, kev and lev in p006, p001, p004. Claude judged: partial.'
  - paper: pmid40883051
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: Postacute COVID-19 syndrome, or long COVID, is estimated to affect 10 to 20% of people infected by SARS-COV-2.1,
      2, 3 Postural orthostatic tachycardia syndrome (POTS) has emerged as a significant cardiovascular phenotype
      among individuals experiencing long COVID.4
    note: 'Found by winnow, kev and lev in p001, p003, p006. Claude judged: partial.'
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Background
    quote: Prior to COVID-19, POTS was a relatively rare phenomenon, affecting otherwise healthy individuals following
      viral illness or trauma.
    note: 'Found by winnow, kev and lev in p005, p009, p025. Claude judged: partial.'
  - paper: pmid40660536
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: It frequently manifests during adolescence and can be triggered by immune stressors, such as viral infections,
      including COVID-19.[3,5,6]
    note: 'Found by winnow, kev and lev in p003, p015, p001. Claude judged: partial.'
  - paper: pmid40492086
    cited: true
    text: full
    license: by-nd
    verdict: partial
    section: Introduction
    quote: This syndrome, characterized by an abnormal increase in heart rate upon standing without a corresponding
      drop in blood pressure, has gained increasing recognition, particularly due to its association with long COVID/post-acute
      sequelae of SARS-CoV-2 infection (PASC)2,3.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Background
    quote: Postural orthostatic tachycardia syndrome (POTS) is characterized by symptoms of orthostatic intolerance
      and is frequently observed in post‐COVID conditions.
    note: 'Found by winnow, kev and lev in p001, p005, p006. Claude judged: partial.'
  - paper: pmid39884840
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Background
    quote: The prevalence is thought to have increased since as autonomic dysfunction, including POTS, is one of
      the most reported post-acute sequelae of COVID-19, affecting up to half of those with long COVID (Larsen et
      al., 2022; Mallick et al., 2023).
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid39882369
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: In the wake of the COVID-19 pandemic, a significant proportion of survivors were noted to have symptoms
      continuing or developing after their acute infection, termed Post Acute Sequelae of COVID (PASC) (11).
    note: 'Found by winnow, kev and lev in p007, p001. Claude judged: partial.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Our findings are similar to those reported in the PASC population although our patients with POTS had
      an average symptom duration of 6 years prior to their brain SPECT while those with PASC in our cohort were
      studied at almost 1 year since their acute COVID-19 infection.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid39857750
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: POTS, one of the most common autonomic disorders, is a frequent sequela of SARS-CoV-2 infection.
    note: 'Found by winnow, kev and lev in p006, p001. Claude judged: partial.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentation
    quote: A woman in her mid-forties with a history of episodic migraine and seasonal allergies developed rapid
      heart rate, dizziness, body pain, fatigue, exercise intolerance, and brain fog after experiencing a mild SARS-CoV-2
      infection.
    note: 'Found by winnow, kev and lev in p005, p001, p004. Claude judged: partial.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: partial.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: This study highlights the growing incidence of POTS and other forms of OI in pediatric patients following
      COVID-19 infection and vaccination, supporting the link between COVID-19 and autonomic dysfunction in children.
    note: 'Found by winnow, kev and lev in p031, p008, p030. Claude judged: partial.'
  - paper: pmid39523946
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: 'Abstract > BACKGROUND:'
    quote: Postural orthostatic tachycardia syndrome (POTS) is a frequently diagnosed cardiovascular disorder after
      COVID-19 infection.
    note: 'Found by winnow, kev and lev in p003, p001, p002. Claude judged: partial.'
  - paper: pmid39207648
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction > Symptoms of PASC
    quote: Recently, POTS has been linked to PASC [20, 26, 27].
    note: 'Found by winnow, kev and lev in p030, p006. Claude judged: partial.'
  - paper: pmid38585346
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Autonomic dysfunction is a common consequence suffered by COVID long-haulers, manifesting in symptoms
      including headache, fatigue, orthostatic intolerance, tachycardia/palpitations, temperature intolerance, and
      more, reflecting the growing incidence of POTS pathophysiology in these patients (7).
    note: 'Found by winnow, kev and lev in p007, p002, p024. Claude judged: partial.'
  - paper: pmid38510743
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: The long Covid syndrome is characterized with orthostatic hypotension, impaired cardiac and cerebral
      perfusion, postural orthostatic tachycardia syndrome (POTS), syncope, chest pain, dyspnea, palpitation, chronic
      fatigue syndrome, ‘brain fog’, memory, cognitive and sleep difficulties, depression and anxiety.
    note: 'Found by winnow, kev and lev in p001, p028. Claude judged: partial.'
  - paper: pmid38392604
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction > Orthostasis, Orthostatic Intolerance, and POTS
    quote: Although well known in other contexts for at least three decades [6,7] (see Table 1), with at least 500,000
      cases in the USA alone [8,9,10], mostly in women (5:1) [5,9,11,12,13,14], POTS has emerged as a frequent symptom
      of both acute [15] and long COVID (e.g., [16,17,18,19,20,21] as part of the wider cardiovascular dysautonomia
      spectrum; see Table 1).
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Results
    quote: 'Thirty‐two patients with long COVID complicated by POTS were followed up (16 males; median age: 28 years).
      The follow‐up period was 159 days, and the interval between COVID‐19 onset and initial hospital attendance
      was 97 days.'
    note: 'Found by winnow, kev and lev in p011, p003, p004. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: There is strong evidence that SARS-CoV-2 may trigger POTS in patients with prolonged COVID-19 syndrome.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37981644
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: This novel condition is referred to as post-acute COVID-19 syndrome (PACS)1 and is defined as persisting
      symptoms > 12 weeks after contracting an acute SARS-CoV-2 infection2.
    note: 'Found by winnow, kev and lev in p002, p001, p005. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Epidemiology
    quote: The timing of POTS symptom onset was concurrent with usual acute COVID-19 symptoms, but it may occur
      months after infection (39, 40).
    note: 'Found by winnow, kev and lev in p001, p004, p014. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports
    quote: Contemporary literature indicates potential links between viral infections and vaccines (particularly
      HPV) with the development of POTS.14,35,36 The earliest reports of a POTS-like syndrome in the aftermath of
      COVID-19 infection emerged in March 2020.37
    note: 'Found by winnow, kev and lev in p021, p013, p020. Claude judged: partial.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The number of people afflicted with this dysautonomia has increased dramatically in recent years due
      to the long-term effects of coronavirus disease (COVID-19); however, it is largely underdiagnosed. This case
      report is about a patient with post-viral neuropathic POTS.
    note: 'Found by winnow, kev and lev in p005, p001, p008. Claude judged: partial.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: partial
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p001, p003. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: INTRODUCTION
    quote: Because viral infection can host various chronic neurological conditions, such as Guillain-Barre syndrome,
      POTS can possibly occur as a post-COVID-19 autonomic nerve involvement.
    note: 'Found by winnow, kev and lev in p004, p001, p002. Claude judged: partial.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: partial
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p022, p024, p025. Claude judged: partial.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Interestingly, POTS itself often develops following infectious diseases and, at least in some cases,
      may be associated with the production of autoantibodies against adrenergic and cholinergic receptors [35].
    note: 'Found by winnow, kev and lev in p046, p003, p035. Claude judged: partial.'
  - paper: pmid36339677
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: POTS has largely been involved in post-viral symptomatology15–18, with 28–41% of POTS cases reported
      to be associated with viral infections19,20, suggesting post viral autoimmune activation is a possible pathophysiological
      mechanism16. With an increasing number of patients being described with a wide variety of symptoms, particularly
      those implicated in autonomic dysfunction, long after their acute COVID-19 infectious period, we aimed to
      review the available literature on post COVID-19 POTS cases.
    note: 'Found by winnow, kev and lev in p001, p003, p007. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Selected Etiology: Post-COVID-19 > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p107, p111, p112. Claude judged: partial.'
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: Post-COVID-19-virus-associated POTS has been reported and seems to be far more prevalent than post-COVID-19-vaccine-associated
      POTS [8,9,15,25,32,33,34]. Despite the handful of cases describing new-onset POTS after the COVID-19 vaccine,
      the vaccine has demonstrated significant protection against SARS-CoV-2 infection and reduces risk of developing
      Long-COVID or post-infectious POTS [35].
    note: 'Found by winnow, kev and lev in p014, p015, p017. Claude judged: partial.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p001, p010, p011. Claude judged: partial.'
  - paper: pmid35852546
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Neuromuskuläre Erkrankungen nach COVID-19: Was ist gesichert? > Autonome Dysfunktion'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35852546. Found by winnow, kev and lev in p012, p030. Claude judged: partial.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: A range of diseases, including viral or bacterial infections, can cause POTS. Because an increasing number
      of patients who recovered from COVID-19 are now reporting POTS-like symptoms including brain fog, tachycardia
      and severe chronic fatigue, some experts believe coronavirus may be a trigger for POTS.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: “Post-COVID-19 Tachycardia Syndrome”
    quote: Numerous reports have described the development of POTS as part of long COVID (19, 25–27) although the
      aetiology remains debated.
    note: 'Found by winnow, kev and lev in p004, p008. Claude judged: partial.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: With associations of viral infections as a potential etiology of POTS and evidence that many COVID-19
      long haulers are developing POTS, platelets may also play a significant role in the etiology or perpetuation
      of the disorder.
    note: 'Found by winnow, kev and lev in p003, p002. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. COVID-19 Infection and Dysautonomia
    quote: A growing body of evidence links PASC to CVAD, with a number of reports suggesting the possibility of
      previously infected COVID-19 patients experiencing symptoms suggestive of POTS [10,13,16,43,44,45,46]. This
      is also consistent with previous evidence hinting at the presence of CVAD in SARS survivors during the 2003
      epidemic [47].
    note: 'Found by winnow, kev and lev in p008, p003, p013. Claude judged: partial.'
  - paper: pmid34729276
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: A growing number of patients diagnosed with COVID-19 disease have been reported to have postural orthostatic
      tachycardia syndrome (POTS) after the acute phase.
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: partial.'
  - paper: pmid34541421
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Cardiovascular Complications
    quote: Several case studies have linked new diagnoses of POTS with prior COVID-19 infection (45, 46, 47), and
      additional surveillance will be necessary to characterize the frequency and persistence of these symptoms.
      Whether and how COVID-19 infection directly causes POTS is still unknown.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid34192289
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Cardiovascular manifestations of PACS > Postural Orthostatic Tachycardia Syndrome
    quote: In two other case series with a total of 10 patients diagnosed with POTS, the timing of POTS symptom
      onset was most often concurrent with usual acute COVID-19 symptoms but cases of POTS occurring up to months
      after initial infection were seen [40,41].
    note: 'Found by winnow, kev and lev in p023, p021, p022. Claude judged: partial.'
  - paper: pmid34151246
    cited: true
    text: full
    license: by
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome and COVID-19
    quote: POTS impacts heart rate, blood pressure, and cardiac function and can be caused by many factors, including
      viral infections.187 Although it remains unclear whether SARS-CoV-2 triggers POTS, emerging evidence indicates
      a close association between COVID-19 and POTS-like symptoms.
    note: 'Found by winnow, kev and lev in p052. Claude judged: partial.'
  - paper: pmid33996867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: We describe three adolescent and young adult patients who had confirmed or probable COVID-19 infections
      early on during the pandemic and were referred for evaluation to the Chronic Fatigue Clinic at the Johns Hopkins
      Children's Center. All patients reported orthostatic intolerance symptoms within the first 2 weeks of illness,
      and 10-min passive standing tests were consistent with postural tachycardia syndrome.
    note: 'Found by winnow, kev and lev in p002, p004, p006. Claude judged: partial.'
  - paper: pmid33869099
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Unlabelled
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33869099. Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
  - paper: pmid33740207
    cited: true
    text: full
    license: none
    verdict: partial
    section: Research opportunities to understand Long-COVID POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33740207. Found by winnow, kev and lev in p004, p007. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - pots
  papers: 59
  evidence:
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: 'Moreover, POTS is also associated with a higher prevalence of atopic conditions and autoimmune disorders
      compared to the general population: Asthma (20.3% (95% CI 19.1–21.5) in POTS vs. 3.3% (95% CI 2.9–3.8) in
      the general population [32]), Hashimoto''s disease (8.3% (95% CI 4.1–16.0) vs. 7.5% (95% CI 5.7–9.6) [33]),
      Raynaud''s syndrome (15.5% (95% CI 14.4–16.7) vs. 4.85% (95% CI 2.1–8.7) [34]), and Sjögren''s syndrome (4.7%
      (95% CI 1.7–12.2) versus 0.06% (95% CI 0.04–0.08) [35]).'
    note: 'Found by winnow, kev and lev in p030, p036. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: The term "secondary POTS" is often reserved for the subtype associated with a chronic disease or autoimmune
      syndrome. About 20% of patients with an autoimmune disease have POTS [18].
    note: 'Found by winnow, kev and lev in p084, p072, p099. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autoimmunity > Comorbidity with undifferentiated connective tissue disease
    quote: POTS and OCADs are commonly comorbid with other autoimmune disorders, with the most common being Hashimoto’s
      thyroiditis (Blitshteyn, 2015). Their association with Sjögren’s syndrome, antiphospholipid syndrome, and
      celiac disease has also been reported (Schofield et al., 2014; Penny et al., 2016; Mannan and Pain, 2023).
    note: 'Found by winnow, kev and lev in p015, p001, p003. Claude judged: supports.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Results
    quote: AR-modulating autoantibody activity was also higher in patients with POTS vs those without and directly
      correlated with heart rate changes.
    note: 'Found by winnow, kev and lev in p025, p004, p005. Claude judged: supports.'
  - paper: pmid39527936
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: While none of these conditions is currently understood to be autoimmune in nature, there appears to be
      a higher prevalence of autoimmunity in individuals with POTS and those with hEDS relative to the general population.
      In a large cohort of patients with POTS, 16% had one or more autoimmune diseases, including Hashimoto’s thyroiditis
      (6%), celiac disease (3%), rheumatoid arthritis (RA) (2%), and systemic lupus erythematosus (SLE) (2%), all
      greater than the prevalence in the general population [10].
    note: 'Found by winnow, kev and lev in p007, p019, p021. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: POTS has a higher prevalence of autoimmune markers and co-morbid autoimmune disorders, e.g., Hashimoto’s
      thyroiditis and rheumatoid arthritis [42].
    note: 'Found by winnow, kev and lev in p014, p003, p015. Claude judged: supports.'
  - paper: pmid38900132
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38900132. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.5. Antiphospholipid
      and Antinuclear Autoantibodies
    quote: A higher prevalence of ANA AAbs and aPL AAbs were found in patients with POTS compared to the general
      population. The presence of Hashimoto’s thyroiditis, systemic lupus erythematosus, and rheumatoid arthritis
      was found to be statistically significantly higher in POTS patients compared to the general population [59].
    note: 'Found by winnow, kev and lev in p021, p030, p001. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Autoimmunity has been proposed as a possible etiological mechanism in POTS, with high prevalence of diverse
      antibodies in previous reports (Fedorowski, 2019). Moreover, increased prevalence of co-morbid systemic autoimmune
      rheumatic disorders have been reported in POTS (Mannan and Pain, 2023), but causative autoantibodies have
      not been found so far (Vernino and Stiles, 2018).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid38311655
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38311655. Found by winnow, kev and lev in p002, p003. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010, p018, p019. Claude judged: supports.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: According to Gunning et al.,110 POTS is associated with increased G-protein coupled receptor autoantibodies.
      Other proposed mechanisms included those against ACE-2 and muscarinic receptors.111
    note: 'Found by winnow, kev and lev in p061. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Auto-antibodies in POTS and Long Covid—significance and implications for future study
    quote: 'The association between POTS and autoantibodies is well recognized: auto-antibodies to the α and β receptors
      on GPCR antibodies, ganglionic acetylcholine receptor antibodies, angiotensin II receptor antibodies and antibodies
      to structural cardiac proteins have been identified in POTS [14, 27, 75–78].'
    note: 'Found by winnow, kev and lev in p009, p020, p001. Claude judged: supports.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: A review of autoimmunity in POTS by Ref. [5] found that “patients with POTS have a higher than expected
      frequency of defined autoimmune disorders such as multiple sclerosis, lupus, Sjögren syndrome or celiac disease”.
    note: 'Found by winnow, kev and lev in p003, p022, p074. Claude judged: supports.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: supports
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid35269395
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The etiology of POTS is unknown but a number of laboratories, including ours, have reported elevations
      of G-protein-coupled adrenergic receptor and muscarinic acetylcholine receptor autoantibodies in POTS patients,
      detected by a variety of techniques, suggesting that the disorder is an autoimmune condition.
    note: 'Found by winnow, kev and lev in p001, p002, p012. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Antibodies and immunology of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p022, p009. Claude judged: supports.'
  - paper: pmid34055446
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: A pathogenesis of POTS includes an autoimmune basis with a high prevalence of positive ANA and comorbid
      autoimmune disorders [3]. Additionally, there has been an association between POTS syndrome and antiphospholipid
      antibody syndrome [4].
    note: 'Found by winnow, kev and lev in p010, p011, p014. Claude judged: supports.'
  - paper: pmid33621398
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Several groups previously confirmed these autonomic manifestations and identified complications in AGID
      or autoimmune POTS patients who were seropositive for the gAChR Abs.
    note: 'Found by winnow, kev and lev in p024, p005, p016. Claude judged: supports.'
  - paper: pmid33562074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: A growing body of evidence suggests that postural orthostatic tachycardia syndrome (POTS) may be an autoimmune
      disorder. We have reported in a previous manuscript that 89% of POTS patients (n = 55) had elevations in G-protein-coupled
      adrenergic A1 receptor autoantibodies and 53% had elevations in muscarinic acetylcholine M4 receptor autoantibodies,
      as assessed by ELISA.
    note: 'Found by winnow, kev and lev in p033, p001, p002. Claude judged: supports.'
  - paper: pmid32983103
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pediatric VVS and/or POTS Comorbid With Allergic Diseases > Pathogenesis > Autoimmunity
    quote: On the other hand, increasing evidence has shown that POTS is related to autoimmunity (57). Blitshteyn
      found that one quarter of the patients had antinuclear antibodies (ANA), almost one third of the patients
      had autoimmune markers, and one fifth of the patients had coexisting autoimmune diseases (58).
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots > Autoimmune Dysfunction
    quote: Autoimmune disturbance has been considered as one of the mechanisms involved in POTS due to frequent
      findings of autoantibodies in patients (11, 86, 87).
    note: 'Found by winnow, kev and lev in p019. Claude judged: supports.'
  - paper: pmid32750291
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion > Orthostatic Symptoms in Relation to Receptor Activity
    quote: The same study indicated that 89% of patients with POTS had autoantibodies against ADRA1 whereas antibodies
      against other adrenergic and muscarinic antibodies were less prevalent.
    note: 'Found by winnow, kev and lev in p033, p001, p016. Claude judged: supports.'
  - paper: pmid32743496
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: Activating autoantibodies (AAb) to adrenergic receptors (AR) have previously been reported in patients
      with postural tachycardia syndrome (POTS). These AAb may contribute to a final common pathway for overlapping
      disease processes, reflecting a possible autoimmune contribution to POTS pathophysiology.
    note: 'Found by winnow, kev and lev in p027, p001, p003. Claude judged: supports.'
  - paper: pmid31547749
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Antiganglionic acetylcholine receptor antibodies were found to be variably present in POTS patients.11,
      13 Our group first reported the presence of activating autoantibodies (AAb) to the α1‐adrenergic (α1AR) and
      β1/2‐adrenergic receptors (β1/2AR) in a significant proportion of patients with POTS in 2014.14
    note: 'Found by winnow, kev and lev in p007, p001, p003. Claude judged: supports.'
  - paper: pmid31495251
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: Our observations provide further evidence that, in most cases, POTS patients have at least 1 elevated
      G‐protein coupled adrenergic autoantibody and, in some instances, both adrenergic and muscarinic autoantibodies,
      supporting the hypothesis that POTS may be an autoimmune disorder.
    note: 'Found by winnow, kev and lev in p002, p001, p003. Claude judged: supports.'
  - paper: pmid31139694
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: All patients with prominent POTS had autoantibodies to β2AR, which suggests antibody‐mediated pathophysiology
      in these patients.
    note: 'Found by winnow, kev and lev in p001, p011, p014. Claude judged: supports.'
  - paper: pmid31001074
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > The Role of Immune System in POTS
    quote: Studies performed recently indicate that patients with POTS have higher prevalence of autoimmune markers
      and co-morbid autoimmune disorders compared with the general population (Blitshteyn, 2015). Accordingly, nearly
      one fourth of patients with POTS have positive ANA and one in three have some type of autoimmune markers (Blitshteyn,
      2015).
    note: 'Found by winnow, kev and lev in p027, p001, p003. Claude judged: supports.'
  - paper: pmid29909990
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29909990. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: A study of 100 consecutive patients with POTS found that 31% of patients had 1 or more antibody markers
      and 20% had comorbid autoimmune disorders such as Hashimoto's thyroiditis, rheumatoid arthritis, or systemic
      lupus erythematosus.35
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: Moreover, autoimmune markers and comorbid autoimmune diseases were also frequent in seropositive POTS
      patients. Anti‐gAChR antibodies were detectable in significant number of patients with POTS, and POTS entailed
      the element of autoimmune basis.
    note: 'Found by winnow, kev and lev in p001, p003, p015. Claude judged: supports.'
  - paper: pmid29618472
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Methods and Results
    quote: All subjects with POTS were positive for one or both autoantibodies to the AT1R and α1‐adrenergic receptor.
    note: 'Found by winnow, kev and lev in p005, p001, p002. Claude judged: supports.'
  - paper: pmid28738696
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28738696. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid27702852
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: It seems apparent that the high percentage of POTS subjects examined by our group present with an apparent
      autoimmune diathesis that supports the concept that these autoantibodies play important role in the pathophysiology
      of this entity.
    note: 'Found by winnow, kev and lev in p018, p031, p002. Claude judged: supports.'
  - paper: pmid26038344
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26038344. Found by winnow, kev and lev in p003, p001, p002. Claude judged: supports.'
  - paper: pmid25087056
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25087056. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid23002038
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions and clinical relevance
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23002038. Found by winnow, kev and lev in p004, p019, p001. Claude judged: supports.'
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Long COVID
    quote: Other major pathophysiologic mechanisms of Long COVID include autoimmune, inflammatory and immune dysregulations,
      which are similar to the pathophysiology of POTS. Elevated serum autoimmune and inflammatory markers have
      been found in patents with POTS and in patients with Long COVID.
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: partial.'
  - paper: pmid41146789
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Presently, it is considered that the etiology of POTS can be related to viral infections or other conditions,
      which involve an excessive activation of the immune system, α-receptor hyperactivity, and the presence of
      autoantibodies against receptor molecules on human cells [24-26].
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid40432440
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results
    quote: Significantly higher levels of angiotensin II type 1 receptor (AT1R) autoantibodies were in the POTS
      group compared with controls (0.67± 0.35 vs. 0.38±0.32, p=0.008).
    note: 'Found by winnow, kev and lev in p001, p006, p023. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Patients with autoimmune-related POTS may also present with autoimmune disorders as comorbidities. The
      onset of POTS in these patients may be related to autoantibodies against ganglionic acetylcholine receptors
      and α1-adrenergic receptors, although no definitive pathways have been identified.
    note: 'Found by winnow, kev and lev in p011, p032. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response. Few of the patients were detected to have autoantibodies to adrenergic, acetylcholine,
      and angiotensin II receptors [12,15].'
    note: 'Found by winnow, kev and lev in p012, p003, p051. Claude judged: partial.'
  - paper: pmid36908200
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Discussion: > Interpretation: > Comorbid Autoimmune Disorders:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36908200. Found by winnow, kev and lev in p015, p020, p041. Claude judged: partial.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Interestingly, POTS itself often develops following infectious diseases and, at least in some cases,
      may be associated with the production of autoantibodies against adrenergic and cholinergic receptors [35].
    note: 'Found by winnow, kev and lev in p046. Claude judged: partial.'
  - paper: pmid36509178
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Hospitalization status
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36509178. Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Although the exact mechanism of vaccine-induced POTS is not clear, the autoimmune pathophysiology might
      be a key component [13-15].
    note: 'Found by winnow, kev and lev in p001, p004, p014. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Selected Etiology: Autoimmune > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p066, p062, p067. Claude judged: partial.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p005, p006. Claude judged: partial.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Discussion
    quote: Furthermore, with cohorts of POTS patients recently being found to have adrenergic or muscarinic autoantibodies
      [36,77,78], and given known MC surface expression of adrenergic and muscarinic receptors which are active
      in the regulation of MC function [36], it even becomes possible, at least in theory, to drive MC activation
      (and thus at least those types of POTS underpinned by MCAS) via such autoantibodies as well.
    note: 'Found by winnow, kev and lev in p020. Claude judged: partial.'
  - paper: pmid34993884
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34993884. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34895744
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34895744. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: It can be speculated from previous studies that autonomic nervous dysfunction in patients diagnosed with
      comorbidities of POTS and chronic fatigue syndrome may be related to autoantibodies against G-protein-coupled
      receptors and small fiber neuropathy.41–43 However, at present, the exact role of these antibodies is not
      fully understood.
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid34484936
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Objective
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34484936. Found by winnow, kev and lev in p001, p003. Claude judged: partial.'
  - paper: pmid34471867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In this case the diagnostic work-up of PoTS led to the diagnosis of autoimmune-mediated neuropathic PoTS
      as a crossroad of PoTS, SFN and autoimmunity.
    note: 'Found by winnow, kev and lev in p023, p001, p004. Claude judged: partial.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: partial
    section: Fisiopatologia e as apresentações clínicas > Amiloidose
    quote: Estudos demonstraram que a teoria autoimune pode ser o mecanismo fisiopatológico das formas “idiopáticas”
      de algumas síndromes disautonômicas, como a falência autonômica pura (FAP), SPOT ou a síndrome da fadiga crônica.43
    note: 'Found by winnow, kev and lev in p124, p050. Claude judged: partial.'
  - paper: pmid31547756
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: There is an emerging body of evidence that suggests an autoimmune basis for POTS.3 Several studies have
      investigated the presence of autoantibodies in POTS and their effects on cholinergic and adrenergic receptors.3
    note: 'Found by winnow, kev and lev in p003, p004, p005. Claude judged: partial.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The Mayo Clinic experience study showed some correlation between autoimmunity and POTS. This study entails
      specific antibodies, such as ganglionic acetylcholine receptor antibody [8] and alpha-1 adrenergic receptor
      antibody that act as partial antagonists and induce reflex compensatory sympathetic activation [9].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Autoimmune/Autoantibodies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p031, p032. Claude judged: partial.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - pots
  papers: 48
  evidence:
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Around 30–60% of POTS patients have symptoms consistent with the ‘hyperadrenergic POTS’ subtype, characterized
      by palpitations, tremulousness, and gastrointestinal (GI) symptoms.[9] Patients with this subtype have elevated
      standing plasma norepinephrine concentrations causing increased sympathetic activation.[3]
    note: 'Found by winnow, kev and lev in p010, p016, p024. Claude judged: supports.'
  - paper: pmid38168762
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Phenotypes
    quote: Hyperadrenergic POTS was the most common phenotype (75.0%, 264/352), followed by hypovolemic POTS (44.9%,
      158/352) and neuropathic POTS (37.8%, 133/352).
    note: 'Found by winnow, kev and lev in p005, p011, p023. Claude judged: supports.'
  - paper: pmid37508741
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: It is currently known to be associated with autonomic nerve dysfunction, hypovolemia, hyperadrenergic
      stimulation, deconditioning, hypervigilance and damaged skeletal muscle pump activity, etc., and these mechanisms
      may exist alone or in combination in patients with POTS [2,3].
    note: 'Found by winnow, kev and lev in p019, p002. Claude judged: supports.'
  - paper: pmid37508589
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Main Pathogenesis of POTS
    quote: A plasma proteomic study revealed that the adrenergic activity was increased in the patients with POTS
      compared with healthy controls [35]. High plasma norepinephrine (NE) levels were found in some children or
      adults with POTS and were positively correlated with symptom severity [23,36].
    note: 'Found by winnow, kev and lev in p011, p031, p032. Claude judged: supports.'
  - paper: pmid35232225
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35232225. Found by winnow, kev and lev in p003, p007, p022. Claude judged: supports.'
  - paper: pmid32621993
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32621993. Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Feigofsky examines
    quote: While the definite pathophysiology remains unknown, POTS is sometimes associated with chronic fatigue
      syndrome,2 several autoimmune disorders,3 Ehlers–Danlos syndrome type 3,4–6 mast cell activation syndrome,6,7
      and hyperadrenergic states.7
    note: 'Found by winnow, kev and lev in p019, p011. Claude judged: supports.'
  - paper: pmid31788462
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Other than that, the clearance mechanism of norepinephrine in POTS patients is damaged and their sympathetic
      activation is prominent (27, 28).
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.2 Hyperadrenergic State
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p022, p016, p017. Claude judged: supports.'
  - paper: pmid25120493
    cited: true
    text: full
    license: by
    verdict: supports
    section: Sympathetic overactivity may be associated with POTS
    quote: Some investigations (Streeten et al., 1988; Schondorf and Low, 1993; Furlan et al., 1998; Jacob et al.,
      1999), but not all (Jacob et al., 2000; Lambert et al., 2008), have reported that POTS patients have greater
      systemic plasma noradrenaline concentrations at rest or during orthostasis compared with healthy controls,
      suggesting that POTS is associated with a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p017, p019. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p003, p001, p024. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p018, p009, p015. Claude judged: supports.'
  - paper: pmid23538032
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION > Possible Mechanisms of Poor Sleep Quality
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23538032. Found by winnow, kev and lev in p005, p033, p038. Claude judged: supports.'
  - paper: pmid21266211
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Pathophysiological Role of Ang II in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21266211. Found by winnow, kev and lev in p030, p004, p021. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: As a part of the definition, POTS is associated with a hyperadrenergic state (Table 1).
    note: 'Found by winnow, kev and lev in p028, p033, p001. Claude judged: supports.'
  - paper: pmid42254140
    cited: true
    text: full
    license: by
    verdict: partial
    section: Body
    quote: Evidence suggests that during sleep, POTS patients can enter a hyperadrenergic state, disrupting normal
      autonomic regulation and perpetuating a vicious cycle of poor sleep and worsened daytime symptoms[4].
    note: 'Found by winnow, kev and lev in p003, p002. Claude judged: partial.'
  - paper: pmid41924132
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Additionally, heightened vascular distensibility promotes venous pooling in the extremities and may precipitate
      a maladaptive autonomic adrenergic response with associated dizziness and palpitations, as seen in POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid41533304
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: We previously reported a subset of patients with POTS characterized by augmented central sympathetic
      outflow, as assessed by increased resting sympathetic nerve traffic (MSNA), and associated with greater diastolic
      blood pressure response to phase 2 of the VM (DBPVM2l_rise) [8]. This central hyperadrenergic phenotype was
      accompanied by increased resting blood pressure and an increase in upright BP.
    note: 'Found by winnow, kev and lev in p035, p036, p001. Claude judged: partial.'
  - paper: pmid41300853
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion > 4.2. ME/CFS Patients with MCA Involvement Experience OI Significantly More Often, Particularly
      Its Subtype POTS
    quote: IF-channel inhibitors, commonly used in angina pectoris and heart failure, are increasingly prescribed
      off-label for POTS, particularly the hyperadrenergic POTS subtype, where patients experience excessive tachycardia
      upon standing [34,35].
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Conclusions
    quote: In patients with POTS, orthostatic increases in NE levels significantly correlated with HR changes and
      elevated activity of naturally occurring AR autoantibodies, supporting exaggerated sympathetic activation
      as a key mechanism.
    note: 'Found by winnow, kev and lev in p025, p044, p004. Claude judged: partial.'
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: The increase of catecholamine is one of the main pathogenesis of POTS (Liao et al., 2013).
    note: 'Found by winnow, kev and lev in p020, p007. Claude judged: partial.'
  - paper: pmid39768649
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: In POTS patients with a HR increase ≥40 bpm, this inverse relation was lost, and SVI changes were significantly
      less compared to POTS patients with a HR increase between 30–39 bpm, suggestive of a hyperadrenergic response.
    note: 'Found by winnow, kev and lev in p001, p004, p026. Claude judged: partial.'
  - paper: pmid39301475
    cited: true
    text: full
    license: by
    verdict: partial
    section: Relationship to post-infectious syndromes including long COVID
    quote: In patients with LC and dysautonomia, there is often a hyperadrenergic state, which drives many of the
      pathophysiologic mechanisms of hyperadrenergic POTS (25).
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Abstract > Background:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p024, p034, p001. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome
    quote: POTS is theorized to be the culmination of multiple underlying pathological processes, including peripheral
      neuropathy/denervation, hypovolemia with altered renin–aldosterone levels, and a hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p011, p009, p013. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: Although the exact pathophysiology mechanism is unclear, it is thought that the combination of autoimmunity,
      relative central hypovolemia, small fiber neuropathy, hyperadrenergic stimulation, and pro-inflammatory cytokine
      production (i.e., cytokine storm) is a critical factor in POTS and COVID-19 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37705599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > VVS combined with POTS group
    quote: Some children with POTS display amplified sympathetic tone, while others demonstrate reduced sympathetic
      activity. The latter form of POTS, known as hyperadrenergic POTS, constitutes approximately 10% of all POTS
      cases (27).
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Etiopathogenic basis
    quote: The pathophysiological mechanisms resulting in autonomic dysfunction in POTS may include sympathetically
      mediated vasoconstriction in the lower limbs (neuropathic POTS), excessive cardiac sympathoexcitation response
      (hyperadrenergic POTS) with increased serum norepinephrine, volume dysregulation (hypovolemia), baroreceptor
      dysfunction, peripheral neuropathy, and autoimmunity due to molecular mimicry following infections by pathogens
      such as Epstein–Barr virus, cytomegalovirus, or Borrelia Burgdorferi (1, 15).
    note: 'Found by winnow, kev and lev in p006, p015. Claude judged: partial.'
  - paper: pmid37378164
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: It can also be divided into hyperadrenergic POTS, an excessive outburst of norepinephrine when initiating
      an erect position.
    note: 'Found by winnow, kev and lev in p003, p006, p008. Claude judged: partial.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: partial
    section: Associations with mast cell activation disorders
    quote: These MCA/POTS patients had predominant flushing breathlessness, headache, lightheadedness, excessive
      diuresis, diarrhoea, nausea and vomiting, and had a marked hyperadrenergic orthostatic response, with higher
      noradrenaline levels and exaggerated blood pressure rise on standing compared with the POTS and control groups
      [95].
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: As compared to healthy people, POTS patients have evidence of higher levels of catecholamines [28] and
      angiotensin II [29] and lower levels of plasma renin and aldosterone [14,17,23] at baseline. There is also
      evidence that with standing POTS, patients have an increase in norepinephrine levels.
    note: 'Found by winnow, kev and lev in p003, p013, p014. Claude judged: partial.'
  - paper: pmid35818599
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: The clinical presentation of pheochromocytoma may often be confused with POTS because of the paroxysms
      of hyperadrenergic symptoms.1
    note: 'Found by winnow, kev and lev in p001, p011. Claude judged: partial.'
  - paper: pmid35620060
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Patient 3
    quote: 'Given her symptoms of flushing, anxiety, and faintness upon assuming an

      upright position, supine (685 pg/mL) and standing (1386 pg/mL)

      norepinephrine levels were assessed and suggested hyperadrenergic POTS.'
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid35351159
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Comorbidities of patients with PF
    quote: Often, subjects with β-adrenergic hyperresponsiveness show symptoms of POTS [15, 16].
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Symptoms > BMI decrease in POTS
    quote: Increased angiotensin II within the CNS can produce sympatho-excitation, which is a major factor in the
      subgroup of hyperadrenergic POTS.
    note: 'Found by winnow, kev and lev in p014, p018. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p026, p014, p025. Claude judged: partial.'
  - paper: pmid33654569
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A significant subset of POTS patients experience persistent sympathetic activation due to hemodynamic
      changes associated with POTS.14
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid33371330
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion > 4.3. Orthostatic Headaches and Migraine
    quote: On the other hand, Novak et al. reported that the pathogenesis of POTS appears to involve a hyperadrenergic
      state and distal neuropathy affecting sympathetic myocardial fibers [27].
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Hyperadrenergic POTS is associated with very high erect norepinephrine levels due to sympathetic overactivity
      or a hyperadrenergic state [12].
    note: 'Found by winnow, kev and lev in p023, p001, p006. Claude judged: partial.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: partial
    section: Perspectives on the Pathogenesis of Pots > Abnormal Autonomic Reflexes and a “Hyperadrenergic” Status
    quote: However, some pediatric POTS patients with a “hyperadrenergic” background have an inability to buffer
      the decrease in baroreceptor activation, leading to persistent sympathetic excitation characterized by sustained
      tachycardia while in an upright position (3, 37).
    note: 'Found by winnow, kev and lev in p012, p011, p013. Claude judged: partial.'
  - paper: pmid30076469
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment by comorbidity, subgrouping, and genetic profile > Treatment by comorbidity
    quote: POTS (14% in our cohort, 38% of tested adolescents) commonly affects adolescents with CVS [7, 18, 31].
      There is evidence of altered autonomic tone at baseline with elevated sympathetic tone and low to normal parasympathetic
      tone [29].
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: Several mechanisms have been proposed for the development of these symptoms including sympathetic denervation
      and central causes such as sympathetic overdrive, hypovolemia, and involvement of the renin-angiotensin-aldosterone
      system.
    note: 'Found by winnow, kev and lev in p010, p011. Claude judged: partial.'
  - paper: pmid27558116
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27558116. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Central Hyperadrenergic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p029, p016, p026. Claude judged: partial.'
  - paper: pmid21906029
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract
    quote: CFS–POTS patients have higher markers of sympathetic activation, but are part of the spectrum of POTS.
    note: 'Found by winnow, kev and lev in p001, p026, p033. Claude judged: partial.'
  - paper: pmid21802629
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Discussion > 4.2 Review of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21802629. Found by winnow, kev and lev in p035, p009. Claude judged: partial.'
  - paper: pmid15710782
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15710782. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid11206727
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 11206727. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - associated_with
  - pots
  papers: 44
  evidence:
  - paper: pmid41924132
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Objective
    quote: The reported associations between EDS/HSD, Postural Orthostatic Tachycardia Syndrome (POTS), and Mast
      Cell Activation Syndrome (MCAS) further complicate the diagnosis and management of the VCS in this specific
      patient population.
    note: 'Found by winnow, kev and lev in p024, p001, p003. Claude judged: supports.'
  - paper: pmid41753313
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: These data show that inflammatory symptoms that are likely consistent with MCAS occur much more frequently
      with postural orthostatic tachycardia in adolescents and young adults than was previously recognized, and
      that joint hypermobility remains very common in this population, as well.
    note: 'Found by winnow, kev and lev in p001, p010, p018. Claude judged: supports.'
  - paper: pmid41668453
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: A growing body of literature suggests that a subset of patients with POTS also have mast cell activation
      syndrome (MCAS), a disorder of dysregulated mast cells with excessive mast cell mediator release, which can
      mimic or exacerbate dysautonomia through symptoms including tachycardia, flushing, GI sensitivities, headache,
      and cognitive dysfunction.
    note: 'Found by winnow, kev and lev in p006, p007, p008. Claude judged: supports.'
  - paper: pmid41300853
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Of interest, an association between neurological or cardiac symptoms, such as cognitive dysfunction or
      OI, particularly POTS (Postural Orthostatic Tachycardia Syndrome), is described not only in ME/CFS but also
      in Mast Cell Activation Syndrome (MCAS) patients [22,23,24].
    note: 'Found by winnow, kev and lev in p001, p005, p018. Claude judged: supports.'
  - paper: pmid40856938
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Mast cell activation syndrome (MCAS) is also a common comorbid condition in POTS, which induces abdominal
      cramping and bloating associated with enhanced secretion of histamine and inflammatory cytokines [1, 17].
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Up to 30 percent of POTS patients have mast cell activation syndrome, and it is well known that EDS type
      III is a mast cell activation disorder [17,18,19].
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid40352770
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: The close association of syndromes of orthostatic intolerance with and without postural orthostatic tachycardia
      syndrome (POTS) with Joint Hypermobility Disorders (JHD) including Hypermobility Spectrum Disorder (HSD) and
      hypermobile Ehlers Danlos Syndrome (hEDS) and with Mast Cell Activation Syndrome (MCAS) is now firmly established.
    note: 'Found by winnow, kev and lev in p012, p027, p001. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Mast Cell Activation
      Syndrome
    quote: Mast cell activation syndrome (MCAS), a subset of mast cell activation disorder (MCAD), is one of the
      conditions that can be associated with POTS and is characterized by either early or excessive mast cell activation
      and histamine release.[13,14]
    note: 'Found by winnow, kev and lev in p017, p015, p016. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: 'Inflammation: In addition to elevated autoimmune and inflammatory markers in POTS patients [45] and
      a higher prevalence of autoimmune disorders [42], POTS frequently co-occurs with a range of other conditions
      that have inflammatory underpinnings, such as: Small Fiber Neuropathy (SFN), characterized by damage to small
      nerve fibers and inflammatory processes [46]; Mast Cell Activation Syndrome (MCAS), involving excessive inflammatory
      mediator release [47]; Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME), associated with immune
      dysregulation and chronic inflammation [48]; and infections such as Lyme disease [49].'
    note: 'Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Response to Guanfacine in POTS Patients with and without Hyperadrenergic Phenotype (Protocol
      2, Treatment Cohort).
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p024, p034, p035. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Potential mechanisms of infection-associated dysautonomia > Chronic neuroinflammation
    quote: POTS has been associated with mast cell activation syndrome (MCAS) (77), a poorly understood multisystem
      disorder of inflammation, with or without allergic phenomena or tissue growth/development anomalies (78).
    note: 'Found by winnow, kev and lev in p021. Claude judged: supports.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: All eight patients were subsequently diagnosed with mast cell activation syndrome; six had comorbid autonomic
      disorders, the most common being postural orthostatic tachycardia syndrome; and four had hypermobile Ehlers-Danlos
      syndrome.
    note: 'Found by winnow, kev and lev in p001, p005, p016. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Associations with mast cell activation disorders
    quote: A prominent overlapping symptom cluster associated with both POTS [56, 57] and Long Covid [89, 90] includes
      a multi-system and often non-specific symptom cluster which is often referred to as ‘mast cell activation
      syndrome’ (and considered to be due to release of mast cell mediators) and includes gastrointestinal disturbances
      (nausea, vomiting, diarrhoea, cramps), asthma like symptoms, flushing, urticaria, angioedema and constitutional
      symptoms such as fatigue and fever [91].
    note: 'Found by winnow, kev and lev in p026, p028. Claude judged: supports.'
  - paper: pmid37241210
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Association with Postural Tachycardia Syndrome, Reduced Cerebral Blood Flow and Orthostatic Intolerance
    quote: The association of MCA with POTS, as an example for orthostatic stress, may be via ME/CFS or separate.
    note: 'Found by winnow, kev and lev in p023, p001, p027. Claude judged: supports.'
  - paper: pmid37234076
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Female reproductive health in illnesses comorbid or associated with Long COVID: A brief overview of
      myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),
      Ehlers-Danlos syndrome (EDS), and endometriosis > Ehlers-Danlos syndrome (EDS), connective tissue disorders
      (CTDs), and reproductive health'
    quote: Notably, symptoms of MCA are prevalent in LC patients (62), and there are substantial rates of diagnostic
      comorbidity between mast cell activation syndrome (MCAS) and EDS (63), ME/CFS (64), and POTS (65).
    note: 'Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid36981522
    cited: true
    text: full
    license: by
    verdict: supports
    section: '3. Treatment > 3.2. Comment: Allergic and Mast Cell Inflammation'
    quote: Some forms of POTS have been associated with mast cell activation syndrome [32] (MCAS), and POTS has
      been identified as part of the phenotype of hereditary forms of tryptasemia [33].
    note: 'Found by winnow, kev and lev in p023, p001, p018. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Mast Cell Activation Syndrome
    quote: MCAS is a common co-morbidity with both POTS and EDS and is a multi-systemic disorder of mast cell hyperactivity
      that typically manifests with allergic symptoms, gastrointestinal dysfunction, dysautonomia and various genito-urinary
      and gynecologic manifestations.26–28
    note: 'Found by winnow, kev and lev in p027, p017. Claude judged: supports.'
  - paper: pmid36252987
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: The importance of diagnosing BASCULE syndrome lies in its association with a spectrum of orthostatic
      intolerance conditions, including syncope, orthostatic hypotension and POTS (a condition associated with mast
      cell activation and hypermobility spectrum disorders).2,3
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid35307584
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35307584. Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: There is rising recognition, too, of associations of MCAS with central and peripheral neuropathic disorders,
      including autonomic disorders such as POTS.
    note: 'Found by winnow, kev and lev in p001, p007, p020. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mechanisms
    quote: Mast cell activation syndrome may be present in some patients with POTS.14 These patients experience
      severe episodic flushing with sinus tachycardia.14
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Furthermore, mast cell activation disorder (MCAD), a condition in which mast cells increase in number
      or excessively release inflammatory mediators,31 was considered to be a comorbidity of adult POTS, and some
      of which might be secondary to allergic disorders.32,33
    note: 'Found by winnow, kev and lev in p024, p029. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Nos casos de pacientes com SPOT que apresentam a síndrome de ativação dos mastócitos, um fator autoimune
      pode estar presente. Esses pacientes apresentam rubor da pele e hipertensão associada com a taquicardia ortostática.
    note: 'Found by winnow, kev and lev in p107, p124. Claude judged: supports.'
  - paper: pmid33178533
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Weinstock et al. report the successful treatment of POTS associated with mast cell activation syndrome
      with intravenous immunoglobulin [18].
    note: 'Found by winnow, kev and lev in p023, p025. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Feigofsky examines
    quote: While the definite pathophysiology remains unknown, POTS is sometimes associated with chronic fatigue
      syndrome,2 several autoimmune disorders,3 Ehlers–Danlos syndrome type 3,4–6 mast cell activation syndrome,6,7
      and hyperadrenergic states.7
    note: 'Found by winnow, kev and lev in p006, p019. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome can occur in association with mast cell activation disorders,
      in which mast cells degranulate inappropriately and release mediators or proliferate to produce inflammatory
      responses that can occur throughout the body, as mast cells are present in all types of tissues.75
    note: 'Found by winnow, kev and lev in p032. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.5 Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Background
    quote: To further complicate matters, 17 of 48 MCAS symptoms overlap with 33 POTS symptoms which is explained
      by comorbidity of the syndromes, where 30% of patients with POTS also have MCAS.5
    note: 'Found by winnow, kev and lev in p002, p014, p015. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p018, p028. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: Some patients with POTS have co-existent mast cell activation. These patients have episodic flushing
      and abnormal increases in urine methylhistamine (the primary urinary metabolite of histamine) [20].
    note: 'Found by winnow, kev and lev in p033, p019. Claude judged: supports.'
  - paper: pmid15710782
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15710782. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid42153984
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Comorbidities
    quote: The proportion of patients with gastroparesis and mast cell activation syndrome (MCAS) were similar to
      a large survey [18].
    note: 'Found by winnow, kev and lev in p047, p049. Claude judged: partial.'
  - paper: pmid41898333
    cited: true
    text: full
    license: by
    verdict: partial
    section: 12. Discussion
    quote: Moreover, other heterogeneous conditions, like HSD, mast cell activation disorder, and POTS, may cause
      similar symptoms together and separately, complicating our overall understanding of the disease process.
    note: 'Found by winnow, kev and lev in p017, p037. Claude judged: partial.'
  - paper: pmid39931100
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Notably, individuals with symptoms of hEDS often present with concomitant autonomic and immune dysfunctions
      such as postural orthostatic tachycardia syndrome (POTS) and mast cell activation disorder (MCAD), respectively,
      whose associations with connective tissue and joint fragility are well documented (10, 19).
    note: 'Found by winnow, kev and lev in p003, p006. Claude judged: partial.'
  - paper: pmid39165715
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: Of these 69 patients, 44 expressed additional symptoms suggesting MCA. Among them, 29 (66%) patients
      exhibited at least one laboratory abnormality related to MCA.
    note: 'Found by winnow, kev and lev in p024, p026, p001. Claude judged: partial.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: A subtype of POTS, hyperadrenergic POTS, has been widely studied because of its association with mast
      cell activation syndrome (MCAS). Although a causative relationship between PCC, hyperadrenergic POTS, and
      MCAS remains unrevealed, these syndromes can overlap.
    note: 'Found by winnow, kev and lev in p006, p001, p024. Claude judged: partial.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1 Introduction
    quote: Mast cell activation disorder has been proposed to be associated with POTS with atypical symptom presentation,
      such as predominant gastrointestinal (GI) symptomatology (Kohno et al., 2021).
    note: 'Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid38269002
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Hypersensitivity, likely related to MCAS development, has been shown to be associated with EDS and POTS,
      and atopic conditions like eosinophilic esophagitis have been found to manifest in these patients (21).
    note: 'Found by winnow, kev and lev in p016, p019. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Selected Etiology: Mast Cell Disorders > Main Points: > DIAGNOSIS:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p080. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: Flushing, headaches, and gastrointestinal symptoms are more prevalent in these individuals, and a recent
      study showed markedly elevated prostaglandins and histamine markers in patients with gastrointestinal complaints,
      reinforcing the case for a mast cell activation disorder in a subset of POTS patients [78]. A case of mast
      cell activation syndrome was described in a 50-year-old female with previous COVID-19 with signs and symptoms
      of POTS [52].
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid34398691
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Methods and Results
    quote: Thus, 42% (29/69) of patients initially diagnosed with POTS exhibited both additional symptoms and at
      least 1 elevated biochemical marker suggesting MCA disorder.
    note: 'Found by winnow, kev and lev in p001, p006, p002. Claude judged: partial.'
  - paper: pmid33869099
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Unlabelled
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33869099. Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
  - paper: pmid30400667
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Materials and Methods > 2.4. Laboratory Testing
    quote: Testing for Mast Cell Activation Disorder (MCAD) and food allergies included serum histamine, tryptase,
      chromogranin A, and IgE blood tests, respectively, (occasionally IgG4 delayed food allergy hypersensitivity
      testing was performed), when clinically indicated (MCAD can also be associated with POTS) [86].
    note: 'Found by winnow, kev and lev in p038. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - associated_with
  - pots
  papers: 35
  evidence:
  - paper: pmid42691689
    cited: true
    text: full
    license: none
    verdict: supports
    section: Autonomic system degenerations, generalized dysautonomia, and disorders of autonomic dysregulation
      > Postural orthostatic tachycardia syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42691689. Found by winnow, kev and lev in p002, p044. Claude judged: supports.'
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Abstract
    quote: Dysautonomia, including postural orthostatic tachycardia syndrome (POTS) and related orthostatic disorders,
      is frequently associated with debilitating gastrointestinal (GI) symptoms in adolescents, including chronic
      nausea, early satiety, postprandial fullness, and functional dysmotility.
    note: 'Found by winnow, kev and lev in p003, p027, p004. Claude judged: supports.'
  - paper: pmid42156945
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: IBS is a common comorbid disease in POTS14.
    note: 'Found by winnow, kev and lev in p004, p033, p037. Claude judged: supports.'
  - paper: pmid42153984
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Comorbidities
    quote: Most participants reported one or more of the common POTS comorbidities. More patients had irritable
      bowel syndrome, autoimmune disease, myalgic encephalomyelitis/chronic fatigue syndrome, and neuropathy than
      other findings [18, 21].
    note: 'Found by winnow, kev and lev in p004, p047. Claude judged: supports.'
  - paper: pmid41952405
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: GI dysmotility, driven by autonomic dysfunction and hypovolemia, is a major contributor to these symptoms.8
      GI symptoms, including nausea, vomiting, and indigestion, which commonly develop and persist even without
      postural changes,8 affect approximately 67% of POTS patients, severely impacting their quality of life (QoL).7,9
    note: 'Found by winnow, kev and lev in p016, p006, p027. Claude judged: supports.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Abnormal gastric emptying and delayed colonic transit were observed in over one‐third of POTS patients
      studied.
    note: 'Found by winnow, kev and lev in p032, p039, p041. Claude judged: supports.'
  - paper: pmid41858767
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Gastrointestinal symptoms in POTS and HSD/hEDS occur frequently, both as functional gastrointestinal
      disorders and as more severe intestinal dysmotility disorders (10-12).
    note: 'Found by winnow, kev and lev in p004, p001, p015. Claude judged: supports.'
  - paper: pmid40856938
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Abdominal pain frequently causes significant morbidity in patients with POTS. The underlying pathophysiology
      is multifactorial and could involve both autonomic and non-autonomic mechanisms. Frequently, patients present
      symptoms such as early satiety, constipation, bloating, and gastrointestinal dysmotility, including delayed
      gastric emptying and intestinal dysmotility.
    note: 'Found by winnow, kev and lev in p014, p015, p018. Claude judged: supports.'
  - paper: pmid40608783
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: We have previously shown that gastrointestinal symptoms were common and moderately severe in POTS, resembling
      the symptomatology found in irritable bowel syndrome (IBS), as well as in gastroparesis [15].
    note: 'Found by winnow, kev and lev in p005, p014, p021. Claude judged: supports.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: supports
    section: Overview of gastroparesis > Normal gastric function
    quote: Gastric dysmotility is associated with conditions such as EDS and POTS which occur from disruptions to
      normal gastric function.
    note: 'Found by winnow, kev and lev in p001, p005, p042. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Gastrointestinal (GI) symptoms are common in postural orthostatic tachycardia syndrome (POTS).
    note: 'Found by winnow, kev and lev in p003, p035, p001. Claude judged: supports.'
  - paper: pmid35307584
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35307584. Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid34765384
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: One retrospective study found that both EDS III and POTS are independent risk factors for gastrointestinal
      (GI) symptoms, including GI dysmotility and gastroesophageal reflux disease [15].
    note: 'Found by winnow, kev and lev in p006, p019. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Gastrointestinal dysfunction in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid33621398
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Sullivan et al. assessed a group of children with functional GI symptoms, mainly abdominal pain, nausea,
      and vomiting, who also underwent tilt table testing, and demonstrated an association with either POTS, neutrally
      mediated hypotension, or POTS with neutrally mediated hypotension.
    note: 'Found by winnow, kev and lev in p024, p027. Claude judged: supports.'
  - paper: pmid33428036
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33428036. Found by winnow, kev and lev in p001, p004, p005. Claude judged: supports.'
  - paper: pmid32494413
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dr. Mehdirad remarks > Mechanisms and symptoms
    quote: It is noteworthy to mention additionally though that it is not uncommon for POTS patients to also demonstrate
      manifestations of other disease states such as hypermobility syndrome,8 vascular compression syndrome,9 and
      irritable bowel syndrome.8 In addition, some patients may present with cholinergic symptoms such as dry mouth,
      dry eyes, delayed gastric transit, early satiety, nausea, constipation and Holmes–Adie pupil (ie, dilated
      pupil that constricts slowly in bright light).10–13
    note: 'Found by winnow, kev and lev in p005, p006. Claude judged: supports.'
  - paper: pmid32489735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: 'On multivariable analysis, only POTS (OR: 5.74, 95% CI: 2.25-16.7, p=0.0005) was significantly associated
      with an increased likelihood of GI dysmotility.'
    note: 'Found by winnow, kev and lev in p052, p054, p006. Claude judged: supports.'
  - paper: pmid30072778
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30072778. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction > Concurrent clinical syndromes > Irritable bowel syndrome (IBS)
    quote: Symptoms of IBS, food intolerance and allergic sinusitis, are commonly reported in individuals with POTS.7
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Background
    quote: Gastrointestinal (GI) symptoms are common in both syndromes.1–4 6 GI symptoms in MCAS can be explained
      by inappropriate release of mediators from mast cells (MCs) with KIT mutations whereas GI motility disorders
      in POTS may be due to active autoimmune muscarinic antibodies causing autonomic imbalance in some patients
      (S Vernino, personal communication, 2017).2
    note: 'Found by winnow, kev and lev in p002, p016, p019. Claude judged: supports.'
  - paper: pmid28191707
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28191707. Found by winnow, kev and lev in p001, p003, p004. Claude judged: supports.'
  - paper: pmid26671111
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26671111. Found by winnow, kev and lev in p004, p001. Claude judged: supports.'
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p004, p022, p024. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > GI Physiology and Pathophysiology as Related to POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p052, p095. Claude judged: supports.'
  - paper: pmid19424509
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: FGID's have been associated with orthostatic intolerance (OI), mainly postural tachycardia syndrome (POTS)
      and syncope [4, 6], but other associations have not been carefully evaluated.
    note: 'Found by winnow, kev and lev in p004, p003. Claude judged: supports.'
  - paper: pmid42437376
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Conclusions
    quote: Overall, > 60% of hEDS/HSD patients report chronic GI symptoms. DGBI, co‐morbidities, including POTS,
      were highly prevalent in hEDS/HSD patients.
    note: 'Found by winnow, kev and lev in p005, p042. Claude judged: partial.'
  - paper: pmid39543811
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Key Results
    quote: 'Patients segregated into three clusters: Cluster 0 (n = 466): hEDS/HSD+ functional foregut disorders
      (FFD) + irritable bowel syndrome (IBS); Cluster 1 (n = 180): hEDS/HSD+ IBS and Cluster 2 (n = 337): hEDS/HSD
      alone. In cluster 0, we demonstrated increased somatization (p <0.0001), anxiety (p <0.0001), depression (p
      <0.0001), PoTS prevalence (p = 0.003), autonomic symptoms (p <0.0001) and reduced quality of life (p <0.0001)
      compared to cluster 2.'
    note: 'Found by winnow, kev and lev in p036, p047, p003. Claude judged: partial.'
  - paper: pmid34993884
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34993884. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > POTS comorbidities
    quote: 'There were two patients with chronic gastritis. The following comorbidities were identified in one patient
      each: epilepsy, prior subarachnoid hemorrhage, anxiety, mitral valve insufficiency, obstructive sleep apnea,
      hypothyreosis, and irritable bowel syndrome.'
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
  - paper: pmid32803794
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Key Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32803794. Found by winnow, kev and lev in p003, p004. Claude judged: partial.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Postural Tachycardia Syndrome and Gastrointestinal Symptoms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p006, p011, p014. Claude judged: partial.'
  - paper: pmid24068608
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24068608. Found by winnow, kev and lev in p005, p003. Claude judged: partial.'
  - paper: pmid23708963
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23708963. Found by winnow, kev and lev in p019, p020, p004. Claude judged: partial.'
  - paper: pmid23212662
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Interpretation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23212662. Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - pots
  papers: 32
  evidence:
  - paper: pmid42787977
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Beyond these physical manifestations, patients with POTS frequently experience significant mental health
      challenges, including anxiety, depression, and reduced quality of life [4].
    note: 'Found by winnow, kev and lev in p004, p005, p022. Claude judged: supports.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Extra‐intestinal comorbidities, including anxiety, chronic fatigue, migraines, and depression, were reported
      in over one‐third of POTS patients, occurring more frequently than gastrointestinal conditions.
    note: 'Found by winnow, kev and lev in p032, p003, p004. Claude judged: supports.'
  - paper: pmid41740821
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41740821. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid40454385
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Studies indicated that 87% of patients with POTS experienced mild-to-moderate anxiety and depression,
      and over half reported disturbed sleep patterns (17, 18). Additionally, anxiety and depression levels could
      be positively correlated with POTS symptom severity (19–21).
    note: 'Found by winnow, kev and lev in p012, p001, p005. Claude judged: supports.'
  - paper: pmid40003288
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Finally, symptoms of anxiety and depression are often comorbid in pediatric patients with orthostatic
      intolerance and/or POTS [11,12,29] and frequently contribute to symptom burden and functional impairment,
      as well as having an impact on the HPA axis [30].
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid39838139
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Psychological similarities can also be identified between LC and POTS, such as higher levels of anxiety
      and depression [34–40] or lower levels of quality of life [10, 35, 41–46] compared with the general population.
    note: 'Found by winnow, kev and lev in p053, p008. Claude judged: supports.'
  - paper: pmid39308845
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Patients with POTS frequently experience a reduced quality of life, with many reporting co-occurring
      anxiety and depression, further complicating symptom management.
    note: 'Found by winnow, kev and lev in p003, p004, p009. Claude judged: supports.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: In this study, many patients with POTS had psychiatric symptoms caused by financial and educational concerns
      because of their inability to go to work or attend school and anxiety about prolonged symptoms.
    note: 'Found by winnow, kev and lev in p003, p023, p024. Claude judged: supports.'
  - paper: pmid37338634
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results
    quote: Common comorbidities include anxiety or depression, migraine, Ehlers–Danlos syndrome or hypermobile spectrum
      disorder, irritable bowel syndrome, iron deficiency, and myalgic encephalomyelitis or chronic fatigue syndrome
      (Table 1).
    note: 'Found by winnow, kev and lev in p014, p023. Claude judged: supports.'
  - paper: pmid33114659
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. Study Limitations
    quote: Finally, it is well known that anxiety and psychological distress are common in POTS.
    note: 'Found by winnow, kev and lev in p057, p044. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Challenge II: Lack Of Standardized Approaches To Physical Rehabilitation And Psychopharmacology >
      Challenge III: Psychological Comorbidities'
    quote: Many teens with POTS report symptoms of depression, anxiety, and hyperactivity, with one study noting
      almost one-fourth of youth reported moderate to severe depressive symptoms (13% and 10%, respectively).5,11,23,47
    note: 'Found by winnow, kev and lev in p006, p019, p020. Claude judged: supports.'
  - paper: pmid29628432
    cited: true
    text: full
    license: none
    verdict: supports
    section: 2. Quality of Life and Psychiatric Profile of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29628432. Found by winnow, kev and lev in p001, p004, p009. Claude judged: supports.'
  - paper: pmid25852449
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: PoTS has also been associated with symptoms of chronic fatigue and high levels of a number of other psychiatric
      symptoms particularly panic, anxiety and depression (Grubb et al., 2006; Garland et al., 2007; Thieben et
      al., 2007; Low et al., 2009; Freeman et al., 2011; Mathias et al., 2012).
    note: 'Found by winnow, kev and lev in p015, p001, p002. Claude judged: supports.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: supports
    section: Neurovisceral phenotypes > Postural Tachycardia Syndrome > Association with psychiatric disorders
    quote: Recent data suggests patients with POTS commonly present with symptoms of depression, elevated anxiety
      and increased anxiety sensitivity, particularly with regards to cardiac symptoms, and have a poorer health
      related quality of life in both the physical and mental health domains (Anderson et al., 2014).
    note: 'Found by winnow, kev and lev in p022, p001, p014. Claude judged: supports.'
  - paper: pmid25009504
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Patients with POTS commonly presented with symptoms of depression, elevated anxiety and increased anxiety
      sensitivity, and had a poorer subjective health related quality of life in both the physical and mental health
      domains.
    note: 'Found by winnow, kev and lev in p012, p018, p019. Claude judged: supports.'
  - paper: pmid23580201
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Individuals with POTS experience increased ratings of depression, anxiety and inattention/ADHD symptoms
      (Raj et al., 2009).
    note: 'Found by winnow, kev and lev in p018, p001, p003. Claude judged: supports.'
  - paper: pmid42342500
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42342500. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Study design
    quote: 'The POTS children were divided into two groups: anxiety/ depression group and non- anxiety / depression
      group according to the above scales scores.'
    note: 'Found by winnow, kev and lev in p001, p002, p007. Claude judged: partial.'
  - paper: pmid39884840
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Background
    quote: The prevalence of mental health symptoms in those with POTS is unknown, as some research has suggested
      that lifetime prevalence of depressive and anxiety disorders among POTS is similar to the general population
      (Raj et al., 2009) while other research has found increased rates of mild to moderate depression and anxiety
      (Attard et al., 2023).
    note: 'Found by winnow, kev and lev in p004, p041, p045. Claude judged: partial.'
  - paper: pmid39540412
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: What Not to Do in Clinic
    quote: Even so, labels of anxiety and other psychiatric diagnoses are likely to be applied to these patients
      along the way. In a survey of over 700 patients meeting criteria for POTS, 83% reported being given at least
      1 psychiatric diagnosis prior to being diagnosed.
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Mast-Cell-Directed Treatment
    quote: In a case report, a MCAS patient with severe MCAS and postural orthostatic tachycardia syndrome experienced
      significant improvement with regard to depression, anxiety, and dysautonomia symptoms using intravenous immunoglobulin,
      LDN, and antibiotic treatment for small intestinal bacterial overgrowth [21].
    note: 'Found by winnow, kev and lev in p001, p027. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Treatment > Nonpharmacologic interventions
    quote: Referral for psychological counseling may be of benefit to patients with POTS due to the sudden and unexpected
      changes in lifestyle that may result in depression or anxiety. Patients who have comorbid mental health disorders,
      including suicidal ideation, should be referred as appropriate based on the situation, such as to mental health
      providers, the ED, or crisis intervention services.
    note: 'Found by winnow, kev and lev in p032, p042. Claude judged: partial.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: The second most common comorbidity in this study was psychological disorders. Psychological factors can
      not only amplify the objective discomfort resulting from OI but also add the diversification and complexity
      of the clinical manifestation in pediatric POTS.
    note: 'Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid34746821
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction > Origin(s) of dyspnea in POTS
    quote: However, their anxiety symptoms may be fundamentally distinct as studies attribute angst to somatic hypervigilance,
      meaning that they tend to report relatively mild, routine sensory information as more distressing or intense
      than normal (Benarroch, 2012) – perhaps a manifestation of augmented interoception. There is more consistent
      evidence of mild to moderate depression in POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid32993834
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32993834. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: In pediatric POTS, poor health increases the rate of depression and anxiety in young patients and their
      parents, which has drawn increasing attention in recent years (9, 10).
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: partial
    section: Clinical Characteristic of Pots in Pediatric Patients
    quote: Psychiatric disorders including anxiety and depression are associated with POTS in child and adolescent
      family members of patients, and child patients with POTS often encounter tragic experiences after contracting
      the illness, with no regular attendance at school and social activities, underachievement, and frequent visits
      to doctors.
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid28442939
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Another small study (n=15) found that the majority of POTS patients suffered from depression,2 while
      Raj et al found that the lifetime prevalence of major depressive disorder was not elevated.39 Clearly, the
      relationship between POTS and depression and their effect on disturbed sleep will require more study.
    note: 'Found by winnow, kev and lev in p004, p021, p024. Claude judged: partial.'
  - paper: pmid25001527
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Subjective Depression and Anxiety Symptoms and Cognitive Difficulties
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25001527. Found by winnow, kev and lev in p014, p021. Claude judged: partial.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: Fatigue > Psychological Correlates of Chronic Fatigue
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p016, p105, p107. Claude judged: partial.'
  - paper: pmid22156614
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22156614. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid18977825
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 18977825. Found by winnow, kev and lev in p031, p020, p021. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - associated_with
  - pots
  papers: 30
  evidence:
  - paper: pmid41301791
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Neurologic Evaluation > 4.2. Examination
    quote: At least 50% of patients with POTS have small fiber neuropathy, which warrants a careful neurologic sensory
      examination, including pinprick and temperature sensation, to help identify small fiber neuropathy [22].
    note: 'Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autoimmunity > Association with autonomic neuropathy
    quote: POTS and OCADs can often occur as part of, or in the context of, autonomic neuropathy. Experts who originally
      described POTS have considered it to be a limited or restricted form of autonomic neuropathy (Schondorf and
      Low, 1993; Vernino et al., 2008).
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid40271232
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Over half of POTS patients have impaired function of the peripheral sympathetic nervous system [7]. Neuropathic
      manifestations of POTS include decreased sweating and venous blood pooling in the legs due to insufficient
      peripheral vasoconstriction, which prevents the patient from maintaining blood pressure in the upper body
      upon standing [7,18].
    note: 'Found by winnow, kev and lev in p008, p036, p001. Claude judged: supports.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: 'POTS and SFN are comorbid conditions, with both being highly prevalent in patients with Long COVID:
      an estimated 30–75% of patients with Long COVID have POTS [6,7], and nearly 70% have autonomic dysfunction
      [8].'
    note: 'Found by winnow, kev and lev in p005, p013. Claude judged: supports.'
  - paper: pmid38537312
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38537312. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Neuropathy: It is estimated that up to half of the POTS cases have some form of small-fiber neuropathy,
      resulting in dysautonomia.'
    note: 'Found by winnow, kev and lev in p003, p013, p019. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Various pathophysiologic mechanisms of POTS exist, but some common ones include hypovolemia, autoimmunity,
      and neuropathy.
    note: 'Found by winnow, kev and lev in p005, p001, p003. Claude judged: supports.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: There is an occurrence of small fiber neuropathy that occurs in POTS.
    note: 'Found by winnow, kev and lev in p037, p042, p004. Claude judged: supports.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Patient's with postural tachycardia syndrome have peripheral autonomic dysfunction.
    note: 'Found by winnow, kev and lev in p036, p029. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.1 Partial Sympathetic Neuropathy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p015, p016. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid23708963
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23708963. Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid19207771
    cited: true
    text: full
    license: none
    verdict: supports
    section: Neuropathic POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19207771. Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid42153984
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Comorbidities
    quote: All but one participant in NOT IMPROVED had one or more of neuropathy, gastroparesis and overactive bladder
      symptoms, compared to only 20% of IMPROVED. An association between neuropathy and gastrointestinal and bladder
      symptoms bas been recognized in patients with POTS [25].
    note: 'Found by winnow, kev and lev in p048. Claude judged: partial.'
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: POTS is a heterogeneous and multifactorial disorder involving both peripheral and central autonomic pathways.
      In neuropathic POTS, peripheral autonomic injury—primarily small‐fiber neuropathy—is a core mechanism.
    note: 'Found by winnow, kev and lev in p023, p025. Claude judged: partial.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: partial
    section: Clinical features and evaluation of dysautonomia
    quote: A thorough cardiac and neurologic exams are recommended, including assessment of pinprick and temperature
      sensation to help identify small fiber neuropathy, a common comorbidity of POTS and other autonomic disorders
      [20].
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid40608783
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Moreover, post-ganglionic sudomotor dysfunction, measured by quantitative sudomotor axon reflex test
      (QSART), reflecting partial sympathetic denervation is common in various autonomic neuropathies [11] and is
      present in some POTS patients [9,12–14].
    note: 'Found by winnow, kev and lev in p001, p004, p005. Claude judged: partial.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. POTS Etiology and Its Complexity
    quote: 'Sympathetic denervation: Sympathetic denervation, characterized by a decrease in sympathetic nerve activity,
      is another factor contributing to autonomic dysfunction in POTS [38]. This denervation disrupts the intricate
      coordination between the nervous and cardiovascular systems, ultimately giving rise to the hallmark symptoms
      of POTS.'
    note: 'Found by winnow, kev and lev in p012, p013. Claude judged: partial.'
  - paper: pmid37968647
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: The involvement of autonomic SFN can produce changes in sweating, dry mouth, and gastrointestinal and
      urinary problems, as well as POTS [17].
    note: 'Found by winnow, kev and lev in p009, p004. Claude judged: partial.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: partial
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p025. Claude judged: partial.'
  - paper: pmid34055418
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The association between POTS and JHS can be explained by predominant peripheral neuropathy in the autonomous
      system and a failure of the peripheral vascular system to maintain resistance in areas exposed to stress due
      to orthostasis, blood stasis in the lower limbs, or pathologies of the central nervous system [11].
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Furthermore, in some patients with neuropathic POTS, intraepidermal nerve fiber density is decreased,
      providing objective support for a small fiber neuropathy in these POTS patients.
    note: 'Found by winnow, kev and lev in p003, p007, p029. Claude judged: partial.'
  - paper: pmid33459162
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33459162. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: PATHOPHYSIOLOGY OF POTS
    quote: The excessive sympathetic tone is considered to be of central origin in hyperadrenergic POTS, but smaller
      increases in plasma NE upon standing, which are not uncommon in POTS, may also result as a compensatory response
      to hypovolemia and peripheral autonomic neuropathy.
    note: 'Found by winnow, kev and lev in p031, p016. Claude judged: partial.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Postural Tachycardia Syndrome and Gastrointestinal Symptoms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p011, p024, p001. Claude judged: partial.'
  - paper: pmid27660311
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27660311. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS > Potential “Etiologies” of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p044, p052, p068. Claude judged: partial.'
  - paper: pmid24647968
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24647968. Found by winnow, kev and lev in p004, p003. Claude judged: partial.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Results
    quote: Nine of 24 subjects had neuropathic POTS and had significantly lower resting and tilted heart rates;
      reduced parasympathetic function; and lower phase 4 valsalva maneuver overshoot compared with those with non-neuropathic
      POTS (P<0.05).
    note: 'Found by winnow, kev and lev in p003, p020, p002. Claude judged: partial.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Considering that POTS patients have high plasma NE levels, it would seem paradoxical that a neuropathy
      is proposed as an underlying process. Yet some of them have a form of dysautonomia, with preferential denervation
      of sympathetic nerves innvervating the lower limbs [22-24].
    note: 'Found by winnow, kev and lev in p024, p027, p042. Claude judged: partial.'
- edge:
  - me_cfs
  - associated_with
  - pots
  papers: 29
  evidence:
  - paper: pmid42746015
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Introduction
    quote: Postural orthostatic tachycardia syndrome (PoTS) can be associated with myalgic encephalomyelitis/ chronic
      fatigue syndrome (ME/CFS).
    note: 'Found by winnow, kev and lev in p005, p001, p003. Claude judged: supports.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Patients with POTS often have a higher prevalence of various comorbidities, including chronic fatigue
      syndrome, syncope, migraines, fibromyalgia, joint hypermobility, Ehlers‐Danlos Syndrome, hypervigilance, anxiety,
      concussions, and autoimmune disorders [3].
    note: 'Found by winnow, kev and lev in p007, p004, p005. Claude judged: supports.'
  - paper: pmid41932997
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Proteomic alterations associated with POTS status in ME/CFS
    quote: These findings suggest that the comorbid POTS phenotype in ME/CFS may be associated with innate immune
      activation and platelet-mediated inflammation.
    note: 'Found by winnow, kev and lev in p019, p009. Claude judged: supports.'
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: POTS, one of the most common autonomic disorders, is a frequent sequela of SARS-CoV-2 as part of Long
      COVID and is a common comorbidity of ME/CFS.8,9
    note: 'Found by winnow, kev and lev in p005, p007. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: POTS is well known to be associated with several conditions, such as chronic fatigue syndrome and joint
      hypermobility, specifically Ehlers-Danlos syndrome type III, which have been linked to extra-articular manifestations
      such as dysautonomia and POTS [15].
    note: 'Found by winnow, kev and lev in p080. Claude judged: supports.'
  - paper: pmid41300853
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Of interest, an association between neurological or cardiac symptoms, such as cognitive dysfunction or
      OI, particularly POTS (Postural Orthostatic Tachycardia Syndrome), is described not only in ME/CFS but also
      in Mast Cell Activation Syndrome (MCAS) patients [22,23,24].
    note: 'Found by winnow, kev and lev in p001, p005, p021. Claude judged: supports.'
  - paper: pmid41225175
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: POTS and certain types of orthostatic intolerance often occur in patients suffering from myalgic encephalomyelitis/chronic
      fatigue syndrome (ME/CFS) [3] who usually require extensive medical care. According to several studies, the
      prevalence of POTS in ME/CFS is estimated between 11% [4] and 25%, but could be even higher because of a lack
      of diagnostic tests in clinical practice and sensitivity of some testing methods [5].
    note: 'Found by winnow, kev and lev in p003, p084. Claude judged: supports.'
  - paper: pmid40761644
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Dysautonomic syndromes like classical and delayed orthostatic hypotension, neurally mediated hypotension,
      postural tachycardia syndrome (POTS), and orthostatic intolerance (OI) in the absence of heart rate and blood
      pressure changes are common in ME/CFS and can severely affect the patient’s daily life (5, 6).
    note: 'Found by winnow, kev and lev in p005, p019, p022. Claude judged: supports.'
  - paper: pmid40365455
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Study population and outcome measures
    quote: Finally, it is estimated that a fair proportion of patients with POTS also meet the current diagnostic
      criteria for ME/CFS (41–43), which is also characterized by multisystemic symptomatology including autonomic
      dysfunction, and is exemplified by moderate to severe PEM.
    note: 'Found by winnow, kev and lev in p041. Claude judged: supports.'
  - paper: pmid38650940
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Our results also highlight a potential shared underlying mechanism between ME/CFS and its major comorbidities
      such as hEDS/HSD, POTS, MCAS, multiple chemical sensitivity, peripheral neuropathy, and the neuro-immune and
      brain-gut interaction axis.
    note: 'Found by winnow, kev and lev in p032, p082. Claude judged: supports.'
  - paper: pmid38540980
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: During the tilt test, 32.5% of the participants demonstrated POTS or OH. The participants with either
      of these two common types of orthostatic intolerance were found to have more problems with sleep and post-exertional
      malaise as assessed by the DePaul Symptom Questionnaire; these patients also reported more physical and health
      function limitations.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: In particular, 11 to 50% of patients with ME/CFS may suffer from postural orthostatic tachycardia syndrome
      (POTS).
    note: 'Found by winnow, kev and lev in p054, p035, p046. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Chronic Fatigue Syndrome
    quote: CFS is a common co-morbidity of POTS, with many patients qualifying for a diagnosis of CFS due to chronic
      fatigue and post-exertional malaise that are highly prevalent in patients with POTS. It has been estimated
      that at least 21% of POTS patients have concurrent CFS.1,2
    note: 'Found by winnow, kev and lev in p028, p017. Claude judged: supports.'
  - paper: pmid35697326
    cited: true
    text: full
    license: none
    verdict: supports
    section: Supportive Lifestyle Practices > Physical Activity
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35697326. Found by winnow, kev and lev in p022, p007. Claude judged: supports.'
  - paper: pmid35689118
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: CFS, in particular, has been frequently observed in those with POTS [61, 62] and could exacerbate the
      cognitive impairments and fatigue associated with POTS (the association between POTS and fatigue is so prevalent
      that the designation “CFS-POTS” has been coined to reflect those who are diagnosed with POTS but also present
      with fatigue that meets the criteria for CFS).
    note: 'Found by winnow, kev and lev in p042, p028, p039. Claude judged: supports.'
  - paper: pmid35241011
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: The association of dysautonomia, particularly in the form of POTS, with chronic fatigue syndrome and/or
      myalgic encephalomyelitis (CFS; ME) is also becoming more understood.
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: One of the possible explanations for the comorbidity with POTS may be immune mechanisms. OI is one of
      the common clinical manifestations of chronic fatigue syndrome.
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid31159884
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Prior literature has established an association between OI symptoms and CFS, and comorbidity of POTS
      (OI symptoms plus postural tachycardia) and CFS [29–32].
    note: 'Found by winnow, kev and lev in p026, p036, p040. Claude judged: supports.'
  - paper: pmid30505831
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Studies in the 1990s brought further attention to the association between ME/CFS and various forms of
      orthostatic hypotension or postural tachycardia syndrome (POTS) (3–8).
    note: 'Found by winnow, kev and lev in p005, p007, p016. Claude judged: supports.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: According to Schondorf et al., 40% of patients with chronic fatigue syndrome also suffer from POTS; indeed,
      chronic fatigue syndrome (CFS) is frequent and of significant comorbidity in POTS [7].
    note: 'Found by winnow, kev and lev in p007, p016. Claude judged: supports.'
  - paper: pmid29391028
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Our paper also draws attention to the potential for neurally mediated syncope and POTS to be associated
      with cervical myelopathy. Both hemodynamic abnormalities are strongly associated with ME/CFS [1, 33, 34],
      and treatment of the orthostatic intolerance can lead to improvements in ME/CFS symptoms and function [33].
    note: 'Found by winnow, kev and lev in p015, p031. Claude judged: supports.'
  - paper: pmid28674681
    cited: true
    text: full
    license: by
    verdict: supports
    section: Etiology and Pathophysiology > Pathophysiological Basis for Symptoms > Circulatory Abnormalities
    quote: Controlled studies have shown a higher prevalence of postural tachycardia syndrome (POTS) and neurally
      mediated hypotension (NMH) in pediatric patients with ME/CFS (49, 51–55).
    note: 'Found by winnow, kev and lev in p035, p189. Claude judged: supports.'
  - paper: pmid26425598
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Indeed, CFS is a frequent and major comorbidity in POTS.5,6 The 2 conditions frequently appear together,
      and research shows that there is a clinically identifiable subgroup of patients with CFS and orthostatic intolerance
      that differs from control subjects and from those with CFS without orthostatic intolerance.4
    note: 'Found by winnow, kev and lev in p003, p007, p008. Claude judged: supports.'
  - paper: pmid24934205
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Overall symptom burden of the groups
    quote: Around 20% of the total cohort reported having CFS and just under 20% had Ehlers-Danlos syndrome, but
      when we considered the PoTS UK population compared with the PoTS clinic cohort, this showed some interesting
      differences, with the PoTS clinic cohort having 42% of the cohort with comorbid CFS/myalgic encephalomyelitis
      (ME) compared with 26% of the PoTS UK having comorbid Ehlers-Danlos syndrome (EDS; table 1).
    note: 'Found by winnow, kev and lev in p033, p025, p027. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: These data confirm the well-established overlap between the POTS and chronic fatigue syndrome [25-27].
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid21906029
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: INTRODUCTION
    quote: A substantial overlap between POTS and CFS has been consistently reported in the literature [10,11,15,16].
      The prevalence of POTS in CFS patients has ranged from 19% [7] to 70% [10], whereas studies in cohorts of
      patients selected for POTS have shown a prevalence of chronic fatigue between 48 and 77% [15,17], and CFS
      between 17 and 23% [17,18].
    note: 'Found by winnow, kev and lev in p001, p002, p003. Claude judged: supports.'
  - paper: pmid41050528
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation
    quote: After a new COVID-19 infection in February 2021, he developed typical long COVID symptoms of dysautonomia,
      post-exertional malaise (PEM), and symptoms compatible with POTS.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid40978926
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: Passive standing tests conducted at home confirmed a >40 bpm increase in heart rate during the first
      10 minutes of standing, compared to supine values. The test provoked typical orthostatic symptoms and no evidence
      of orthostatic hypotension, consistent with postural tachycardia syndrome (POTS) [14].
    note: 'Found by winnow, kev and lev in p017. Claude judged: partial.'
  - paper: pmid33996867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: All patients reported orthostatic intolerance symptoms within the first 2 weeks of illness, and 10-min
      passive standing tests were consistent with postural tachycardia syndrome. After 6 months of illness, all
      three patients met criteria for ME/CFS.
    note: 'Found by winnow, kev and lev in p002, p006, p017. Claude judged: partial.'
- edge:
  - sleep_disturbance
  - associated_with
  - pots
  papers: 24
  evidence:
  - paper: pmid42254140
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: Evidence suggests that during sleep, POTS patients can enter a hyperadrenergic state, disrupting normal
      autonomic regulation and perpetuating a vicious cycle of poor sleep and worsened daytime symptoms[4]. Recently,
      sleep disturbances among individuals with POTS have gained attention, however, limited discussion exists on
      the influence of modifiable lifestyle factors on this critical aspect of the condition.
    note: 'Found by winnow, kev and lev in p003, p005. Claude judged: supports.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Individualized Therapy > 3.1. Individualized Therapy for POTS > 3.1.1. Physiological Indicators
      Predicting the Efficacy of Non-Pharmacotherapy Treatment in Children with POTS
    quote: Patients with POTS have a significantly decreased quality of life because of sleep problems [56]. Children
      who sleep for less than 8 h a day have an almost six times higher risk of developing POTS than those with
      a daily sleep duration of ≥8 h [57].
    note: 'Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid35689118
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Factors influencing fatigue in patients with orthostatic syncope
    quote: Four papers reported that patients with POTS [35, 42, 45] and VVS [46] have significant sleep problems,
      including poorer sleep quality and greater levels of sleep disturbances, relative to healthy controls [35,
      42, 45, 46].
    note: 'Found by winnow, kev and lev in p029, p024, p044. Claude judged: supports.'
  - paper: pmid35303039
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In addition, sleeping disorder was common in pediatric postural tachycardia syndrome (POTS) that was
      thought to have similar hemodynamic characteristics to pediatric STS [1, 21].
    note: 'Found by winnow, kev and lev in p024, p006. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Sleeping disorders in children with POTS have attracted increasing attention. Like other behavioral problems
      in children, abnormal sleep is usually defined by parental observations.
    note: 'Found by winnow, kev and lev in p027. Claude judged: supports.'
  - paper: pmid33231164
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Study Objectives
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33231164. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid31024242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In contrast, the PSQI score of >5 in our POTS cohort is indicative of poor sleep quality (Buysse et al.,
      1989) and also differed significantly from controls.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid29773483
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29773483. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29628432
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Potential Mechanisms Underlying Psychological and Cognitive Dysfunction in POTS > 4.4 Sleep Disturbances
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29628432. Found by winnow, kev and lev in p017, p029. Claude judged: supports.'
  - paper: pmid29163944
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Besides their chief complaint of orthostatic intolerance, sleep and fatigue probably rank as the most
      common and disabling complaints in children with POTS.3
    note: 'Found by winnow, kev and lev in p004, p014, p006. Claude judged: supports.'
  - paper: pmid28442939
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Sleep
    quote: According to the PSQI, 98.4% of POTS patients surveyed had poor sleep quality (compared to 69.4% of controls),
      and the POTS group had significantly worse mean overall sleep scores than controls (t[873]=17.75; p<0.001).
    note: 'Found by winnow, kev and lev in p003, p015, p016. Claude judged: supports.'
  - paper: pmid27206906
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 27206906. Found by winnow, kev and lev in p004, p001, p002. Claude judged: supports.'
  - paper: pmid26859225
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26859225. Found by winnow, kev and lev in p005, p014. Claude judged: supports.'
  - paper: pmid26695400
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Objective
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26695400. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid26611942
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background And Aim
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26611942. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Disorders Overlapping with POTS > Chronic Fatigue Syndrome (CFS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid25071706
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Many patients with postural tachycardia syndrome (PoTS) suffer from fatigue, daytime sleepiness, and
      sleeping disturbances.
    note: 'Found by winnow, kev and lev in p017, p001, p003. Claude judged: supports.'
  - paper: pmid23999934
    cited: true
    text: full
    license: none
    verdict: supports
    section: Conclusions > Sleep quality may affect brain fog
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23999934. Found by winnow, kev and lev in p020, p010. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Fatigue, Sleep Problems & Quality of Life in POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid23538032
    cited: true
    text: full
    license: none
    verdict: supports
    section: RESULTS > Sleep Assessments by Sleep Logs (Table 2)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23538032. Found by winnow, kev and lev in p004, p008, p030. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: However, Bagai et al. found a higher prevalence of poor sleep quality in patients with POTS than in healthy
      control participants [2].
    note: 'Found by winnow, kev and lev in p004, p022. Claude judged: supports.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Many chronically ill patients, including those with POTS, complain of poor sleep but a lack of sufficient
      data to link between POTS, depression, and disturbed sleep might have limited the variability, as explained
      by Pederson and Book [26].
    note: 'Found by winnow, kev and lev in p014, p016. Claude judged: partial.'
  - paper: pmid28769598
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Body
    quote: However, sleep disturbance has not been thoroughly investigated as a cause of increased suicidal risk
      in patients with POTS.
    note: 'Found by winnow, kev and lev in p002, p006. Claude judged: partial.'
  - paper: pmid25474569
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Previous studies have suggested that compared with normal subjects, children with POTS sleep less. With
      fatigue, the symptoms of POTS get worse [15], [16].
    note: 'Found by winnow, kev and lev in p028, p003, p006. Claude judged: partial.'
- edge:
  - chronic_migraine
  - associated_with
  - pots
  papers: 20
  evidence:
  - paper: pmid41420770
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Abstract > Results:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41420770. Found by winnow, kev and lev in p003, p034, p006. Claude judged: supports.'
  - paper: pmid40585261
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Abstract > Results:'
    quote: An abnormal cardiovascular response to tilt was present in the majority (63%) of which POTS was the most
      common etiology (56.2%).
    note: 'Found by winnow, kev and lev in p003, p036, p039. Claude judged: supports.'
  - paper: pmid40520610
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Compared to the general population, where 6.5% of men and 18.2% of women experience migraines, the PoTS
      population in previous studies demonstrates a greater prevalence of migraine of up to 40% (5, 20, 21).
    note: 'Found by winnow, kev and lev in p024, p026, p036. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Migraine Headaches
    quote: Migraines are frequently reported among POTS patients, although the etiology of this association is not
      understood.[44]
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid38966085
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Discussion > Associated factor: migraine'
    quote: Migraine is one of the most common co-morbidities in POTS patients with studies reporting frequencies
      from 28 to 61% (23, 24).
    note: 'Found by winnow, kev and lev in p037, p038, p040. Claude judged: supports.'
  - paper: pmid38912309
    cited: true
    text: full
    license: by
    verdict: supports
    section: Theoretical and auto/biographical review > Recovery and expectations
    quote: '‘A frequently described comorbidity in POTS patients is migraine, as well as other chronic headache
      types’ (Bryarly et al., 2019: 1216); ‘Intractable migraines often lead to physical inactivity, which may exacerbate
      orthostatic intolerance, and conversely, the increased sympathetic activity associated with POTS may contribute
      to increased frequency of headaches’ (Bryarly et al., 2019).'
    note: 'Found by winnow, kev and lev in p036. Claude judged: supports.'
  - paper: pmid36992793
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Postural Orthostatic Tachycardia Syndrome (POTS), a form of orthostatic intolerance, is common in patients
      with primary headache (Khurana and Eisenberg, 2011; Cook and Sandroni, 2018).
    note: 'Found by winnow, kev and lev in p004, p005. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Migraine
    quote: It is estimated that 40% of POTS patients also experience migraine, making migraine a significant consideration
      when caring for pregnant women with POTS.1,2
    note: 'Found by winnow, kev and lev in p015, p017, p018. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What other conditions commonly occur in patients with POTS?
    quote: Common comorbid conditions seen with POTS4,21 include hypermobile Ehlers–Danlos syndrome, mast cell activation
      syndrome,22 migraine and ME/CFS (Table 1).18
    note: 'Found by winnow, kev and lev in p018, p006, p017. Claude judged: supports.'
  - paper: pmid34866935
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Discussion
    quote: Migraine and hyperventilation syndrome, which were also common comorbidities of pediatric POTS in our
      study, are thought to be related to autonomic nervous dysfunction.
    note: 'Found by winnow, kev and lev in p026, p022. Claude judged: supports.'
  - paper: pmid34246578
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Pathophysiology of POTS
    quote: The associations of POTS with migraine headache, the hypermobile form of Ehlers-Danlos syndrome (hEDS)
      (De Wandele et al., 2014) and the hypermobility spectrum disorder, allergic disorders like mast cell activation
      syndrome (MCAS) (Shibao et al., 2005), and autoimmune disorders have been clearly described.
    note: 'Found by winnow, kev and lev in p023. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical associations & co-morbidities
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p009, p014. Claude judged: supports.'
  - paper: pmid33174112
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33174112. Found by winnow, kev and lev in p001, p017, p019. Claude judged: supports.'
  - paper: pmid32823577
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: In addition, many patients experience other chronic conditions whose symptoms cannot be mechanistically
      explained by postural intolerance or excessive tachycardia [2]. These include the following:–visceral pain
      and dysmotility of the upper or lower gastrointestinal tract, bladder, and other organs [3,4];–chronic fatigue
      [5,6], fibromyalgia [7], and sleep disturbances [8];–joint hypermobility and Ehlers–Danlos syndrome type III
      [9,10]; –chronic headache, including migraine and orthostatic headache [11,12].
    note: 'Found by winnow, kev and lev in p004, p036. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Part II: Recommendations For Treating Pain In Youth With POTS+Pain'
    quote: Chronic pain is a common occurrence among individuals with POTS, with headaches, migraines, abdominal
      pain, muscle cramping, joint pain, leg pain, and musculoskeletal pain being the most commonly reported types
      of pain.7,8,13,55–57 In fact, between 30% and 88% of youth with POTS report chronic daily headache, migraine,
      abdominal pain, and musculoskeletal pain.8,11–13
    note: 'Found by winnow, kev and lev in p030, p004, p022. Claude judged: supports.'
  - paper: pmid31549738
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31549738. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Clinical Presentation of POTS > Common Clinical Features > Orthostatic symptoms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Headaches and POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p096, p052, p055. Claude judged: supports.'
  - paper: pmid20819844
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20819844. Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract
    quote: There are sporadic reports of the autonomic nervous system dysfunction in migraine and fibromyalgia.
      We report a case of POTS associated with migraine and fibromyalgia.
    note: 'Found by winnow, kev and lev in p001, p002, p012. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - pots
  papers: 19
  evidence:
  - paper: pmid41602336
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Patients with chronic fatigue, POTS, and fibromyalgia experience decreased blood flow to the brain (9,
      11, 17, 18) and therefore vascularly linked.
    note: 'Found by winnow, kev and lev in p022, p025. Claude judged: supports.'
  - paper: pmid39544990
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: HYCH and POTS are syndromes of orthostatic intolerance with cerebral hypoperfusion associated with reduced
      orthostatic cerebral blood flow, hypocapnia, mild autonomic failure and small fiber neuropathy of a similar
      degree and distribution; except for tachycardia in POTS.
    note: 'Found by winnow, kev and lev in p036, p004, p025. Claude judged: supports.'
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Cerebral hypoperfusion secondary to hypocapnia is well documented in the literature to be associated
      with POTS diagnosis; however, it has not previously been evaluated in the other post-vaccine POTS cases.
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid32140630
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: First, our study shows that in response to head-up tilt, ME/CFS patients with either delayed orthostatic
      hypotension or POTS develop a cerebral blood flow reduction of 28%, and 29%, respectively, at the end of the
      upright position. This is highly significantly different from the 7% reduction in controls with a normal tilt
      test.
    note: 'Found by winnow, kev and lev in p073, p081, p082. Claude judged: supports.'
  - paper: pmid30256820
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Cerebral hypoperfusion in OI can be related to hypocapnia which causes cerebral vasoconstriction and
      reduces cerebral blood flow. This mechanism, e.g. hypocapnic cerebral hypoperfusion, was described in POTS
      [2].
    note: 'Found by winnow, kev and lev in p024, p001, p004. Claude judged: supports.'
  - paper: pmid24711524
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24711524. Found by winnow, kev and lev in p034, p001, p004. Claude judged: supports.'
  - paper: pmid42605371
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The review found that abnormal cerebral blood flow (CBF) was reported in 61% of 56 POTS patients with
      cognitive dysfunction, and that sustained cognitive stress induced a greater reduction in CBF velocity in
      POTS patients than in controls, at approximately 7.8% and 1.8%, respectively.
    note: 'Found by winnow, kev and lev in p050, p001, p011. Claude judged: partial.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In an interesting study [39], out of 1925 patients presenting for autonomic function testing, patients
      reporting nausea were found to have decreased cerebral blood flow, which is associated with POTS.
    note: 'Found by winnow, kev and lev in p034. Claude judged: partial.'
  - paper: pmid41740821
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41740821. Found by winnow, kev and lev in p004, p005. Claude judged: partial.'
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Syncope, characterized by a transient loss of consciousness resulting from cerebral hypoperfusion, occurs
      in approximately 20% of patients with POTS [4]. However, it is generally considered an uncommon manifestation
      in this population, suggesting that syncope may rarely be a direct consequence of POTS [4].
    note: 'Found by winnow, kev and lev in p003, p041. Claude judged: partial.'
  - paper: pmid41020219
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1 Introduction
    quote: In severe cases, the peripheral vasculature resistance is unable to compensate fully, resulting in a
      reduction in effective circulation and varying degrees of cerebral hypoperfusion.
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Cerebral hypoperfusion is prevalent in those with POTS and cognitive dysfunction even whilst supine,
      contributing to reduced quality of life.
    note: 'Found by winnow, kev and lev in p001, p006, p011. Claude judged: partial.'
  - paper: pmid35689118
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Brain fog has been described to impede cognitive performance in patients with POTS, and the cause of
      brain fog has been attributed to a reduction in cerebral blood flow [77]. Accordingly, cerebral hypoperfusion
      may not only be linked to fatigue but also to the cognitive deficits seen in patients with POTS, with the
      cognitive decline observed being attributed to excessive levels of synaptic norepinephrine [78].
    note: 'Found by winnow, kev and lev in p045, p010, p042. Claude judged: partial.'
  - paper: pmid35463901
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: POTS syndrome is caused by cerebral hypoperfusion, in which the symptoms include lightheadedness, syncope,
      palpitations, and fatigue.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid33777484
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods > Criterion for diagnosing orthostatic intolerance
    quote: Orthostatic intolerance (OI) is the umbrella term for a heterogeneous group of disorders of hemodynamic
      regulation characterized by excessive pooling of blood in the dependent areas of the body during upright posture,
      resulting in insufficient cerebral perfusion, which triggers symptoms typically relieved by recumbency. Both
      POTS and NCS patients have OI.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid33280488
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract > Methods and Results
    quote: The CBFv decreased in both groups (condition, P=0.04) following PCST, but a greater reduction in CBFv
      was observed in the POTS versus control group (−7.8% versus −1.8%; interaction, P=0.038). Notably, the reduced
      CBFv following PCST in the POTS group was similar to that seen during orthostatic stress (60.0±14.9 versus
      60.4±14.8 cm/s).
    note: 'Found by winnow, kev and lev in p002, p003, p012. Claude judged: partial.'
  - paper: pmid33050553
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: In the present study, a significantly higher reduction in cerebral blood flow was found in severe ME/CFS
      patients with POTS compared to severe ME/CFS patients without a history of POTS.
    note: 'Found by winnow, kev and lev in p001, p014, p018. Claude judged: partial.'
  - paper: pmid25002851
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Decreased upright cerebral blood flow (CBF) with hyperpnea and hypocapnia is seen in a minority of patients
      with postural tachycardia syndrome (POTS). More often, CBF is not decreased despite upright neurocognitive
      dysfunction.
    note: 'Found by winnow, kev and lev in p001, p003, p035. Claude judged: partial.'
  - paper: pmid22156614
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22156614. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - associated_with
  - pots
  papers: 19
  evidence:
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: This severe side effect indicates that providers need to be aware of this strong association of HPV vaccinations
      and POTS.
    note: 'Found by winnow, kev and lev in p009, p017, p001. Claude judged: supports.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p015, p002. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: De novo POTS is noted in a number of cases post-vaccination of HPV. One case report noted that there
      is a possible temporal relationship between the vaccination of Gardasil and onset of POTS [7,10].
    note: 'Found by winnow, kev and lev in p012, p001, p008. Claude judged: supports.'
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: Among these, Postural Orthostatic Tachycardia Syndrome (POTS) has garnered attention due to reported
      cases following COVID-19 vaccination [2].
    note: 'Found by winnow, kev and lev in p001, p006, p008. Claude judged: partial.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. POTS Etiology and Its Complexity
    quote: The onset of POTS is frequently linked to triggers, such as long COVID-19, the human papillomavirus (HPV)
      vaccine, infections, or trauma, which can subsequently lead to immunological changes.
    note: 'Found by winnow, kev and lev in p018, p014. Claude judged: partial.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: For example, human papillomavirus (HPV) vaccination programs have demonstrably reduced HPV infection
      rates, but concerns regarding rare vaccine adverse events (VAEs), such as POTS, have emerged [5,6,7]. There
      is also mounting evidence that suggests that coronavirus-2019 (COVID) infection and its vaccination protocols
      can induce autonomic dysfunction, including POTS and inappropriate sinus tachycardia (IST) [8,9,10].
    note: 'Found by winnow, kev and lev in p012, p001, p003. Claude judged: partial.'
  - paper: pmid38176772
    cited: true
    text: full
    license: none
    verdict: partial
    section: Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38176772. Found by winnow, kev and lev in p013, p025, p026. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: partial
    section: 10. POTS and vaccination
    quote: In a cohort of 2,84,592 COVID-19-vaccinated individuals, using a sequence–symmetry analysis, the odds
      of receiving the diagnosis of POTS 90 days after vaccination compared with 90 days before vaccination was
      1.33 (1.25–1.41). The risk for POTS-related diagnoses was 5.35 (5.05–5.68) times higher after SARS-CoV-2 infection
      than after vaccination.
    note: 'Found by winnow, kev and lev in p001, p034, p035. Claude judged: partial.'
  - paper: pmid37650075
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Background
    quote: It has been described after coronavirus disease-19 (COVID-19) as well as after COVID-19 vaccination.
    note: 'Found by winnow, kev and lev in p003, p012, p001. Claude judged: partial.'
  - paper: pmid37303827
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37303827. Found by winnow, kev and lev in p001, p002, p009. Claude judged: partial.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS-like symptoms following COVID-19 vaccination
    quote: We identified 18 cases of reported POTS following COVID-19 vaccination from the available literature
      (Table 1).
    note: 'Found by winnow, kev and lev in p016, p017, p002. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports
    quote: Contemporary literature indicates potential links between viral infections and vaccines (particularly
      HPV) with the development of POTS.14,35,36
    note: 'Found by winnow, kev and lev in p021, p022. Claude judged: partial.'
  - paper: pmid36530759
    cited: true
    text: full
    license: none
    verdict: partial
    section: Expert opinion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36530759. Found by winnow, kev and lev in p008, p001, p004. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: However, POTS can be precipitated by immunologic stressors such as viral infection or vaccination [3].
      Notably, reports of adult cases of new-onset POTS after COVID-19 mRNA vaccination have been emerging [12-15].
    note: 'Found by winnow, kev and lev in p014, p002, p004. Claude judged: partial.'
  - paper: pmid35937046
    cited: true
    text: full
    license: by
    verdict: partial
    section: Postural orthostatic tachycardia syndrome and its possible effect on LQTS
    quote: Postural orthostatic tachycardia syndrome (POTS) is another rare condition that may result from COVID-19
      vaccination, supported by at least 2 case reports.23,24
    note: 'Found by winnow, kev and lev in p012, p002, p011. Claude judged: partial.'
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Conclusions
    quote: While we cannot imply causality, the initial onset of POTS symptoms was closely linked in time to administration
      of the COVID-19 vaccination, similar to previously reported cases of POTS after COVID-19 vaccination.
    note: 'Found by winnow, kev and lev in p018, p001, p004. Claude judged: partial.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: 7. Conclusions
    quote: POTS has been reported to occur after vaccination with Gardasil.
    note: 'Found by winnow, kev and lev in p001, p007, p023. Claude judged: partial.'
  - paper: pmid24102827
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24102827. Found by winnow, kev and lev in p002, p004. Claude judged: partial.'
- edge:
  - systemic_autoimmune_disease
  - associated_with
  - pots
  papers: 19
  evidence:
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Additionally, autoimmune conditions such as asthma [32], Hashimoto's disease [33], Raynaud's syndrome
      [34], and Sjögren's syndrome [35] are more prevalent in POTS patients compared to the general population.
    note: 'Found by winnow, kev and lev in p030, p032, p036. Claude judged: supports.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Amongst them, chronic diabetes mellitus is the most common disease related to POTS [19]. Frequent associations
      include Hashimoto’s thyroiditis, Sjogren’s syndrome, antiphospholipid syndrome, systemic lupus erythematosus
      (lupus), and rheumatoid arthritis [19].
    note: 'Found by winnow, kev and lev in p084, p003, p009. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autoimmunity > Comorbidity with undifferentiated connective tissue disease
    quote: POTS and OCADs are commonly comorbid with other autoimmune disorders, with the most common being Hashimoto’s
      thyroiditis (Blitshteyn, 2015). Their association with Sjögren’s syndrome, antiphospholipid syndrome, and
      celiac disease has also been reported (Schofield et al., 2014; Penny et al., 2016; Mannan and Pain, 2023).
    note: 'Found by winnow, kev and lev in p015, p031, p017. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: Furthermore, 20% of POTS patients have a diagnosis of a coexisting autoimmune disease, including but
      not limited to Hashimoto’s thyroiditis, celiac disease, Sjogren’s disease, rheumatoid arthritis, and systemic
      lupus erythematosus [5,6,7].
    note: 'Found by winnow, kev and lev in p004, p030. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Support for an autoimmune mechanism in POTS and other forms of stress
    quote: 'There is a compelling association between POTS and autoimmunity: POTS is associated with a higher-than-expected
      frequency of defined autoimmune disorders. One cohort had positive anti-nuclear antibodies in 25% patients
      and a concurrent autoimmune diagnosis in 20% [43].'
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid36908200
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Discussion: > Interpretation: > Implications for Clinical Care:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36908200. Found by winnow, kev and lev in p042, p011, p015. Claude judged: supports.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: A review of autoimmunity in POTS by Ref. [5] found that “patients with POTS have a higher than expected
      frequency of defined autoimmune disorders such as multiple sclerosis, lupus, Sjögren syndrome or celiac disease”.
    note: 'Found by winnow, kev and lev in p001, p003, p021. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Results > Autoimmmune Disorders
    quote: Approximately 20% of patients with POTS have comorbid autoimmune disorders, including Hashimoto’s thyroiditis,
      rheumatoid arthritis, lupus, APS, Sjogren’s syndrome and celiac disease.43,44
    note: 'Found by winnow, kev and lev in p033, p017. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p006. Claude judged: supports.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: What is the pathophysiology of POTS?
    quote: Many patients describe a postviral onset,29–32 and 15%–20% of patients with POTS report a history of
      an autoimmune disorder such as Hashimoto thyroiditis, rheumatoid arthritis or Sjögren syndrome.4
    note: 'Found by winnow, kev and lev in p018, p021. Claude judged: supports.'
  - paper: pmid35156619
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction > Discussion
    quote: In some autoimmune conditions, POTS was described and includes systemic lupus erythematosus, Sjögren’s
      syndrome, multiple sclerosis, Raynaud’s phenomenon, and ASIA syndrome.11–15
    note: 'Found by winnow, kev and lev in p012. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Antibodies and immunology of POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p022. Claude judged: supports.'
  - paper: pmid34055446
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: Although POTS is most commonly caused by dysfunctional regulation of blood pressure, there is an association
      with autoimmune conditions. Among the most common are rheumatoid arthritis and Sjogren's disease [5].
    note: 'Found by winnow, kev and lev in p011. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: A study of 100 consecutive patients with POTS found that 31% of patients had 1 or more antibody markers
      and 20% had comorbid autoimmune disorders such as Hashimoto's thyroiditis, rheumatoid arthritis, or systemic
      lupus erythematosus.35 Postural orthostatic tachycardia syndrome has also been reported in association with
      Sjögren's syndrome and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Secondary forms of POTS occur in association with other disorders, most commonly diabetes mellitus. Other
      conditions include amyloidosis, sarcoidosis, alcoholism, systemic lupus erythematosus, Sjögren’s syndrome,
      heavy-metal intoxication, joint hypermobility syndrome, pure autonomic failure, multiple-system atrophy and
      paraneoplastic syndrome [7].
    note: 'Found by winnow, kev and lev in p017. Claude judged: supports.'
  - paper: pmid42299385
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: First, the patient had SS manifested not only by thickening of the skin but also by vascular involvement
      in the form of migraine, POTS and Raynaud’s syndrome. Each of these manifestations has been described separately
      along with SS (8-10).
    note: 'Found by winnow, kev and lev in p007, p003, p012. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Primary Postural Orthostatic Tachycardia Syndrome and Pathophysiologic Mechanisms
    quote: Patients with autoimmune-related POTS may also present with autoimmune disorders as comorbidities.
    note: 'Found by winnow, kev and lev in p011, p058. Claude judged: partial.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patients with systemic autoimmune diseases may be at slightly increased risk for developing a neuropathic
      POTS phenotype - for instance, Sjogren’s syndrome is diagnosed at higher rates among POTS patients who have
      reduced IENFD [26].
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid33244220
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Sjogren’s syndrome (SS) is well characterized across neurology and rheumatology journals to be associated
      with both impaired autonomic function and postural orthostasis.
    note: 'Found by winnow, kev and lev in p004, p006, p032. Claude judged: partial.'
- edge:
  - deconditioning_evidence
  - associated_with
  - pots
  papers: 15
  evidence:
  - paper: pmid41357159
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41357159. Found by winnow, kev and lev in p036, p010, p039. Claude judged: supports.'
  - paper: pmid40538940
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Deconditioning is considered to be closely related to PoTS (13, 14).
    note: 'Found by winnow, kev and lev in p007, p008, p009. Claude judged: supports.'
  - paper: pmid36000435
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: POTS has been associated with conditions causing peripheral autonomic denervation and connective tissue
      disorders (Joint hypermobility syndrome, Ehlers‐Danlos syndrome), chronic fatigue syndrome, autoimmune disorders,
      and deconditioning.
    note: 'Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid35557616
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Evidence suggests that physical deconditioning is an important aspect of POTS syndrome and can worsen
      symptoms (50). In the case that we presented and in our retrospective cohort, both the symptoms from PANS
      and POTS often lead to inactivity and deconditioning, and this deconditioning may further contribute to POTS.
    note: 'Found by winnow, kev and lev in p034. Claude judged: supports.'
  - paper: pmid31802934
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: 'Challenge I: Complexities And Misunderstandings'
    quote: Diagnosis is further complicated by the fact that patients sometimes present with POTS as well as a concurrent
      diagnosis of deconditioning.1 The presence of deconditioning is considered a differential diagnosis (i.e.,
      weighing the probability of one diagnosis versus the other diagnosis when they present with similar clinical
      features) for POTS and 70% of youth present with a concurrent diagnosis of deconditioning,1 making it difficult
      for clinical providers to name POTS as the primary diagnosis.
    note: 'Found by winnow, kev and lev in p012, p006, p030. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.8 Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Physical deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p030. Claude judged: supports.'
  - paper: pmid25980576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Section 1: Postural Tachycardia Syndrome Definition > Physiology > Deconditioning'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25980576. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid25168872
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Many patients with POTS limit physical activity whether due to pervasive fatigue and malaise or difficulty
      from orthostatic intolerance, presumably the reason why the majority of patients with POTS are deconditioned.
      Parsaik et al. (2012) found peak oxygen uptake () <85% predicted value in 90% of patients with POTS.
    note: 'Found by winnow, kev and lev in p004, p005, p019. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Exercise Physiology, Deconditioning, and POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p059, p061, p028. Claude judged: supports.'
  - paper: pmid24386408
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: A recent study drew attention to the presence of deconditioning in POTS patients [28]. While the present
      data do not help disentangle the interaction between deconditioning and POTS, the presence of these levels
      of fatigue provides a possible explanation for the observed deconditioning and suggests that deconditioning
      may be present irrespective of POTS etiology.
    note: 'Found by winnow, kev and lev in p033, p034. Claude judged: supports.'
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p030, p028. Claude judged: partial.'
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p026, p040. Claude judged: partial.'
  - paper: pmid28286774
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: POTS and OI have been frequently described in chronic fatigue syndrome and fibromyalgia, a fact that
      suggests that these conditions may share deconditioning.
    note: 'Found by winnow, kev and lev in p026. Claude judged: partial.'
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p027, p025. Claude judged: partial.'
- edge:
  - small_fiber_neuropathy_dx
  - associated_with
  - pots
  papers: 15
  evidence:
  - paper: pmid41301791
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Presyncope and Autonomic Dysfunction
    quote: Presyncope is also common in patients with small fiber neuropathy, which is one of the most common comorbidities
      of POTS and Long COVID [13,14].
    note: 'Found by winnow, kev and lev in p008. Claude judged: supports.'
  - paper: pmid40271232
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: The relationship between POTS and SFN is well-established, but the diagnosis of SFN is currently either
      clinical or through skin punch biopsy.
    note: 'Found by winnow, kev and lev in p008, p036, p001. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: 'In addition to elevated autoimmune and inflammatory markers in POTS patients [45] and a higher prevalence
      of autoimmune disorders [42], POTS frequently co-occurs with a range of other conditions that have inflammatory
      underpinnings, such as: Small Fiber Neuropathy (SFN), characterized by damage to small nerve fibers and inflammatory
      processes [46]; Mast Cell Activation Syndrome (MCAS), involving excessive inflammatory mediator release [47];
      Chronic Fatigue Syndrome (CFS)/Myalgic Encephalomyelitis (ME), associated with immune dysregulation and chronic
      inflammation [48]; and infections such as Lyme disease [49].'
    note: 'Found by winnow, kev and lev in p013, p015. Claude judged: supports.'
  - paper: pmid38537312
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38537312. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Neuropathy: It is estimated that up to half of the POTS cases have some form of small-fiber neuropathy,
      resulting in dysautonomia.'
    note: 'Found by winnow, kev and lev in p013. Claude judged: supports.'
  - paper: pmid33459162
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33459162. Found by winnow, kev and lev in p003, p001. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.1 Partial Sympathetic Neuropathy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Autoimmunity > Association with autonomic neuropathy
    quote: However, a non-length-dependent or patchy distribution of small fiber neuropathy can also occur, especially
      in conjunction with systemic autoimmune disorders (Gemignani et al., 2022).
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentation
    quote: However, an autoimmune basis of post-COVID POTS was evident given a positive ANA, comorbid SFN, and post-infectious
      onset of symptomatology.
    note: 'Found by winnow, kev and lev in p005, p003, p007. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Small Fiber Neuropathy
      and Complex Regional Pain Syndrome
    quote: SFN is suspected to contribute to the underlying pathologies of many different conditions, including
      POTS, CFS, complex regional pain syndrome (CRPS), and fibromyalgia, among others, and overlaps considerably
      with CPRS.[30]
    note: 'Found by winnow, kev and lev in p027, p028, p030. Claude judged: partial.'
  - paper: pmid37968647
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Small fiber neuropathy (SFN) has been suggested to be a possible mediator of POTS [16]. SFN can affect
      both autonomic and sensory fibers [17].
    note: 'Found by winnow, kev and lev in p004, p009. Claude judged: partial.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: 'Conclusion: A subset of patients with postural orthostatic tachycardia syndrome have evidence of small
      fiber neuropathy.'
    note: 'Found by winnow, kev and lev in p004, p037, p006. Claude judged: partial.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Furthermore, in some patients with neuropathic POTS, intraepidermal nerve fiber density is decreased,
      providing objective support for a small fiber neuropathy in these POTS patients.
    note: 'Found by winnow, kev and lev in p007, p003, p027. Claude judged: partial.'
  - paper: pmid24647968
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24647968. Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pathophysiology of POTS > Neuropathic POTS
    quote: Yet some of them have a form of dysautonomia, with preferential denervation of sympathetic nerves innvervating
      the lower limbs [22-24]. There have been several findings consistent with this hypothesis.
    note: 'Found by winnow, kev and lev in p024. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - postinfectious_evidence
  papers: 12
  evidence:
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Wallukat et al. conducted a study in which 31 patients with POTS and COVID-19 were examined. All patients
      had positive autoantibodies ranging from two to seven.
    note: 'Found by winnow, kev and lev in p006, p027, p034. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Autoimmunity: Many patients, after a viral illness, develop POTS symptoms, which are suspected to be
      due to an autoimmune response.'
    note: 'Found by winnow, kev and lev in p012, p001. Claude judged: supports.'
  - paper: pmid25087056
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25087056. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Autoimmunity > Autoimmunity in Long COVID
    quote: G protein-coupled receptor antibodies, including against alpha- and beta-adrenergic antibodies and muscarinic
      antibodies, previously identified in patients with POTS, as well as autoantibodies to antinuclear and extractable
      nuclear antigens, have also been found in patients with Long COVID (Wallukat et al., 2021; El-Rhermoul et
      al., 2023; Son et al., 2023).
    note: 'Found by winnow, kev and lev in p001, p013, p019. Claude judged: partial.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. POTS Etiology and Its Complexity
    quote: The onset of POTS is frequently linked to triggers, such as long COVID-19, the human papillomavirus (HPV)
      vaccine, infections, or trauma, which can subsequently lead to immunological changes.
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: Although the exact pathophysiology mechanism is unclear, it is thought that the combination of autoimmunity,
      relative central hypovolemia, small fiber neuropathy, hyperadrenergic stimulation, and pro-inflammatory cytokine
      production (i.e., cytokine storm) is a critical factor in POTS and COVID-19 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013. Claude judged: partial.'
  - paper: pmid29687025
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Results > Clinical assessment of autonomic function in patients with seropositive POTS in second analysis
    quote: Antecedent infections were reported in five patients (50%) with seropositive POTS, but there were no
      differences between seropositive and seronegative patients.
    note: 'Found by winnow, kev and lev in p001, p014. Claude judged: partial.'
  - paper: pmid28738696
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28738696. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Pathophysiology of POTS > Autoimmune/Autoantibodies
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p031. Claude judged: partial.'
  - paper: pmid19058765
    cited: true
    text: full
    license: none
    verdict: partial
    section: Postural Tachycardia Syndrome (POTS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 19058765. Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - systemic_autoimmune_disease
  papers: 12
  evidence:
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: 'Moreover, POTS is also associated with a higher prevalence of atopic conditions and autoimmune disorders
      compared to the general population: Asthma (20.3% (95% CI 19.1–21.5) in POTS vs. 3.3% (95% CI 2.9–3.8) in
      the general population [32]), Hashimoto''s disease (8.3% (95% CI 4.1–16.0) vs. 7.5% (95% CI 5.7–9.6) [33]),
      Raynaud''s syndrome (15.5% (95% CI 14.4–16.7) vs. 4.85% (95% CI 2.1–8.7) [34]), and Sjögren''s syndrome (4.7%
      (95% CI 1.7–12.2) versus 0.06% (95% CI 0.04–0.08) [35]).'
    note: 'Found by winnow, kev and lev in p030, p036. Claude judged: partial.'
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In our study, patients also had autoimmune diseases, which were Sjogren’s syndrome, Crohn’s disease,
      psoriatic arthritis, and multiple sclerosis. Research is underway to establish a link between certain autoantibodies,
      such as G-protein-coupled adrenergic receptors and muscarinic cholinergic receptor antibodies found in elevated
      levels in POTS, which corresponds to the theory that POTS may have an immune-mediated pathogenesis [19].
    note: 'Found by winnow, kev and lev in p084, p009. Claude judged: partial.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Autoimmunity > Comorbidity with undifferentiated connective tissue disease
    quote: POTS and OCADs are commonly comorbid with other autoimmune disorders, with the most common being Hashimoto’s
      thyroiditis (Blitshteyn, 2015). Their association with Sjögren’s syndrome, antiphospholipid syndrome, and
      celiac disease has also been reported (Schofield et al., 2014; Penny et al., 2016; Mannan and Pain, 2023).
    note: 'Found by winnow, kev and lev in p015, p031, p018. Claude judged: partial.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.5. Antiphospholipid
      and Antinuclear Autoantibodies
    quote: Blitshteyn performed a retrospective review of POTS patients to evaluate comorbid autoimmune disorders
      and the presence of AAbs. Autoimmune disorders were present in 20/100 patients, including Hashimoto’s thyroiditis
      (11/100), antiphospholipid syndrome (5/100), rheumatoid arthritis (4/100), celiac disease (3/100), systemic
      lupus erythematosus (2/100), and Sjögren’s syndrome (2/100).
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid36816268
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Introduction
    quote: Patients with one AD are often more prone to others. A review of autoimmunity in POTS by Ref. [5] found
      that “patients with POTS have a higher than expected frequency of defined autoimmune disorders such as multiple
      sclerosis, lupus, Sjögren syndrome or celiac disease”.
    note: 'Found by winnow, kev and lev in p003, p074, p022. Claude judged: partial.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Some cases of neuropathic POTS are thought to arise from immune-mediated neuropathy. In this cohort,
      there was a trend toward higher rates of comorbid autoimmune disease among patients with evidence of SFN compared
      to patients without, though the difference was not statistically significant.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Selected Etiology: Autoimmune > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p068. Claude judged: partial.'
  - paper: pmid35156619
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction > Discussion
    quote: In some autoimmune conditions, POTS was described and includes systemic lupus erythematosus, Sjögren’s
      syndrome, multiple sclerosis, Raynaud’s phenomenon, and ASIA syndrome.11–15
    note: 'Found by winnow, kev and lev in p003, p012. Claude judged: partial.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p013, p022. Claude judged: partial.'
  - paper: pmid34055446
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: A pathogenesis of POTS includes an autoimmune basis with a high prevalence of positive ANA and comorbid
      autoimmune disorders [3].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid31498378
    cited: true
    text: full
    license: none
    verdict: partial
    section: Medical Causes and Contributors
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 31498378. Found by winnow, kev and lev in p012, p022. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: A study of 100 consecutive patients with POTS found that 31% of patients had 1 or more antibody markers
      and 20% had comorbid autoimmune disorders such as Hashimoto's thyroiditis, rheumatoid arthritis, or systemic
      lupus erythematosus.35 Postural orthostatic tachycardia syndrome has also been reported in association with
      Sjögren's syndrome and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - associated_with
  - hypermobility_heds
  papers: 11
  evidence:
  - paper: pmid42509985
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion > 3.1. Dysautonomia and the Rationale for Prokinetic Bridge Therapy
    quote: 'Patient 3 illustrates a further layer of this pathophysiology: the overlap between POTS, hypermobile
      Ehlers–Danlos syndrome (hEDS), and disorders of gut–brain interaction. Connective tissue laxity in hEDS is
      increasingly recognized as a contributor to GI dysmotility and visceral hypersensitivity through mechanisms
      distinct from, but overlapping with, autonomic dysregulation [18].'
    note: 'Found by winnow, kev and lev in p027, p036. Claude judged: supports.'
  - paper: pmid41858767
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Introduction
    quote: Gastrointestinal symptoms in POTS and HSD/hEDS occur frequently, both as functional gastrointestinal
      disorders and as more severe intestinal dysmotility disorders (10-12).
    note: 'Found by winnow, kev and lev in p004, p001. Claude judged: supports.'
  - paper: pmid39543811
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: 'Two specific DGBI clusters exist in the hEDS/HSD cohort: those with mainly functional foregut disorders
      (FFD) with overlapping irritable bowel syndrome (hEDS/HSD + FFD + IBS) and those with predominantly IBS (hEDS/HSD
      + IBS).'
    note: 'Found by winnow, kev and lev in p003, p032, p005. Claude judged: supports.'
  - paper: pmid34765384
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: One retrospective study found that both EDS III and POTS are independent risk factors for gastrointestinal
      (GI) symptoms, including GI dysmotility and gastroesophageal reflux disease [15].
    note: 'Found by winnow, kev and lev in p006, p019. Claude judged: supports.'
  - paper: pmid32803794
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32803794. Found by winnow, kev and lev in p003, p001, p004. Claude judged: supports.'
  - paper: pmid32489735
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: GI dysmotility among patients with hEDS is not uncommon and possibly underdiagnosed.
    note: 'Found by winnow, kev and lev in p054, p008, p012. Claude judged: supports.'
  - paper: pmid29891041
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29891041. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Postural Tachycardia Syndrome, Gastrointestinal Symptoms, and related co-morbidities GI symptoms
      in Postural Tachycardia Syndrome and Ehlers-Danlos
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p016, p015, p028. Claude judged: supports.'
  - paper: pmid42691689
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic system degenerations, generalized dysautonomia, and disorders of autonomic dysregulation
      > Postural orthostatic tachycardia syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42691689. Found by winnow, kev and lev in p044. Claude judged: partial.'
  - paper: pmid40387691
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Methods
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 40387691. Found by winnow, kev and lev in p002. Claude judged: partial.'
  - paper: pmid39268060
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Gastroparesis is a chronic disorder involving symptoms of delayed gastric emptying and may be closely
      associated with hEDS and POTS, and may be underreported.
    note: 'Found by winnow, kev and lev in p069, p071, p001. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - long_covid
  papers: 11
  evidence:
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Autoimmunity
    quote: Similar to POTS, autoimmunity is considered to be one of the major mechanisms of Long COVID, with an
      associated increased risk, overall incidence and range of autoimmune conditions after SARS-CoV-2 infection.21,37
    note: 'Found by winnow, kev and lev in p007, p012. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: supports
    section: Autoimmunity > Autoimmunity in Long COVID
    quote: G protein-coupled receptor antibodies, including against alpha- and beta-adrenergic antibodies and muscarinic
      antibodies, previously identified in patients with POTS, as well as autoantibodies to antinuclear and extractable
      nuclear antigens, have also been found in patients with Long COVID (Wallukat et al., 2021; El-Rhermoul et
      al., 2023; Son et al., 2023). The pro-inflammatory mediators, non-specific antibodies, and antibodies important
      to the function of the autonomic nervous system are thought to be implicated in the development of post-COVID
      autonomic disorders, such as POTS and OCADs (El-Rhermoul et al., 2023).
    note: 'Found by winnow, kev and lev in p001, p013, p019. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion > 3.2. Individualizing Treatment Plans
    quote: With evidence that many patients suffering from long COVID can develop autoimmune-mediated orthostatic
      intolerance, prompt recognition is important as it can expedite appropriate treatment [9].
    note: 'Found by winnow, kev and lev in p006, p027, p047. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Long Covid—the new pandemic
    quote: Notable autoantibodies include functionally active autoantibodies to the GPCRs (including α1- and β2-adrenoceptors,
      angiotensin receptor, nociception-like opioid receptor and muscarinic M2-receptor) [11]. This is significant
      for the overlap with POTS [12] and autonomic nervous system.
    note: 'Found by winnow, kev and lev in p004, p009, p001. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 7. Diagnosis of Post-COVID Dysautonomia
    quote: PASC patients with POTS-like symptoms feature a high prevalence of circulating AAbs, at times with peculiar
      patterns [57] (Figure 1).
    note: 'Found by winnow, kev and lev in p038, p025. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. POTS Etiology and Its Complexity
    quote: The mechanisms behind this association are not fully elucidated but may involve inflammation, microthrombi,
      and autoimmunity [59,60].
    note: 'Found by winnow, kev and lev in p014, p019. Claude judged: partial.'
  - paper: pmid38900132
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38900132. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Recently, there was a surge in the incidence of POTS after the COVID-19 pandemic. Functional antibodies
      against different GPCRs have also been demonstrated in the serum of symptomatic post-COVID-19 patients.[23]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: Although the exact pathophysiology mechanism is unclear, it is thought that the combination of autoimmunity,
      relative central hypovolemia, small fiber neuropathy, hyperadrenergic stimulation, and pro-inflammatory cytokine
      production (i.e., cytokine storm) is a critical factor in POTS and COVID-19 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The exact mechanisms of post-COVID-19 POTS are unclear. Still, different hypotheses have been given,
      including autoantibody production against autonomic nerve fibers, direct toxic effects of SARS-CoV-2, or sympathetic
      nervous system stimulation secondary to infection.
    note: 'Found by winnow, kev and lev in p012, p001. Claude judged: partial.'
  - paper: pmid36509178
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion > Hospitalization status
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36509178. Found by winnow, kev and lev in p037. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - mast_cell_activation
  papers: 10
  evidence:
  - paper: pmid39109428
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39109428. Found by winnow, kev and lev in p024, p034, p035. Claude judged: supports.'
  - paper: pmid38526146
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract
    quote: A subtype of POTS, hyperadrenergic POTS, has been widely studied because of its association with mast
      cell activation syndrome (MCAS). Although a causative relationship between PCC, hyperadrenergic POTS, and
      MCAS remains unrevealed, these syndromes can overlap.
    note: 'Found by winnow, kev and lev in p006, p001, p020. Claude judged: supports.'
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: supports
    section: Associations with mast cell activation disorders
    quote: These MCA/POTS patients had predominant flushing breathlessness, headache, lightheadedness, excessive
      diuresis, diarrhoea, nausea and vomiting, and had a marked hyperadrenergic orthostatic response, with higher
      noradrenaline levels and exaggerated blood pressure rise on standing compared with the POTS and control groups
      [95].
    note: 'Found by winnow, kev and lev in p028. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mechanisms
    quote: These patients experience severe episodic flushing with sinus tachycardia.14 The patient will have a
      hyperadrenergic response to position change and an elevated urine methylhistamine during flushing episodes.14
    note: 'Found by winnow, kev and lev in p014. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.5 Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p022. Claude judged: supports.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p029. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p018. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pathophysiology of POTS > Mast Cell Activation
    quote: These patients often have a hyperadrenergic response to posture, with both orthostatic tachycardia and
      hypertension.
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid15710782
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 15710782. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: A patient with severe POTS, MCAS and SIBO responded to a combination of LDN, IVIg and antibiotic therapy.
      We theorise that pre-existing MCAS was the driving force for hyperadrenergic POTS in this patient.
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - me_cfs
  papers: 10
  evidence:
  - paper: pmid41859298
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Long COVID
    quote: Both ME/CFS and POTS are major phenotypes associated with Long COVID, and autonomic dysfunction is present
      in nearly 70% of patients with Long COVID, making it a major pathophysiologic mechanism.18,19
    note: 'Found by winnow, kev and lev in p007, p013. Claude judged: supports.'
  - paper: pmid40627388
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: Despite the diverse symptoms in individual patients, studies have shown that many long COVID and ME/CFS
      sufferers share hallmark symptoms such as fatigue, postexertional malaise (PEM), unrefreshing sleep, orthostatic
      intolerance (OI), and cognitive dysfunction. These symptoms align with the 2015 Institute of Medicine (IOM)
      diagnostic criteria for ME/CFS (2, 3, 8, 14–17).
    note: 'Found by winnow, kev and lev in p004, p010, p032. Claude judged: supports.'
  - paper: pmid38600563
    cited: true
    text: full
    license: by
    verdict: supports
    section: Background
    quote: Following acute SARS-CoV-2 infection, a subset of individuals continues to suffer from lingering symptoms
      very similar to those associated with ME/CFS. It has been estimated that about half of people presenting with
      long COVID at six months meet the case criteria for ME/CFS [7, 8].
    note: 'Found by winnow, kev and lev in p006, p053. Claude judged: supports.'
  - paper: pmid36981522
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: At the extreme end of the severity spectrum, some individuals with long COVID also meet the criteria
      for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), raising the possibility that symptom management
      approaches for ME/CFS may benefit some long COVID patients. We describe the long-term outcomes of a 19-year-old
      male who developed profound impairment consistent with ME/CFS after a SARS-CoV-2 infection early in the pandemic.
    note: 'Found by winnow, kev and lev in p001, p003, p006. Claude judged: supports.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: supports
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p022, p024, p037. Claude judged: supports.'
  - paper: pmid36611357
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: Pairwise comparison of the average increase in heart rate relative to basal values between the cohorts
      at each minute of the active standing test showed that in ME/CFS that developed after COVID-19, there is a
      more pronounced increase in heart rate starting from the 6th minute of the test compared to the control group.
      This allowed us to assume that POTS is one of the key characteristics of ME/CFS of post-COVID genesis.
    note: 'Found by winnow, kev and lev in p035, p040, p046. Claude judged: supports.'
  - paper: pmid33996867
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: In all three, ME/CFS symptoms were prominent from the outset, as were symptoms and signs of orthostatic
      intolerance, consistent with an early contribution of circulatory disturbances to the pathogenesis of symptoms,
      before the onset of physiological changes due to inactivity. The preliminary findings of this case series
      have the potential to inform the investigation and treatment of what has been termed “long COVID” (8) or post-COVID-19
      ME/CFS.
    note: 'Found by winnow, kev and lev in p004, p006, p013. Claude judged: supports.'
  - paper: pmid41050528
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Case presentation
    quote: After a new COVID-19 infection in February 2021, he developed typical long COVID symptoms of dysautonomia,
      post-exertional malaise (PEM), and symptoms compatible with POTS.
    note: 'Found by winnow, kev and lev in p002, p009. Claude judged: partial.'
  - paper: pmid40883051
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: Our findings add to the hypothesized associations between ME/CFS and long COVID, often discussed together
      due to overlapping symptomatology and infectious etiopathogenesis.12,35, 36, 37
    note: 'Found by winnow, kev and lev in p035. Claude judged: partial.'
  - paper: pmid35241011
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: CFS/ME has been associated with several viruses, including the 2003 severe acute respiratory syndrome
      coronavirus (SARS-CoV; 6), and has been recently garnering media attention as a post-acute consequence of
      SARS-CoV-2 infection.
    note: 'Found by winnow, kev and lev in p005. Claude judged: partial.'
- edge:
  - hypovolemic_evidence
  - associated_with
  - pots
  papers: 9
  evidence:
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: Hypovolemia is one of the main pathological features in POTS [3,4,6,7]. POTS patients frequently experience
      hypovolemia, which may be caused by insufficient fluid intake and excessive fluid loss.
    note: 'Found by winnow, kev and lev in p003, p001, p008. Claude judged: supports.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Along with tachycardia with orthostatic intolerance, other symptoms can also accompany the syndrome.
      In the majority of patients, intravascular volume is reduced, thus leading to decreased venous return to the
      heart and causing reflex tachycardia and orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p001, p005. Claude judged: supports.'
  - paper: pmid32655482
    cited: true
    text: full
    license: by
    verdict: supports
    section: Pots Subtypes in Children and Adolescents > Hypovolemic POTS
    quote: Hypovolemia could be observed in nearly 30% of POTS patients, as Thieben et al. estimated (16). In our
      experience, over fifty percent of children and adolescents with POTS have low blood volume (5).
    note: 'Found by winnow, kev and lev in p010, p011, p018. Claude judged: supports.'
  - paper: pmid23753844
    cited: true
    text: full
    license: none
    verdict: supports
    section: Pathophysiology of POTS > Hypovolemia & Blood Volume Regulation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23753844. Found by winnow, kev and lev in p028, p015, p020. Claude judged: supports.'
  - paper: pmid16262605
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 16262605. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid40027266
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: POTS is an autonomic disorder characterized by excessive reflex sympathetic excitation triggered by orthostatic
      stress. The pathophysiology remains elusive; however, central hypovolemia has been identified as the mechanism
      leading to venous pooling, hypovolemia, deconditioning, and hyperadrenergic state.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid34268642
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic Disorders and Headache
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34268642. Found by winnow, kev and lev in p015, p019. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A subset of patients with POTS has low levels of standing plasma renin activity, aldosterone, and blood
      volume as compared to normovolemic patients [10].
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - differential_syncope_oh
  - associated_with
  - pots
  papers: 7
  evidence:
  - paper: pmid41300849
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Syncope, characterized by a transient loss of consciousness resulting from cerebral hypoperfusion, occurs
      in approximately 20% of patients with POTS [4].
    note: 'Found by winnow, kev and lev in p003, p040, p041. Claude judged: partial.'
  - paper: pmid36518687
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Results
    quote: Patients with vasovagal syncope (VVS) coexisting with postural orthostatic tachycardia syndrome (POTS)
      were more likely to take pharmacological treatments than those with VVS or POTS only (χ2 = 41.696, P < 0.01).
    note: 'Found by winnow, kev and lev in p031, p004, p005. Claude judged: partial.'
  - paper: pmid36252987
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: The importance of diagnosing BASCULE syndrome lies in its association with a spectrum of orthostatic
      intolerance conditions, including syncope, orthostatic hypotension and POTS (a condition associated with mast
      cell activation and hypermobility spectrum disorders).2,3
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Conclusion
    quote: We have to keep this possibility in young patients of transient loss of consciousness because it may
      coexist with NCS.
    note: 'Found by winnow, kev and lev in p002, p005, p014. Claude judged: partial.'
  - paper: pmid31250563
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: VVS can occur in patients diagnosed with the postural tachycardia syndrome (POTS). The incidence of VVS
      in POTS patients is believed to be about 30%, similar to its incidence in the general population (Raj 2006;
      Kimpinski et al. 2012), which is consistent with our experience.
    note: 'Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
  - paper: pmid30838497
    cited: true
    text: full
    license: none
    verdict: partial
    section: Head-up tilt in the diagnostic evaluation of syncope
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30838497. Found by winnow, kev and lev in p070. Claude judged: partial.'
  - paper: pmid26198889
    cited: true
    text: full
    license: none
    verdict: partial
    section: Disorders Overlapping with POTS > Vasovagal Syncope (VVS)
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 26198889. Found by winnow, kev and lev in p020, p017. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - mast_cell_activation
  papers: 6
  evidence:
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: The frequent co-occurrence in patients with hEDS of mast cell activation syndrome (MCAS), a poorly defined
      disorder marked by episodic hypersensitivity and gastrointestinal symptoms, adds additional diagnostic ambiguity[16–19].
    note: 'Found by winnow, kev and lev in p046, p009, p045. Claude judged: supports.'
  - paper: pmid40843452
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion > Small Fiber Neuropathy
    quote: An association between hEDS and mast cell disorders has been made in previous studies56 but the true
      prevalence of mast cell disorders in hEDS remains unclear due to differing clinical criteria used in the definition
      of the mast cell disorders.57, 58, 59 In our study, 61% of patients used anti-histamine medications, and 41%
      had a history of symptoms associated with mast cell activation syndrome.
    note: 'Found by winnow, kev and lev in p049. Claude judged: supports.'
  - paper: pmid40352770
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: It has been recognized for more than two decades, but only recently become well-established in the past
      five years, that the conditions of orthostatic intolerance with an underlying contributing etiology of autonomic
      neuro-immune axis dysfunction (sometimes referred to generally as dysautonomia), what we term here, orthostatic
      intolerance syndromes (OIS), as well as joint hypermobility disorders (JHD), and mast cell activation syndrome
      (MCAS) co-segregate in patients who have these disorders (1–5).
    note: 'Found by winnow, kev and lev in p012, p001, p005. Claude judged: supports.'
  - paper: pmid39931100
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Notably, individuals with symptoms of hEDS often present with concomitant autonomic and immune dysfunctions
      such as postural orthostatic tachycardia syndrome (POTS) and mast cell activation disorder (MCAD), respectively,
      whose associations with connective tissue and joint fragility are well documented (10, 19).
    note: 'Found by winnow, kev and lev in p003, p006, p024. Claude judged: supports.'
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: All eight patients were subsequently diagnosed with mast cell activation syndrome; six had comorbid autonomic
      disorders, the most common being postural orthostatic tachycardia syndrome; and four had hypermobile Ehlers-Danlos
      syndrome.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What other conditions commonly occur in patients with POTS?
    quote: Hypermobility spectrum disorder may co-occur with mast cell activation disorder in some patients with
      POTS.
    note: 'Found by winnow, kev and lev in p018. Claude judged: partial.'
- edge:
  - fibromyalgia
  - associated_with
  - pots
  papers: 6
  evidence:
  - paper: pmid42691689
    cited: true
    text: full
    license: none
    verdict: supports
    section: Autonomic system degenerations, generalized dysautonomia, and disorders of autonomic dysregulation
      > Postural orthostatic tachycardia syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42691689. Found by winnow, kev and lev in p044. Claude judged: supports.'
  - paper: pmid40546538
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In our clinic, we often see POTS patients experience pain through common comorbidities like fibromyalgia
      (FM), headaches, and migraines. FM is a pain-related comorbidity [13].
    note: 'Found by winnow, kev and lev in p033. Claude judged: supports.'
  - paper: pmid38348221
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: POTS frequently presents with chronic comorbidities or conditions that are unrelated to orthostatic intolerance,
      such as migraine, fibromyalgia, chronic fatigue, and allergic disorders (Liao et al., 2017; Chelimsky and
      Chelimsky, 2018).
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: Fibromyalgia, which is also a disease of young women, was found to be associated with POTS in a study
      [32-33].
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid26425598
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Such typical CFS symptoms that are overrepresented in POTS patients include migraine, incapacitating
      fatigue, fibromyalgia, unrefreshing sleep, and impaired memory or concentration.
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: Postural orthostatic tachycarda syndrome (POTS) has been documented in migraine [1] and fibromyalgia
      [2], which is defined when the orthostatic symptoms are associated with a heart rate (HR) increment of more
      than 30 beats per minute (bpm) or a standing HR of 120 bpm or more in the absence of postural hypotension
      [3].
    note: 'Found by winnow, kev and lev in p001, p012, p002. Claude judged: supports.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - hypermobility_heds
  papers: 5
  evidence:
  - paper: pmid41924132
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Additionally, heightened vascular distensibility promotes venous pooling in the extremities and may precipitate
      a maladaptive autonomic adrenergic response with associated dizziness and palpitations, as seen in POTS.
    note: 'Found by winnow, kev and lev in p008. Claude judged: partial.'
  - paper: pmid39301475
    cited: true
    text: full
    license: by
    verdict: partial
    section: Relationship to post-infectious syndromes including long COVID
    quote: Adrenaline, a key effector hormone of the sympathetic nervous system, is elevated in hyperadrenergic
      POTS. It has been shown to inhibit the function of human fibroblasts and modulate the expression of local
      growth factors, thereby potentially explaining a mechanism of adrenaline-induced connective tissue dysfunction
      (29, 30).
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid35620060
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Patient 3
    quote: Given her symptoms of flushing, anxiety, and faintness upon assuming an upright position, supine (685
      pg/mL) and standing (1386 pg/mL) norepinephrine levels were assessed and suggested hyperadrenergic POTS.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid34510391
    cited: true
    text: full
    license: none
    verdict: partial
    section: Overlap of Dysautonomia and Hypermobility Syndromes
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34510391. Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid25713509
    cited: true
    text: full
    license: by
    verdict: partial
    section: Neurovisceral phenotypes > Joint hypermobility > Association with psychiatric disorder
    quote: In disorders that typically involve impaired collagen (present in blood vessels) such as joint hypermobility
      and postural tachycardia syndrome it is likely that reduced venous return during standing due to venous pooling
      or denervation causing low plasma volume may be responsible for a an increased sympathetic state–as the body
      attempts to compensate for these abnormalities—resulting in orthostatic intolerance and associated symptoms
      (Bohora, 2010; Benarroch, 2012; Mathias et al., 2012).
    note: 'Found by winnow, kev and lev in p009, p011. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - neuropathic_evidence
  papers: 5
  evidence:
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: 'POTS and SFN are comorbid conditions, with both being highly prevalent in patients with Long COVID:
      an estimated 30–75% of patients with Long COVID have POTS [6,7], and nearly 70% have autonomic dysfunction
      [8]. The prevalence of SFN in Long COVID is unknown, but appears to be similarly high and close to 70% based
      on small studies [9,10].'
    note: 'Found by winnow, kev and lev in p005, p013. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction and background
    quote: SARS-CoV-2 can access multiple organ systems through the ACE-2 receptor [18]. Its pathophysiology is
      postulated to include virus- or immune-mediated damage to the autonomic nervous system.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: We suspect a neuropathic cause of POTS in our patient that may be secondary to a viral cause, due to
      his history of infection with COVID-19.
    note: 'Found by winnow, kev and lev in p005, p001, p015. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: INTRODUCTION
    quote: Because viral infection can host various chronic neurological conditions, such as Guillain-Barre syndrome,
      POTS can possibly occur as a post-COVID-19 autonomic nerve involvement.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: partial
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - physical_trauma_onset
  - associated_with
  - pots
  papers: 5
  evidence:
  - paper: pmid42369281
    cited: true
    text: full
    license: by
    verdict: partial
    section: Links between trauma and nervous system dysregulation and autonomic symptom burden
    quote: These associations certainly do not prove a cause-effect relationship between trauma and POTS, nor are
      we proponents of such a simplistic explanation. However, the associations support a model in which continued
      activation of survival circuits bias the brain toward maladaptive persistent sympathetic activation with failure
      to restore healthy parasympathetic (vagal) dominance.
    note: 'Found by winnow, kev and lev in p020, p035. Claude judged: partial.'
  - paper: pmid40694349
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: While concussion is the second leading trigger of pediatric postural orthostatic tachycardia syndrome
      (POTS),7 a chronic AD condition affecting approximately 1% of youths worldwide,8 the association of AD with
      concussion is poorly understood due to limited research and inconsistent AD definitions used across studies.9,10,11,12,13,14,15,16
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid35647216
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Background
    quote: Moreover, concussion was found to be the second most common trigger preceding POTS onset in a group of
      708 patients at a pediatric autonomic disorders clinic, second only to infection among the triggers assessed.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: 'Abstract > Summary of Key Points:'
    quote: Data recorded and entered into a database during clinic visits from a large pediatric institution indicate
      that 11.4% of individuals diagnosed with POTS report onset of symptoms within 3 months of sustaining a concussion.
    note: 'Found by winnow, kev and lev in p003, p012, p031. Claude judged: partial.'
  - paper: pmid20865679
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20865679. Found by winnow, kev and lev in p001, p002, p003. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - associated_with
  - small_fiber_neuropathy_dx
  papers: 5
  evidence:
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Pathophysiology of POTS > 4.1 Partial Sympathetic Neuropathy
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p015. Claude judged: supports.'
  - paper: pmid40271232
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: In POTS patients with neuropathic symptoms, skin nerve biopsy can show decreased intraepidermal nerve
      fiber density (NFD) indicative of small fiber neuropathy (SFN) [19,20].
    note: 'Found by winnow, kev and lev in p008, p036, p001. Claude judged: partial.'
  - paper: pmid37968647
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Small fiber neuropathy (SFN) has been suggested to be a possible mediator of POTS [16]. SFN can affect
      both autonomic and sensory fibers [17].
    note: 'Found by winnow, kev and lev in p004, p009. Claude judged: partial.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: These patients with evidence of autonomic SFN are likely to have a neuropathic subtype of POTS, though
      evidence of one subtype does not rule out the presence of other subtypes, given the heterogeneity of the disorder.
    note: 'Found by winnow, kev and lev in p004, p033, p037. Claude judged: partial.'
  - paper: pmid33764697
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Furthermore, in some patients with neuropathic POTS, intraepidermal nerve fiber density is decreased,
      providing objective support for a small fiber neuropathy in these POTS patients.
    note: 'Found by winnow, kev and lev in p007, p003. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - long_covid
  papers: 4
  evidence:
  - paper: pmid38510743
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Long Covid syndrome, neuro-cardiologic complications and prognosis
    quote: A long Covid syndrome may be clinically manifested with orthostatic hypotension, postural orthostatic
      tachycardia syndrome (POTS), syncope, chest pain, dyspnea, palpitation, chronic fatigue syndrome, ‘brain fog’,
      memory, cognitive and sleep difficulties, anosmia, headache, signs of impaired cardiac and cerebral perfusion,
      depression and anxiety [57,59,60]. A higher prevalence of psychiatric syndromes - post-traumatic stress disorder
      (PTSD) (28 %), depression (31 %), anxiety (42 %), insomnia (40 %), and obsessive-compulsive (OS) symptoms
      (20 %) was also reported [61].
    note: 'Found by winnow, kev and lev in p001, p026, p028. Claude judged: supports.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. COVID-19 Infection and Dysautonomia
    quote: Recent evidence showed the significant burden of fatigue, symptoms of autonomic dysfunction, and mood
      disorders in the aftermath of COVID-19 infection, but reassuringly did not demonstrate pathological findings
      during investigations for autonomic function [33]. Fatigue is linked to the higher prevalence of anxiety and
      post-traumatic stress disorder in COVID-19 survivors [23,27,33,54], while somatic anxiety in patients with
      chronic fatigue has been directly associated with autonomic nervous system dysfunction [55].
    note: 'Found by winnow, kev and lev in p013, p003. Claude judged: supports.'
  - paper: pmid39317338
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Abstract > Results
    quote: In comparison to the group without post COVID-19 long-term cardiovascular symptoms, the group with post
      COVID-19 long-term cardiovascular symptoms exhibited a significantly higher prevalence of anxiety and depression
      (25.0% vs. 4.6%, p = 0.000), as well as significantly elevated C-reactive protein (42.3 mg/L vs. 20.3 mg/L,
      p = 0.014) and D-dimer (0.3 mg/L vs. 0.22 mg/L, p = 0.024).
    note: 'Found by winnow, kev and lev in p003, p019, p023. Claude judged: partial.'
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Results
    quote: Many patients had psychiatric symptoms that required psychiatric intervention and selective serotonin
      reuptake inhibitor prescription.
    note: 'Found by winnow, kev and lev in p003. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - long_covid
  papers: 4
  evidence:
  - paper: pmid39301475
    cited: true
    text: full
    license: by
    verdict: supports
    section: Relationship to post-infectious syndromes including long COVID
    quote: In patients with LC and dysautonomia, there is often a hyperadrenergic state, which drives many of the
      pathophysiologic mechanisms of hyperadrenergic POTS (25).
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Autonomic Dysfunction and COVID‐19
    quote: The potential mechanisms are likely related to an imbalance between sympathetic and parasympathetic activity,
      as well as hemodynamic abnormalities such as reduced systemic venous return, augmented splanchnic and extremity
      pooling, decreased cardiac output, and decreased cerebral perfusion. This dysregulation manifests as a decrease
      in parasympathetic tone and an increase in sympathetic activity, particularly during postural changes from
      supine to upright positions.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid39076856
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. Symptoms and Pathologic Findings of Cardiovascular Disease in Post-Acute COVID-19 Syndrome > 5.2
      Pathologic Findings > 5.2.4 Postural Orthostatic Tachycardia Syndrome (POTS)
    quote: "Autonomic dysfunction in long COVID is provoked by the hyperadrenergic \nstate and the resetting of\
      \ baroreceptor control, which is stimulated by \nangiotensin II upregulation."
    note: 'Found by winnow, kev and lev in p043, p042. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: Although the exact pathophysiology mechanism is unclear, it is thought that the combination of autoimmunity,
      relative central hypovolemia, small fiber neuropathy, hyperadrenergic stimulation, and pro-inflammatory cytokine
      production (i.e., cytokine storm) is a critical factor in POTS and COVID-19 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - mast_cell_activation
  papers: 4
  evidence:
  - paper: pmid37255928
    cited: true
    text: full
    license: by
    verdict: partial
    section: Associations with mast cell activation disorders
    quote: A prominent overlapping symptom cluster associated with both POTS [56, 57] and Long Covid [89, 90] includes
      a multi-system and often non-specific symptom cluster which is often referred to as ‘mast cell activation
      syndrome’ (and considered to be due to release of mast cell mediators) and includes gastrointestinal disturbances
      (nausea, vomiting, diarrhoea, cramps), asthma like symptoms, flushing, urticaria, angioedema and constitutional
      symptoms such as fatigue and fever [91].
    note: 'Found by winnow, kev and lev in p026, p028. Claude judged: partial.'
  - paper: pmid36981522
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. Discussion
    quote: Afrin and colleagues have hypothesized that pre-existing MCAS might predispose patients to develop long-COVID
      after a SARS-CoV-2 infection by contributing to a hyperinflammatory response [35]. Our patient had not been
      diagnosed with MCAS prior to the acute infection but had a strong history of allergies, and his plasma histamine
      levels were elevated on several occasions, consistent with that diagnosis.
    note: 'Found by winnow, kev and lev in p023, p025, p034. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 5. How Does SARS-CoV-2 Infection Cause Long-Term Dysautonomia?
    quote: A case of mast cell activation syndrome was described in a 50-year-old female with previous COVID-19
      with signs and symptoms of POTS [52].
    note: 'Found by winnow, kev and lev in p028, p038. Claude judged: partial.'
  - paper: pmid33869099
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Learning Points
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33869099. Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - neuropathic_evidence
  papers: 4
  evidence:
  - paper: pmid38537312
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38537312. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid41089328
    cited: true
    text: full
    license: by
    verdict: partial
    section: Autoimmunity > Association with autonomic neuropathy
    quote: However, a non-length-dependent or patchy distribution of small fiber neuropathy can also occur, especially
      in conjunction with systemic autoimmune disorders (Gemignani et al., 2022). Autoimmune and immune-mediated
      etiologies have been suggested as among the major underlying mechanisms in autonomic neuropathy, with immunotherapy
      being recommended as the first-line treatment (Gavrilova et al., 2022; Maier et al., 2022; Gendre, 2024; Nakane
      et al., 2024).
    note: 'Found by winnow, kev and lev in p018, p001, p022. Claude judged: partial.'
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In this cohort, there was a trend toward higher rates of comorbid autoimmune disease among patients with
      evidence of SFN compared to patients without, though the difference was not statistically significant. Patients
      with systemic autoimmune diseases may be at slightly increased risk for developing a neuropathic POTS phenotype
      - for instance, Sjogren’s syndrome is diagnosed at higher rates among POTS patients who have reduced IENFD
      [26].
    note: 'Found by winnow, kev and lev in p037, p039. Claude judged: partial.'
  - paper: pmid28116654
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 28116654. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - associated_with
  - neuropathic_evidence
  papers: 4
  evidence:
  - paper: pmid42153984
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion > Comorbidities
    quote: An association between neuropathy and gastrointestinal and bladder symptoms bas been recognized in patients
      with POTS [25].
    note: 'Found by winnow, kev and lev in p048. Claude judged: supports.'
  - paper: pmid29549458
    cited: true
    text: full
    license: none
    verdict: supports
    section: Results > Postural Tachycardia Syndrome and Gastrointestinal Symptoms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29549458. Found by winnow, kev and lev in p011, p014, p024. Claude judged: supports.'
  - paper: pmid23708963
    cited: true
    text: full
    license: none
    verdict: supports
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23708963. Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid41858767
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Abstract
    quote: Bowel and skin biopsies from patients with gastrointestinal disorders have revealed neuropathic changes
      and altered connective tissue.
    note: 'Found by winnow, kev and lev in p004, p001. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - post_vaccination_onset
  papers: 4
  evidence:
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: The diagnosis of orthostatic intolerance is often preceded by a viral illness or vaccination [12,13,14,15,16].
      In the COVID-19 era, orthostatic intolerance was frequently encountered post SARS-CoV-2 infection and vaccination,
      providing further evidence of an autoimmune etiology [16,17].
    note: 'Found by winnow, kev and lev in p006, p034. Claude judged: supports.'
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: Several clinical observations suggest that autoimmune pathophysiology plays a role in POTS. These observations
      include disease onset following viral infections or vaccination, family history of systemic autoimmune disorders,
      and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Although the exact mechanism of vaccine-induced POTS is not clear, the autoimmune pathophysiology might
      be a key component [13-15].
    note: 'Found by winnow, kev and lev in p014, p004. Claude judged: partial.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p012, p005, p006. Claude judged: partial.'
- edge:
  - me_cfs
  - associated_with
  - postinfectious_evidence
  papers: 4
  evidence:
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: supports
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p021, p022. Claude judged: supports.'
  - paper: pmid38600563
    cited: true
    text: full
    license: by
    verdict: partial
    section: Background
    quote: Following acute SARS-CoV-2 infection, a subset of individuals continues to suffer from lingering symptoms
      very similar to those associated with ME/CFS. It has been estimated that about half of people presenting with
      long COVID at six months meet the case criteria for ME/CFS [7, 8].
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
  - paper: pmid33996867
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: We recently evaluated three adolescents and young adults in whom COVID-19 illness had been confirmed
      with direct testing or was highly suspected based on the timing of the onset of symptoms in association with
      peak local and regional pandemic cases, close exposure to confirmed cases, along with characteristic clinical
      features such as anosmia. In all three, ME/CFS symptoms were prominent from the outset, as were symptoms and
      signs of orthostatic intolerance, consistent with an early contribution of circulatory disturbances to the
      pathogenesis of symptoms, before the onset of physiological changes due to inactivity.
    note: 'Found by winnow, kev and lev in p004, p006, p013. Claude judged: partial.'
  - paper: pmid29391028
    cited: true
    text: full
    license: by
    verdict: partial
    section: Results > Case reports
    quote: Patient 1 was well until a viral gastrointestinal illness at age 12. Thereafter she reported progressive
      fatigue along with unrefreshing sleep, post-exertional malaise (PEM), problems with short-term memory and
      attention, headache, myalgias, arthralgias, sore throat, and tender glands, thus satisfying the clinical criteria
      for ME/CFS.
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
- edge:
  - endometriosis
  - associated_with
  - pots
  papers: 4
  evidence:
  - paper: pmid42787977
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Among 1,322 female POTS patients, 229 (17.3%) also carried a diagnosis of endometriosis.
    note: 'Found by winnow, kev and lev in p003, p004, p007. Claude judged: supports.'
  - paper: pmid42641290
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42641290. Found by winnow, kev and lev in p003, p004. Claude judged: supports.'
  - paper: pmid37234076
    cited: true
    text: full
    license: by
    verdict: supports
    section: 'Female reproductive health in illnesses comorbid or associated with Long COVID: A brief overview of
      myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), postural orthostatic tachycardia syndrome (POTS),
      Ehlers-Danlos syndrome (EDS), and endometriosis > Endometriosis'
    quote: Approximately 36% of women with ME/CFS (n = 36) and 20% of women with POTS (n = 65) report endometriosis
      (42, 48, 88).
    note: 'Found by winnow, kev and lev in p020, p026. Claude judged: supports.'
  - paper: pmid22721633
    cited: true
    text: full
    license: none
    verdict: supports
    section: 4. Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 22721633. Found by winnow, kev and lev in p019, p024. Claude judged: supports.'
- edge:
  - iron_deficiency
  - associated_with
  - pots
  papers: 4
  evidence:
  - paper: pmid32974246
    cited: true
    text: full
    license: by
    verdict: supports
    section: Perspectives on the Pathogenesis of Pots > Iron Insufficiency
    quote: Low ferritin and vitamin D levels have been found in adolescents with POTS (78). Low iron storage accompanied
      by mild anemia is more prevalent in pediatric POTS patients than in healthy children in the United States
      (79).
    note: 'Found by winnow, kev and lev in p017, p024. Claude judged: supports.'
  - paper: pmid23720007
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Interpretation
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23720007. Found by winnow, kev and lev in p003, p004, p001. Claude judged: supports.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Additional Associations
      and Postural Orthostatic Tachycardia Syndrome Mimickers > Iron Deficiency and Anemia
    quote: Whether iron deficiency is specifically related to POTS or serves as a mimicker via diminished venous
      return is still under review.[11]
    note: 'Found by winnow, kev and lev in p038. Claude judged: partial.'
  - paper: pmid21886073
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21886073. Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - sleep_disturbance
  papers: 4
  evidence:
  - paper: pmid42254140
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: Evidence suggests that during sleep, POTS patients can enter a hyperadrenergic state, disrupting normal
      autonomic regulation and perpetuating a vicious cycle of poor sleep and worsened daytime symptoms[4].
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid35303039
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Compared with a control group, the nocturnal catecholamine levels were increased in patients with insomnia
      [12].
    note: 'Found by winnow, kev and lev in p024, p006. Claude judged: partial.'
  - paper: pmid25474569
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Lastly, the possible explanation was that the sleep disturbance might relate with heightened sympathetic
      activation [36].
    note: 'Found by winnow, kev and lev in p028. Claude judged: partial.'
  - paper: pmid23538032
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION > Possible Mechanisms of Poor Sleep Quality
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23538032. Found by winnow, kev and lev in p039, p041, p004. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - hyperadrenergic_evidence
  papers: 3
  evidence:
  - paper: pmid40537187
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > AR autoantibody activity in patients with POTS
    quote: Previous studies have shown that patients with hyperadrenergic POTS exhibit increased AR autoantibodies
      activity, characterized by enhanced β1-AR and diminished α1-AR signaling.28
    note: 'Found by winnow, kev and lev in p025, p044, p004. Claude judged: supports.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: partial
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Nos casos de pacientes com SPOT que apresentam a síndrome de ativação dos mastócitos, um fator autoimune
      pode estar presente. Esses pacientes apresentam rubor da pele e hipertensão associada com a taquicardia ortostática.
    note: 'Found by winnow, kev and lev in p124. Claude judged: partial.'
  - paper: pmid29682372
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: This study entails specific antibodies, such as ganglionic acetylcholine receptor antibody [8] and alpha-1
      adrenergic receptor antibody that act as partial antagonists and induce reflex compensatory sympathetic activation
      [9].
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
- edge:
  - fibromyalgia
  - associated_with
  - hypermobility_heds
  papers: 3
  evidence:
  - paper: pmid25917768
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25917768. Found by winnow, kev and lev in p014, p003, p015. Claude judged: supports.'
  - paper: pmid42691689
    cited: true
    text: full
    license: none
    verdict: partial
    section: Autonomic system degenerations, generalized dysautonomia, and disorders of autonomic dysregulation
      > Postural orthostatic tachycardia syndrome
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42691689. Found by winnow, kev and lev in p044. Claude judged: partial.'
  - paper: pmid39582682
    cited: true
    text: full
    license: by
    verdict: partial
    section: Headache disorders in hEDS and HSD > Migraine
    quote: In patients who had both HSD/hEDS and fibromyalgia, migraine was reported in 63.8% and chronic migraine
      in 34.1% (18).
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - me_cfs
  papers: 3
  evidence:
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: Patients with hEDS demonstrated significantly elevated rates of comorbid conditions, particularly MCAS,
      POTS, and ME/CFS, which were also associated with increased likelihood of developing Long COVID.
    note: 'Found by winnow, kev and lev in p006, p011, p049. Claude judged: supports.'
  - paper: pmid40978926
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Third, JH and hEDS are risk factors for ME/CFS, and there is emerging evidence that hEDS is also a risk
      factor for TOS.
    note: 'Found by winnow, kev and lev in p030, p033. Claude judged: supports.'
  - paper: pmid24934205
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Discussion
    quote: Our finding of high levels of comorbidity, particularly CFS and EDS, is important as it might point towards
      an underlying overlapping mechanism.23–25 We believe that more work is needed to understand this spectrum
      of diseases and whether lessons could be learnt from one disease that could be applied to others.
    note: 'Found by winnow, kev and lev in p033. Claude judged: partial.'
- edge:
  - functional_neurological_disorder
  - associated_with
  - pots
  papers: 3
  evidence:
  - paper: pmid38953100
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: These concurrent symptoms lead patients to accumulate multiple comorbid disorders, including fibromyalgia,
      chronic fatigue syndrome, and postural orthostatic tachycardia syndrome.
    note: 'Found by winnow, kev and lev in p003, p025. Claude judged: supports.'
  - paper: pmid42804409
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 42804409. Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid37378164
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: A diagnosis of conversion disorder was presumed due to the rare seizure-like activity in POTS.
    note: 'Found by winnow, kev and lev in p006, p009. Claude judged: partial.'
- edge:
  - hormonal_transition_onset
  - associated_with
  - pots
  papers: 3
  evidence:
  - paper: pmid41753164
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Hormonal influence has been long recognized by the disorder predominantly affecting women of reproductive
      age, with frequent onset around menarche, exacerbation of symptoms before or during menses, and pregnancy
      being one of POTS triggers.
    note: 'Found by winnow, kev and lev in p001, p018. Claude judged: supports.'
  - paper: pmid36908200
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Results: > Initial POTS onset during pregnancy:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36908200. Found by winnow, kev and lev in p032, p030. Claude judged: partial.'
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pubertal Hormones as Potential Contributors to Vasovagal Syncope and Postural Orthostatic Tachycardia
      Syndrome
    quote: While it is certainly not possible to imply causality between these pubertal hormone changes and disorders
      of orthostatic tolerance in adolescents, the coincidental timing of these profound hormonal changes – many
      of which have marked cardiovascular effects - and the timing of onset of VVS and POTS, together with the observation
      that many youth “grow out” of their symptoms (Kizilbash et al., 2014), is suggestive of a link between pubertal
      hormone changes and susceptibility to syncope in females.
    note: 'Found by winnow, kev and lev in p005, p054, p001. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - gi_dysmotility
  papers: 2
  evidence:
  - paper: pmid39543811
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Key Results
    quote: In cluster 0, we demonstrated increased somatization (p <0.0001), anxiety (p <0.0001), depression (p
      <0.0001), PoTS prevalence (p = 0.003), autonomic symptoms (p <0.0001) and reduced quality of life (p <0.0001)
      compared to cluster 2.
    note: 'Found by winnow, kev and lev in p003, p005, p050. Claude judged: supports.'
  - paper: pmid41952073
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Extra‐intestinal comorbidities, including anxiety, chronic fatigue, migraines, and depression, were reported
      in over one‐third of POTS patients, occurring more frequently than gastrointestinal conditions. IBS is the
      most common DGBI affecting 25% of POTS patients.
    note: 'Found by winnow, kev and lev in p005, p032. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - gi_dysmotility
  papers: 2
  evidence:
  - paper: pmid34993884
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34993884. Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid33621398
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: In this study, we confirmed that GI symptom onset, POTS, dry eye only, and nausea and vomiting among
      upper GI dysfunctions were frequent in pediatric patients with AAD.
    note: 'Found by winnow, kev and lev in p024. Claude judged: supports.'
- edge:
  - anxiety_depression
  - associated_with
  - hyperadrenergic_evidence
  papers: 2
  evidence:
  - paper: pmid23580201
    cited: true
    text: full
    license: by
    verdict: supports
    section: DISCUSSION
    quote: Activation of the SNS has been associated with depression and patients with major depression are at an
      increased risk for heart disease (Musselman et al., 1998). Interestingly, a cardiac NE uptake deficiency,
      characterized by decreased clearance of NE in the heart, and decreased DHPG:NE ratios, like that seen in POTS,
      has been described in individuals with depression (Barton et al., 2007).
    note: 'Found by winnow, kev and lev in p003, p018. Claude judged: supports.'
  - paper: pmid40276022
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Discussion
    quote: What’s more, researchres confirmed that anxiety and depression could act on hypothalamic-pituitary-adrenocortical
      axis (HPA) and produce hyperactivity of the sympathetic nervous system (Remme, 1998). Studies have shown that
      depression and anxiety could increase sympathetic excitability, upregulated levels of catecholamine in the
      blood, and heart rate (Wang et al., 2018).
    note: 'Found by winnow, kev and lev in p007, p020. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - hypermobility_heds
  papers: 2
  evidence:
  - paper: pmid41446482
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A small category of POTS patients with co-existing Ehlers-Danlos syndrome type III (hypermobility type)
      also present with a spectrum of psychiatric illnesses comprising anxiety disorders, particularly panic disorders
      and agoraphobia [20].
    note: 'Found by winnow, kev and lev in p086, p003. Claude judged: partial.'
  - paper: pmid32295399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case
    quote: She had developed anxiety and depression secondary to the highly disabling headache. She had recently
      been diagnosed with hypermobile Ehlers Danlos Syndrome (hEDS).
    note: 'Found by winnow, kev and lev in p006. Claude judged: partial.'
- edge:
  - arrhythmia_differential
  - associated_with
  - long_covid
  papers: 2
  evidence:
  - paper: pmid40692561
    cited: true
    text: full
    license: by
    verdict: partial
    section: Methods and analysis > Design, selection/treatment of subjects, interventional methods, data analysis
      > Aims and objectives
    quote: The second aim is to determine the potential benefits of ivabradine treatment for those with LHC-associated
      POTS or IST.
    note: 'Found by winnow, kev and lev in p005, p001, p020. Claude judged: partial.'
  - paper: pmid35355961
    cited: true
    text: full
    license: by
    verdict: partial
    section: “Post-COVID-19 Tachycardia Syndrome”
    quote: It has been suggested that persistent tachycardia seen in long COVID, labelled “post-COVID-19 tachycardia
      syndrome,” may present as inappropriate sinus tachycardia or POTS (22).
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - long_covid
  papers: 2
  evidence:
  - paper: pmid40014480
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > Autonomic Dysfunction and COVID‐19
    quote: The potential mechanisms are likely related to an imbalance between sympathetic and parasympathetic activity,
      as well as hemodynamic abnormalities such as reduced systemic venous return, augmented splanchnic and extremity
      pooling, decreased cardiac output, and decreased cerebral perfusion.
    note: 'Found by winnow, kev and lev in p023. Claude judged: partial.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Interestingly, others have used various imaging techniques to evaluate neurocognitive dysfunction including
      F-Fluorodeoxyglucose positron emission tomography (F-FDG-PET), functional MRI, diffusion MRI, and SPECT in
      those with PASC27. They identified a high prevalence of functional imaging abnormalities in PASC with findings
      of cerebral hypoperfusion that correlated with functional decline27.
    note: 'Found by winnow, kev and lev in p011, p006, p015. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - long_covid
  papers: 2
  evidence:
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Patients with hEDS were more likely to be diagnosed with Long COVID compared to similar patients without
      hEDS. This was especially true for those who also had conditions such as chronic fatigue, immune conditions,
      or issues with heart rate and blood pressure regulation.
    note: 'Found by winnow, kev and lev in p006, p011, p045. Claude judged: supports.'
  - paper: pmid40624434
    cited: true
    text: full
    license: by
    verdict: supports
    section: Clinical features and evaluation of dysautonomia
    quote: Assessment for joint hypermobility with the Beighton scale is warranted in patients with dysautonomia
      to identify hypermobility spectrum disorders (HSD) and hypermobile Ehlers-Danlos syndrome (EDS), which are
      highly prevalent in patients with POTS, post-COVID dysautonomia and other forms of dysautonomia [22].
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
- edge:
  - hypovolemic_evidence
  - associated_with
  - long_covid
  papers: 2
  evidence:
  - paper: pmid38240001
    cited: true
    text: full
    license: by
    verdict: partial
    section: INTRODUCTION
    quote: Factors contributing to the development of POTS after COVID‐19 infection are hypovolemia, neurotropism,
      inflammation, and autoimmunity.
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid37435242
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In the majority of patients, intravascular volume is reduced, thus leading to decreased venous return
      to the heart and causing reflex tachycardia and orthostatic intolerance. Patients who have been on prolonged
      bed rest or are in a deconditioned state are likely to develop decreased blood volume [5].
    note: 'Found by winnow, kev and lev in p001, p004, p005. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - mast_cell_activation
  papers: 2
  evidence:
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: 6. Discussion
    quote: Another hypothesized mechanism, seemingly congruent with an observed non-trivial frequency with which
      MCAS and some associated comorbidities seem to drive the humoral immune system to erroneously produce unneeded
      antibodies [66,69,70,71,72,73,74,75,76], might be MCAS-induced production of autoantibodies driving vasodilation
      via direct or indirect action upon the vascular endothelium.
    note: 'Found by winnow, kev and lev in p020, p021. Claude judged: partial.'
  - paper: pmid33886735
    cited: true
    text: full
    license: by
    verdict: partial
    section: Síndrome Postural Ortostática Taquicardizante (SPOT)
    quote: Nos casos de pacientes com SPOT que apresentam a síndrome de ativação dos mastócitos, um fator autoimune
      pode estar presente.
    note: 'Found by winnow, kev and lev in p124. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - associated_with
  - mast_cell_activation
  papers: 2
  evidence:
  - paper: pmid40856938
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Mast cell activation syndrome (MCAS) is also a common comorbid condition in POTS, which induces abdominal
      cramping and bloating associated with enhanced secretion of histamine and inflammatory cytokines [1, 17].
    note: 'Found by winnow, kev and lev in p014. Claude judged: partial.'
  - paper: pmid29326369
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Background
    quote: Gastrointestinal (GI) symptoms are common in both syndromes.1–4 6 GI symptoms in MCAS can be explained
      by inappropriate release of mediators from mast cells (MCs) with KIT mutations whereas GI motility disorders
      in POTS may be due to active autoimmune muscarinic antibodies causing autonomic imbalance in some patients
      (S Vernino, personal communication, 2017).2
    note: 'Found by winnow, kev and lev in p002, p016, p019. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - neuropathic_evidence
  papers: 2
  evidence:
  - paper: pmid40843452
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Abstract > Conclusions
    quote: This study provided evidence of cerebrovascular dysregulation with reduced orthostatic cerebral blood
      flow velocity associated with symptoms of cerebral hypoperfusion, frequent small fiber neuropathy, and widespread
      but mild autonomic failure in hEDS.
    note: 'Found by winnow, kev and lev in p005, p047. Claude judged: supports.'
  - paper: pmid34055418
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: The association between POTS and JHS can be explained by predominant peripheral neuropathy in the autonomous
      system and a failure of the peripheral vascular system to maintain resistance in areas exposed to stress due
      to orthostasis, blood stasis in the lower limbs, or pathologies of the central nervous system [11].
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - associated_with
  - post_vaccination_onset
  papers: 2
  evidence:
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: There is evidence that HPV vaccinations can trigger mast cell activation syndromes [15]. This can explain
      the association of HPV-triggered POTS and the association of EDS type III.
    note: 'Found by winnow, kev and lev in p011. Claude judged: partial.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: We too have observed a number of such cases (all following vaccination with the Gardasil product), and
      have found several to have detectable mast cell activation syndrome (MCAS) as well as histories suggesting
      that MCAS was likely present long before vaccination.
    note: 'Found by winnow, kev and lev in p001, p007, p023. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid38510743
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Long Covid syndrome, neuro-cardiologic complications and prognosis
    quote: A long Covid syndrome may be clinically manifested with orthostatic hypotension, postural orthostatic
      tachycardia syndrome (POTS), syncope, chest pain, dyspnea, palpitation, chronic fatigue syndrome, ‘brain fog’,
      memory, cognitive and sleep difficulties, anosmia, headache, signs of impaired cardiac and cerebral perfusion,
      depression and anxiety [57,59,60]. A higher prevalence of psychiatric syndromes - post-traumatic stress disorder
      (PTSD) (28 %), depression (31 %), anxiety (42 %), insomnia (40 %), and obsessive-compulsive (OS) symptoms
      (20 %) was also reported [61].
    note: 'Found by winnow, kev and lev in p001, p026, p028. Claude judged: partial.'
  - paper: pmid34821709
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. COVID-19 Infection and Dysautonomia
    quote: Recent evidence showed the significant burden of fatigue, symptoms of autonomic dysfunction, and mood
      disorders in the aftermath of COVID-19 infection, but reassuringly did not demonstrate pathological findings
      during investigations for autonomic function [33]. Fatigue is linked to the higher prevalence of anxiety and
      post-traumatic stress disorder in COVID-19 survivors [23,27,33,54], while somatic anxiety in patients with
      chronic fatigue has been directly associated with autonomic nervous system dysfunction [55].
    note: 'Found by winnow, kev and lev in p013. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - associated_with
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Comorbid conditions commonly observed in hEDS, including MCAS, POTS, and ME/CFS, were significantly more
      prevalent in patients with hEDS with Long COVID than in those without.
    note: 'Found by winnow, kev and lev in p046, p045. Claude judged: partial.'
  - paper: pmid33869099
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Learning Points
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33869099. Found by winnow, kev and lev in p001, p002. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - associated_with
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: INTRODUCTION
    quote: Because viral infection can host various chronic neurological conditions, such as Guillain-Barre syndrome,
      POTS can possibly occur as a post-COVID-19 autonomic nerve involvement.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
  - paper: pmid36639608
    cited: true
    text: full
    license: none
    verdict: partial
    section: Major findings > ME/CFS, dysautonomia and related conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36639608. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - associated_with
  - postinfectious_evidence
  papers: 2
  evidence:
  - paper: pmid38173801
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: POTS and Functional Autoantibodies
    quote: These observations include disease onset following viral infections or vaccination, family history of
      systemic autoimmune disorders, and association with peripheral neuropathy of autoimmune origin.[2]
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports
    quote: Contemporary literature indicates potential links between viral infections and vaccines (particularly
      HPV) with the development of POTS.14,35,36
    note: 'Found by winnow, kev and lev in p021. Claude judged: partial.'
- edge:
  - arrhythmia_differential
  - associated_with
  - pots
  papers: 2
  evidence:
  - paper: pmid33654569
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Moreover, the presence of coexisting arrhythmia can make symptoms difficult to control. Assessing and
      treating POTS patients for underlying SVT can improve their POTS symptoms and, thus, their quality of life.7
      The purpose of this study was to bring forth the observation that SVT and POTS can occur together.
    note: 'Found by winnow, kev and lev in p002, p001, p007. Claude judged: supports.'
  - paper: pmid34035985
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Here, we present one of the first case series demonstrating a similar relationship between sinus node
      dysfunction and much rarer etiologies of tachyarrhythmia—that is, postural tachycardia syndrome and inappropriate
      sinus tachycardia.
    note: 'Found by winnow, kev and lev in p001, p016. Claude judged: partial.'
- edge:
  - surgery_onset
  - associated_with
  - pots
  papers: 2
  evidence:
  - paper: pmid41561794
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: A 39-year-old woman developed debilitating systemic symptoms following the placement of a synthetic mid-urethral
      sling for stress urinary incontinence. Previously in good health, she experienced sepsis and adrenal crisis
      immediately postoperatively, followed by persistent symptoms including fatigue, postural orthostatic tachycardia
      syndrome (POTS), neuropathic pain, cognitive dysfunction, autonomic instability, and recurrent infections.
    note: 'Found by winnow, kev and lev in p001, p015. Claude judged: partial.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract > Introduction
    quote: We report a case of postural tachycardia syndrome occurring after the surgical correction of an aortic
      coarctation, and coexisting with upper airway resistance syndrome.
    note: 'Found by winnow, kev and lev in p004, p001, p003. Claude judged: partial.'
- edge:
  - deconditioning_evidence
  - associated_with
  - prolonged_bed_rest
  papers: 2
  evidence:
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p030. Claude judged: partial.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: partial
    section: 4. Pathophysiology of POTS > 4.8 Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - sleep_disturbance
  papers: 2
  evidence:
  - paper: pmid40648966
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Both patients with MDD and anxiety presented at older age, were less sleepy, and reported more frequently
      disrupted sleep than their non-affected counterparts.
    note: 'Found by winnow, kev and lev in p016, p019, p020. Claude judged: partial.'
  - paper: pmid28442939
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: Insomnia has been linked with increased rates of depression,19 and approximately 50% of people with invisible
      illness suffer from depression,20 one of the greatest risk factors for suicide.
    note: 'Found by winnow, kev and lev in p004, p007. Claude judged: partial.'
- edge:
  - neuropathic_evidence
  - associated_with
  - systemic_autoimmune_disease
  papers: 2
  evidence:
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patients with systemic autoimmune diseases may be at slightly increased risk for developing a neuropathic
      POTS phenotype - for instance, Sjogren’s syndrome is diagnosed at higher rates among POTS patients who have
      reduced IENFD [26].
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: Postural orthostatic tachycardia syndrome has also been reported in association with Sjögren's syndrome
      and celiac disease, both of which are known to cause autonomic neuropathies.73,74
    note: 'Found by winnow, kev and lev in p031. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - cerebral_hypoperfusion_evidence
  papers: 1
  evidence:
  - paper: pmid30883381
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Comments > Differential diagnosis of hemodynamic orthostatic dizziness/vertigo
    quote: However, a positive screen for anxiety or depression does not rule out a hemodynamic or other causes
      of symptoms as psychiatric disorders often co-exist with medical morbidity.
    note: 'Found by winnow, kev and lev in p038. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - endometriosis
  papers: 1
  evidence:
  - paper: pmid42787977
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Much like POTS, endometriosis exerts a substantial toll on both quality of life and psychological well-being.
      Affected individuals frequently experience anxiety, depression, fatigue, and limitations in social and occupational
      activities [9,10].
    note: 'Found by winnow, kev and lev in p030, p004, p006. Claude judged: supports.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - fibromyalgia
  papers: 1
  evidence:
  - paper: pmid41602336
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Patients with chronic fatigue, POTS, and fibromyalgia experience decreased blood flow to the brain (9,
      11, 17, 18) and therefore vascularly linked.
    note: 'Found by winnow, kev and lev in p025. Claude judged: supports.'
- edge:
  - chronic_migraine
  - associated_with
  - fibromyalgia
  papers: 1
  evidence:
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: Fibromyalgia was diagnosed in between 22 and 40% of migraine [8]. Patients who suffered from both migraine
      and fibromyalgia were older, and reported incapacitating headaches, more insomnia and mental stress, and lower
      quality of life [8].
    note: 'Found by winnow, kev and lev in p001, p010, p002. Claude judged: supports.'
- edge:
  - deconditioning_evidence
  - associated_with
  - fibromyalgia
  papers: 1
  evidence:
  - paper: pmid23862007
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: Deconditioning of the muscles, consequence of pain related physical inactivity, is assumed to lead to
      autonomic dysfunction in fibromyalgia [3].
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - functional_neurological_disorder
  papers: 1
  evidence:
  - paper: pmid38953100
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: FND and comorbid conditions and the autonomic nervous system > Autonomic nervous system in psychiatric
      symptoms and disorders
    quote: Psychiatric symptoms and disorders are often co-occurrent with FND and considered risk factors [118].
      Psychiatric disorders have characteristic autonomic patterns.
    note: 'Found by winnow, kev and lev in p009, p042. Claude judged: partial.'
- edge:
  - deconditioning_evidence
  - associated_with
  - gi_dysmotility
  papers: 1
  evidence:
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p027, p003, p022. Claude judged: supports.'
- edge:
  - fibromyalgia
  - associated_with
  - gi_dysmotility
  papers: 1
  evidence:
  - paper: pmid39543811
    cited: true
    text: full
    license: by
    verdict: partial
    section: RESULTS > Downstream statistical analysis > Somatization—PHQ‐12 scores (Tables 5 and 6)
    quote: Patients with overlap hEDS/HSD + IBS had significantly higher median PHQ‐12 scores than hEDS/HSD alone
      (p <0.01). This cluster had significantly more fibromyalgia pain type symptoms such as back pain, pains in
      the arms/legs/joints and headaches versus hEDS/HSD alone (p ≤ 0.05) (D1 and D2).
    note: 'Found by winnow, kev and lev in p032. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - hormonal_transition_onset
  papers: 1
  evidence:
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pubertal Hormones as Potential Contributors to Vasovagal Syncope and Postural Orthostatic Tachycardia
      Syndrome
    quote: It is conceivable that pubertal increases in these hormones, many of which have secondary actions to
      promote vasodilatation, impair vasoconstriction, decrease blood volume, promote hypocapnia and cerebral hypoperfusion,
      and contribute to excessive tachycardia, unmask a susceptibility to disorders of orthostatic intolerance in
      girls with a previously unknown predisposition to poor orthostatic tolerance.
    note: 'Found by winnow, kev and lev in p054. Claude judged: partial.'
- edge:
  - chronic_migraine
  - associated_with
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid38912309
    cited: true
    text: full
    license: by
    verdict: partial
    section: Theoretical and auto/biographical review > Recovery and expectations
    quote: '‘A frequently described comorbidity in POTS patients is migraine, as well as other chronic headache
      types’ (Bryarly et al., 2019: 1216); ‘Intractable migraines often lead to physical inactivity, which may exacerbate
      orthostatic intolerance, and conversely, the increased sympathetic activity associated with POTS may contribute
      to increased frequency of headaches’ (Bryarly et al., 2019).'
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
- edge:
  - deconditioning_evidence
  - associated_with
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid33860871
    cited: true
    text: full
    license: none
    verdict: partial
    section: Results > Representative cases > Postural tachycardia syndrome > Patient 1
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33860871. Found by winnow, kev and lev in p026, p040, p041. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - hypermobility_heds
  papers: 1
  evidence:
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Others have shown that those with joint hypermobility and myalgic encephalomyelitis had more pronounced
      reduction in CBF on transcranial doppler during orthostatic stress than those without joint hypermobility28.
      In our study, hEDS was similarly associated with higher rates of abnormal CBF on SPECT, highlighting the need
      for further investigations into the interrelated effects of these disorders and neurocognitive impairment.
    note: 'Found by winnow, kev and lev in p012, p006, p015. Claude judged: supports.'
- edge:
  - deconditioning_evidence
  - associated_with
  - hypermobility_heds
  papers: 1
  evidence:
  - paper: pmid34331416
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34331416. Found by winnow, kev and lev in p001, p013. Claude judged: supports.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid41602336
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Decreased cerebral blood flow has been correlated with brain fog symptoms, and what has been regarded
      as autonomic nervous system dysfunction could relate to functional hypovolemia because of venous pooling in
      the pelvis leading to decreased cardiac venous return and resulting diminished cerebral perfusion as described
      by Edgell et al. (15).
    note: 'Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - gi_dysmotility
  - associated_with
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid25483980
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25483980. Found by winnow, kev and lev in p025. Claude judged: partial.'
- edge:
  - hormonal_transition_onset
  - associated_with
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid31798399
    cited: true
    text: full
    license: by
    verdict: partial
    section: Pubertal Hormones as Potential Contributors to Vasovagal Syncope and Postural Orthostatic Tachycardia
      Syndrome
    quote: It is conceivable that pubertal increases in these hormones, many of which have secondary actions to
      promote vasodilatation, impair vasoconstriction, decrease blood volume, promote hypocapnia and cerebral hypoperfusion,
      and contribute to excessive tachycardia, unmask a susceptibility to disorders of orthostatic intolerance in
      girls with a previously unknown predisposition to poor orthostatic tolerance.
    note: 'Found by winnow, kev and lev in p054. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid40601666
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1 Introduction
    quote: In addition, hypovolemia is closely associated with sympathetic nervous system (SNS) activation, which
      exacerbates the symptoms of tachycardia [9].
    note: 'Found by winnow, kev and lev in p003. Claude judged: supports.'
- edge:
  - deconditioning_evidence
  - associated_with
  - long_covid
  papers: 1
  evidence:
  - paper: pmid34265539
    cited: true
    text: full
    license: none
    verdict: partial
    section: Potential mechanisms of autonomic impairment in post-acute COVID syndrome > Deconditioning
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34265539. Found by winnow, kev and lev in p030. Claude judged: partial.'
- edge:
  - anxiety_depression
  - associated_with
  - mast_cell_activation
  papers: 1
  evidence:
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: This syndrome is associated with various neurologic and psychiatric disorders, including headache, dysautonomia,
      depression, generalized anxiety disorder, and many others.
    note: 'Found by winnow, kev and lev in p001, p012, p016. Claude judged: supports.'
- edge:
  - chronic_migraine
  - associated_with
  - mast_cell_activation
  papers: 1
  evidence:
  - paper: pmid38003876
    cited: true
    text: full
    license: by
    verdict: supports
    section: 5. Mast Cells
    quote: This MC-mediated pathway is thought to be one of the mechanisms underlying migraine pain pathophysiology,
      and migraine is one of the most common comorbidities noted in patients with MCAS [26].
    note: 'Found by winnow, kev and lev in p018. Claude judged: supports.'
- edge:
  - endometriosis
  - associated_with
  - mast_cell_activation
  papers: 1
  evidence:
  - paper: pmid37241210
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is often associated with various other syndromes
      or conditions including mast cell activation (MCA), dysmenorrhea and endometriosis, postural tachycardia (POTS)
      and small fiber neuropathy (SFN). The causes of these syndromes and the reason for their frequent association
      are not yet fully understood.
    note: 'Found by winnow, kev and lev in p001, p003, p004. Claude judged: partial.'
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - me_cfs
  papers: 1
  evidence:
  - paper: pmid32140630
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: The main finding of this study is that extracranial Doppler imaging demonstrates a significant reduction
      in cerebral blood flow during head-up tilt test in ME/CFS patients compared to healthy controls.
    note: 'Found by winnow, kev and lev in p073, p078, p084. Claude judged: supports.'
- edge:
  - differential_syncope_oh
  - associated_with
  - me_cfs
  papers: 1
  evidence:
  - paper: pmid35056406
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: Our study report on 429 ME/CFS patients shows that differences in hemodynamic outcomes as for instance
      hypotension or POTS can be present in ME/CFS patients with a high incidence of orthostatic intolerance [7].
    note: 'Found by winnow, kev and lev in p001, p015, p018. Claude judged: partial.'
- edge:
  - fibromyalgia
  - associated_with
  - me_cfs
  papers: 1
  evidence:
  - paper: pmid40890788
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: This hypothesis is supported by previous studies suggesting that sustained focus on changing bodily sensations
      enabled patients to effectively utilize mindfulness-related skills, re-establishing sensorimotor integration
      and facilitating non-judgmental reconnection with bodily sensations, which leads to improvements in physical
      and psychological symptoms, functionality, and quality of life for patients with fibromyalgia [24, 25], a
      common comorbidity of ME/CFS.
    note: 'Found by winnow, kev and lev in p015. Claude judged: supports.'
- edge:
  - mast_cell_activation
  - associated_with
  - me_cfs
  papers: 1
  evidence:
  - paper: pmid41300853
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: 'Conclusions: MCA appears to be a frequent and clinically relevant comorbidity in ME/CFS and is associated
      with a higher prevalence of OI, particularly POTS.'
    note: 'Found by winnow, kev and lev in p001, p018, p020. Claude judged: supports.'
- edge:
  - hypermobility_heds
  - associated_with
  - neurodevelopmental_disorder
  papers: 1
  evidence:
  - paper: pmid41686757
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 41686757. Found by winnow, kev and lev in p001. Claude judged: supports.'
- edge:
  - hypovolemic_evidence
  - associated_with
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid33490373
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Patient's with postural tachycardia syndrome have peripheral autonomic dysfunction. A subset of patients
      with POTS has low levels of standing plasma renin activity, aldosterone, and blood volume as compared to normovolemic
      patients [10].
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
- edge:
  - me_cfs
  - associated_with
  - neuropathic_evidence
  papers: 1
  evidence:
  - paper: pmid37968647
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Both patients with post-COVID-19 condition and ME/CFS could develop these types of neuropathies [20–22].
    note: 'Found by winnow, kev and lev in p009. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - physical_trauma_onset
  papers: 1
  evidence:
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: COMORBIDITIES OF POTS AFFECTING EXERCISE TOLERANCE
    quote: The correlation between POTS and hereditary connective tissue disorders is particularly important in
      the postconcussion population as development of craniocervical instability, craniocervical dyskinesia, and
      Chiari brainstem compression requires critical medical attention and can be primarily related to concussion
      or whiplash injuries as well as hypermobile Ehlers-Danlos syndrome.71,72
    note: 'Found by winnow, kev and lev in p030. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - post_vaccination_onset
  papers: 1
  evidence:
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: Here, we recommend additional research and vigilance to identify potential associations with patients
      with hEDS developing POTS after HPV vaccination.
    note: 'Found by winnow, kev and lev in p017, p001, p006. Claude judged: partial.'
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: Although the exact pathophysiology mechanism is unclear, it is thought that the combination of autoimmunity,
      relative central hypovolemia, small fiber neuropathy, hyperadrenergic stimulation, and pro-inflammatory cytokine
      production (i.e., cytokine storm) is a critical factor in POTS and COVID-19 infection.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - associated_with
  - postinfectious_evidence
  papers: 1
  evidence:
  - paper: pmid41282714
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Patients with hEDS were more likely to be diagnosed with Long COVID compared to similar patients without
      hEDS. This was especially true for those who also had conditions such as chronic fatigue, immune conditions,
      or issues with heart rate and blood pressure regulation.
    note: 'Found by winnow, kev and lev in p006, p045, p046. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - associated_with
  - pots
  papers: 1
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p059, p051. Claude judged: partial.'
- edge:
  - secondary_sinus_tachycardia
  - associated_with
  - pots
  papers: 1
  evidence:
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: It is still unclear if this is due to a high prevalence of anxiety as a coexisting condition in patients
      with POTS or if there is just an overlap of symptoms between the two conditions [49].
    note: 'Found by winnow, kev and lev in p045, p049. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - associated_with
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid38537312
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38537312. Found by winnow, kev and lev in p003, p004. Claude judged: partial.'
- edge:
  - long_covid
  - associated_with
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: Here, we present a case of a patient with IT and post-COVID POTS and SFN who experienced significant
      improvement of IT after receiving intravenous saline, suggesting that IT may be a symptom of POTS and SFN.
    note: 'Found by winnow, kev and lev in p005, p002, p003. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - associated_with
  - small_fiber_neuropathy_dx
  papers: 1
  evidence:
  - paper: pmid39852767
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Case Presentation
    quote: However, an autoimmune basis of post-COVID POTS was evident given a positive ANA, comorbid SFN, and post-infectious
      onset of symptomatology.
    note: 'Found by winnow, kev and lev in p005, p007. Claude judged: partial.'
- edge:
  - sleep_disturbance
  - associated_with
  - surgery_onset
  papers: 1
  evidence:
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: To the best of our knowledge, this is the first reported case of POTS arising after this type of surgery.
      Additionally, a coexisting sleep-related breathing disorder characterized as upper airway resistance syndrome
      (UARS) was diagnosed by an extensive sleep study.
    note: 'Found by winnow, kev and lev in p004. Claude judged: partial.'
- edge:
  - chronic_migraine
  - associated_with
  - systemic_autoimmune_disease
  papers: 1
  evidence:
  - paper: pmid42299385
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Discussion
    quote: Each of these manifestations has been described separately along with SS (8-10). In a study of 16 SS
      patients, 13 presented with a history of migraine (3).
    note: 'Found by winnow, kev and lev in p007, p003, p012. Claude judged: supports.'
- edge:
  - small_fiber_neuropathy_dx
  - associated_with
  - systemic_autoimmune_disease
  papers: 1
  evidence:
  - paper: pmid36349067
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: In this cohort, there was a trend toward higher rates of comorbid autoimmune disease among patients with
      evidence of SFN compared to patients without, though the difference was not statistically significant.
    note: 'Found by winnow, kev and lev in p037. Claude judged: partial.'
- edge:
  - postinfectious_evidence
  - trigger_of
  - pots
  papers: 30
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Infectious illnesses are well-recognized POTS triggers, with up to 40% of COVID-unrelated POTS cases
      reporting a post-infectious symptom onset (e.g., following Epstein–Barr virus, Mycoplasma pneumoniae, influenza,
      or other upper respiratory infections) [20, 48].
    note: 'Found by winnow, kev and lev in p003, p036, p041. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: POTS can be triggered by diverse initiating events, often making its exact initiating event challenging
      to pinpoint. Commonly, POTS is preceded by a viral infection, which can disrupt the autonomic nervous system’s
      functioning.
    note: 'Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid40533427
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: Infection was the most frequent trigger of POTS symptom onset (197 people, 39.4%), including 163 with
      POTS secondary to severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infections (32.6%) (Box).
    note: 'Found by winnow, kev and lev in p003, p009. Claude judged: supports.'
  - paper: pmid39875497
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Participant characteristics
    quote: A discernible trigger with temporal proximity to POTS symptom onset was found in 71% of the cohort. SARS-CoV-2
      infection was the most common of these (29%) followed by infections other than COVID-19 (20%), and trauma/concussion
      (13%).
    note: 'Found by winnow, kev and lev in p002, p005. Claude judged: supports.'
  - paper: pmid39838139
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: Hence POTS, a syndrome most commonly triggered by viral infections, also associated with cognitive difficulties
      and highly prevalent among patients with LC, becomes a suitable option to achieve this objective.
    note: 'Found by winnow, kev and lev in p006, p044. Claude judged: supports.'
  - paper: pmid39678714
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: Researchers suggest that COVID-19 can trigger POTS, as a significant amount of patients who recover from
      COVID-19 are now showing POTS-like symptoms such as brain fog, tachycardia (elevated HR), and severe chronic
      fatigue.9
    note: 'Found by winnow, kev and lev in p007, p008. Claude judged: supports.'
  - paper: pmid39552985
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) often manifests following an acute infection.
    note: 'Found by winnow, kev and lev in p001, p005, p028. Claude judged: supports.'
  - paper: pmid38958137
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: RESULTS
    quote: The median age of onset of POTS symptoms was 13 (IQR 11–14) years, with over half of patients reporting
      onset within 3 months of a specific event (Table 3), such as infection (45.6%), concussion (22.8%), pubertal
      changes (7.0%), surgery (12.3%), growth spurt (6.1%), physical trauma/fracture (2.6%), or extreme stress or
      emotional trauma (1.8%) (Figure 4).
    note: 'Found by winnow, kev and lev in p024, p035. Claude judged: supports.'
  - paper: pmid38390594
    cited: true
    text: full
    license: by
    verdict: supports
    section: Dysautonomia and small-fiber neuropathy often occur as a complication of certain infections
    quote: Approximately half of patients with POTS report symptoms of a preceding infection (3). Infectious causes
      of POTS include EBV, herpes viruses, flavivirus, enterovirus 71, retroviruses (HIV), and SARS-CoV-2 (7).
    note: 'Found by winnow, kev and lev in p002, p007. Claude judged: supports.'
  - paper: pmid37822957
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Up to 50% of patients with POTS describe a viral infection as the trigger of their symptoms.
    note: 'Found by winnow, kev and lev in p005, p006. Claude judged: supports.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'Discussion > Central Illustration > COVID-19: a Trigger for Dysautonomia?'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p025. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction > Clinical Features
    quote: Antecedent illness with viral infections of the upper respiratory and gastrointestinal tracts have been
      reported prior to onset of POTS.2,14,15 Offending organisms identified include Epstein-Barr virus, Influenza
      and Borrelia burgdorferi.16
    note: 'Found by winnow, kev and lev in p010, p020, p021. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusions
    quote: POTS is a rare dysautonomia that has been increasing in prevalence in the United States, and one of the
      causes of POTS may be post-viral neuropathy.
    note: 'Found by winnow, kev and lev in p001, p008, p020. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p008, p010, p012. Claude judged: supports.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: A range of diseases, including viral or bacterial infections, can cause POTS. Because an increasing number
      of patients who recovered from COVID-19 are now reporting POTS-like symptoms including brain fog, tachycardia
      and severe chronic fatigue, some experts believe coronavirus may be a trigger for POTS.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid34993433
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > POTS onset and symptoms
    quote: 'More male than female patients experienced POTS onset within 3 months after a specific event (46.1%
      vs 40.9%, P = 0.02). The most common event preceding POTS onset was an infection (female patients: 42.1% vs
      male patients: 37.6%, P = 0.2).'
    note: 'Found by winnow, kev and lev in p020, p031. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: While the pathogenesis of PTS is heterogeneous, infection is a well-characterized trigger of PTS, with
      28% reporting PTS onset following a viral prodrome.
    note: 'Found by winnow, kev and lev in p004, p002, p005. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: POTS is known to be triggered by viral and bacterial infections, such as influenza and Epstein-Barr virus.12
      In addition, there are case reports of individuals developing symptoms of and fulfilling the diagnostic criteria
      for POTS 6 to 8 months following recovery from COVID-19 infection.13
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Epidemiology & natural history
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p001, p008. Claude judged: supports.'
  - paper: pmid33786700
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33786700. Found by winnow, kev and lev in p016, p004, p006. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Although the mechanisms for the development of POTS are not well-understood, patients with POTS often
      report experiencing a trigger such as a viral illness, electrical injury, lightning injury, gastric bypass
      surgery, or traumatic brain injury weeks to months prior to the onset of symptoms.5–7
    note: 'Found by winnow, kev and lev in p001, p005, p011. Claude judged: supports.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p010, p009. Claude judged: supports.'
  - paper: pmid29343965
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: The onset of POTS symptoms may be gradual and can be triggered by an infective illness.
    note: 'Found by winnow, kev and lev in p002, p010. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Typical Presentations of POTS > Triggering Conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p035, p037. Claude judged: supports.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: partial.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Postural Orthostatic Tachycardia Syndrome
    quote: There is strong evidence that SARS-CoV-2 may trigger POTS in patients with prolonged COVID-19 syndrome.
    note: 'Found by winnow, kev and lev in p061. Claude judged: partial.'
  - paper: pmid36575713
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36575713. Found by winnow, kev and lev in p003. Claude judged: partial.'
  - paper: pmid35056336
    cited: true
    text: full
    license: by
    verdict: partial
    section: 4. Discussion
    quote: In the present study, in the long-haul COVID-19 patients with POTS, the orthostatic intolerance/POTS
      complaints began early after the start of the viral infection symptoms (1–3 weeks), consistent with other
      published case reports [5,7,9,56].
    note: 'Found by winnow, kev and lev in p001, p031, p028. Claude judged: partial.'
  - paper: pmid34053992
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: We herein report a 25-year-old woman who developed new-onset postural orthostatic tachycardia syndrome
      (POTS) following COVID-19 infection without pneumonia. Three weeks after being diagnosed with COVID-19, she
      began experiencing fatigue, feeing unwell, intermittent palpitation, dyspnea and chest pain, especially while
      getting up from the sitting position.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
  - paper: pmid32848537
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: A higher proportion of POTS patients reported symptoms of antecedent infections in our group of adolescents
      (60%) than previously described for adults (35%) (Kimpinski et al., 2012).
    note: 'Found by winnow, kev and lev in p039. Claude judged: partial.'
- edge:
  - post_vaccination_onset
  - trigger_of
  - pots
  papers: 25
  evidence:
  - paper: pmid39538129
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Results > Clinical management
    quote: Several case reports and case series have illustrated the clinical manifestations and management of POTS
      following COVID-19 vaccination. Sanada et al. (2022) presented a 13-year-old male who developed myocarditis
      and POTS after receiving the second dose of the Pfizer-BioNTech vaccine, initially presenting with severe
      fatigue, headache, and sleep disturbances.
    note: 'Found by winnow, kev and lev in p021, p022, p023. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Not only does contracting SARS-CoV-2 infection confer the possibility of developing long COVID and subsequent
      development of POTS, but recipients of the SARS-CoV-2 vaccine have also been shown to develop POTS at a higher
      rate. The proposed explanation is that an immunological response was elicited by the administration of the
      vaccination, resulting in similar symptoms to long COVID.
    note: 'Found by winnow, kev and lev in p029, p034. Claude judged: supports.'
  - paper: pmid37650075
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Abstract > Discussion
    quote: The temporal association of POTS with the COVID-19 vaccination in a previously healthy patient and the
      lack of evidence of an alternative aetiology suggests COVID-19 vaccination is the potential cause of POTS
      in this patient. To our knowledge, this is the first case reporting severe, long-term, and treatment-refractory
      POTS following COVID-19 vaccination with mRNA1273.
    note: 'Found by winnow, kev and lev in p002, p003, p005. Claude judged: supports.'
  - paper: pmid36732397
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36732397. Found by winnow, kev and lev in p004, p005. Claude judged: supports.'
  - paper: pmid36530759
    cited: true
    text: full
    license: none
    verdict: supports
    section: From the editor
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36530759. Found by winnow, kev and lev in p001, p003, p010. Claude judged: supports.'
  - paper: pmid36475233
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: In this report, we present a case of myocarditis and POTS occurring in a 13-year-old male following COVID-19
      mRNA vaccination.
    note: 'Found by winnow, kev and lev in p002, p001, p006. Claude judged: supports.'
  - paper: pmid35891154
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Discussion
    quote: POTS has been reported post vaccination, such as for human papillomavirus vaccination and COVID-19 vaccination
      [21,22,23].
    note: 'Found by winnow, kev and lev in p001, p008, p010. Claude judged: supports.'
  - paper: pmid35725868
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35725868. Found by winnow, kev and lev in p001, p002, p006. Claude judged: supports.'
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: New-onset POTS was judged as “definitely associated” and was increased by the HPV vaccines (3675 vs.
      3352, RR 1.08 (95% CI 1.01 to 1.15), NNH 144, p = 0.03, I2 = 29%) [16].
    note: 'Found by winnow, kev and lev in p021, p001, p002. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: It is postulated that disruption of the body’s autonomic nervous system in POTS has potential triggers
      from viral infections and vaccines. De novo POTS is noted in a number of cases post-vaccination of HPV.
    note: 'Found by winnow, kev and lev in p001, p005, p008. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Discussion
    quote: Case reports have documented adolescent girls developing symptoms of orthostatic intolerance and excessive
      tachycardia consistent with POTS in the days and weeks following Gardasil immunization [10,11].
    note: 'Found by winnow, kev and lev in p006, p009, p010. Claude judged: partial.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: While the vaccine has been shown to have numerous benefits in preventing severe illness from COVID-19,
      some patients have reported experiencing symptoms similar to Long-COVID after vaccination, including OI and
      POTS. In our study, two patients developed orthostatic symptoms following COVID-19 vaccination, and it is
      crucial to continue monitoring these individuals to assess the long-term effects of the vaccine on autonomic
      function.
    note: 'Found by winnow, kev and lev in p035. Claude judged: partial.'
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Secondary Postural Orthostatic Tachycardia Syndrome and Associated Disorders > Additional Associations
      and Postural Orthostatic Tachycardia Syndrome Mimickers > Human Papilloma Virus and COVID-19 Vaccination
    quote: Similarly, Kwan et al. reported increased odds of a new POTS diagnosis after COVID-19 vaccination in
      a cohort of 284,592 patients within 90 days of vaccination.[35] POTS-associated diagnoses were 1.52-fold more
      likely after than before COVID-19 vaccination, although significantly less likely than in individuals infected
      with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    note: 'Found by winnow, kev and lev in p041. Claude judged: partial.'
  - paper: pmid39109119
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: This case presentation highlights a possible association between dTdap booster vaccination and the subsequent
      development of POTS in a 40-year-old female patient. The temporal relationship between vaccination and symptom
      onset, confirmed diagnosis via tilt table testing, absence of alternative etiologies, and concordance with
      typical POTS demographics strengthen the argument for a vaccine-adverse event (VAE).
    note: 'Found by winnow, kev and lev in p001, p004, p012. Claude judged: partial.'
  - paper: pmid38176772
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38176772. Found by winnow, kev and lev in p002, p006, p008. Claude judged: partial.'
  - paper: pmid37303827
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37303827. Found by winnow, kev and lev in p001, p002, p005. Claude judged: partial.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: 'Abstract > RESULTS:'
    quote: Additionally, it seems that POTS-like symptoms could be triggered after immunization with Pfizer- BioNTech,
      Moderna, and Oxford-AstraZeneca COVID-19 vaccines.
    note: 'Found by winnow, kev and lev in p016, p026, p004. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: However, there have been a few case reports published in peer-reviewed journals that show patients affected
      with POTS after receiving mRNA COVID-19 vaccination. The exact mechanism of action is not known at this time,
      but an autoimmune response to vaccination is one of the possible mechanisms.
    note: 'Found by winnow, kev and lev in p051. Claude judged: partial.'
  - paper: pmid36852364
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: We present a case of a 15-year-old South Asian male who developed suspected postural orthostatic tachycardia
      syndrome (POTS) two weeks after receiving the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine
      booster, which was successfully managed with low-dose fludrocortisone and ivabradine. Clinicians should be
      aware of the Pfizer-BioNTech COVID-19 vaccine being implicated with the onset of POTS.
    note: 'Found by winnow, kev and lev in p001, p004, p010. Claude judged: partial.'
  - paper: pmid36718484
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: We also found three case reports of POTS after COVID-19 vaccination. Although causality between POTS
      and vaccines cannot be inferred from these cases, some vaccines are associated with various autoimmune neurological
      diseases such as Guillain-Barre syndrome or multiple sclerosis [37].
    note: 'Found by winnow, kev and lev in p008, p013. Claude judged: partial.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: partial
    section: Patient 3
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p004, p005, p006. Claude judged: partial.'
  - paper: pmid35611338
    cited: true
    text: full
    license: none
    verdict: partial
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35611338. Found by winnow, kev and lev in p005. Claude judged: partial.'
  - paper: pmid29876157
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: According to Tomljenovic et al.'s case study in 2014, a young school girl presented with flu-like symptoms,
      such as a sore throat, low-grade fever, fatigue, swollen glands, and intense headaches two months after her
      human papilloma vaccine (HPV) injection. Her symptoms related to orthostatic intolerance worsened over time
      so much so that she had to go to school in a wheelchair due to chronic fatigue.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid26425598
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > POTS, CFS, and the ASIA Syndrome
    quote: In conclusion, herein we described a case of disabling CFS/POTS secondary to qHPV Gardasil vaccination
      with symptom onset at 2 months following the second vaccine booster.
    note: 'Found by winnow, kev and lev in p001, p008, p018. Claude judged: partial.'
  - paper: pmid25882168
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25882168. Found by winnow, kev and lev in p002, p001, p004. Claude judged: partial.'
- edge:
  - long_covid
  - trigger_of
  - pots
  papers: 22
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Newly diagnosed CAD following COVID-19 infection and vaccination
    quote: Following COVID-19 infection, 22 individuals were newly diagnosed with POTS, 12 with VVS, and 1 with
      delayed and 1 with transient OH, whereas in 39 cases presenting with new-onset OI the diagnostic workup excluded
      any CAD (i.e., OIw/oCAD). In most newly diagnosed CAD, the causal association with the passed COVID-19 infection
      was deemed probable (34 out of 36, 94%).
    note: 'Found by winnow, kev and lev in p022, p003, p036. Claude judged: supports.'
  - paper: pmid40734755
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Background
    quote: As one of the most typical phenotypes of cardiovascular autonomic dysfunction, postural orthostatic tachycardia
      syndrome (POTS) is commonly observed as a sequelae of coronavirus disease infection.
    note: 'Found by winnow, kev and lev in p001, p008, p010. Claude judged: supports.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Long COVID-19 triggers an extended inflammatory response, characterized by the continuous production
      of cytokines and other inflammatory mediators [61]. This prolonged state of inflammation can lead to systemic
      effects, including damage to the vascular endothelium [62] and dysregulation of the ANS [63], creating fertile
      ground for the development of conditions such as POTS.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid38673062
    cited: true
    text: full
    license: by
    verdict: supports
    section: 2. Pathophysiology > 2.2. Pathophysiology of Postural Orthostatic Tachycardia Syndrome > 2.2.4. COVID-19
      and POTS
    quote: Not only does contracting SARS-CoV-2 infection confer the possibility of developing long COVID and subsequent
      development of POTS, but recipients of the SARS-CoV-2 vaccine have also been shown to develop POTS at a higher
      rate.
    note: 'Found by winnow, kev and lev in p029, p027. Claude judged: supports.'
  - paper: pmid38173173
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Postural Orthostatic Tachycardia Syndrome
    quote: There is strong evidence that SARS-CoV-2 may trigger POTS in patients with prolonged COVID-19 syndrome.
    note: 'Found by winnow, kev and lev in p061. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: POTS and COVID-19 > Prevalence
    quote: Recently a case series study of 20 patients post-COVID-19 infection reports that almost a third of patients
      experience frequent autonomic symptoms like dizziness, syncope, and palpitations within 6–8 months of acute
      infection.16 Roughly 2–14% of survivors develop POTS, with another 9−61% who experience POTS-like symptoms
      within 6–8months.33
    note: 'Found by winnow, kev and lev in p020, p021. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: The number of people afflicted with this dysautonomia has increased dramatically in recent years due
      to the long-term effects of coronavirus disease (COVID-19); however, it is largely underdiagnosed.
    note: 'Found by winnow, kev and lev in p001, p008. Claude judged: supports.'
  - paper: pmid36590760
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: It is estimated that up to 3 million people in the United States may have had POTS before the pandemic
      but the prevalence is now significantly higher due to post-COVID POTS that may follow a SARS-CoV-2 infection
      as part of the post-acute sequelae of the virus.3
    note: 'Found by winnow, kev and lev in p002. Claude judged: supports.'
  - paper: pmid36575713
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36575713. Found by winnow, kev and lev in p003. Claude judged: supports.'
  - paper: pmid36530759
    cited: true
    text: full
    license: none
    verdict: supports
    section: The question
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36530759. Found by winnow, kev and lev in p001, p003, p005. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p010, p012, p026. Claude judged: supports.'
  - paper: pmid35056336
    cited: true
    text: full
    license: by
    verdict: supports
    section: 4. Discussion
    quote: In the present study, in the long-haul COVID-19 patients with POTS, the orthostatic intolerance/POTS
      complaints began early after the start of the viral infection symptoms (1–3 weeks), consistent with other
      published case reports [5,7,9,56].
    note: 'Found by winnow, kev and lev in p001, p028. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: In response, one author analysed how COVID-19 may mechanistically give rise to PTS.7 In this case series,
      we detail the clinical characteristics and treatment response of seven consecutive highly active young patients
      who developed PTS following infection with COVID-19.
    note: 'Found by winnow, kev and lev in p004, p002, p005. Claude judged: supports.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: supports
    section: Body
    quote: In addition, there are case reports of individuals developing symptoms of and fulfilling the diagnostic
      criteria for POTS 6 to 8 months following recovery from COVID-19 infection.13 It has been suggested that the
      risk of developing POTS post-COVID-19 is higher in those with a preexisting, underlying autoimmune and/or
      inflammatory process or in those with a history of concussion.12
    note: 'Found by winnow, kev and lev in p007. Claude judged: supports.'
  - paper: pmid34053992
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: We herein report a 25-year-old woman who developed new-onset postural orthostatic tachycardia syndrome
      (POTS) following COVID-19 infection without pneumonia.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid33786700
    cited: true
    text: full
    license: none
    verdict: supports
    section: Abstract > Conclusions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33786700. Found by winnow, kev and lev in p001, p004, p006. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Autonomic dysfunction presenting as POTS can be a delayed manifestation of COVID-19 infection.
    note: 'Found by winnow, kev and lev in p001, p011, p013. Claude judged: supports.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p002, p009, p010. Claude judged: supports.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. COVID-19-Related POTS > 2.2. Presumed Mechanism for COVID-19-Related POTS > 2.2.3. Direct Viral
      Infection
    quote: The COVID-19 virus can directly cause POTS symptoms (Figure 2).
    note: 'Found by winnow, kev and lev in p015. Claude judged: partial.'
  - paper: pmid37391116
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Discussion > Central Illustration > COVID-19: a Trigger for Dysautonomia?'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 37391116. Found by winnow, kev and lev in p025, p029. Claude judged: partial.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: Because an increasing number of patients who recovered from COVID-19 are now reporting POTS-like symptoms
      including brain fog, tachycardia and severe chronic fatigue, some experts believe coronavirus may be a trigger
      for POTS.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - long_covid
  - trigger_of
  - postinfectious_evidence
  papers: 11
  evidence:
  - paper: pmid41275041
    cited: true
    text: full
    license: by
    verdict: supports
    section: Results > Newly diagnosed CAD following COVID-19 infection and vaccination
    quote: Following COVID-19 infection, 22 individuals were newly diagnosed with POTS, 12 with VVS, and 1 with
      delayed and 1 with transient OH, whereas in 39 cases presenting with new-onset OI the diagnostic workup excluded
      any CAD (i.e., OIw/oCAD). In most newly diagnosed CAD, the causal association with the passed COVID-19 infection
      was deemed probable (34 out of 36, 94%).
    note: 'Found by winnow, kev and lev in p003, p022, p036. Claude judged: supports.'
  - paper: pmid39775762
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 39775762. Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case presentation
    quote: A 39-year-old male with no significant past medical history presented with a 12-month history of sinus
      tachycardia and chest palpitations, which the patient reported started after infection with COVID-19.
    note: 'Found by winnow, kev and lev in p001, p008. Claude judged: supports.'
  - paper: pmid35853576
    cited: true
    text: full
    license: none
    verdict: supports
    section: 'POTS: Prevalence, clinical presentation, and pathophysiology'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35853576. Found by winnow, kev and lev in p010, p012, p026. Claude judged: supports.'
  - paper: pmid34993394
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Introduction
    quote: In response, one author analysed how COVID-19 may mechanistically give rise to PTS.7 In this case series,
      we detail the clinical characteristics and treatment response of seven consecutive highly active young patients
      who developed PTS following infection with COVID-19.
    note: 'Found by winnow, kev and lev in p004, p002, p006. Claude judged: supports.'
  - paper: pmid34053992
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: Body
    quote: We herein report a 25-year-old woman who developed new-onset postural orthostatic tachycardia syndrome
      (POTS) following COVID-19 infection without pneumonia. Three weeks after being diagnosed with COVID-19, she
      began experiencing fatigue, feeing unwell, intermittent palpitation, dyspnea and chest pain, especially while
      getting up from the sitting position.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
  - paper: pmid33786700
    cited: true
    text: full
    license: none
    verdict: supports
    section: Introduction
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 33786700. Found by winnow, kev and lev in p004, p006, p014. Claude judged: supports.'
  - paper: pmid33262898
    cited: true
    text: full
    license: by
    verdict: supports
    section: Conclusion
    quote: Autonomic dysfunction presenting as POTS can be a delayed manifestation of COVID-19 infection.
    note: 'Found by winnow, kev and lev in p001, p013. Claude judged: supports.'
  - paper: pmid32880754
    cited: true
    text: full
    license: none
    verdict: supports
    section: Body
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32880754. Found by winnow, kev and lev in p009, p010. Claude judged: supports.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports
    quote: Contemporary literature indicates potential links between viral infections and vaccines (particularly
      HPV) with the development of POTS.14,35,36 The earliest reports of a POTS-like syndrome in the aftermath of
      COVID-19 infection emerged in March 2020.37
    note: 'Found by winnow, kev and lev in p020, p021. Claude judged: partial.'
  - paper: pmid35470419
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Body
    quote: A range of diseases, including viral or bacterial infections, can cause POTS. Because an increasing number
      of patients who recovered from COVID-19 are now reporting POTS-like symptoms including brain fog, tachycardia
      and severe chronic fatigue, some experts believe coronavirus may be a trigger for POTS.
    note: 'Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - surgery_onset
  - trigger_of
  - pots
  papers: 5
  evidence:
  - paper: pmid41561794
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: A 39-year-old woman developed debilitating systemic symptoms following the placement of a synthetic mid-urethral
      sling for stress urinary incontinence. Previously in good health, she experienced sepsis and adrenal crisis
      immediately postoperatively, followed by persistent symptoms including fatigue, postural orthostatic tachycardia
      syndrome (POTS), neuropathic pain, cognitive dysfunction, autonomic instability, and recurrent infections.
    note: 'Found by winnow, kev and lev in p001, p015. Claude judged: supports.'
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: supports
    section: 1. Introduction
    quote: In some individuals, POTS may also emerge following significant physical or emotional stress, surgery,
      or pregnancy, indicating a potential link to bodily stressors and changes [8].
    note: 'Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid33623665
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: DISCUSSION
    quote: There has only been one case report in the literature reporting the development of POTS following thoracic
      surgery, involving a repair of an aortic coarctation [6]. Similarly, identified potential risk factors included
      surgery, prolonged bed rest, and use of antihypertensives that worsen orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p010, p001, p007. Claude judged: supports.'
  - paper: pmid22889291
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract > Conclusion
    quote: This is the first reported case describing the occurrence of postural tachycardia syndrome after the
      surgical correction of an aortic coarctation.
    note: 'Found by winnow, kev and lev in p003, p001, p002. Claude judged: supports.'
  - paper: pmid39355826
    cited: true
    text: full
    license: by
    verdict: partial
    section: Conclusion
    quote: POTS may occur after ablation in the AV junction. The mechanism is unknown and possibly related to the
      modulation of the ICNS from the radiofrequency energy application.
    note: 'Found by winnow, kev and lev in p008, p017. Claude judged: partial.'
- edge:
  - physical_trauma_onset
  - trigger_of
  - pots
  papers: 4
  evidence:
  - paper: pmid35647216
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Background
    quote: Moreover, concussion was found to be the second most common trigger preceding POTS onset in a group of
      708 patients at a pediatric autonomic disorders clinic, second only to infection among the triggers assessed.
    note: 'Found by winnow, kev and lev in p004. Claude judged: supports.'
  - paper: pmid29864098
    cited: true
    text: full
    license: by-nc-nd
    verdict: supports
    section: OVERVIEW OF POTS
    quote: In a retrospective study of 722 patients with POTS enrolled in a pediatric patient database, 11.4% of
      patients identified a temporal link to a concussive event precipitating their POTS symptoms.32
    note: 'Found by winnow, kev and lev in p003, p012. Claude judged: supports.'
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Typical Presentations of POTS > Triggering Conditions
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p035. Claude judged: supports.'
  - paper: pmid20865679
    cited: true
    text: abstract
    license: none
    verdict: supports
    section: Abstract > Results
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 20865679. Found by winnow, kev and lev in p003. Claude judged: supports.'
- edge:
  - post_vaccination_onset
  - trigger_of
  - autoimmune_evidence
  papers: 3
  evidence:
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: supports
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p004, p006, p012. Claude judged: supports.'
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: This spike protein acts as an intracellular antigen, which in turn stimulates the immune system to form
      neutralizing antibodies that will block viral entry into host cells [18]. It is our speculation that the formation
      of antibodies triggers an autoimmune response that stimulates POTS disease, like it does in the patient in
      this case.
    note: 'Found by winnow, kev and lev in p008, p001, p011. Claude judged: partial.'
  - paper: pmid26425598
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion > POTS, CFS, and the ASIA Syndrome
    quote: In conclusion, herein we described a case of disabling CFS/POTS secondary to qHPV Gardasil vaccination
      with symptom onset at 2 months following the second vaccine booster. With the concurrent detection of elevated
      ANA, lupus anticoagulant, antiphospholipid, and subsequent diagnosis of Raynaud’s, this case fully meets the
      criteria for the recently identified ASIA syndrome (Table 2).
    note: 'Found by winnow, kev and lev in p001, p018, p008. Claude judged: partial.'
- edge:
  - autoimmune_evidence
  - trigger_of
  - pots
  papers: 2
  evidence:
  - paper: pmid33968543
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: Postural orthostatic tachycardia syndrome (POTS) is an impaction of the autonomic nervous system initiating
      orthostatic tachycardia. There are numerous triggers for POTS including viruses, vaccines, and an autoimmune
      basis.
    note: 'Found by winnow, kev and lev in p001, p008, p011. Claude judged: supports.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: 'Abstract > RESULTS:'
    quote: Whilst the exact pathogenetic mechanism behind POTS is yet to elucidated, there has been increasing evidence
      pointing towards an autoimmune dysfunction.
    note: 'Found by winnow, kev and lev in p004, p019. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - trigger_of
  - pots
  papers: 2
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Exercise Physiology, Deconditioning, and POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051, p059. Claude judged: supports.'
  - paper: pmid33623665
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: DISCUSSION
    quote: There has only been one case report in the literature reporting the development of POTS following thoracic
      surgery, involving a repair of an aortic coarctation [6]. Similarly, identified potential risk factors included
      surgery, prolonged bed rest, and use of antihypertensives that worsen orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p010. Claude judged: partial.'
- edge:
  - long_covid
  - trigger_of
  - autoimmune_evidence
  papers: 1
  evidence:
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Moreover, the immune response to COVID-19 can lead to autoimmunity, where the body produces antibodies
      that mistakenly target the autonomic nervous system [60].
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
- edge:
  - surgery_onset
  - trigger_of
  - autoimmune_evidence
  papers: 1
  evidence:
  - paper: pmid41561794
    cited: true
    text: full
    license: by
    verdict: supports
    section: Case Presentation
    quote: Given the timeline of symptom onset immediately after surgery, concerns were raised about the potential
      for an autoimmune syndrome triggered by the synthetic mesh of the urethral sling.
    note: 'Found by winnow, kev and lev in p001, p004. Claude judged: supports.'
- edge:
  - post_vaccination_onset
  - trigger_of
  - hyperadrenergic_evidence
  papers: 1
  evidence:
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: partial
    section: Patient 3
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p005, p007. Claude judged: partial.'
- edge:
  - long_covid
  - trigger_of
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid39200375
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. POTS Etiology and Its Complexity
    quote: Simultaneously, long COVID-19 can cause hypovolemia through various pathways, including decreased intake
      due to illness or direct viral effects on gastrointestinal systems leading to losses through diarrhea [64].
      The resultant decrease in blood volume challenges the body’s ability to maintain adequate blood circulation,
      especially upon standing, which can trigger or exacerbate POTS symptoms.
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
- edge:
  - prolonged_bed_rest
  - trigger_of
  - hypovolemic_evidence
  papers: 1
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051. Claude judged: supports.'
- edge:
  - deconditioning_evidence
  - trigger_of
  - pots
  papers: 1
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Cardiovascular Pathophysiology of POTS > Bedrest Causes POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p051. Claude judged: supports.'
- edge:
  - hormonal_transition_onset
  - trigger_of
  - pots
  papers: 1
  evidence:
  - paper: pmid36908200
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Results: > Initial POTS onset during pregnancy:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36908200. Found by winnow, kev and lev in p030, p032. Claude judged: partial.'
- edge:
  - hypermobility_heds
  - trigger_of
  - pots
  papers: 1
  evidence:
  - paper: pmid40729147
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: Additionally, a strong association between POTS and Ehlers–Danlos Syndrome Type III (EDS) exists. Eighty
      (80) percent of patients with EDS have POTS.
    note: 'Found by winnow, kev and lev in p001, p006. Claude judged: partial.'
- edge:
  - mast_cell_activation
  - trigger_of
  - pots
  papers: 1
  evidence:
  - paper: pmid35062788
    cited: true
    text: full
    license: by
    verdict: partial
    section: 1. Introduction
    quote: We therefore hypothesize that in at least some patients who have suffered the onset of POTS following
      HPV vaccination, vaccination-induced worsening/escalation of previously unrecognized MCAS may be a key driver
      of PHPPV POTS—therefore the recognition and control of MCAS prior to vaccination might reduce AE risk.
    note: 'Found by winnow, kev and lev in p021, p007. Claude judged: partial.'
- edge:
  - systemic_autoimmune_disease
  - trigger_of
  - pots
  papers: 1
  evidence:
  - paper: pmid39678714
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction
    quote: However, potential triggers include hereditary factors, underlying conditions such as diabetes, amyloidosis,
      sarcoidosis, cancer, or after a viral illness, traumatic event, pregnancy, or may be associated with autoimmune
      disorders such as lupus, Sjogren syndrome, and celiac disease.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
- edge:
  - differential_syncope_oh
  - differential_diagnosis_of
  - pots
  papers: 19
  evidence:
  - paper: pmid41767063
    cited: true
    text: full
    license: by
    verdict: partial
    section: Differential Diagnosis
    quote: Differential diagnoses included OH, VVS, inappropriate sinus tachycardia (IST), psychogenic pseudosyncope
      (PPS), epilepsy, acute cerebrovascular disease, and primary cardiac disease. Although BP dropped during positional
      changes, syncope was not due to OH.
    note: 'Found by winnow, kev and lev in p014, p016. Claude judged: partial.'
  - paper: pmid39741599
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: Given the complexity of the ANS and the potential for overlapping symptoms with other conditions, careful
      differentiation between POTS, other forms of OI, and other potential causes of dizziness and syncope is essential.
    note: 'Found by winnow, kev and lev in p036. Claude judged: partial.'
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: partial
    section: 3. Diagnosis of COVID-19-Related POTS
    quote: Typical differential diagnoses include vasovagal syncope, orthostatic hypotension, dehydration, syncope,
      inappropriate sinus tachycardia, chromaffinoma, anxiety, depression, and unrecognized drug-related side effects
      [30].
    note: 'Found by winnow, kev and lev in p018, p020. Claude judged: partial.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: But in our patient, there was no fall in SBP or DBP, and HR increased by 35-40 bpm on head-up tilt. So
      OH was ruled out.
    note: 'Found by winnow, kev and lev in p007, p023. Claude judged: partial.'
  - paper: pmid37248893
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: COVID-19 vaccination induced autoimmunity
    quote: Consider the difficulty faced by clinicians in distinguishing POTS from postural vasovagal syncope, a
      transient loss of consciousness caused by reduced cerebral blood flow.
    note: 'Found by winnow, kev and lev in p019. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Introduction > Definition of POTS
    quote: This must occur in the absence of orthostatic hypotension and without a clear alternative etiology.
    note: 'Found by winnow, kev and lev in p006, p008, p024. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Orthostatic hypotension is already an exclusion criterion for the diagnosis of POTS.
    note: 'Found by winnow, kev and lev in p045, p039, p044. Claude judged: partial.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: If findings are negative, a complete cardiological and neurological evaluation should be performed to
      rule out other causes of tachycardia, such as viral myocarditis and reflex syncope. Lastly, a tilt table test
      should be performed to rule out orthostatic hypotension before making the diagnosis of POTS.
    note: 'Found by winnow, kev and lev in p016. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Pediatric Considerations > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p188, p192, p042. Claude judged: partial.'
  - paper: pmid35818599
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: Differential Diagnosis
    quote: However, elevation of epinephrine and norepinephrine is atypical of POTS, as is the presence of orthostatic
      hypotension, which excludes the diagnosis of POTS.
    note: 'Found by winnow, kev and lev in p005, p003. Claude judged: partial.'
  - paper: pmid35742222
    cited: true
    text: full
    license: by
    verdict: partial
    section: Abstract
    quote: The clinical characteristics of postural tachycardia syndrome and vasovagal syncope are similar but their
      treatments differ. Therefore, their differential diagnosis is important to guide the correct treatment.
    note: 'Found by winnow, kev and lev in p005, p001, p002. Claude judged: partial.'
  - paper: pmid35720084
    cited: true
    text: full
    license: by
    verdict: partial
    section: The Role of Dysautonomia in the Clinical Course of COVID-19 > Dysautonomia in Post-COVID-19 Condition
      > Orthostatic Intolerance Syndromes > Postural Orthostatic Tachycardia Syndrome (POTS)
    quote: There may be an overlap between POTS and other disorders, in particular, orthostatic hypotension, vasovagal
      syncope, panic disorders, psychogenic pseudosyncope, chronic fatigue syndrome, Ehlers–Danlos syndrome, mast
      cell activation disorder and cardiac arrhythmias and should be considered in complex cases (71, 75).
    note: 'Found by winnow, kev and lev in p065, p068. Claude judged: partial.'
  - paper: pmid35372154
    cited: true
    text: full
    license: by
    verdict: partial
    section: Introduction
    quote: Therefore, differentiating VVS from POTS is very important in clinical practice (4, 6). Currently, the
      differential diagnosis between these two diseases is mainly based on the clinical features and haemodynamic
      responses during the head-up tilt test (HUTT) (2, 7).
    note: 'Found by winnow, kev and lev in p001, p005, p007. Claude judged: partial.'
  - paper: pmid35288409
    cited: true
    text: full
    license: by-nc-nd
    verdict: partial
    section: What other disorders can cause orthostatic intolerance?
    quote: Patients with orthostatic hypotension of 20 mm Hg or greater may have symptoms of orthostatic intolerance
      and may also have orthostatic tachycardia, but the presence of orthostatic hypotension precludes a diagnosis
      of POTS.6
    note: 'Found by winnow, kev and lev in p012, p013, p008. Claude judged: partial.'
  - paper: pmid34928881
    cited: true
    text: full
    license: by
    verdict: partial
    section: Body
    quote: The Canadian Cardiovascular Society (CCS) position statement on POTS further delineates that while sustained
      orthostatic hypotension within 3 minutes of standing precludes a diagnosis of POTS, transient initial orthostatic
      hypotension lasting less than a minute may occur in some patients with POTS.7
    note: 'Found by winnow, kev and lev in p005, p023. Claude judged: partial.'
  - paper: pmid33150760
    cited: true
    text: full
    license: by
    verdict: partial
    section: Discussion
    quote: After performing tilt table testing on a group of suspected POTS patients in this study, ten were found
      to have orthostatic hypotension and nine had syncope. In patients with orthostatic symptoms, tilt table testing
      is the preferred tool for differentiating between these types of orthostatic intolerance.
    note: 'Found by winnow, kev and lev in p027, p022. Claude judged: partial.'
  - paper: pmid32222376
    cited: true
    text: full
    license: none
    verdict: partial
    section: POTS background
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 32222376. Found by winnow, kev and lev in p010, p028, p026. Claude judged: partial.'
  - paper: pmid27525257
    cited: true
    text: full
    license: by
    verdict: partial
    section: 2. Methods > 2.2. Autonomic Cardiovascular Testing > 2.2.2. Postural Tachycardia Syndrome (POTS)
    quote: POTS is defined by the presence of orthostatic symptoms associated with an increment of heart rate by
      ≥30 BPM held for more than 30 seconds when changing position from supine to upright in the absence of orthostatic
      hypotension [7].
    note: 'Found by winnow, kev and lev in p017, p010, p045. Claude judged: partial.'
  - paper: pmid21977261
    cited: true
    text: full
    license: none
    verdict: partial
    section: DISCUSSION
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 21977261. Found by winnow, kev and lev in p017, p013, p019. Claude judged: partial.'
- edge:
  - secondary_sinus_tachycardia
  - differential_diagnosis_of
  - pots
  papers: 13
  evidence:
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Diagnosis of COVID-19-Related POTS
    quote: Because symptoms associated with orthostatic tachycardia can occur in several diseases other than COVID-19-related
      POTS, other possible causes of orthostatic tachycardia should be excluded [31]. Blood laboratory examinations
      such as blood cell count, comprehensive metabolic panel, and thyroid function test can exclude non-cardiac
      causes of tachycardia such as hyperthyroidism and hypothyroidism.
    note: 'Found by winnow, kev and lev in p018, p019, p020. Claude judged: supports.'
  - paper: pmid37654428
    cited: true
    text: full
    license: by
    verdict: supports
    section: 6. Diagnosis
    quote: In the differential diagnosis of POTS, it is important to exclude other causes of sinus tachycardia such
      as dehydration, hyperthyroidism, other viral infections, pulmonary embolism, cardiac disease, anxiety, anemia,
      metabolic disorders, deconditioning, or chronic fatigue syndrome (82).
    note: 'Found by winnow, kev and lev in p021, p022. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: After ruling out the common causes of tachycardia and syncope, a diagnosis of POTS was established.
    note: 'Found by winnow, kev and lev in p001, p012, p013. Claude judged: supports.'
  - paper: pmid37261636
    cited: true
    text: full
    license: by
    verdict: supports
    section: Methods > Patients and study design
    quote: Other causes of tachycardia, such as hypovolemia, cardiac diseases, hyperthyroidism, acute illness, severe
      deconditioning, infections or use of cardioactive drugs [20, 21] were excluded during the clinical examination
      process.
    note: 'Found by winnow, kev and lev in p009. Claude judged: supports.'
  - paper: pmid36938206
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: If findings are negative, a complete cardiological and neurological evaluation should be performed to
      rule out other causes of tachycardia, such as viral myocarditis and reflex syncope. Lastly, a tilt table test
      should be performed to rule out orthostatic hypotension before making the diagnosis of POTS.
    note: 'Found by winnow, kev and lev in p016. Claude judged: supports.'
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 3. Diagnosis > 3.1 Diagnostic Criteria
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p004, p011. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Clinical Presentation of Postural Tachycardia Syndrome (POTS) > Diagnostic Criteria & Common Clinical
      Features
    quote: The syndrome must occur in the absence of prolonged bed rest, medications that impair autonomic regulation
      (such as vasodilators, diuretics, antidepressants or anxiolytic agents), or any other chronic debilitating
      disorders that might cause tachycardia (such as dehydration, anemia or hyperthyroidism).
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
  - paper: pmid40271232
    cited: true
    text: full
    license: by
    verdict: partial
    section: Materials and methods
    quote: Patients could be included in our study only if they were seen by a neurologist at our institution, had
      a diagnosis of POTS, were between the ages of 18 and 50, had a positive tilt table test without orthostatic
      hypotension, had POTS symptoms for at least six months, and had a workup ruling out other causes of sinus
      tachycardia.
    note: 'Found by winnow, kev and lev in p012. Claude judged: partial.'
  - paper: pmid37204997
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Review of Clinical Reports > Diagnosis
    quote: Important differentials include, dehydration with associated orthostasis, neural-reflex syncope, inappropriate
      sinus tachycardia, phaeochromocytoma, psychiatric conditions, and often under-recognized medication related
      side effects.31
    note: 'Found by winnow, kev and lev in p024, p027. Claude judged: partial.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: partial
    section: Review
    quote: Patients with dehydration usually present with an elevated heart rate, which could give a false-positive
      diagnosis of POTS. Therefore, we should avoid diagnosing POTS in patients with an acute or chronic diagnosis
      of dehydration, such as polyuria, vomiting, dehydration, etc.
    note: 'Found by winnow, kev and lev in p045, p046, p047. Claude judged: partial.'
  - paper: pmid36074973
    cited: true
    text: full
    license: none
    verdict: partial
    section: 'Selected Etiology: Post-COVID-19 > Main Points:'
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 36074973. Found by winnow, kev and lev in p042, p108, p188. Claude judged: partial.'
  - paper: pmid35870086
    cited: true
    text: full
    license: none
    verdict: partial
    section: Discussion
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 35870086. Found by winnow, kev and lev in p009. Claude judged: partial.'
  - paper: pmid30838497
    cited: true
    text: full
    license: none
    verdict: partial
    section: Head-up tilt in the diagnostic evaluation of orthostatic intolerance
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30838497. Found by winnow, kev and lev in p063. Claude judged: partial.'
- edge:
  - arrhythmia_differential
  - differential_diagnosis_of
  - pots
  papers: 3
  evidence:
  - paper: pmid29523389
    cited: true
    text: full
    license: none
    verdict: supports
    section: 3. Diagnosis > 3.1 Diagnostic Criteria
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 29523389. Found by winnow, kev and lev in p004, p011. Claude judged: supports.'
  - paper: pmid37519618
    cited: true
    text: full
    license: by
    verdict: partial
    section: Case presentation
    quote: The differential diagnosis, in this case, was OH, vasovagal syncope (VVS), inappropriate sinus tachycardia
      (IST), neurally mediated syncope (NMS), and POTS.
    note: 'Found by winnow, kev and lev in p007, p001. Claude judged: partial.'
  - paper: pmid23270259
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 23270259. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - medication_induced_tachycardia
  - differential_diagnosis_of
  - pots
  papers: 3
  evidence:
  - paper: pmid39202605
    cited: true
    text: full
    license: by
    verdict: supports
    section: 3. Diagnosis of COVID-19-Related POTS > Differential Diagnosis
    quote: Certain drugs can trigger tachycardia, which may complicate the diagnosis of COVID-19-related POTS [52].
    note: 'Found by winnow, kev and lev in p020. Claude judged: supports.'
  - paper: pmid37009342
    cited: true
    text: full
    license: by
    verdict: supports
    section: Review
    quote: 'Medication-induced tachycardia: Several medications can induce tachycardia and lead to the misdiagnosis
      of POTS.'
    note: 'Found by winnow, kev and lev in p046, p037. Claude judged: supports.'
  - paper: pmid30838497
    cited: true
    text: full
    license: none
    verdict: supports
    section: Head-up tilt in the diagnostic evaluation of orthostatic intolerance
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 30838497. Found by winnow, kev and lev in p063. Claude judged: supports.'
- edge:
  - anxiety_depression
  - differential_diagnosis_of
  - pots
  papers: 2
  evidence:
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: partial
    section: Body
    quote: Diagnosis of POTS is often delayed due to a clinical presentation that includes a constellation of non-specific
      symptoms. These symptoms overlap with various other conditions, including anxiety and depression.
    note: 'Found by winnow, kev and lev in p007. Claude judged: partial.'
  - paper: pmid25156902
    cited: true
    text: abstract
    license: none
    verdict: partial
    section: Abstract > Literature Review
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 25156902. Found by winnow, kev and lev in p003. Claude judged: partial.'
- edge:
  - prolonged_bed_rest
  - differential_diagnosis_of
  - pots
  papers: 2
  evidence:
  - paper: pmid34144933
    cited: true
    text: full
    license: none
    verdict: supports
    section: Potential pathophysiological mechanisms
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 34144933. Found by winnow, kev and lev in p015, p007. Claude judged: supports.'
  - paper: pmid16943900
    cited: true
    text: full
    license: by
    verdict: supports
    section: Clinical Presentation of Postural Tachycardia Syndrome (POTS) > Diagnostic Criteria & Common Clinical
      Features
    quote: The syndrome must occur in the absence of prolonged bed rest, medications that impair autonomic regulation
      (such as vasodilators, diuretics, antidepressants or anxiolytic agents), or any other chronic debilitating
      disorders that might cause tachycardia (such as dehydration, anemia or hyperthyroidism).
    note: 'Found by winnow, kev and lev in p005. Claude judged: supports.'
- edge:
  - iron_deficiency
  - differential_diagnosis_of
  - pots
  papers: 1
  evidence:
  - paper: pmid39559520
    cited: true
    text: full
    license: by-nc
    verdict: supports
    section: Body
    quote: Diagnosis of POTS requires ruling out of other conditions with similar presentations, including thyroid
      disorders, adrenal gland disorders, anemia, iron deficiency, and electrolyte abnormalities, among many others.[6]
    note: 'Found by winnow, kev and lev in p008, p038. Claude judged: supports.'
- edge:
  - systemic_autoimmune_disease
  - differential_diagnosis_of
  - pots
  papers: 1
  evidence:
  - paper: pmid24819031
    cited: true
    text: full
    license: none
    verdict: supports
    section: POTS > Diagnostic Evaluation of Possible POTS
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 24819031. Found by winnow, kev and lev in p074. Claude judged: supports.'
- edge:
  - plasma_blood_volume_assay
  - measures
  - intravascular_volume
  papers: 1
  evidence:
  - paper: pmid39614968
    cited: true
    text: full
    license: by
    verdict: supports
    section: Introduction
    quote: Rebreathing small amounts of carbon monoxide (CO) offers a noninvasive, safe alternative to measure hemoglobin
      mass and blood volume.
    note: 'Found by winnow, kev and lev in p007, p038, p032. Claude judged: supports.'
- edge:
  - active_stand_test
  - measures
  - orthostatic_heart_rate_increment
  papers: 1
  evidence:
  - paper: pmid40003288
    cited: true
    text: full
    license: by
    verdict: supports
    section: Abstract
    quote: AYAs showed significant reduction in active stand test heart rate increase (p < 0.001; d = 1.07) and
      maximum heart rate (p = 0.002, d = 0.76) from admission to discharge.
    note: 'Found by winnow, kev and lev in p001. Claude judged: supports.'
- edge:
  - active_stand_test
  - part_of
  - autonomic_reflex_screen
  papers: 1
  evidence:
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p001, p011. Claude judged: partial.'
- edge:
  - valsalva_maneuver
  - part_of
  - autonomic_reflex_screen
  papers: 1
  evidence:
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p001. Claude judged: partial.'
- edge:
  - cerebral_blood_flow_measurement
  - part_of
  - orthostatic_challenge_testing
  papers: 1
  evidence:
  - paper: pmid26909037
    cited: true
    text: full
    license: by
    verdict: supports
    section: Discussion
    quote: To evaluate patients using the outlined classification, it is essential to monitor CBFv in addition to
      heart rate, blood pressure, and respiratory variables during the tilt test.
    note: 'Found by winnow, kev and lev in p013, p039. Claude judged: supports.'
- edge:
  - valsalva_maneuver
  - part_of
  - orthostatic_challenge_testing
  papers: 1
  evidence:
  - paper: pmid38937334
    cited: true
    text: full
    license: none
    verdict: partial
    section: Abstract
    quote: null
    note: 'Quote withheld on the public site: the text has no open (CC) licence (a PubMed abstract or a full text
      without one). See PubMed 38937334. Found by winnow, kev and lev in p001. Claude judged: partial.'
not_added:
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - autoimmune_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid24572257
  - pmid29102451
  - pmid31547749
  - pmid32743496
  - pmid33505857
  - pmid35118574
  - pmid35853576
  - pmid36873318
  - pmid40537187
- edge:
  - neuropathic_evidence
  - proposed_mechanism_of
  - autoimmune_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid29864098
  - pmid36349067
- edge:
  - neuropathic_evidence
  - proposed_mechanism_of
  - cerebral_hypoperfusion_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid22783324
- edge:
  - arrhythmia_differential
  - proposed_mechanism_of
  - hyperadrenergic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid42299168
- edge:
  - cerebral_hypoperfusion_evidence
  - proposed_mechanism_of
  - neuropathic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid22783324
  - pmid38390594
- edge:
  - gi_dysmotility
  - proposed_mechanism_of
  - neuropathic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid29549458
- edge:
  - hyperadrenergic_evidence
  - proposed_mechanism_of
  - neuropathic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid9868411
- edge:
  - hypovolemic_evidence
  - proposed_mechanism_of
  - postinfectious_evidence
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid34821709
- edge:
  - systemic_autoimmune_disease
  - proposed_mechanism_of
  - postinfectious_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid35288409
- edge:
  - active_stand_test
  - evidence_for
  - autoimmune_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid40537187
- edge:
  - genetic_testing
  - evidence_for
  - hyperadrenergic_evidence
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid11458707
- edge:
  - cardiac_mri
  - evidence_for
  - hypovolemic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid20579544
- edge:
  - cerebral_blood_flow_measurement
  - evidence_for
  - hypovolemic_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid39895557
- edge:
  - thermoregulatory_sweat_test
  - evidence_for
  - pots
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid36349067
- edge:
  - lifestyle_modification
  - indicates
  - cerebral_hypoperfusion_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid41301791
- edge:
  - lifestyle_modification
  - indicates
  - deconditioning_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid16943900
- edge:
  - auricular_vagus_nerve_stimulation
  - indicates
  - hyperadrenergic_evidence
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid37631004
- edge:
  - exercise_reconditioning
  - indicates
  - hypermobility_heds
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid36074973
- edge:
  - beta_blocker_therapy
  - indicates
  - long_covid
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid37209261
- edge:
  - exercise_reconditioning
  - indicates
  - postinfectious_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid29864098
- edge:
  - immunomodulatory_therapy
  - treats
  - anxiety_depression
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid38003876
- edge:
  - ivabradine_therapy
  - treats
  - mast_cell_activation
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid40627388
- edge:
  - cerebral_hypoperfusion_evidence
  - associated_with
  - differential_syncope_oh
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid35056406
- edge:
  - chronic_migraine
  - associated_with
  - hypermobility_heds
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid41924132
- edge:
  - hyperadrenergic_evidence
  - associated_with
  - physical_trauma_onset
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid29864098
- edge:
  - arrhythmia_differential
  - associated_with
  - postinfectious_evidence
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid40692561
- edge:
  - structural_cardiopulmonary_disease
  - associated_with
  - pots
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid29850268
- edge:
  - hypermobility_heds
  - associated_with
  - small_fiber_neuropathy_dx
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid41801611
  - pmid42399338
- edge:
  - differential_syncope_oh
  - associated_with
  - structural_cardiopulmonary_disease
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid29850268
- edge:
  - gi_dysmotility
  - associated_with
  - systemic_autoimmune_disease
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid41952073
- edge:
  - hypermobility_heds
  - associated_with
  - systemic_autoimmune_disease
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid36908200
  - pmid38673548
- edge:
  - postinfectious_evidence
  - associated_with
  - systemic_autoimmune_disease
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid34144933
- edge:
  - post_vaccination_onset
  - trigger_of
  - neuropathic_evidence
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid25990003
- edge:
  - gi_dysmotility
  - differential_diagnosis_of
  - pots
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid40856938
- edge:
  - hypermobility_heds
  - differential_diagnosis_of
  - pots
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid38176772
  - pmid41020219
- edge:
  - long_covid
  - differential_diagnosis_of
  - pots
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid39741599
- edge:
  - cerebral_blood_flow_measurement
  - part_of
  - autonomic_reflex_screen
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid27525257
- edge:
  - head_up_tilt_test
  - part_of
  - autonomic_reflex_screen
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid34604136
- edge:
  - plasma_catecholamine_assay
  - part_of
  - autonomic_reflex_screen
  reason: All three models found it, but Claude judged that the paragraphs do not state it.
  papers:
  - pmid33886735
- edge:
  - active_stand_test
  - part_of
  - orthostatic_challenge_testing
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid34055686
- edge:
  - head_up_tilt_test
  - part_of
  - orthostatic_challenge_testing
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid40276022
- edge:
  - plasma_catecholamine_assay
  - part_of
  - orthostatic_challenge_testing
  reason: Claude confirmed it, but only in papers where lev did not find it (winnow and Kev did).
  papers:
  - pmid33740206
